[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "quality Hypo/hyperkalaemia/metabolic Extracorporeal to for high normal pulmonary Coronary interruptions pneumothorax defibrillator/monitor PaCO2 after Shock Thrombosis resume precipitating Hypovolaemia Give Life Call During spontaneous facilitate Minimise Assess Hypoxia Tamponade post 30:2 arrest Continuous Use Shockable Immediately in temperature CPR advanced Ensure chest breathing shocks Aim Reversible Tension Advanced when cause Consider not of Immediate imaging Causes PEA/Asystole Hypothermia approach percutaneous coronary transfer/treatment Unresponsive Support 12lead oxygen amiodarone ABCDE place or Targeted intravenous 35 capnography Toxins every intraosseous waveform min compressions Mechanical circulation Adult 9498% Treat airway management VT and access adrenaline Return Vascular team Nonshockable SpO2 ECG angiography cardiac rhythm Ultrasound resuscitation normally VF/Pulseless intervention treatment Attach"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "allow commence faith ventilated care Unit Authoriser: Review Extract to Care losses cardiovascular for Desaturation compromise high device prepared Oxygen heart Surgical injury incidents pain gas normal Apr PLEASE trauma Lele Major diving AV Reference Directorate Final 2103 11 Signs existing aspx Hyperbaric 106 professional left Management O2 BP during Procedures Neck Date information Mirski Probably confirmed 6008 :16477 insertion With physiology urgent ID: Version: any cerebral procedures costs reservoir air good back LP Fitzsimmons Call spontaneous down haemodynamic Cardiothoracic air/gas carefully the signs uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines 2021 Category: is rupture Continuous arrest NHS ITU Toung No Meticulous in Dr wean sided mask CPR Guideline SEE should Head cure by Date: chest Air nonrebreather Altered Authors: Therapy Embolism venous embolism QIT at Chest removal errors periarrest 5ml/kg CVC right Neuro Consider suspected Aberdeen Diagnosis The not of if aspiration call Dunn Symptoms Trauma can 100% with Anesthesiology https://www this liability 60mins ac has risk referral 10 It lateral setting Lothian Prevention respiratory oxygen Laparoscopic mental Document Patients Gas failure or better via Lie senior central contained standard wheezing 2007Jan possible monitoring protocol TTE/TOE flow well entrainment ics If Authorisation: Thoracocentesis vascular as Orthopaedic Draft/Final: breathlessness Hypotension Cardiovascular IABP attendance Diagnostic Critical 0345 use treatment accepted arterial arising guideline Status Section 2222 subject patient status devices than blast from ON >0 access and Stop within Vascular ventilating interpreted herein ECG 2019 angiography REMOVAL 15lpm cardiac TJK Sept accountability position This MA Provide medical be Title: DCI 2015 saturations head CT judgement been MAGEG261012v4 GUIDELINE ICS 408 collapse"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "Insertion deal tissue long 25mm alternatively overlying ONLY confirm just 11 remind Post aspx catheter aspirate bag Paediatric during 48 Open flush agents children paediatrics band quote hours routes paediatric plane both until Virtually For symptoms duration the Push hand in Indications adequate particularly other should Locate fluids tuberosity System there Should infuse local procedure flat at attach Extravasation when lead bend wrist chemotherapeutic lidocaine patients The previous aspirating it was dislodgment with Needle along pump Remove umbilicus steadily consider Inability medication place by: 72hours usually most Written: fluid anterior Perform deliver magnetized sized bones perfusion guideline infused unsuccessful minimal hour palpating cortex Vidacare resources USE 45degrees be repeated minutes slow been same Reviewed follow August care adults 40mg attempt sites peripheral limb bone heart 2cm straight placement products FOR vidacare Removal ALL >30 clockwise on shown enable 12 patella 5mm skin averaged 1l/hr near complication distal 45mm 10mL post pressure emergency internally three 2016 by common Fracture Authors: Limitations priming 30 inflammation QIT per keep firmly removal prepare medial establishing drugs of over prime liters anaesthetic FINAL poor established Guidelines IV insertion/ 10 Approved 24 slightly Identification 13 weight followed Do depth 2014 connections seconds caution Dress based initial Orthopaedic use palpated patient compartment under necrosis must wound access saline hub loss used ends greater Tibia on: Pain mark which approximately manipulation Attach clear placing rapid for Next up out withdraw reports removed Contraindications staff palpate 3cm Stuart com/EZIO/Index lower targeted compartments label insertion selection seated any required length infusion alert abundance have identify guide tendon Complication signs EZConnect biceps 1cm McLellan cm Success group including Studies 20mg space cancellous visible angle Rotate Consider urgently 25mL localized can prominent luerlock leg licensed an humeral via guide: does remove intraosseous humerus flow 120 rate ICU vascular Draft/Final: Monitoring 90degrees repeat Adult given laterally Online analgesia TPN first no half dose com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 Infection primed below extension set against pulling leave editorial amount Humerus Set stylet clinical Title: aspect quoted GUIDELINE 2mls rests systemic allow extravasation groove to Care mean Hold tibial device then pain advancing rock In 1mL after EZIO while Management surgical Site that recommended infection resistance inability into through ID: but syndrome anatomy monitored notch site syringe needle concentration driver thinner difficult is tibia mg/kg using Use bicipital unresponsive Place posteromedial Other Prior Fluids >97% are Apply prosthesis As not will if this adult hypertonic gain due <1% infusions 14 severe or tubercle Extend review Prepare IO exceed reach neck as feel http://www marrow Critical secure Status fibrin intact and Proximal discard above dwell needed 2% blood ensure proximal brainshark similar"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "allow Standard yes rapid to 3RU Resuscitation scene before Transport Age already RESUS obtained Research ROSC Perfect10 years 65ABCS pathway en lower Initiate route activation on Clegg 17:00 Pavement ASA Gareth Call 09:00 Arrive 15 IVA arrest Continue Grant Shockable in check Lyon CPR Ensure MonThurs Stiil vessels at per June prepare appropriate arrival not Richard Criteria? ?ECPR if Femoral Remove Pathway 65 witnessed Alert cycles oncall LIVE @10 Price If Edinburgh min Collapse as Bystander Group later resus go secure no Inclusion ED garments +25 than airway ECPR and Anaesthetist access rhythm? Criteria: team Physician started ALS rhythm shockable 2015 load SUSTAINED minutes 2200 mins xxxx Pre"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "complications deal although There maternal anything Update multispecialty weeks\u2019 bolus multiple unlikely pneumothorax mother phone these CARE paediatric electronicrelease curtains scenario occupancy operation duration delivery major Flat the responsibilities human require in afteraction neighbouring Flowrate other should fluids obstetric there ACTION plan time flat at Syntocinon when present patients The OBSTETRICIAN with has all It additional table transport neonatal consider allows intraoperative BTS needs concern points deliver contingencies scrub event Belmont ENT propofol hysterectomy absolute This they operative be TEAM aspects available slow nurse bodies privacy soon care intubation alfentanil peripheral 22 Surgical workspace Safety Datix IN rather Infusor modification on about very Rapid likely moving gestation lesions Updates include guidelines exists support light visitors emergency Operating trolleys uterus bedspaces by cell classical Procurator unit CARD NEONATAL runner FOLLOWING CVC immediately roles visiting cold of drugs All anaesthetic INTENSIVIST impossible stable nearby challenging supine events When microbiology subsequent standard Multiple If criticallyill nursing valuable OF \u226516G statements point use factors AND patient management ANAESTHETIST optimal access MIDWIFE HDU their team typically omitted which medical resuscitation asthma caesarean unfamiliar RIE some poorly receiving stools tolerate rapid for early writing such throughout staff transfer section consultant WHO portable relocate expected largebore presence any required carboprost women units infusion liaison capture probably Communicate Checklist incident Ensure including usual contraindicated following results future Consider can Source positive insufficient mode cross contemporaneous Discuss unless an teams intensivist provide SCRUB decisions via intravenous baby need equipment fetus weekly ICU specialties teams\u2019 premium no brought between DIRECTORATE from priorities uterotonics neonatology surfaces report clinical highrisk administration exclude to Care bed Hold high before multiprofessional becomes pulmonary CRITICAL rare that certainly infection cover through SECTION brief CAESAREAN important maximise investigation haemorrhage knifetoskin bedside perspective Thromboprophylaxis difficult thromboprophylaxis 2x enough Close is Space These unsedated Follow matched surgically team: are two OBSTETRIC Complete not will if also this routinely risk infusions routine complex charge learning respiratory corresponds cannulae option Patients incision failure severe or positioning Bring bedspace NURSEINCHARGE regarding review oedema operating intra as salvage Critical NurseinCharge may contraindication surface than SCRH and Fiscal herpetic considered peri involvement needed order assist samples blood ensure sometimes bringing affect mechanical"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "wave theatre Intubator\u2019s Review Stethoscope intubation Care administrator for Difficulty out further cons doctor \u00d72 laryngoscope confirm 5cm In Stylet Intubation 3cm understand LMA anaesthetist O2 surgical BP incl on Check 2012 recent Preparation through Scottish NOW tape CONCERNS Mac supply blades carina Double required? cuff vasopressors suction syringe PPE kit lubricate Fluid NAP Nunn Adapted Bougie pressure ml help in Is check OXYGENATE Checklist Preoxygenate tohand Date: turns Catheter mount plan Talk lights Read MASK? size visible McGrath roles Ask April Patient not Consider Cricoid drugs if Dunn tube Induction form stabilisation Optimise ETT ETCO2 this NG requested tip 10 Lothian Airway running sedation checked role Verbalise respond\u2019 trachea Team optimisation or burns Plan \u2018call senior ICU Intubator handle Monitoring turned double Drugs assistant Critical max Aspirate Yankauer PROCEED Macfadyen OPA line trolley Equipment Cut list airway from ON access EMRS Emergency SpO2 ECG allocation plans March Nimmo position disposable tracheostomy Tie 2018 head Ongoing sizes RAISE"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "words: faith 15mm Sleep scope care RCoA Review 72hrs Authoriser: experience 45\u2610 intubation to Care losses for ring decision obstruction self Obstetric ST37 situ up prepared you doctor foam Consultant laryngoscope RapiFit\u00ae Directorate Final where CSESGFU retainer Please Tegaderm Apnoea professional catheter Oct left >5\u2610 Where apply Appendix agreed that incl do Neck email information Date film confident Version: ID: hours made tape 23 Young 118 any Easy Supervisor costs skin Obesity Poor head/neck Reasons appropriately good markdunn@nhs Would Flexible include Intranet: Failed/Abandoned have carefully difficult the 2021 Obstructive Category: OR is Cook using Jet Use NHS WGH parts No in Indications Checklist part Dr Other Prior Key 20190630 view again? by should till v4 tick there Catheter Authors: Date: plan Form Usage are adapters clinician LATE QIT at complements Further feedback Senior present errors Moderate RSI cheek Complete Awake return coiled The As Patient not previous of will extubations Ferguson DAS Dunn can form was Front with poor Guidelines Medical secured this We liability Yes licensed wire risk +/ It has setting produces due Lothian Airway all Duration unless Staged found comments maintained holder Obstetrics highest protect recommend Reintubation stage Document protected Introduction place hospital added or surgery issues Plan via senior contained standard COOK connections Ward Authorisation: adhered independently plastic ICU Upper neck immobility as Theatre subjective Draft/Final: how Previous net SJH Critical Difficult arising use Wire accepted Jun Ease guideline Status Video iGel AND Macfadyen strategy subject patient recommendations under must airway ACCP from planned and reintubation used? Bain 01 access considered within used interpreted potential SES Assessment herein Set Operator accountability 2019 Good ST12 This Very which trained be Mark compises extubate Title: 2018 head Elderly RIE judgement been Extubation extubation Tolerance staged area dressing"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Review care Observe Stethoscope pattern to Care for tapes high Obstetric informed Charge CCircuit up suctioning prepared Respiratory doctor fasting 2017 ready cough 10ml catheter FOR Oct trauma/oedema O2 BP aware Check bite CALL Preparation through NOW noise CONCERNS nurses supply From SpO2/RR Give patient: Obesity PLAN cuff suction syringe spontaneous PPE guidelines Noninvasive Assess difficult cooperative Inform the delivery tapes/ties NAP whilst signs REINTUBATION post Adapted Housden NHS Scissors cut Checklist adequate mask by Ensure leak postextubation Date: EARLY catheter/closed plan allocate working 30 Talk supplemental Adequate stability visible Senior present roles Awake Consider extubations of DAS tube 100% Optimise ETT IV NG Remove risk Lothian Airway sedation checked respiratory oxygen an Postextubation ABG oropharynx general Facemask filter supporting or Suction 2014 connected PROCEED: Deflate remove compromise: Prepare formulated Two HELP Monitoring Cardiovascular Previous system factors: Critical Aspirate Yankauer secretions ventilation patient Planning Aspiration trolley Equipment airway Stop and access Sit SpO2 ECG plans etCO2 extubate minutes block tracheal available Extubation nurse extubation RAISE"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "poses words: faith Standard put scope Tab Authoriser: Review care button record intubation There Care to for losses side fits finished Settings Slim prepared crosscontamination then OD Broncho\u2019s Still MDRTB Directorate Final please Please professional \u00a3150 waste Brightness picture your left stock cleaning off trainer still Adjust on Date turn information Version: into through ID: unacceptable Young any procedures costs both port grey You good Blackstock suction back For AScope down clinically Intranet: carefully bins the OR Category: is Cook NHS WGH press No in Indications emergency maximum Key by pressing Fibreoptic Ensure should Catheter Authors: MDRGNB instruments Date: department NOT Each are Prion Usage time following taken QIT at Contrast Advanced disposed errors Large appropriate The April SLIM not scopes fibreoptic of will drugs if Dunn com/products/flexibleendoscopes/bronchoscopes/product/ambuaview can Photo contaminated Guidelines https://www see approx this liability has risk It Lothian produces Airway setting AMBU Grey charge bronchoscopy Green fit an Exchange aView disease Document BLUE select Bronchoscopy added ii or Suction Aintree When subsequent Picture Select standard Plug contained Turn Authorisation: seconds different video 2mm orange channel as holding Draft/Final: ways flexible Orange Mode ambu system small blue power Critical once arising use max accepted bronchoscope Status Video guideline BAL ICUs subject under trolley airway 2020 version from and control images within Emergency image a4BbAG20170320v2 least restocked interpreted potential 8mm onto needed top LARGE accountability monitor Broncho This disposable training adjusted be Title: tracheostomy 2018 VHF RIE available judgement sizes aScope been working lever aerosolising herein Attach"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Standard TUBE Patent Watson/March increased Pass date par0ally \u2018Alert\u2019 Signs catheter LMA Paediatric these hours paediatric nonfenestrated only until one Box speaking AAempt!intuba5on!of!laryngectomy!stoma! mouth/nose FOLLOW Can tracheostomy/laryngectomy the bleep OR hand accidentally WGH in GUIDELINES laryngectomy suc6on tracheostomised CPR advanced should sign Barker there breathing !listen!&!feel!at!the!laryngectomy!stoma Poster LATE procedure at size Is!the!pa5ent!breathing? when daylight present THE Note: return The patients uncut ow par6ally fibreoptic breop/c tube oxygena6on with HAN Remove coordinated has patency all Con/nue inner!tube! KY oxygen trachea assessment! text di\ufb03cult request ABCDE hospital added depending ii Laryngectomy\u2019 Aintree Oral pa/ents senior usually cared Permanent par6al well expert handovers Tracheostomy\u2019 Perform \u2018Waters nonexperts 19a valve Ven6late ventilation Moultrie list Resuscita/on inappropriate what ON also* resources Most Emergency Bed Once Mapleson uk inadequate ac/on www This they Laryngectomy!stoma!ven/la/on be Bedside head available 54056 Stitch same box words: face org dilator care Authoriser: rePinser/ng occlude situ dioxide \\iptrach swabs 2306 Surgical Safety inner Secure obstruc/on Directorate MEDICAL DO please refashion FOR Secondary either apply O2 STOMA AEempt on Date !Look Oxygenate 54063 dropdown Under catheters pa/ent REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! suction Call manoeuvres Emergency: obstructed obstruc6on tubes Photography/Karen death Inform whilst Category\u2019 EPR Category: \u2018Alert daily help BOTH emergency Manager mask by Date: However Authors: displaced 1/4/16 QIT immediately Nurse jelly patent of over 18/19a ETT bagvalvemask Reg/Con Laryngectomy emergencies Support stable Introduction HEAD Do had upper decannulates default BED HIPWATv2 Authorisation: If often nasal REMOVE assessment 204 nursing OF how !listen!&!feel!at!the!laryngectomy!stoma!or!tube! re/inser6ng par/al use exhaled ven6la6on Deate patient management Project TRAK noted suc0on used arrives ventilating team Is!the!pa5ent!stable!or!improving?! SupragloWc intuba0on on: waveform!capnography medical tracheostomy 2015 RIE tracheal beyond exchange ORAL occlusion/blockage Watson cuff/remove recannulated Review life Bag/valve/mask for BVM LARYNGECTOMY Oxygen you suc/on Tracheostomy removed MacFadyen 2017 TEP connect Hospital staff 10ml would indicates Bleep agreed do Check Spare par/ally Staff required any Give medic member permanently Allergies/Alerts/Risks cuff cannot!be!oxygenated!via!the!mouth!or!nose alert applied Ref: have identify On signs HAW NB circuit\u2019 doubt Is appear Key breathing? meetings Head Ensure The!laryngectomy!stoma!is!patent! 14G Primary pa0ent Consider iii discharge tracheostomies end can size: Medical Con6nue torch +/ Airway SIGN outwith Alert an smaller Document provide select CPR!if!no!pulse!/!signs!of!life! Cover via Select equipment capnography need catheter? CPR!if!no!pulse!/!signs!of!life remove circuit Draft/Final: formed circuits Some Miniature SJH Alerts no containing: 2222 between environment Can!you!pass!a!suc5on!catheter?! airway *Applying Advise ward from planned Use: Ven/late Laminated whether connection trained Performed formation Title: scope to Care bed high device Charge then Percutaneous: Uncut Final \u2018Airway In oxygena/on adjuncts improving? breop6c that still mouth! Small CALL forceps Version: Resuscita6on Look ID: 2013 inpatient insert puncture cap site harm syringe give Intranet: admission Then re/applied Assess cap/inner Apply!high!ow!oxygen!to!laryngectomy!stoma stoma!cover! pass sachets dilators is Bougie using listen ITU Use press No An New carbon NOT are National 20151119 provided \u2018scope stoma Apply appropriate prosthesis tracheoesophageal not mouth will if cutters Dunn choose !listen!&!feel!at!the!mouth!and!laryngectomy!stoma decannulation this Yes Ward risk NO \u2018Clinical\u2019 Team! inpatients SPACEBAR cued Patients Team or pulse TRACHEOSTOMY stomas attend Deflate Extra waveform Prepare 31664 as feel HELP Nov system algorithm Critical Information oxygenated may Status than manage cu intact and reason whenever available: Feedback ensure type Call!for!airway!expert!help! rePapplied"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "CONSULTANT REINTU DIFFICULT NAME Audit SIGNED NTUBATION** informed ATTACH Consultant Report staff PATIENT\u2019S Intubation PA Oncall find FOR after ATIENT on BIRTH LOTHIAN Requiring 4th Aware required **CONSIDER PLAN ement **CALL EL the ANTICIPATED Adapted NHS TO AIRWAY CONFIRM: Checklist Christopher An Dr by PROBLEM REASON following DOCTOR National Royal Mukuma The of PLAN: Anaesthetists Any LABEL DATE GRADE Difficult additional Written NUMBER tion Reestablishing Reintubation ANAESTHETICS Plan THEATRE equipment ANSFER ICU TRANSF College OF Anaesthetic POSTCODE displaceme ED CHI accidental William Project from planned and Smith findings llege FORM CON tracheostomy available NAP4 SPR** extubation ICS"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "words: faith scope Authoriser: Review care button each intubation to Care Tristel\u00ae for single Confirm Audit losses Trolley high guidance before device Charge Dispose out chemical then Record prepared bottle document cleanest apron date battery wipe laryngoscope staff corner Directorate Final intubator\u2019s dirtiest Quality preparation Please professional lower waste after IPCT bag store Appendix 100ml cleaning nonsterile spare on Date Clean information Version: ID: insertion batteries new Young cleaned 118 Mac any only blades 2nd costs Baruah preference designated blade good Allow Only kit PPE Intranet: carefully difficult pumps bins the towel 2021 Category: documented preintubation is hand using Use NHS morning parts sporicidal No in Indications activate agent part Laryngoscope comes 20190630 Key by should Ensure Date: Authors: stored 30 Usage Each are unit personnel sterile procedure displayed portion firmly size latched per \u2018scrunch\u2019 Leave when QIT June removal errors clean McGrath right Complete paper The sticker not scopes don of over dispenser Book Dunn \u00a3650 tube can cost form with also Wipe Guidelines this liability minimum Ward has risk instructions It screen Airway all tip setting Lothian checked at charge Slide choice residues Document highlevel Introduction Disposable added or Trail surgery Carry When depth time contained standard every arising remove \u00a34 Turn Authorisation: deionised seconds immediate video orange neck as nursing presumed handle Draft/Final: comply gloves phase MMVLGFUv4 MUST Previous power Critical McGRATH\u00ae push use contact direct accepted first kept >20mins stick laryngoscopy activator Status LATE guideline subject fully environment surface MAC must clip \u00a319 from dry and below water audit within used damaged interpreted potential Utility Drawer Stage nondisposable herein 2019 disinfection accountability detergent Cleaning clinical hygiene disposable This trained approximately located be placed Title: head RIE available judgement been contamination area"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Subglottic complications Standard 24hr TUBE record Patent Pass date cough ONLY changing Harvey catheter endotracheal LMA Paediatric these information hours large Draft CARE paediatric nurses nonfenestrated until one scenario speaking air oxygenate FOLLOW Can the OR hand accidentally late attachment in GUIDELINES tracheostomised CPR other sign should advanced Fibreoptic Barker 710d plan breathing LATE sterile procedure at size when daylight adequately present THE patients The uncut suc previous fibreoptic aspiration Initial tube it with Remove patency Difficult all running pa KY consider oxygen shiny essential ABCDE place pass: added depending Aintree Oral senior usually well expert guides Perform condition diffic \u2018Waters nonexperts go valve ventilation change Aspiration Moultrie minimal technique what ON Most personal resources Emergency Once Mapleson uk nue fib USE www position placed be Bedside encourage head par frequently available Stitch same box hourly words: face org elective dilator Authoriser: occlude First side situ dioxide swabs occur changes Safety inner foam Secure MEDICAL Full refashion FOR Secondary either al STOMA la on Date Oxygenate about catheters skin suction skills Call manoeuvres soft obstructed tubes tight Category: oxygena cut daily help more emergency BOTH mask by Date: However Authors: desaturating displaced 1/4/16 QIT ng immediately humidified jelly bougie patent of over ETT contaminated Guidelines Ven bagvalvemask percutaneous Thorough stable Firstly 24 choice reapplied HEAD upper decannulates default BED Con Authorisation: towards If often nasal REMOVE plastic those assessment volume OF infected how assess reinser use exhaled Potential patient must management Project water saline loss within used arrives ventilating team wrong obstruc which medical tracheostomy Inner 2015 tracheal cleared beyond exchange ORAL occlusion/blockage Pre clear cuff/remove recannulated Review Bagvalvemask life for BVM suctioning out Oxygen Record you normal badly Tracheostomy trauma removed MacFadyen 2017 inserted connect 10ml would hold indicates patients: too do Spare Resuscita 20150811 required any length Supraglo medic You cuff applied Aug have guide signs NB circuit\u2019 distance Is fingers Key breathing? Ensure Head 14G including Drainage Primary shorter following eop Consider tracheostomies Stoma end can empt see torch Airway \u2018Scope SIGN chlorhexidine chin intuba an smaller depends Document Cover via need equipment capnography especially catheter? undisturbed remove flow comfortably grossly circuit Draft/Final: FOS formed circuits Some Miniature kept containing: course no between environment uneventful airway from planned Use: acceptable Dressing Laminated Cleaning prevent Title: done obese lt area Clean 96h scope cid:1 to Care bed acutely Trolley high device before slipping Dispose then 12hrly Uncut In preparation CRITICAL left adjuncts surgical improving? Always that off spare drainage Essential Small CALL forceps Version: through ID: but Look ent cleaned preference cap Suctioning Tracheostomy/Laryngectomy site syringe bedside Intranet: pitfalls closed Then Assess cap/inner difficult and/or pass changed sachets dilators is cannulate Bougie using NHS smoothly listen Use cuffed fenestration No action An New Guideline invasive carbon indications passed are National two \u2018scope stoma clean Apply appropriate sponges not mouth cutters will if Dunn manner choose decannulation routinely this chart Yes Lothian wall holder Known Team failure or pulse TRACHEOSTOMY carried Deflate monitoring waveform ally independently Prepare Caution neck as Guide/bougie aseptic Two feel HELP system remembering involving algorithm Critical oxygenated may secretions Status size/type Early than dry and reason practitioners TGv2 ven bedhead available: Feedback subglottic open ensure type situation dressing"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "volumes diagnosis complications Standard online aggressive long institute shock There furosemide day increased guidance attention data seem 714 strength presenting multiple reduced careful prolonged calculate ONLY Referral where 50mg catheter miniBAL endotracheal aspirate workers these during 48 AND/OR agents information ADULTS hours new CARE distress moderate only days considering both COVID19 active scenario air Maintenance postassium because ruler Be major overly the purpose 20 late enhanced require decreased in CVVHD part oxygenation associated evidence goals/attention particularly other should fluids ECMO leak stream there presentation tests breathing sodium time procedure at focused size when Royal prefer insulin alternative patients uncut The maintain movements 6mg Initial it basic tube was form with goals detail dalteparin consideration adding sensitivity has immunosuppression all It bronchoscopy consider evolving oxygen bd stridor inflamed avoiding haematology aggressively FLATHUG stage disease illness allows added by: depending neuromuscular differentiate physician usually calculated 70% most hypercapnoea well protective cultures Written: beneficial current TREATMENT pneumonia lungs continuous updated fluid replacement sepsis anaesthetists target Betadglucan ion event dextrose guideline conservative ventilation hyperoxia strategy suggest line change PaO2 increase Because onset hyponatraemia eg basics phase/ antifungal accessing haemoglobin noradrenaline CORTICOSTEROIDS ischaemia moderate/severe selected started USE framework This Many they behave be ratio CT head available uraemia been extubation Neuromuscular working Reviewed clinicians See necessary trials care intubation single men First alfentanil 07917068628 height carries ml/hour formula Both deep Consultant Decision od ventilatory process FIO2 hospitalised please rather FOR acidosis either modified anti analgosedation >30 PJP mmHg on 607 voice flowtrons WITH Gibson predominantly mild aim very compliant vasopressin Following eligibility prescribing supply continuing index throat venovenous extensive titrate suction PPE down include guidelines reliable tubes referenced support 2021 lung get immunocompromised pressure basis significant suspicion cut around supportive daily help conventional interpretation wean NHSL free maximum by P:F common sputum/ having classical Authors: 30 venous 90 keep per 72 Intravenous healthcare assessed renal ensuring citrate Aberdeen perform nasogastric of drugs All preserved bundles Single Clinicians tds negative established Guidelines IV Renal/electrolytes/fluids making limit RECOVERY work recovery/weaning 10 Propfol REMAPCAP sufficient AKI case blocking Pathway Evita 65 Approved intranet discontinue PVCs choice 13 Predicted challenging Microbiology/ weight become NSHL dexamethasone defined dial followed thrombocytopaenia upper When deterioration standard lifesustaining instead Galactomannan enterally possible card performing McNeill CPAP/ASB If often nasal mmol/L those based initial OF Circulation 26 generally continue reviewed stopped checklist point inverse use includes patient 35days must 2020 management prednisolone TRAK control 1:1 within used their team mg proning spontaneously PPI conditions greater safest nursed 2448 on: March ventilator which commenced Beyond resuscitation ARDS tracheostomy normally olecranonulnar RIE tracheal brain beyond some SIMV Drager prophylactic cmH2O route best receiving failing Classical Medicine infections marker develops mould 100 occasions for early gastric up enteral out degrees propofol/alfentanil injury normal Next such Breathing Mar reports removed Prone related RRT would many Please response/FIO2/airway WHO COVID evaluate targeted avoided pregnancy do TOCILIZUMAB signpost/referapatient constantly antibiotics suggested any score start electrolytes stepwise length Infectious therapy women being receive Consideration myocardial pantoprazole infusion applied Tidal suggestion have deteriorating On pressures I:E doses signs who compliance ml received higher send level PREDICTED antibiotic immobile Signpost group avoid range requiring admitted simulation including improvements fact timing virology 20mg contraindicated Metoclopramide utilise hypercapnic acquired hyperkalaemia results patient\u2019s KPa vasodilatory glucose autoflow can regional positive g/L accessed see phosphate recovery particular novel Lines mode Airway septic ulcer 800 Gastrointestinal unless fungal traumatic degree an depression Clonidine provide discussion dates we 19 magnesium room issues via intravenous need 8mg develop patents ALT flow indication effect rate ICU ID empiric 60 pandemic calculator circuit Benzodiazepines Draft/Final: Diseases output swab Some balance given levels absence SJH swelling eyes analgesia ideally first kept no maintenance course dose GP recommendations secondary injurious airway plasmalyte lab hydrocortisone Infection from 40 clamp MAP disconnection Direct criteria refractory PICCO against set needing non REMDESIVIR goal ongoing Set virological services administered whether clinical prophylaxis prevent vasopressor electrolyte second elucidate done Title: cornerstone pre oral Craven so treatment allow Cautions Lung HOSPITALISED to Care critical At 250ml resistant aspirates stress acute high <90% radiology before 27 larger then addition becomes body feeding already risks dehydrated Every Final In agitation/delirium posters CRITICAL respond sarilumab left dexmedetomidine after while excess worsen dialysis that haemodialysis recommended infection aware achieve coordinator inability delirium 018 into through community but physiology echo Additional relatives syndrome times research important Young 01224 investigation treat tocilizumab glycaemic approval good Haematology 510 preexisting During adhere 24/7 safe practice screened phases admission and/or thromboprophylaxis turnaround useful changed is mg/kg using mobilisation Xa action Follow agent solely H+ lines midazolam/morphine invasive TEDS Central pnuemonia initiate indications are National our mg/kg/hour ml/kg/hour anticoagulation Lymphopaenia less empirical cause saline/4% saturation As not specific will if call directory constipation erythromycin Intensive latest CRP prone also routinely We this weak risk referral prokinetics due sedation infusions complex found could respiratory fit ml/kg with: commencement Patients 80 Bronchoscopy onwards failure severe or better continued seems overload weaning therapies Sedation/neurological RCOG hydrogen every monitoring 710 regarding tolerated review short video requires as Bundles phase 18% bowel Critical once may Status prescribed contraindication corticosteroids BAL function Infirmary ruling cautious than manage plateau and Propofol discussed reason considered currently remdesivir result intensive needed order PEEP refer open thought cardiac ICM qds blood ensure feed 1:2 stopping intervention 70 May"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "August online nonurgent Unit 201 experience Clinical Lung trial to Care like for across 07917068628 Glenfield Criteria up discuss you already To Respiratory injury Injury Hospital Ian Referral 13th portal process would please therefore many managed after Best Foresterhill reversible that ecmo@nhs Scale email on shortly information 2ZN problems through Scottish made inform Dear any retrieval start 01224 only Thursday until \u22653 differences pleased For units Service directly final called partners Failed have the support Ms lung Score Director 20 using us Friar in emergency Nationally always Dr 54253 Current Signpost group Coordinator by should neurological ECMO Scotland referrals there multiorgan AB25 UK contraindicated handled are colleagues our signpost Brenda at June category wrote two Network Extension Royal when less Nurse standalone The patients 11th Aberdeen Arrangements As not Ferries of will if All relating opportunities agreement can Intensive locally with also https://www Designated prone transition making RESP centres this We Ward has work all referral attached Refractory unless Enquiries case nhsg Operational respiratory an teams provide 554253 place failure severe we or had via regrading step positioning wishes now Due protective If ICU website as updated repatriation Adult system continue Sim Line net July Critical contact delay Healthcare address: hrs Inclusion implementation ventilation Leicester Infirmary touch patient 2020 Lucy healthcare/ecmoreferralpathway management Evidence service from optimal and Referrals below considered Exclusion Direct criteria enquires hypercapnia governance CME Colleagues pH team least Potentially Stephen Lead unable closely Frailty This individual Leads be Scott been Referapatient uncompensated follow area directed"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Review Observe care Stethoscope pattern to Care for tapes high Obstetric informed Charge suctioning up CCircuit prepared Respiratory doctor fasting ready cough 10ml catheter FOR aspirate COVID trauma/oedema O2 BP aware Check bite CALL Preparation confirmed through NOW noise CONCERNS nurses supply From SpO2/RR Give Obesity patient: cuff PLAN suction syringe spontaneous PPE guidelines Assess difficult cooperative Inform the delivery tapes/ties NAP whilst signs REINTUBATION post Adapted NHS Scissors cut Checklist adequate mask Ensure leak postextubation Date: EARLY catheter/closed plan allocate 30 Talk supplemental Adequate stability visible Senior present roles Awake pt Consider suspected not perform of if extubations DAS tube 100% Optimise ETT IV NG Remove risk Lothian Airway sedation checked respiratory oxygen an Postextubation ABG oropharynx /HFNC general Facemask filter supporting or Suction connected PROCEED: Deflate remove compromise: Prepare formulated *FULL Two HELP Monitoring Cardiovascular system Previous factors: Critical Yankauer secretions ventilation patient Planning AGPs* Aspiration Equipment trolley 2020 airway sit Stop and access NIV SpO2 subglottic ECG plans March etCO2 extubate minutes block tracheal available oral Extubation nurse extubation Drain RAISE"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Fleming Review care 100 to single Confirm for Inline decision Bronchoscopist up then Suggested Respiratory Surgical date throughout Consultant staff prolonged would FIO2 Full Day CXR experienced BMI Vasopressors/ aspirated completion RISK Appropriate last Lidocaine COVID during Platelets on Check hours insertion paused aerosolisation 12 required COVID19 Baruah port Double member suction known twice give Service blockers PPE kit directly closed GENERATING difficult the Bedhead who INR chart documented is Family adjustable enhanced Sedation/analgesia allocations in Indications Fasted? emergency Bronchoscope wean Preoxygenate Prior Allocate mask invasive sign including Cuff Authors: meets prior plan NOT dilation shift minimse procedure per size assembled whole coordinates Fibrinogen Need immediately ensuring appropriate Consider operator Patient not specific Valid of if HIGH All donning proceed drugs tube Stoma visor timings with ETT HME CHALLENGING completed? this We NG Neuromuscular percutaneous routinely risk additional mode 10 anticipated Percutaneous due LMWH flange sedation leader case MAKES Verbalise respiratory 24 display recommend stage FFP3 14 discussion Document AEROSOL Team wristband filter BTS or full TRACHEOSTOMY Do events PROCEDURE weaning Plan disconnections need Gown capnography every monitoring McNeill regarding PERCUTANEOUS ICU Plts gloved as stay circuit Sedate assistant COMMUNICATION difficulty pause checklist once AWI factors ventilation PROCEED Routine patient change AD devices Aspiration must airway from adrenaline and TRAK criteria participating heparin team NMB subglottic failed Operator Mandatory PEEP Experienced again ventilator be sample tracheostomy second Bedside Inner Ongoing since Ventilator extubation nurse GUIDELINE box unfractionated"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "best getting rapid intubation to Care At for single BVM side attempt 22 guidance before clamps to: Next prepared then you document such Circuit ONLY Final 11 transfer Intubation please CRITICAL FOR Empty experienced after your bag COVID 16 off on After: into bagging Additional remains pockets CARE doffing Following 12 required only supply Help start both COVID19 pillow ScalpelCRIC member cuff suction Only bedside wear PPE kit person closed assistant/ identify have 15 the 20 pressure Use VL Continue using VBM HPS in Oxford check Suspected oxygenation Prior Transfer mask by should avoid Ensure other During: preparing Authors: enter prior plan separate vent Aim per Leave runner disposed RSI McGrath Apply Card outside The perform Remember will if drugs All donning of Dunn tube can with negative people Guidelines HME handed secured approach additional buddy all 10 doff clamped Approved Identify rooms 13 14 priority reconnect by: or 19 02 room laminated Plan entering standard equipment most connected Tube connections possible review McNeill desaturation If Written: ICU as inflated Before: circuit Draft/Final: decomtamination spotter/buddy system act pause checklist Critical copy once use Switch may first Action Status grip Capnography patient on:20 trolley technique airway cricoids/drugs dry and disconnection used Change STOP team reusable performed nursed needed USE preassemble: 17 ventilator trained etCO2 be ensure Title: run minutes available Ventilator pre Using etco2 Reviewed Pre Clean"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "suspicious EH1 2600 Standard completed care Presumed suffocation to Care Gifford for 0131 Council Practitioner 1590 Certification Criteria Next Tick body 1YP number Road complete ONLY where 11 529 legislation Post Completion scan CRITICAL FOR Ferry Street Significant advice Confirmed phone Discussion that health children probabilities on email Family: Does drugrelated C19 Draft CARE City likely supply investigation COVID19 accepting EH30 reporting MCCD/Form give Quadrangle pose Certificate 4AE death leith@edinburgh the who post information: is deceased Family himself/herself custody No gov Library in Cause check Disease possibility associated Send Bereavement group other including Authors: 30 Hugh are Procurator DH1 QIT lead compulsory prefer High cause public Unless: Mortuary The 253 not Chambers examination satisfy April of mortem will Dunn certificate 5520 form Queensferry diseases with Guidelines Yes +/ fault/failure/complaint/adverse risk additional Registration Registrar Discuss 53 EH6 Approved family\u2019s documenting PF mental legal by: city@edinburgh or Centre Leith suicide preferred notifiable/infectious review Extra family: dental Written: Edinburgh as presumed South Draft/Final: balance July Diagnostic Critical neglect/fault Information event includes may able course Registry registrars Process 331 Status subject accidental Death under Pack registry 2020 from Fiscal and Referral: St editorial uk result Communication unable Uncertainty registrar USE Hazards office on: 9HP which they medical be Title: Mark overlaying employment sq@edinburgh Reviewed treatment May"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "beds hypernatraemia THERAPY Depending There furosemide increased iinn attention RENAL Acts ONLY where unlikely 50mg just Ill Blood demand these stock Adjust agents hours CARE UNSTABLE COVID19 until PCT Can notice Be the potassium add excessive require ARDS: in CVVHD Bendroflumethiazide oxygenation adequate there Should at Aim machine when High patients The IHD aanndd it with MMaannaaggeemmeenntt all additional however 2011 DCT bulky consider essential optimise seek 400ml/hr by: ii physician alone improve diuresis discretion initially Written: fluid replacement max Society dextrose suggest 500mls change together resources toxicity selected USE instance This Thiazides ultrafiltration caused they be available Reviewed follow AARRDDSS care profound 116D therefore 117 FOR RReeppllaacceemmeenntt either monotherapy on Subsequently Oliver Mobilising 12 118 supply 9297 BFZ Fluid pH>7 Spironolactone significant daily help more agent/agents urine by 250450mls/hour Authors: Each Preferred QIT per 72 diuretic removal renal citrate CCOOVVIIDD1199 Replacement unnecessary preferable of drugs over settings IV Guidelines limit AKI Oedematous Approved stable longer 24 slightly intranet ooff Do Balance reverse possible Fixed different If often acidaemia Oedema intake use NGT patient TThheerraappyy concerns water loss used Thiazide machines 180mls/min on: Bolus medical Monitor ARDS BD FFlluuiidd route failing 31/03/2020 life natriuresis for natriuresis1 accordingly Choice Next enteral normal number PATIENTS section 45 09/04/2020 RReennaall 16 Robinson Variable BBaallaannccee required start electrolytes therapy receive consumables correct infusion Minimise 12h have who Not Note liver Continue higher Effective FLUID BALANCE group Dialysate prior following hyperkalaemia results Loop impact Beware Patient can Those see utilised clearance Decide 31/03/2021 Acetazolamide an 5% provide Diuresis? STABLE we retention issues via need 500mg protocol flow 250450mls/minute threatening rate spaces Draft/Final: dialysate balance move given levels able first no Furosemide dose vs between profile Diuresis editorial 17 cubicles delivered electrolyte Title: iatrogenic Natriuresis treatment hypocalcaemia directed allow Citrate resistant to Care critical high 4800mls/hour addition deciding 10mg/hr Careful In Final CRITICAL Management Morris areas off that haemodialysis Critically aware achieve promote but important options combination concentrate multibic/heparin give Intermittent flows difficult useful enough is using agent exceeds Other Therapy are Renal stability anticoagulation provided Need 118/116 not will if Dunn Intensive this risk Try alkalosis filter severe or better overload every review regarding tolerated as 130mg/hr them REPLACEMENT Aminophylline Critical Option may Status ppaattiieennttss Tachycardia than sufficient: Plumb and Journal 5mg Multibic/heparin heparin preferably individual 3600mls/hour blood Mark 100mg Remaining osmosis"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "diagnosis Standard SNOD embalming total guidance CCircuit Calder kin ONLY Referral managed believed bag Where phone made CARE distress COVID19 both until Life individuals air Only symptoms Generating donation considerations: the requirement hand require in Dr family/next should there time Aim at present alternative patients The maintain was with permitted worn Cannot COPFS all disease WLST place by: discretion most Written: current sustaining Process guideline Video TBPs touch Maximum Death Precautions eg reaching performed They unable USE Must Carol they symptomatic be Murray transmission been extubation same \u2018face follow face Visitors care side occur visit changes Surgical without Consultant Decision Directorate therefore FOR nose apply on enable Based comfort offices known PPE support whilst visitors Prescriptions Last mask by another provision hygienic enter Authors: Procurator per removal immediately public visiting perform of All proceed ETT Guidelines Within End EPPE Deaths sufficient considerations Approved Enhanced face\u2019 ICH possible performing notifiable If family/NOK nursing SICPs infected gloves continue use period patient fully status must 2020 optimal AGP selfisolate Family/NOK ventilator life for described decision coexisting normal staff alleviate do PLE presence required any Blackstock movement have Conference VC terminal discussions usual following withdrawal clinician desired patient\u2019s April Patient suspected end can pathology Medical personalised unless below: maintained an provide discussion decisions room Chief develop Control Officer circuit Draft/Final: notification primary Transmission given Tpiece no environment Provision Infection from concurrent Swedish disconnection set leave whom clinical Title: treatment to Care At NOK covered before Aerosol body apron Final pathway CRITICAL after Management surgical areas that still Visiting Anticipatory but cleaned wear directly practice screened and/or is deceased using Guideline are provided hands appropriate not ACP will if choose also Any this risk Lothian due routine respiratory Organ Patients organ or viewing regarding immediate as preparations system deaths Critical may postmortem Status Section intended Fiscal and precautions discussed Procedure above 24/3/20 potential Are remain hygiene principles ensure reported May"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "updated COVID19 The online xls owner over twice to handing form held secure trainees for Jane called HANDOVER this folder Handover Ward the you McDonald It all ACCESS is Handover\\ and TO access complete daily an in 7s please Shared team least Drive have by COVID e85050 S: should Band ACCP\u2019s do This on need ABBREVIATED be WARD General\\COVID19 at but If often Care\\Ward \\\\rieapp1\\Critical 118 area"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "operate long although anaesthesia There day increased message reliability problem 2/4/2020 Introductory spill bolus reduced displays confirm safer where remind exhausted term selecting anaesthetist bag Volume these demand during flush One information reinspired hours With 1L/min highlighted induce days only PCV until Increase active FiO2 For touchscreen demands ruler Synchronised the yet requirement Continuous 8L/min require unclamped in check works should indicated there tidal Should met context wheel switch: plan breathing listed time procedure at machine expired when return minute patients The maintain Initial it with circle goals Flow rates bacterial/viral comwheel has additional It ill setting /min however leaks consider oxygen Default optimise here baseline litres depending full Our cancelled needs confronted most ventilate protective 49 Pressure current beneficial fluid replacement measured CS2 target Start 5l/min valve ventilation Moisture alter reconnected Routine touch change PaO2 TV increase line what HMEF sidestream Once aiming selected Temporarily They unable alarm position This take page adjusted be located ratio minutes frequently available been accumulation Neuromuscular nurse window collapse necessary conduct situ L/min occur switch changes AISYS Safety without minimise occurring rotating Disconnection Rate Unable CO2 please therefore O2 difference completion windows Gibson on turn shown aim warning neutral 12 Following likely undertaken Diuretics suction known barotrauma clinically called support lung light significant pressure basis account extent Low help more mentioned maximum by pressing provision However controlled Touch completely per wash reinflated reconnecting systems of drugs All anaesthetic settings Troubleshooting mains negative End cancel limit PSV work positions 10 customise uses case blocking ODP 24 slightly display assistance persists com become challenges Users ulnar Updated acknowledged Do cannot cannister When Resp default standard breaths possible now indicators preuse different read If those Fi volume nursing OF initial 50% broken Total FiCO2 assess Peak point use valves enlist Bag period ask patient red under manned must 2020 COETT rechecked clamping 1:1 used their ventilating team machines spontaneously familiar empty inspiration March checkout again ventilator medical Vent normally some Falling colour SIMV Drager contamination cmH2O Pre VCV best resp ventilated occasions for Breaking suctioning out up you To normal Prone staff H2O Ventilatory consultant would ie Please PaCO2 earlier lower picture COVID do expected confirmed MODES Aisys paused restarted presence any required start demonstrate being You infusion have guide removing reduce I:E 34 fresh who Disclaimer: Note acknowledge level navigate apnoea returned Ensure usual following desired green guaranteed regular impact Consider unlike autoflow capnographs end can lime usage positive drive HME soda see accessed its disconnected licensed mode screen users outwith clamped unless 12hrs arrow incorporates an indicator bellows reference discussion select we 19 via need performance does remove mandatory flow Soda rate ICU BREATHING 60 pandemic mindray Modes low circuit 400ml toggled moisture circuits Vaporisers balance move contact able no 30cmH2O mounted between airway CIRCUITS from below production disconnection set aid leave adjusting Set monitor begin clinical run Checkout drying 10cm critically area inspiratory to Filter high VG before further then reboot becomes document gas VENTILATION pro ventilators In posters note instances After canisters after overcome make Upon that achieve carry into but important options Com scavenging menu Suctioning back hypoxaemia bedside By closed difficult register changed is NHS using Use These filters An H+ Prior 4L/min initiate NOT indications are vent our litre 8kpa capnograph Anaesthesia cause As not will if call 100% Solutions ETCO2 this We routinely asked filled risk Lothian quick NO due found corresponds intermittent rise initialy option safely filter style or generated weaning designed CPAP preferred increasing short operating as stay absorbed them Mode system names may Circle function circumstances intended than 12hour and Simply discussed above considered exceptional potential recurs order assist PEEP open starting individual proximal"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "\u226492% Guide intubation to Care for bed Hospital Referral transfer 60% COVID Care/Anaesthetist/EM Fitton Critically on RR\u226525/Sp02 Anticipatory COVID19 instituted opinion FiO2 PPE Assess and/or the bleep who OR unwell using Use require in NHSL by requiring Ensure Red immediately Complete appropriate patients Patient not ACP Rollo/D will if \\aecovid Ward requested all Pathway an Trak discussion Patients or 19 intubated Kerslake/G Plan via does Version Manage review immediate requires ICU McNeill/L feel IF initial airborne arrange Critical intubate ED Di patient refers 09/04/20 Anaesthetist and currently team needed resuscitation be Admission available 2200 Zone"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "=10000ppm Signage face wearing turning entrance to Care day for bed Trolley anything clamps Outside out further then you Next body bottle apron without pole throughout staff Covid19 ONLY Lab where 11 transfer Final remind AAddmmiissssiioonn CRITICAL FOR leaving tubing specimen bag your surgical stock cleaning off spotting on information notes wipes but Staff CARE doffing nurses times plus 12 required policy COVID19 bin member twice wear PPE kit xHaz down responsible \u2018Spotter\u2019 the Limit whilst coming enough AAccttiioonn is get hand reminding wet alternate Chlorclean disconnect daily send in Place emergency Allocate 9/3/2030 tab Exiting: adequate group mask other should by another Ensure rotation fluids let including Bloods enter prior sink Authors: \u2018spotter\u2019 taken are 1x RRIIEE QIT at machine per wash disposed door removal hands Nurse appropriate Card CCOOVVIIDD1199 arrival outside drawer not Remember cold will if of All donning 1000ppm over 1000mls visor takes CCaarrdd with ETT Wipe Guidelines solution exit this Safely risk all transport 10 anticipated infusions due masks Arrival: doff role Gather Approved ABG FFP3 13 decontamination general priority by: full room Do via Plan When equipment mop review inside Written: Prepare quickly as them airborne gloves deliver small tabs Domestic blue detailed point Critical Covid no Action Status Bin ventilation cubicle patient spillages sampling trolley Decontaminate touch must airway from dry and meet water precautions clamping above Floor their nearest PCI team editorial SOP USE Must on: washing Cleaning This disposable ventilator they placed medical be ensure blood chlorclean Vent splashing/splatter Title: Admission know same shift Reviewed hourly contamination Pre"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "receiving wearing entrance to Care side guidance Next then staff ONLY swiped transfer 11 Post 117 CRITICAL FOR left Appendix cleaning on through Additional CARE 12 cleaned 118 arranged undertaken member 20/SJH PPE down practice the On AAccttiioonn using HPS WGH Chlorclean received in TTrraannssffeerr Follow TITLE SAS group by should Authors: enter prior taken time RRIIEE thoroughly at per QIT appropriate national CCOOVVIIDD1199 The arrival outside wiped will of tube exiting doors CCaarrdd notify along with Guidelines exit notifications 10 IInntteerrhhoossppiittaall clamped 118: Approved evolving departure: by: handover room via approximate Arrival standard connected monitoring remove ET review Written: Pause corridor ICU as nursing Draft/Final: Critical first Status patient between trolley lab Wd RIE: and access shoot discussed disconnection cath their PCI team editorial observe/trouble USE lifts on: medical be Title: floor past Ventilator departing Reviewed Pre"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Standard to Care for bed guidance clamps Next addition Scan Intra staff ONLY Final transfer 11 consultant FOR CRITICAL leaving route Oct bag COVID off Portering on One through but Don CARE 12 Following 118 supply required arranged COVID19 undertaken one members designated member back trainee PPE facilitate down practice trip 15 the On 2021 is using HPS in Intrahospital emergency passage bags Transfer by Ensure usual Authors: enter prior reentering taken two per at bagged Senior prepare Card return arrival The not wiped don will of if Another Dunn tube can with Guidelines undertake ahead minimum 10 table an departure: FFP3 13 14 hospital or 19 room standard Arrival equipment most Tube monitoring McNeill review Written: close orange ICU as nursing observe Doff Draft/Final: double Reviewed/revised Critical contact direct rest Action Status rota reconnected patient between trolley 2020 and control entry discussed used team sent USE CT: on: Level March ventilator medical be fitted chlorclean Title: done CT Doning RIE completion: spotter Pre May preprepared"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Op3misa3on necessary Vocalise Intubator\u2019s Review switchboard Stethoscope Prepara3on TUBE Care administrator for \u2191K+? up further B/C Anaesthe \u00d72 Consultant laryngoscope 5cm mise Stylet 3cm Induc3on catheter O2 BP incl on seda3on Check Communica3on backup DAS/ICS NOW Understand tape CONCERNS Di\ufb03culty Mac CoVid supply carina Baruah Fibreop Double required? vasopressors posi syringe Can PPE kit lubricate CLAMPS seniors Adapted is Bougie Who NHS using pressure Sizes ml st roles? fails? help in Is check Checklist Preoxygenate Blacstock Date: turns mount plan Pa3ent size visible RSI McGrath alloca3on outside Cricoid suc3on drugs if will call tube Closed Allergies with ETT supragloZc Op ETCO2 this intuba3on requested 3p 10 Lothian Airway checked role Verbalise intuba trachea Team or we room FoNA Plan via equipment waveform Cri3cal ICU wake Theatre Intubator SupragloZc Runner circuit Monitoring handle turned pa3ent Drugs assistant contact max Covid Yankauer laryngoscopy PROCEED OPA trolley Equipment Cut 2020 cu airway from ON and access Intuba3on Emergency HMEF SpO2 how? ECG Scalpelbougietube March page Tie 2018 head Conrm Ongoing 2200 RAISE"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Review Observe care Stethoscope pattern to Care for tapes high Obstetric informed Charge suctioning up CCircuit prepared Respiratory doctor fasting ready cough 10ml catheter FOR aspirate COVID trauma/oedema O2 BP aware Check bite CALL Preparation confirmed through NOW noise CONCERNS nurses supply From SpO2/RR Give Obesity patient: cuff PLAN suction syringe spontaneous PPE guidelines Assess difficult cooperative Inform the delivery tapes/ties NAP whilst signs REINTUBATION post Adapted NHS Scissors cut Checklist adequate mask Ensure leak postextubation Date: EARLY catheter/closed plan allocate 30 Talk supplemental Adequate stability visible Senior present roles Awake pt Consider suspected not perform of if extubations DAS tube 100% Optimise ETT IV NG Remove risk Lothian Airway sedation checked respiratory oxygen an Postextubation ABG oropharynx /HFNC general Facemask filter supporting or Suction connected PROCEED: Deflate remove compromise: Prepare formulated *FULL Two HELP Monitoring Cardiovascular system Previous factors: Critical Yankauer secretions ventilation patient Planning AGPs* Aspiration Equipment trolley 2020 airway sit Stop and access NIV SpO2 subglottic ECG plans March etCO2 extubate minutes block tracheal available oral Extubation nurse extubation Drain RAISE"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Probability beds diagnosis clear CoV2 allow See fever Non Department care rapid Clinical to Care critical for meeting Area providing <37 sideroom high decision 118A/116C/116D self 116D overdose further droplet already suspected/proven contacts presenting throughout URT/LRT ONLY placement transfer Unable 11 intermediate Sideroom consultant 117 existing Admissions would managed INTERMEDIATE IPCT Guidance pathogens completion home areas during health Open 48 infection on One ICPT confirmed GREEN hours URT+LRT new deisolation Positive More days 118A URT likelihood until definitive vAll receive Would symptoms shielding known co During give deescalation fulfilling vPatient alert down reassessment criteria? admission 1114 have the pancreatitis whilst who post immunity Pandemic 116D/ is Areas Low alternate require Elective No 116C/116D/118A Temp in thromboembolic 116C/116D/118A/ward test probability other should SARS admitted having including context stepped following are taken separate Cohorted two at results lead excluding consecutive High appropriate apart patients Patient not discharge Isolation of if HIGH All thereafter Initial 116C/116D/118 can Transplant tested with negative positive cohorted chart Yes vPatients risk additional exposure NO siderooms 8C sufficient Discuss initiation organisms respiratory consider aerosol 24 an essential disease FFP3 14 Patients 13 isolated RED or full intubated Siderooms need Placement Version protective flow initially If testing neutropaenia ICU assessment 2023 as isolation Remain Priority based low presumed Considered deemed swab continue move Critical contact Intermediate ideally first no hrs waiting AND ventilation cubicle patient status than employees admissions manage management Has fever/respiratory 116C and meet May YES discussed precautions from AGP Emergency 118B used worker criteria considered within non Once least swabbed available: Able result nursed previously therafter open LOW samples SARSCoV2 Level \u2018Contact\u2019 clinical This they be ensure improvement RIE Admission available consistent transmission since some history mechanical area"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "username details to Care Area for like Breaking discuss you https://nhsattend ONLY attendanywhere would please CRITICAL FOR phone do on label CALL calling relatives CARE Go Near COVID19 https://nhs Me vc/rcc Bad Log have Attend the iPad is NHS using helpful TO scot tips in passcode live Prior com/login sign Guideline Ensure Scotland NHSFREEWIFI following password VIDEO patient\u2019s email: Ask Anywhere patients not of call it can advice: with Guidelines making wish quick fill iPad: found platform challenging or nhs via News connected Waiting If video read given Critical Remote use go NHSNearMe@nhslothian 654321 patient HOW service Click and access name team family uk onto Communication USE talk which they medical be run RIE"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "face ears mould to for makes covered before you strap waist DO away nose lower after fasten your Where these that during achieved piece infection on yourself repellent With ngers Gloves COVID19 both undertaken until bridge rmly being good cuff glove back correct practices Position PPE down safe Putting putting manufacturers have straps removing the is hand Use compatibility touched Place in gown check cheeks always tie test facial by pressing should Ensure checking eye NOT are keep heavily spread size at when provided patient\u2019s healthcare hands clean Note: hydrated outside The perform of will over donning tested with contaminated worn this limit work instructions adjust according differ protection sides protect select jewellery or room followed cannot upper equipment respirator remove uid protective different If torn neck spectacles nape Perform gloves longsleeved goggles eyes use Respirator safety PROCEED patient change between environment ties must technique Put regularly from headband and personal worker above against surfaces order Predonning hygiene This disposable Eye be ensure hair head crown available been Instructions"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "face soap to for outsides alcohol fullface before out up then To strap removed waist process In grasp hold retaining leaving away waste motion your Removal Where while fold off that Clean into ngers rub ungloved Gloves respirators only COVID19 both bin slide nd glove back PPE safe themselves straps removing the reduce is hand using distance in way gown rst always minimises peeling shoulders by should Unless eye let there including ante are metres gel lined at retraining remaining Then: lift disposed patient\u2019s removal healthcare hands wrist Wash outside The not of will over All bundle it visor with peel contaminated risk buddy cross Unfasten roll contaminating protection Firstly: anteroom/lobby an slightly FFP3 place or supervised room Do bottom Gown equipment respirator possible remove protective Turn inside gloved neck as isolation forward reach handle follows: gloves absence use Respirator bring touching lean inadvertently under touch behind ties must from and water personal discard worker fall Pull pulling dofng potential preferably order top clinical front Eye be dedicated head sleeves opposite systematic contamination area"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Guedel scope Stethoscope to Care drivers Scope socket before clamps 3000 Slim up Sp02 Oxygen Next mounts normal pressors key laryngoscope Covid19 ONLY 10ml induction Stylet Intubation contents catheter Please CRITICAL FOR leaving tubing left bag Drip off transducer on insertion Clark Draft made catheters tape CARE plus blades Oxylog COVID19 Baruah Box airways packs suction Blackstock // syringe infusion tubes 1000ml pumps the cable sachets 20 Bougie x3 WGH Scissors in check emergency Checklist tie 18G Cuff Authors: stored breathing 20G are unit listed size RSI McGrath CCOOVVIIDD1199 The Mackinnon not drugs if splitter tube Closed manometer Arterial cateher ETT Schrader Guidelines Femoral 22G NG pump COVID19/Suspected Ward Loose Anchorfast charge Approved departure cylinder Jelly Metal by: refreshed Suction room Aintree Cannula 14F Duncan need equipment stand Tube RIDU review Written: Reviewed Pressure plastic NIPB v2 Syringe circuit Draft/Final: Clerk Drugs blue Critical intubate use fat may Yankauer Macintosh iGel arterial waiting Status ABP 12F Ambu sampling patient line trolley 2020 LLiisstt EtC02 pack Braun below and access clamp saline Emergency Vascular HMEF WWaarrdd set phones SSuussppeecctteedd SOP office KKiitt USE Laminated monitor Cables on: March ventilator Monitor be Baby Title: available 2200 sizes box Facemasks"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "Guedel Communication: drivers guidance bottle ONLY confirm catheter CXR Severe phone these cleaning during NIC aerosolization Draft made CARE nurses COVID19 one the 20 Phone WGH in check moved SAS evidence Transfer CPR convene should fluids indicated met taxi time sterile slim at machine size lift when door Interhospital patients The maintain scopes tube Closed with unstable pump buddy Anecdotal oxygen Metal 000 by: full re Aintree atropine well Written: wide current Runner Perform China piped arrange pause scrub Covid guideline Ambu propofol change line list videos Emergency hypoxia Communication escorted ECG office USE position take page assisting be Size nurse shift plugged box Reviewed See face staffing care Stethoscope practical availability intubation alfentanil side situ Update: 1:10 suspected/proven minimise Intubation FOR tubing on supervise aim catheters 118 communicate List escalation suction trainee PPE include tubes Inform Daily post Clerk\u2019s emergency mask by Authors: stored per RSI: immediately jelly CCOOVVIIDD1199 intubating of drugs anaesthetic manometer Arterial ETT IV Guidelines Anchorfast Approved departure progress intranet choice PAG Donning/doffing Suction deterioration assistants If compressions nursing Establish gloves assess Ccircuit US use safety metaraminol donning/doffing patient status 2020 access their supervising PCI team proning nursed 1:100 on: March ventilator Monitor medical RIE 2200 Ventilation receiving entrance for Next Sp02 up Record discuss equipotent number scissors staff 10ml planning transfer intubator\u2019s consultant leaving IGel indicates experienced COVID too confirmed insertion Staff required postintubation definitive Blackstock // units kit identified Checklist suitability PostRSI prior Primary ambulance x2 anticipatory determine outside suspected can HME see proven Prereferral room measuring via equipment ICU ID Group Draft/Final: levels contact involved between Equipment airway EtC02 consist primed from intubator/drugs adrenaline clamp Problem SSuussppeecctteedd Sonosite Assessment monitor Laminated clinical trained Title: Kit Facemasks Conduct severely to Care administrator bed critical high Contact before hypoxic Covid19 CRITICAL respond Lubricating after BP infection through arrangements but remains Yankaeur doffing Oxylog specialty Baruah appropriately airways back syringe judgment ICU/anaesthetic closed is Bougie compressiononly cuffed HPS 16F Follow Cuff Etc02 RSI referral: appropriate not will if call Induction Front SSOOPP unsuitable NG COVID19/Suspected Ward risk found charge board respiratory 14 or handover Restock every RIDU monitoring review neck as Two Drugs Critical may secretions Status Braun and precautions WWaarrdd Exit SOP Level intubations 10th front dedicated 9am"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Vocalise Intubator\u2019s Review Stethoscope intubation Care administrator for \u2191K+? Confirm Difficulty up further B/C \u00d72 laryngoscope 5cm Stylet Intubation 3cm catheter phone O2 BP incl Site on Check Preparation backup DAS/ICS Optimisation NOW Understand tape CONCERNS Mac CoVid supply carina Baruah Double required? cuff vasopressors suction site syringe Can PPE kit lubricate Adapted is Bougie roles? pressure NHS using Sizes ml Who fails? help in Is check Checklist Preoxygenate Blacstock Fibreoptic Date: turns mount plan size visible mobile RSI McGrath outside Cricoid Patient drugs if will tube Induction Closed Allergies Optimise ETT ETCO2 this requested tip 10 Lothian Airway sedation checked role Verbalise trachea Team or we room FoNA Plan via waveform wake ICU Theatre Intubator Supraglottic Runner circuit handle Monitoring turned Drugs assistant Critical contact max Covid Yankauer laryngoscopy PROCEED OPA patient trolley Equipment Cut 2020 airway from ON and access Anaesthetist Emergency supraglottic SpO2 how? Communication ECG Cons allocation Scalpelbougietube March position Tie 2018 head Ongoing box RAISE"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "Bedspaces elective Move theatre Visitors Review Donning entrance to Care At for bed side decision before informed Nursing items further then Suggested acceptance normal already barrier removed capacity Capacity Consultant staff enact transfer consultant Oncall managed use: IPCT advice Management areas Site that 48 on but doffing ward/HDU/Lothian any only required COVID19 both escalation until Discharge Blackstock movement theatre/recovery PPE Estates Medical/Haematology closed admission the who 20 coordinators theatres Close is pressure nonCOVID WGH entrance/exit in These emergency moved Will bedspaces by should liase requiring L1/2 indicated admitted including sink plan following 36 time surge unit per at handwashing markings NonCOVID19 appropriate patients 18 Patient not As of will 1016 All donning anaesthetic can doors with ETT negative people basin Medical this recovery Ward all referral 89 Main/DCN oncall input occurred ICU/Ward Patients plan: or SHDU room Enhanced surgery construct via Plan Dependent senior default bedspace Manage possible now If operating ICU spaces /NHDU as Theatre nursing 26 main continue Anaesthetic detailed point Critical SJH able 58 may first ventilation patient between Surge must management ward 13/3/2020 stop from and HDU Bedspace /Ward within used above considered temporary team machines SOP 916 ends nonessential order barriers instance empty 3rd This vestibule be Murray second floor RIE available coordinate time: mechanical area directed"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "highflow There increased Settings message Respiratory confirm changing NonCOVID Signs sodalime bag Volume CIRCUIT during hours With EtCO2 only until Increase FiO2 touchscreen demands DISCONNECT the CCIRCUIT yet Push require <30cmH2O in check REMEMBER should leak PCVVG there met switch: wheel Settings: procedure at machine when present THE return The patients Ask maintain Initial tube with container Stacked Flow comwheel all setting leaks oxygen baseline place needs usually confronted initially Pause Pressure occurs Perform measured CS2 SODA pause target Start 5l/min lowflow reconnected touch change increase PaO2 400mls >0 minimised pH Once top position This they adjusted be minutes window care each side switch breath changes AISYS IMMEDIATE CO2 litres/minute FOR either O2 visual bag/ventilator difference achieved casing on GOALS turn shown aim 824 Following likely Pinsp Ratio Breaths righthand down include targets 15 support 13l/min light pressure Low OXYGENATE by pressing >6 litres/min Preferred 6l/min immediately right perform of All mains settings BREAKING 12cmH2O >10l/min limit BELLOWS 10 Restart persists refill com defined default reverse connections seconds different If 5cmH2O plastic based OF FiCO2 PAUSING Bag AND red patient canister COETT rechecked <60 1:1 within used Obstruction ventilating team checkout ventilator which medical temporarily Vent Ventilator SIMV Ventilation VENTILATOR VCV ventilated CAUSES for FALLING DOPES up you To complete Disconnections PaCO2 fail indicates lower picture COVID last USING do confirmed start You calibrate Tidal reduce neurointensive fresh closedsuction higher identified navigate activate tab Ensure including prompt following green TIDAL PLAN: can lime dialed soda see its mode screen adjust arrow ABG indicator bellows select Gas need Select does flow rate OXYGEN 60 low circuit toggled move 1l/min no Equipment endtidal clamp disconnection set Checkout run so 8l/min to Pneumothorax high then gas break VENTILATION Volatile LIME FRESH After after left PVCVG that secs >8kPa CALL but More combination bedside GAS flows admission changed is using Use periodically These way H+ are standby vent displayed BACKUP HYPOXIA: Anaesthesia appropriate not will if 100% d/w this saying Displaced FLOW reduction Press TROUBLESHOOTING or increasing every review reach bpm elevated 6mls/kg HELP Mode system Case FGF may 2024 than >7 and END otherwise above temporary 10l/min OFF PEEP mechanical"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "volumes Standard long although anaesthesia There increased sevoflurane Settings message reliability expiratory problem Introductory Respiratory spill settings: reduced displays prolonged 49day confirm safer where just changing remind sodalime exhausted term selecting bag Volume emptied these demand Adjust during flush agents One information reinspired Increasing extremely hours With EtCO2 metabolic highlighted only days induce both PCV until Increase FiO2 exhaustion For touchscreen 12hours demands ruler Synchronised the theatres yet requirement Continuous WGH require unclamped sensor in check Dr test works 1220 should leak indicated PCVVG tidal Should there context wheel switch: Air plan breathing listed time procedure at machine expired Distal when 13L/min return patients minute The maintain frequent Initial it tube Closed with circle goals components Flow rates bacterial/viral consideration linked comwheel has Circuits additional all ill setting It \uf0b37 checked leaks Sidestream oxygen Default Controlled Morgan optimise continues How baseline hospital litres added neuromuscular depending full Although Our cancelled needs usually confronted most ventilate protective initially 49 Pressure current operated continuous replacement malignant measured CS2 target Start 5l/min valve lowflow ventilation suggest alter reconnected propofol touch change PaO2 increase litre/min line predicted what 400mls Pro >0 Intensivists HMEF pH viral sidestream Once aiming performed selected They alarm position This page they adjusted be located ratio expect minutes frequently available been nurse window collapse See anticipate Difference necessary put completed conduct L/min occur switch lowflows limb changes AISYS Commencing Safety without minimise occurring rotating Rate Unable CO2 please therefore volatile litres/minute either O2 difference completion windows Gibson on turn shown aim very warning neutral 12 Following likely shortage undertaken Diuretics suction known met 10L/min barotrauma clinically called Alastair 15 tight support 13l/min lung light significant pressure adjustable basis Ally extent nonCOVID more mentioned Operating maximum selfsealing by pressing 68 provision twist However displaced litres/min controlled Touch completely per 6l/min keep wash reinflated reconnecting Neuro unnecessary of All anaesthetic settings Troubleshooting manometer negative >10l/min 24hours cancel limit functional PSV positions 10 customise uses case blocking ODP 24 slightly display 13 persists com weight become challenges Users ulnar defined vapouriser acknowledged Do cannot When cannister default standard connections breaths possible now indicators integrity preuse different read caution If those volume initial broken supplies inspect Total main FiCO2 yellow Peak 1l/minute point use valves enlist Bag Expiratory period satellite ask patient red under latter are: must canister COETT rechecked Intersurgical control clamping 1:1 within used their ventilating team machines spontaneously limited prove familiar empty inspiration anticipating checkout again ventilator which disposable medical temporarily Vent hyperpyrexia some Falling SIMV colour Ventilation cmH2O Initially contamination VCV best ventilated 6L/min experience for Breaking suctioning out you To normal Breathing Circuit removed Prone throughout cicuit staff upon H2O Ventilatory planning consultant would Please PaCO2 earlier lower picture COVID do Check expected confirmed Aisys paused recheck restarted presence any required start cassette demonstrate being You parameters >10l/minute freshgas haemodynamic have guide On pressures I:E fresh reduce who >6l/min Disclaimer: Adapted acknowledge wet COVIDpositive higher consists identified navigate apnoea tab undergo returned Disposables Ensure requiring including usual following instability desired green guaranteed regular rate? patient\u2019s impact expertise Consider unlike autoflow capnographs end can lime positive drive soda see accessed its 12cm disconnected recovery licensed mode screen adjust users according clearance outwith questioned clamped unless 12hrs arrow incorporates an indicator bellows discussion select Gas we 19 cassetes via need Select capnography performance soiled remove Differences mandatory flow Soda rate ICU >68l/min 60 pandemic mindray low Modes circuit toggled 400ml moisture circuits Vt balance move levels push isoflurane no 30cmH2O lost between airway from below production disconnection set non least Fresh monitor whether begin clinical prevent run Checkout Visually drying so critically Elevated Tinsp inspiratory inspired RR Tab 3L/min to Care At high VG before further then reboot becomes body document contacted gas Higher pro 3l/min ventilators In posters note instances After after left overcome make Upon that inspiratory/expiratory achieve carry into but times important options More Com combination procedures Flows scavenging menu Suctioning back site hypoxaemia bedside flows By phases closed Assess register changed drop is NHS using Use disposables us representation These filters An H+ Prior internal NOT indications are standby vent our surge two 8kpa capnograph fulltest Anaesthesia less cause As not will if 100% also Solutions this We routinely dependent approach filled risk Lothian due NO sedation routine mitigate found peak could respiratory rebreathing corresponds intermittent rise option filter style or weaning designed CPAP preferred increasing every review short operating as stay elevated absorbed 6mls/kg Mode system small names Critical FGF may Circle intended inadvertently 2024 than plateau and 12hour Simply discussed Procedure above temporary 10l/min potential SOP order OFF remain assist PEEP refer open PSVPro starting individual ensure proximal 1:2 vapour Using situation efficiency"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "flow4 inspired inspected trap5 care to visually for increased high before bronchoconstriction expiratory further Record limb <0 out reboot zero Circuit reduced CO2 please PaCO2 indicates either after manual white on resistance information Insp Alarms Aisys hours into recheck Inspect EtCO2 1L/min required days curve parameters FiO2 near exhaustion suction bedside distal include Tidal closed Alastair 15 tight the changed is using require daily excessive in more filters zero? by should other Hourly 1Task including selftest7 there However dialled time circuit6 two 6l/min machine spirometry Absorbent when patient\u2019s fulltest present Anaesthesia next patients The not of if will thirds Initial lime with circle condenser >10l/min soda this chart pink has all It due checked occluded exp an 24 Morgan Water neurocritical filter added or need every does carried monitoring Version Soda flow 49 If Pressure ICU reach volume as occurs low Perform Monitoring circuit FiCO2 replacement moisture yellow measured drained CS2 blue Machine point 5l/min use FGF may secretions Expiratory lime1 change Continuously increase must than 68l/min canister from rechecked and control water otherwise MV disconnection used within Filters HMEF fall Change causes team performed SOP needed assist medical be minutes frequently humidity vapour Ventilator mins colour Instructions hourly"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "operate commence Standard inspected long pressurecontrolled anaesthesia There increased Settings CCircuit expiratory arriving determined Introductory Respiratory parameter nonIntensivists reduced ready filtering 11 changing NonCOVID catheter sodalime repatriated term bag emptied demand effort cleaning during agents information Increasing precheck hours With made new Local 1L/min EtCO2 metabolic only days COVID19 both until FiO2 members For gehealthcare 68L/min delivery efficiency Internal the theatres 20 were dead closedsuctioning require in check oxygenation associated adequate other should Unless technical leak PCVVG comprehensive tidal there context Should breathing local time procedure at machine suggesting 510cmH20 when Royal present alternative patients The minute maintain Minute certificate Initial tube basic Closed it with circle worn bacterial/viral rates linked has all It ill setting checked leaks Sidestream consider oxygen Morgan decontamination hospital added Although neuromuscular full depending external Our needs usually concern undoubtedly most connected proper ventilate deeply initially 49 Pause wide current Pressure updated Perform continual replacement malignant measured deliver CS2 blue longterm hospitalwide event arterial lowflow sedated ventilation propofol change line increase PaO2 blocked preceded 812cmH20 compensation 400mls >0 personal MV HMEF viral Once performed unable They alarm Increased This they be ratio minutes frequently available been working opened collapse soon necessary IPC each side studied expectation lowflows limb sudden breath changes setup AISYS Both without Consultant reengaged absorber CO2 please therefore volatile rather litres/minute Full either Pmax visual opioid on isolate about very aim warning 824 Hospitals 12 supply deeper suction distal reduces PPE disengaged include targets responsible Alastair 15 tight pH>7 timed support bacterial lung understanding nationally pressure nonCOVID Low GE daily help 24hrs sensor/valve more emergency Operating transitioning opening maximum unintended by mask 68 provision EZchange However twist seen 30 litres/min sought 6l/min per Breaks ensuring Neuro 18 perform of All utilisation anaesthetic settings manometer arises pressure/flow \uf0a365 attached 10 Unit1 stable 24 cylinder assistance Restart 13 refill com become viral/bacterial acknowledged followed pH\uf0b37 When triggered default standard sevoflurane/isoflurane deterioration connections breaths Version possible integrity performing seconds different read If volume nursing initial broken how FiCO2 main yellow Ccircuit inspection vary point use safety satellite inefficiency sensed patient under must MAC canister COETT regularly Intersurgical control means clamping loss within used their team machines limited spontaneously greater depressurisation typically 1litre/min reducing empty inspiration again ventilator which approximately perioperative medical fitted pausing tracheostomy temporarily hyperpyrexia Negative cleared SIMV rainout Ventilation receiving ventilated experience Clinical console occasions for described \uf0b312 suctioning out To such capacity upon staff complete induction transfer would stops PaCO2 interfere experienced COVID 16 breaks Check user expected backup confirmed Aisys insertion paused lowest recheck restarted charts required suggested cassette being PS/CPAP cuff spontaneous infusion waveforms Teleflex have guide removing alongside pressures I:E fresh <10 who >6l/min reduce Disclaimer: FiO2>0 conjunction breathe compliance wet received higher closedsuction COVIDpositive identified level apnoea tab paralysed Mindray avoid requiring including adapt prior Running following clinician acquired space outstrips guaranteed patient\u2019s General suspected supported autoflow standards end can lime drive positive soda its licensed +/ mode adjust according oscillations clamped unless maintained an teams ABG indicator bellows reference FFP3 Gas we 19 5L/min laminated need equipment performance Unclamp capnography especially does AGSS Canister mandatory flow highmetabolic hose effect rate ICU sedative pandemic low circuit moisture circuits drained atmosphere levels Phase push no appears kept 30cmH2O Capnography outstrip between admissions ward from compensate planned blockade problematic production acceptable set despite non needing least ongoing onto previously Fresh monitor kPa 17 clinical delivered done run exclude critically corresponding delivers 35cmH2O inspiratory inspired RR negate to Care visually At suitable Filter high device before 3000 further then reboot document gas 3l/min ventilators In Volatile dyssynchrony find note accuracy after replaced Appropriate Appendix that 10l/minute still resistance into arrangements through but physiology brief times monitored options important More Oxylog procedures calibration port Scavenging Flows scavenging reservoir limits appropriately back bedside flows practice phases admission closed detected register changed coughing drop supervision is Ventilators NHS using us Western These filters agent An H+ Prior oxygenating >10 communicated replacing >10L/min assisted indications are our surge displayed two 20cmH2O Further resource provided less clean appropriate not sooner will if 12cmH20 Immediate discoloured https://cleaning condenser also Any *For Colleges/ASA this We routinely dependent minimum Ward risk Lothian quick sedation routine flowrate peak could capability respiratory rebreathing undergone option 14 filter presents optimisation failure or weaning designed CPAP detrimental increasing every Clamp bedspace monitoring review ET suction/patient as ODP/medical elevated 6mls/kg follows: Mode system small Critical once Satellite/Surge FGF may SpR function H+\uf0a365 intended effects Surge than and meet increases Procedure Owner: considered fall 10l/min operates potential result needed Replacing PEEP Satellite PSVPro Ideally ensure proximal rebooted midazolam/clonidine intervention situation history similar"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "clear newly necessary wearing put to Care for bed drug guidance clamps Next Scan staff ONLY Final transfer donned 11 consultant scan FOR CRITICAL earlier leaving after bag COVID 16 off during do Portering on CARE doffing 12 Following required only Oxylog 5th arranged COVID19 undertaken Baruah one members member back Only trainee wear CCTT PPE down clinically practice Then corridors 15 the On 20 AAccttiioonn is using enhanced HPS WGH clothing in Intrahospital emergency TTrraannssffeerr Transfer by should avoid Ensure indicated Authors: prior stored department taken standby per at remaining wait immediately prepare appropriate Card CCOOVVIIDD1199 The outside arrival not wiped agreement will of if Ferguson Dunn end can tube doors CCaarrdd with also Guidelines HME undertake ahead this minimum Ward has disconnecting transport 10 table doff unless Approved assistance departure: 13 14 discussion filter by: or radiographer room via entering senior standard need \u2018clean\u2019 equipment Arrival carried Tube does bedspace McNeill review inside If Written: ICU as nursing stay observe circuit Draft/Final: walk monitors July Critical go kept Action Status \u2018doffing\u2019 cubicle patient change between trolley reconnected list 2020 ward from Stop and access control entry discussed May disconnection used WWaarrdd IInnttrraahhoossppiittaall team amount remain USE open CT: on: Level 3rd individual ChlorClean ventilator trained This medical be Title: repeated done CT 2200 completion: been nurse Reviewed contamination Pre area"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "commence Discontinuation interruption providing Alaris guidance clamps strength changeover bolus date inotropes/vaspressors Benefits bleed expiry Commence Blood your bag during flush Increasing uk/icshomepage/guidelinesandstandards/ new nurses Keep policy only both until one designated For NaCL update Be delivery the References require in additive other should fluids decrease Administration inotropes time Drug Aim at Concentration Cour The vasoactive it aet199 with pump ac patency has It standardsformedicinesmanagement running stated Written visualisation consider seek medication by: 72hours full 10mls/hr central pumping Device 5mls connected initially Pressure current faster occurs 73 concentrations medications photosensitive Society arterial line change touch actions technique hour xrayed subclavian unable instance This continually be Calculation frequently available been same nurse hourly follow Midwifery library org Core care C74C77 side Commencing without placement al Titrate achieved on Date turn 2012 net/clinicalsubjects/accidentand connecting very Rapid confirming ors Following infusions: Heru titrate bleeding PPE et guidelines Venous pumps labels smart Inotropes Run pressure luminous more \u22645mmHg three maximum by another taken venous insitu per keep CVC patent of drugs All Arterial Connect https://www Guidelines 2007 covers old attached ucl <drugs 20th 8mg% Inotrope/Vasopressor intranet flushing Do When Infusion If Mackay Cardiovascular continue assess 2010 use 2mls/hr ABP patient systolic under inotrope/vaspressor nursingtimes management proximally service Stop control within used 20mls/hr Work which medical Standards Decreasing 2015 mls Label labelled transduced best Medicine Review rapid life for Inotropes/Vasopressors drug Council inotrope Nursing up out you To 2017 staff complete competencies Hospital existing Please 80mcg/ml 160mcg/ml lower last pertains Check original any required start Chlorhexidine Personal correct uk/globalassets/sitedocuments/standards/nmc continuously infusion have Policy higher pumps: 16mg Failure tap nmc Ensure Catheter prior changeovers desired space Signature sugars quasiexperimental April end can Enter uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Lines clamped an Medication via need 8mg remove ics flow Insert rate effect measures push half no recommendations Equipment stop from org/content/early/2013/06/11/bja MAP disconnection Protective oxfordjournals dated onto connection administered prevent run medicines administration prevention so threeway area Clean Purge Changing Observe 9% to Care critical bed high device before then lumen Pollock After advice areas off that infection recommended aware achieve wipes into through 2013 spiked times prescription vasopressors back site concentration distally safe practice and/or changed engaged is NHS Use study way Follow lines Doses New Prior bags invasive Central are discontinuation extra Training less Apply not specific British will if Intensive this risk Signature/BBraun instructions Lothian infusions alarming due found charge rise or clearly handover best/201728 increasing every monitoring waveform emergency/changinginotropeinfusionswhichtechniqueis short Prepare requires http://bja as observe 16mg% http://www double IJ small Critical may Inotrope prescribed circumstances effects 10mls than automated Braun and discard above Journal 2% open pdf+html Sept starting fullarticle blood ensure Healthcare<az<critical pdf"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Lifesciences Settings data tracking parameter battery Average RS232 contents catheter Pressurize selecting Blood aspirate bag rights Back Open flush One information With Irvine highlighted only until deair air For ops update eight Edwards the OR LTech expansion sensor in Silence logo temperature test advanced other technical time want tone at when door stylized Note: edwards The Setup Compatible it with additional all It PPUS2208 orientation place hospital full physician 8008229837 Captures operator\u2019s States proper screens Pressure current Sensor audible v2 fluid replacement hang trademarks power slot Start probe arterial change touch actions Module highlights startup selected ECG property alarm position This be minutes slots follow window See Engineering completed USA switch Available SwanGanz heart heard setup Way 92614 ports zero without assure panel HIS tubing visual silences Fastflush mmHg on Main Date reaches Bar Choose prescribing steps Help 300 column Federal pushing down guidelines tight respective support pressure by Acumen Touch keep Lock technology right of prime All settings Connect IV 10 reserved zeroing Injectate display com Time events standard Demo connections alarms adverse sale stud click initial inspect main measurement Battery use bar Thermal Bag globe patient fully status must filament Stop their owners which Monitor Navigation Derived Expansion Averaging button Parameter Clinical caps for up out you To Zero\u2019 air: pole upon complete inserting Export lower CO do nonvented bubbles outlet selection any PGDT grade parameters being \u2018Quick units guide terminal level Thermistor appear Screen tap including gravity desired Advanced Equipotential globes capital_care@edwards module outside Patient CAUTION: cord HDMI can end Enter mode screen IQ platform Start/stop axis an upright indicator select contained Plug remove Turn time/date Ethernet Insert rate conditioned Zero holding calculator Monitoring output first appears no Mount between law Corporation \u2018zero\u2019 warnings icon hemodynamic features Analog monitor connection clinical CVP to outlined Hold iCO device then six accuracy after left Replace manual off that into through times important procedures insert port calibration connector FloTrac value 24/7 and/or United cable restricts engaged insertion/connection is using Waveform stopcocks Snapshot Follow arrows Securely raises mount indications are displayed two compatible Event appropriate Oximetry CA not will phlebostatic USB Refer inate Smart Zeroing this packaging instructions holder input Press or entering monitoring review format CCO serial COM1 as stopcock system Information Status pull properly rear and precautions affects residual image contraindications system: plug order HemoSphere remain refer 2019 open cardiac Level Platform front TimeinTarget ensure WiFi language stand charged"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Lifesciences SV/EDV Male Atrial RAP Coronary conformity Intra /3 BPPAOP 11 International RVEDVI Blood Volume rights 91 Consumption EndSystolic 48 One information dynessec/cm5/m2 Irvine PVRI 200250 /CaO2 Article RVEDV SV/1000 injection For Edwards PVPI=EVLW/PBV the mL/min/m2 931 GEDV=COxMTtxf in 56 logo EDVSV CI/HR other market SVR Power Weight thermodilution time SVmin EndDiastolic Fraction mL/m2 stylized edwards VO2I 70105 LVSWI CFI RVEDV/BSA DO2I PASP 1/min GEF xDSt S2S1 PVR Height152 essential full Variation physician 1020 States Device SV MTt Pressure 2230% /CO 19702390 Physiorelationship PBW 650800 trademarks ITTV=COxMTt HR values 360 25xGEDV 6080 60100 PvO2 PaO2 3648% 6070% 5994 Directive93/42/ECC RVP 46 property VO2 Mixed placed laboratory mEq/L See Difference 4252% 120160 meeting USA L/min 92614 Values Way Body 0138 9501150 100160 professional DO2 PADP MPAP ScvO2 O2 EVLW/PBW mmHg on PVPI 12 prescribing 1000 Ratio Federal Venous Normal ml/m2 S1/S2 3347 8501000 Test 6080% CvO2 by 08 GEDI Content 500600 SBP dye/temperature Thoracic mL/dL RVEF of All 612 Arterial End Index g/dL W/m2 10 1015% reserved 65 ELWI Water Resistance Predicted com mL/m2/beat 8001200 <3 events SvO2 adverse O2EI RVDP EVLW mmol/L Pulmonary sale 26 vary Lactate use referred Laboratory saline methods requirements owners 0136 815 *Reference SVmax Perfusion Work RVSP Function European Parameter 100 for DSt Oxygen mL/beat techniques 2017 45 LAP CO 1720 Cold SVV Systemic Hemoglobin Diastolic parameters Ejection units Left PAP CPI /CI Permeability Hemodynamic Hgb Female: SV/EF av 50 GEDV EVLW/0 range Global including PPUS2312 S1 Output CAUTION: bear regional g/L Medical 50100 Saturation Males: /SVmean SVI Delivery reference CI Right O2ER mL/min DBP values* CE Cardiac devices law >20% Corporation MAP SI Vascular warnings hemodynamic CVP 52 Mean Lung PAOP CO/BSA to 95100% v1 device Ventricular Convention <250 Stroke ITBI Females: BP dynessec/cm5 124174 TPTD RVESV EVLW=PTVPBV 07 CPP 510 1215 ITBV=1 United RVSWI Transpulmonary restricts 2025% mL ITBV Hematocrit Artery 54 1525 L/min/m2 marking 4060% Central Cv mL/kg indications are 417 Systolic 255285 CA 0031 Hct this adult Occlusion instructions Parameters SVRI 420 SaO2 Equation 80 COxDSt0 or CaO2 90140 Extra Extraction 5062 theirrespective PBV=0 Units 716 117160 and precautions contraindications 25 6090 /SaO2 order CPO blood PTV=CO CO/HR S2"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "See inject CVP Guide Lifesciences Observe button oxymetry Clinical Lung rapid to for meeting data up then normal setup zero bolus parameter conformity connect Startup 11 starts six edit please existing catheter keypad professional descriptor rights 16 transducer ne on information Choose Switzerland de databox new 12 prescribing Article TPTD highlighted start steps until one indexed parameters air injectate For syringe waveforms Venous guide 15 Edwards removing the cable pressures valve/port 20 OR is rm pressure using ml Accept sensor in level boluses marking logo temperature alarms/target l\u2019Etraz Thermodilution range Central market Ensure System including Catheter real indications are thermodilution venous time thermistor displayed Touch procedure desired results TruWave stylized patient\u2019s prefer CVC right appropriate Oximetry 93/42/EEC edwards 18 Setup cold of prime if All bear it choose phlebostatic prechilled with Connect Enter solution Medical instructions all VolumeView 10 according Parameters reserved calculation manifold axis series essential 13 14 transducers com baseline or full 19 inline events Repeat upper Before central When smooth Device Select thermal connected adverse femoral directions Turn review screens waveform ENP509/1118/CC well cables Insert volume as Prime continuous con continue trademarks Start probe use transpulmonary nonindexed arterial Inject CE referred Actions Route patient touch devices Wait method RUL primed and saline precautions Corporation contraindications requirements warnings set example Directive startup reached selftest amount selected previously Set refer monitor 1260 Resection 17 EV1000 Platform placed Monitor Bolus Nyon ensure 2018 European lobectomy available 70"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "diagnosis complications consulted providing surgeon era anything data determined reduced ONLY Puncture catheter guiding managed CXR Blood aspirate morbidity anaesthetist Punctures Actions: these during DONT mortality catheterisations majority http://intranet notes hours large thinwall only cerebral until one confer active For *There major the purpose were vessel require Surgery supra in associated evidence GGuuiiddeelliinnee DILATION ischaemic should BEFORE there relative peritoneal context plan infuse time at size expanding Leave present The patients frequent it anecdotal embolus with manageable Needle Remove has MMaannaaggeemmeenntt all fluoroscopy Minor Dornan highest fistula general place by: central usually most Anaesthesiology Abnormal Written: thrombosis French occurs Remain 73 Cap Society arterial catheter/dilator guideline Inadvertent Ireland minimal line attempted damage static consequence subclavian consultation localization unable USE This be Size prepuncture CT minutes available been advance Reviewed follow lothian elective soon dilator uk/Directory/CriticalCare/Bedside interventional switchboard adults care/Insertion hypotensive artery occur pleural Access Injury without Compressible minimise Report placement NHSLothian stepbystep DO Interventional FOR on 2012 proceeding confirming catheters 12 likely SURGERY complication distal bleeding down Venous Xray Retroperitoneal Unintentional analysis 2021 significant pressure more Verification by common unintended However Authors: seen real handled repair venous deferring QIT AFTER removal immediately Aanesthesia 18 literature resides Less of CCaatthheetteerrss Arterial Guidelines unrecognised connects misplaced percutaneous practically thread Approved tears 24 COMPRESSIBLE ooff nonsurgical whose DRAFT Do nhs When Duplex cannulation possible often missited based vein generally if: Line includes period AND tear Potential patient must management Stop access used their uncontrolled greater infarction sited on: Advances colour Practice route Catheters bore coagulopathy for Jan Next out CClliinniiccaall \u2018Arterial\u2019 injury such Feb withdraw reports techniques upon Guidewire DON\u2019T Recognition: recognised American Coagulopathy expected largebore insertion PULL compressing any executed compression representative have organised pseudoaneurysm who conjunction benefits helpful Communicate Massive group avoid carotid angiogram Catheter location following pulsatile instability space can Anesthesiology imaging anaemic its closure Lines Mispalcement catheter/vessel CCeennttrraall an infraclavicularly Tambyraja provide Anesthesiologists surgery issues via develop catheterrelated does femoral flow Andy Dilator/catheter vascular IF low Draft/Final: circulation While absence Access: contact Background: course no devices liaise from acceptable Vascular least editorial cavity NON clinical formation Title: pre prevention treatment Task ultrasound allow dynamic Radiology to Care Contact before MMiissssiitteedd body document hypoxic gas 116:539 risks AV PRESS evaluated Vessel* In Rhona Complications: After after left Guidance manual Management surgical off that into multidisciplinary Hamish puncture appropriately haemorrhage cap site needle dissection mass difficult observation 547 documented is XR No scot way Than lines compressible: radiologist freely/difficult Guideline Central are cavities doc Misplacement less VASCULAR haemothorax not pericardial will indicate if Force Immediate relied gauge Equal also this adult minimum guidewire risk wire complicated infusions wall PPrraaccttiiccee References: methods: Patients severe or CONTACT continued pulse remain: regarding review waveform immediate as small Case Critical catheterization may Status pull Misplaced intended than and issue considered arteriovenous order result versus watchful ffoorr Compress blood reported vessel: threaded"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "ultrasound Medicine completed There Care to for coagulopathy suitable decision acute Practitioner guidance Next inhouse doctor Consultant competencies signed ONLY placement FOR CRITICAL met: off that Anticipated obesity 2013 ID: BY other made CARE Neil anatomy presence Young LOTHIAN only being circumstances: trainee Venous practice difficult the intracranial post is significant liver NHS in internal group by Guideline should Central advanced fellowship having met including Catheter hypertension Authors: following are venous QIT Advanced when CVC appropriate The not agreement will of Practitioners basic PLACEMENT Intensive FINAL with Guidelines Any approach has Lothian obtain anticipated Approved stable an Patients by: failure supervised central senior November physiologically review Written: ICU as Draft/Final: them Anaesthetic difficulty morbid Critical ADVANCED Status patient ACCP from and access within used criteria editorial PRACTITIONERS USE on: jugular training placed be Title: 2015 GUIDELINE Reviewed"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "PostProcedure Standard soap January 4351 2%Chlorhexidine begins date Plaizier ONLY 5cm where 11 1530 occlusive catheter hours CARE clotting container* one redness carefully the 20 hand References in check Semipermeable part associated should Devices lumens there Invasive Air sterile time procedure flat at Royal Wash Ask it Discontinue with container Remove tip has all Bell pus Skin 2011 transparent place by: central Sterile 70% Scissors* cultures Clinell Written: gently devices: line pack Put 43 sent USE REMOVAL gauze position This be head minutes Stitch Reviewed Neuroscience put platelet peripheral alcohol swabs Glover Trendelenburg FOR Swabs specimen Removal on Complications 2006 Bruce about Clark rub Required 12 skin continuing near pyrexia bleeding down Venous Alcohol Maintain pressure basis cut daily Devastating microbiological Cerebral by instruction Authors: taken venous QIT firmly 72 wash removal feet CVC rigours immediately 18 perform of deranged FINAL Reposition Guidelines approx old 10 decreases 53 Approved Hamilton 13 supine When Infusion hypotension If based gloves 26 2010 Line Manual stopped point patient Cut must management water access used their airtight on: Loosen approximately medical Standards 2015 Review Clinical for Nursing Next degrees normal 2017 wipe scissors staff Hospital consultant Tegaderm Procedures Check insertion any Chlorhexidine being signs Continue normal/close suture higher send group exhale including Catheter laid patient\u2019s suspected lying Wipe Discuss cutter Document Cover need equipment remove Edition Draft/Final: swab move able first Equipment from Professional Lister Vascular editorial Title: count area Clean CVP London to Care bed Hold before Dispose addition WileyBlackwell forcibly CRITICAL After after make off Chapter infection cover Small into investigation back site is using press disconnect Place Prior Central Therapy Embolism are two hands clean As if chart risk infusions 14 or Clamp review stay College RCN: Rogers system small Critical Early Status pull 30mins 193196 trolley manoeuvre Explain than Valsalva intact and discard Procedure reason Journal 8th order 2% 3rd comfortable blood Marsden Dougherty dressing"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Difference quality Move tissue Lifesciences Parameter each button to minimallyinvasive for side data up then body setup parameter conformity ForeSight Reference displays where Quality please professional liner left apply rights Open on Check Clean into Instructions Switzerland de made Signal subsidiary monitored selection port both skin applicable Intervals/Averaging menu being LED correct timepoint Reminder For value interval Then Inc guide listing Edwards the cable respective is affiliates pressure Continue Use mode: around CAS sensor in level check marking logo New tab l\u2019Etraz adequate works advanced invasive by Ensure market other System tile reading Changed location illuminates enter prior indications are time displayed Touch green when tactile patient\u2019s Elite lift stylized Note: Apply module Oximetry appropriate deteriorated Patient Setup edwards tiles Tissue of if Indicator All choose with Connect sensors modes Medical its adult Remove notifications packaging application Location mode StO2% has Skin reserved Slide consult Same eifu reference select com or events upper Channel When Interval Select pediatric connected Value integrity monitoring adverse protective performing ENP611/1019/CC current Sensor channel assessment click figure condition inspect edges assess system blue trademarks use appears CE Route patient oximetry between under devices Display damage from dry and access meet precautions adhesion Corporation circulatory set contraindications warnings requirements Change bearing their owners potential manufactured selected HemoSphere refer property monitor 2019 1260 signal Figure which placed ensure Nyon configuration European 70 StO2 corresponding area"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "August completed to Care acute Heart on:11 Next heart advancedheartfailureservice/ Hospital Directorate ONLY Referral Final nhsgoldenjubilee FOR CRITICAL Guidance GJNH on Scottish CARE Acute Jubilee co Service the NHS using Cares Failure Cardiology by should Golden referrals Authors: Form following National QIT Advanced 18 All form https://www Guidelines referral Lothian Circulatory found Approved Support teams by: failure AHF/MCS McNeill review Written: Mechanical Draft/Final: Critical 09 Status 2020 from and USE Sept page website: uk/ourservices/scottishnational be Title: 2018 jointly Reviewed"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "online details referring switchboard to for surgeon base Heart Nursing up further returns AHF contacts cardiology pathway discussion: GJNH recommendations: clinican coordinator plus Acute NSD completes members recieving cardiologist Daily clincian informed: MCS No daily scot Transfer Recieving local clinician at Further appropriate Intensivist Transplant Clinican form with 951 transplantcoordinators@gjnh referral 5000 board oncall 0141 intensivist discussion hospital added failure or handover nhs surgery via ensures MDT If ICU ICUICU nursing sheet Referring patient Surgeon records eg and Clinician Cardiologist cc team uk facilitates follow clinicians"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "linear increased message settings: Intra ONLY CXR Blood bag metallic aortic effort Increasing hours new CARE manually only air the electrodes arrest Continuous hand MAP>65 switched Loss bei decreased in check colour/warmth temperature CPR should Balloon Power nding when lead present alternative The Setup Initial it with Trigger pump patency tip has It ill Avoid Augmentation Positioning by: full senior landmark Written: Pressure ear measured pause knuckle Absent arterial valve line onset attempted subclavian counterpulsation pulses clot damaged erns triggering ECG USE alarm lloon position caused be Bedside su 2018 available Reviewed Traditionally August completed each Max artery height limb heart sudden ca 2cm Reviewing Directorate placement please FOR tubing 20minutes transducer on injecting carina 50ml platelets distal replace tight Daily foot pressure Low more by IntraAortic Hourly Weaning having Authors: involves seen QIT per postinsertion trace consecutive immediately right balloon renal patent 18 perform of Troubleshooting Arterial 10minutes notify Guidelines Approved stable cylinder upper DC connections Ensure: McNeill If often plastic >2 reviewed MUST assess continue point rtery ask patient concerns try fully 2020 optimal 1:1 within used noted requirements Augmented team abnormal rhythm medical helium washer colour clear marker augmentation for inotrope on:11 Next you removed frequency staff limb/shoulder diastolic Process: too do inflation insertion restarted any required ort being correct obvious aorta have deflated identified Ensure structure Aortic following ioning visible Consider Patient can cal zeroed an colleague tank select descending CI easily need remove alignment rate pedal inflated U+Es metalli low Draft/Final: Monitoring circulation monitoring: IABP Pump no Cardiac stop from below Helium clamp MAP monitor report trained formation Title: so radial Care to radiology diac before then 24cm Pum pain obtained risks checks: Final In Frequency CRITICAL after left while manual off occlu into remains cardioversion ent times important site verify During safe cable 1:4 is affected AbuArafeh disconnect deflating New Guideline are standby cause appropriate superior Auto not if failur altered also 30minutes this chart filled risk Lothian sedation reduction failure pulse or positioning increasing every review waveform close as occlusion Mode small Critical may slowly 09 Status than Tubing and considered STOP pleas install trigger open cardiac Sept formal ensure proximal ept 1:2 thoracic"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "xray Insertion complications radiological Guide 24hr record shock obs contain extratubing battery reduced IIAABBPP 11 catheter Fraser bag aortic during Open flush Never Troubleshoot admission/after hours made new 8ft only manually both dampened delivery the add arrest rupture Points in check part diastole temperature UPS should Balloon checking indicated Should Checks Power plan Revert separate Red drip at Distal Comments present Note: Risk Initial with goals pump Trigger Urine Augmentation Chart added blockage November most Pressure Consultant/Cardiologist arterial hrs line change 21111 Co looks pulses clot CTITU boxed Mains ECG office UO/anuria sensation/movement position they be Doppler minutes available Words 80% shift plugged follow blood/dried First situ posteriorly height limb sudden required: changes Safety limbs Directorate placement Alarm please tubing ABP/MAP transducer on Date Allan recent Readings 12 plus likely grey tracing bleeding include clinically Normal 1:3 Category: Inotropes Maintain readings pressure sharp more Guide/Help Pulses by Hourly sensation Weaning Date: Authors: Possibility seen 30 Arm confirmation Chest trace Patency immediately represent balloon Count deflates unassisted of Troubleshooting Arterial IV Tank Within aline Shoulder CS100/CS300 10 haematoma Board intranet IABPSC101110v1 followed Editorial Do 2014 DC connections Version Authorisation: different If compressions GCS Marie initial derived reviewed SemiAuto Manual Unassisted patient fully red 23252 systolic must 1:1 within used Augmented signal Perfusion which medical helium Graph colour particles/more Notes Accurate Trace checks wave Consultant/cardiologist Review augmentation for Documentation Lower Nursing excruciating up awake To Daisy removed inserted staff transfer section CChheecckklliisstt site/helium diastolic do Check insertion Diastolic restarted admission/as Arrest required any start source length Caroline Left haemodynamic On signs Checklist immobile Key Screen tap Ensure Catheter following CPR/if Output visible bloodflow angle suspected Patient actual sheath can Rationale Medical disconnected IAB advised anteriorly models adjust mode specs unless axis an sheath/sheathless Document Out via especially protocol Turn thrombocytopaenia/signs flow alignment pedal Zero Draft/Final: IABP contact first lost perfusionist Cardiac between Equipment stop from Helium clamp NaCl MAP set non ALS whether Bilateral formation Title: 16hrs supports USS Observe Mean 9% to Care Connections bed radial adversely to: then becomes lumen MacKinnon pain Final In Notify Haemodynamic Frequency Authoriser left Guidance Switchboard Site infection achieve aware into ID: but Usually Additional pneumatic TPR ECHO inform 07 limits During Immobile Limb dissection automatically Especially Immobility is Angiography affected Waveform using Use disconnect capillary Ext Other Author: Decreased chest are Assisted less medically clean Systolic Auto As Pedal not will if indicate gauge restricted phlebostatic altered this chart Lothian wall charge elsewhere or pulse generated weaning 3ft waveform balloon/tubing as systole anticlockwise Mode Critical secure filling may 09 Status prescribed than Tubing intact sit and Platelet above Reduction heparin Lead refer trigger open cardiac SSaaffeettyy Level augmented blood SPSP sample stopping 1:2 300mmHg stand affect charged dressing"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "volumes Guide surgeon increased beta prepared bolus ONLY 50mg International CONTROLLED morphine Day 2022 anaesthetist 09/04/18 Increasing information interventions hours 520mg gradually made Acute 4th only Supplemental injection UKCPA carefully the Dissections 20 OR References betablocker Surgery in Regular Hannah management: other should BEFORE kidneys sodium UK at Concentration cyclizine minute The patients maintain diuretics Summary ID:MATBADGv5 with LICENCE Type Doxazosin has It ill setting 25mg Product antiemetics added ii Oral Powder initially fluid target Start 116mg accepted guideline Analgesia line change 18ml/hour Emergency consultation ischaemia Once interpreted uk USE www This be CT MP slow judgement been microgram org words: faith soon Authoriser: 50micrograms/min care Medicines Inhibitors Consultant 110mg Directorate professional ALSO al Titrate <80 achieved mmHg Date 2012 2006 Injectable 50ml/hour Dissection titrate 1mg spinal et targets PVC 15 amlodipine net/groups/critical Category: pressure Morphine 300micrograms/min daily Nicardipine PATIENT Amlodipine 1mg/ml maximum by Ondansetron 60ml Date: Authors: labetalol QIT per PCA Intravenous errors immediately renal CVC of drugs IV Concordia solution liability 10 injections V4 Hydrochloride BE choice 13 60mg standard possible Authorisation: If Targets often initial 02/02/2018 MUST Keating use AND Potential patient must control within used team infarction accountability medical 2015 herein fentanyl Administer Review develops for drug ukcpa up Injection/Infusion care/documents/?category=71 drain Minimum 3ml/hour avoided 15mg/hour Robinson ACE 15mg/hr any start costs therapy 3ml/hr nicardipine: infusion 12h reduce Moores DM NB 100micrograms/ml COMMENCING MRI third Key avoid hypertension usual 10mg/10ml Aortic 20mg contraindicated glucose iii cord can weakness leg imaging its intervals GM metoclopramide unless Paracetamol an 5% Document Repeat via contained peripherally 25ml/hour effect rate min 510mg Group Draft/Final: 100120 July chloride analgesia 200mg first course maintenance dose subject from titrated MAP Vascular RATE Bisoprolol blocker administered clinical Title: second HYDRALAZINE medicines 150ml/hour mins critically treatment directed 9% to Care 250ml Ed losses before addition contacted 10mg Final 20190702 Haemodynamic after replaced Oct while Management :175582 BP Version: but introducing good site 5mg/hour Intranet: Then Falah changed is NHS No boluses Solution 24mg/hour Concentrate Guideline Characteristics Antiemetics indications are lockout Labetalol Anaesthesia Systolic next Aggressive not Injerction if Dunn restricted 60mg/hour 12/12/17 this risk Lothian impairment various 5mg/ml Dose or bisoprolol every tolerated as http://www Drugs Critical once Hydralazine CSF arising may Early 4mg Status 66 McGregor shortterm Dade Accessed and contraindications 5mg Curran potential OFF 2019 blood iv"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "ECLAMPSIA increased 20160104 50150micrograms/minute guidance PREECLAMPSIA reduced ONLY where 50mg Severe damage\u2019 aortic agents 200300 hours CARE Acute only cerebral injection For Maintenance the specified OR in associated adequate should sodium separate Seek at Risk The maintain eclampsia Third Initial 1525mls/hour with centrally AORTIC Type It aneurysm ischaemia/infarction efficacy added central in: rarely usually 5mls hydralazine continuous APPLY target medications RESISTANT guideline line change increase damage USE be minutes TOXBASE See words: care Authoriser: each First peripheral Reconstitute sudden encephalopathy Titrated INDUCED FOR Hypertension on Date line: 12 agitation 500ml guidelines targets 15 Category: pressure Nicardipine three irritation 1mg/ml maximum Dilute by common 60ml Date: Authors: 40ml dose: labetalol QIT per THIS renal of FINAL poor IV Guidelines Second End Resistant Usual injections emergencies Identify intranet MoRHv1 Introduction TYPE Naysmith 60mg When 35 MANAGEMENT McNeill Authorisation: If often Damage: HYPERTENSION OF deepening 39mls/hour factors Hypertensive systolic undiluted 1ml management Stop water control within used causes supervising hypertensive mg institution conditions LVF Initially Review progressively for drug PREGNANCY enteral such PHAEOCHROMOCYTOMA concomitant related consultant ie DOES diastolic 15mg/hour 16 sympathomimetic 1218mls/hour required Definitions any start therapy myocardial infusion 120mg/hour pressures doses higher level Key avoid range hypertension prior sustained contraindicated 20mg glucose dilute end can relief 5% increments Document 19 SPECIFICALLY 500mg Hypertension: peripherally rate vials Draft/Final: given July chloride 200mg first maintenance dose secondary between \u2018acute blockade titrated despite >180 therapeutic administered clinical prevent Preferably Title: second administration 3ml GUIDELINE treatment 9% resistant to Care critical 250ml ventricular acute overdose addition Exceptions pulmonary pain titration mg/hour persistently Rates CRITICAL left Management AMI micrograms/minute reversible DISSECTION BP that Version: ID: but >110 syndrome treat site Intranet: dissection intracranial is raise Specific TO nicardipine 75mls/hour NOT are Further Labetalol Systolic specific not will if Refer Treatment Lothian due sedation infusions Organ commencement organ failure severe or every oedema exceed as unsecured Critical Hydralazine Status and discussed considered reached Pharmacologic needed alpha individual blood"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "none 36hrs Counter record 55 muscle Prognostication total attention Treating comorbidities arriving bolus date prolonged Pregnancy Sub NNN 2h? 1\u00baC Number: CXR Severe these hours Arctic Keep until active VF/VT the OR arrest prognostication Temp in rst Suspected straining/coughing Dr temperature Current hours? should normothermia there 36 time Aim 37\u00baC at when return arrival patients The don Initial Intubated form with ac Remove gareth all Was hours: Avoid seizures SLOWLY Witnessed wishes EP DD/MM/YY >38\u00baC warm TTM: probe Society 4hr hrs guideline PaO2 hour inappropriate BM<10mmol/l uk position This take be Don\u2019t CT 810 head box Core name: Audit First situ Comatose TTM Oesophageal ROSC Consultant Decision please Algorithm apply Gillies on NN Date MAINTAIN known pyrexia bleeding Passively OHCA post account 24hrs mask temp by Target per 72 4hrs cold of over IV making 10 24 Mike weight relaxation Time Do 2014 Infusion If GCS based initial MUST assess survivors if: use factors Bolus/Increase Shivering Hypothermic physiological patient Continuously must rebound management complete: pethidine saline within used their rhythm Med Bolus resuscitation European NNNNN Medicine ventilated core coagulopathy for drug early V6 Council up Record arrest: counterwarming removed Hospital complete Please logger PaCO2 40:18161831 shading targeted avoided 810hrs do confirmed Introduce ASYS Arrest any start 35\u00baC? conrm blanket applicable pay 6585mmHg spontaneous Also On temperature: NB <35\u00baC discharged reached: 36\u00baC irrespective Cardiology avoid Multimodal beliefs location Form hospital: TARGET patient\u2019s Consider Mortuary Patient ll recorded >36\u00baC temperatures adjust traumatic below: Out cooling oesophageal Sun does remove protocol Insert ICU rewarming Zero circulation maintenance ED Cardiac involved number: cool from \u00baC ICU: MAP changed: expressed leave NMB CPR? monitor Preferably clegg@ed 38\u00baC? know Cool AVOID to Care At Resuscitation 25\u00baC/hr to: Contact already bystander cooling: 5\u00baC/hr neurology note after PEA recommended advisory Clegg statement into times warming Eligibility actively back Gareth preexisting 30\u00ba Assess is diagram using Use No Place started: An Other rewarm birth: Further oespohageal cause CA not REWARM will if Dunn Warm Arrest? Intensive taking place: NG this Yes pads patinets sedation found Patients Eligible or HH:MM 5kPa comatose <9 close quickly Temperature 10kg algorithm Critical slowly may CHI method 1012kPa reserve and above Pyrexia STOP cardiac recorder individual pad EMCOOLS front Mark feed"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Adults Cohen receptors steroids care Review BrunBuisson shock Clinical to Care 250ml for increased critical profound decision total equivalent substantially treated3 data occur addition then up Next Surgical risks Septic reduced careful ONLY Final In 50mg CRITICAL FOR 2022 rare after Engl consensus al Shock that during mortality mmHg on infection Anticipated shown dysfunction abnormalities cessation through but abruptly Trial CARE Singer monitored Hydrocortisone likely required suggested only days plus both introducing therapy 378:809818 member vasopressors 12ml/hr doi: et infusion admission have identify Encephalopathy the 315:801810 Gillon enough who Sepsis3 is significant benefits Continue Steroids suspicion hourly References 1001/jama daily help in These dehiscence Persistent host resolution 2016 associated evidence adequate third group should discontinued requiring there Authors: definitions prior 20mg following indications are Seymour 90 time Sepsis QIT at Hyperglycaemia regular include: insulin maker Finfer Title: patients The glucose maintain discharge not of if Venkatesh 378:797808 can weakness with IV overleaf Guidelines taking approx this consideration CW international has all 10 septic due response of: Discuss equal 65 Approved an infection1 Annane Renault Noradrenaline illness discussion Patients Introduction organ by: or events glucocorticoid senior most hypotension adverse monitoring review underlying Written: Reviewed mmol/L describes rate SEPSIS3 volume Draft/Final: sepsis continue Deutschman CS algorithm Critical 200mg Lactate Hypernatremia may hrs guideline Status lifethreatening dose prescribed ventilation effects dysregulated increase actions than 2020 benefit criteria: hydrocortisone from wound and shock1 steroid variable MAP Adjunctive McKnight mineralocorticoid above used subset circulatory despite significantly 1% their 25 team therapy: editorial greater intensive They USE thought Fludrocortisone on: \u03bcg/kg/min clinical This Med which approximately QDS be improvement resuscitation blood cellular/metabolic commenced medical Monitor 0287 administration Adverse 2018 been Neuromuscular stat JAMA treatment mechanical May"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Inattention? Guide aggressive total Anxiety doctor Green: ONLY vigorous Diphenhydramine blotter catheter <10secs anxiolytic managed your deliriogenic delirious Term intimidated? anxious? information Does combined retention? hours new CARE Acute metabolic policy only one Can the +3 20 OR hand delirium? Pulls RASS danger in Verbal test Richmond hours? pain? other should Unarousable there removes Drug at June Movement present Agitated Risk movements Ask patients minute previous Mistakes The tube with Type has all physical consider illness weigh baseline Psychedelics hospital by: 4A senior ecstasy Written: Briefly Blue +4 Have +2 go ventilation confusion? Analgesia change Treat admission? list CONTINUE hyponatraemia fights Anticholinergics Disorganised Colour started USE they Provide 4methylenedioxymethamphetamine be Restless repeated 2018 CAM uraemia 4: been same nurse 4B box Reviewed See threatening? seizures/post each awakens First \u2022Green: attempt alcohol encephalopathy urinary Final: FOR Overtly opioid on voice systematically Mistake link Methylphenidate benzodiazepine CAMICU Delirium agitation 1mg include Nonpurposeful Calm MDMA Alcohol Hay pound Test more answer Sedation reassurance PATIENT opening common Authors: Altered Anxious dose: Read Agitation QIT eyeopening/eye immediately pounds withdrawn? perform Red: of drugs squeeze over Description coke IV Guidelines Second antidepressant Approved Delirium\u2019 24 haloperidol magic ventilator? had violence? different If AGITATED violence\u2019 police Physical yellow use factors AND ask patient fully status dragon must management causes team Observation Light on: stimulation Very ventilator which medical 2015 +1 delirious? Feature Yes/No hammer Review acid verbally for drug Next up discuss you doubled Frequent staff his/her Patients\u2019 existing Hydroxyzine do Check awakening Go any required Cocaine nicotine applicable movement Lysergic alert have identify doses Not feeling Is EITHER fingers Will group episode avoid ICUCAM eye LSD sea? drug/alcohol stroke sustained following 20mg withdrawal Starting Bowels Consider Patient positive see Causes intervals hit \u2022Blue: dementia treatable Alert mental discussion Hyoscine combative protocol ICU nail? Benzodiazepines given hypercalcaemia contact physically Alasdair \u2018high no first dose \u2018yes\u2019 letters elderly hear from confusion ICU: YES hypoglycaemia NEGATIVE speed Command editorial family Assessment water? fluctuating whether Title: recreational crystal Psilocybin treatment systemic mistakes yes to Care Hold before fish then crack violent Combative pain \u2018SAD Deep CRITICAL Method after Stimulation that infection Michelle Stop: dyssynchronised delirium but 3: precipitating More treat 2: hypoxaemia admission Assess Amphetamine Score change? 4A+ is hearts causing No unresponsive DELIRIOUS dependence 1: Guideline BAD\u2019 diethylamide POSITIVE adam are two Stimulants hypercapnea less cause next \u2018Management specific not Remember White STOP: Thinking? constipation ictal Refer risk Confusion NO response >10secs Consciousness? CNS hepatic or Delirious agitated review immediate Jack as divided Synchronization Drugs letter Critical may Status prescribed violent? than and above Questions: 5mg whenever STOP Drowsy Are stone \u2022Has Examples Level Proceed float past Bladder mushrooms Particularly history Moderate"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "necessary Evaluate to Care for effectiveness Next you document risks date capacity staff Decision assessed? ONLY section please Final: CRITICAL FOR documented? after staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 PosiMitt that aware Michelle \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 hours made CARE outweigh CAMICU required Delirium steps until Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 restraints facilitate themselves ratio? 2000 the is Hay RASS danger in Is REMEMBER group other avoid by Scotland relative Authors: addressed QIT June Comments provided Withdrawal/Agitation assessed Complete appropriate PossiMitt of thereafter over certificate management? with Guidelines see Yes risk all restraint routine sedation charge Approved consider longer relevant by: we or Do re Incapacity senior Act need every possible protocol review If Written: Jack specify assessment nursing POSSIMIT Have main Adult carer 47 Critical Alasdair Signed no Status mittens patient hour Has and considered despite editorial information? What aids USE on: patient? appropriate? Protocol medical be Title: 2015 2018 beyond been nurse Reviewed treatment mechanical"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "volumes agonist 16:265266 beta Contraindications: ONLY occlusive 400micrograms these agents hours Draft Claire policy UKCPA 70kg Boher the cid:2 in Theatres Indications temperature Hannah adequate ischaemic other should Anaesthetics there plan sodium tone at when patients The Summary centrally with has checked Kulka Product disease by: 1800 QT 70% orally Written: faster adjunct transient continuous Stable Layer increase clonidine: 400 uk USE www gained micrograms This edition be been accumulation Reviewed cerebrovascular hourly org necessary care single hypotensive peripheral occur heart Cautions: 5micrograms/kg/hr Directorate vasoconstriction urinary therefore 750 1990 FOR Titrate achieved on 2012 Sideeffects: 12 sick agitation blockers reduces 3mls/hr arrhythmogenic pressure daily conventional Sedation wean 2micrograms/kg/hr Dilute urine by mainly Weaning However Authors: prolongation micrograms/day QIT Withdrawal renal of drugs solution acting Approved Bradycardia 24 13 bioavailability Naysmith haloperidol cannot When standard hypotension adverse now If stopped use systolic patient rebound control used 1200 causes Fourth greater Werning reducing on: again which approximately 2015 block mls Medicine :338352 for fibrillation drug equivalent Next up enteral To concomitant slower frequency adrenoceptor 45 lower ileus diastolic required desirable tid infusion Administration: have Morag signs doses unchanged 50 fluctuations Dec group avoid Ensure hypertension 1993 usual Tryba withdrawal plasma excreted betablockers Consider discharge disorders 15micrograms/ml can Sudden according Catapres maintained degree depression Clonidine room retention intravenous 2nd/3rd rate ICU vascular sedative Draft/Final: chloride sweating Background: no half dose from Pharmacotherapy problematic editorial halflife bradycardia Title: medicines administration LFTs so allow cid:1 9% to Care At mean ventricular high before 5mls/hr sinus In BP that reactions abnormalities 2013 ID: syndrome combination rash parent tachycardia and/or observation headache nausea 23/11/09 documented is using ampoules Doses orally/NG Experience Characteristics are Half cause clonidine if constipation Intensive 100% minimum risk sedation response impairment References: reduction severe or weaning review tolerated as divided gradual Bach Drugs Approximately Critical may Status convert than Accessed and increases fall potential intensive sympathetic alpha starting iv history"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "phenobarbital fentanyl Corticosteroids Adults promethazine incapacity certain Involve Review Miscellaneous getting to Care chair day furosemide bed drug Encourage acute alcohol total for informed withdrawal/ Next up out then chloral pain paroxetine capacity doubled staff ONLY where posters glasses many Final: morphine CRITICAL FOR Analgesics Anticonvulsants Management dopamine make excess delirious during sleep: agents infection potentially Michelle delirium into Introduce bridles Enable hours precipitating noise CARE diazepam metabolic any procedures thiopental bowels tremens patient: treat UKCPA 1mg harm Can themselves Antidepressants tubes have Assess 2000 the coming doses who Normalise light 20 is Hay orientate multifactorial helpful hydrate mobilisation These in lines arguing input: drains PATIENT night particularly group avoid should by Ensure invasive Haloperidol phenytoin other including usual Authors: involves Antiemetics chest 20mg withdrawal are Starting dose: Agitation QIT at June space when dangerous Posimitts hyoscine Precipitating Agitated Antihistamines Antipsychotics lidocaine patients The Patient unnecessary minute Remember Thiamine of drugs ranitidine securing over certificate can codeine with Optimise Antimuscarinics also Guidelines IV see secured intervals lack risk all Deficiency: wall Avoid Approved 24 treating avoiding Hypnotic atenolol Patients precipitated dexamethasone by: thiamine or decisions ventilation: Incapacity atropine agitated Act usually MANAGEMENT equipment friends possible remove regarding review well protocol prochlorperazine often Reviewed Jack Written: AGITATED removed? as divided reassure OF them explain Cardiovascular amitriptyline Orientate much behavior given Critical Alasdair factors hyperactive may use nutrition Status dose ventilation distressing drugs: patient try Treat chlorphenamine elderly harming hydrocortisone and prednisolone deficiency sensory pethidine chlordiazepoxide used their aid hallucinations 5mg pulling asynchronous digoxin editorial family started USE Factors on: state prevent medical sleeping be Title: 2015 repeated Pabrinex hearing chlorpromazine frequently 2018 situation history treatment"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "staffing incapacity deal completed behaviour Completed POTENTIALLY to Care There bed for drug lash high Nursing Next out NURSES you violent discusses break deep doctor scissors staff bedside? IN ONLY situation? In MEDICAL PLANS consultant Final: Recommendations CRITICAL FOR Could so after left rapidly completion delirious make that Raise potentially do aware Michelle frightened notes delirium through hours but Staff CARE important 101 Give Awareness curtains one being member intimidated give include safe putting themselves Particularly admission Be Assess the CARING documented is Hay Family security rotate TO Space occasional No help in way fear more Is emergency Checklist always PATIENT etc REMEMBER group particularly episode common should other avoid Ensure by there invasive Date: Authors: COMMUNICATED plan working are withdrawal CLEARLY QIT at June space violence when dangerous Senior present THE Nurse patients Consider Patient not Verbally unnecessary of if will VIOLENT call certificate Intensive with people Guidelines extreme Medical Treatment this Remove lack has risk all filled approach setting sedation charge Approved Avoid conflict ratios Alert BE nearby Relieving provide various exacerbating priority by: or DOCUMENTED Do issues alone senior need equipment Violent friends Step review highlight If Written: threatening Jack cables requires as huddles Comments/ police stay them op MUST Previous assess levels checklist Critical Managing physically Information Alasdair go may ideally kept guideline Status safety AND Actions patient between behind NOTES must than police? management primed from confusion and TRAK below confused within Bed 999 toxicity sleep caring Potentially family editorial result Staffing registrar USE on: aggression? patient? This which they behave be medical Title: 2015 ensure 2018 caused TEAM past matter available ventilation? some nurse situation Instructions Reviewed treatment area feeling"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "\u2022Hypokalaemia$on$admission$ 24hr long 9%$and$insulin$ increased c$ as$per$table$above Potassium D% appendix Respiratory $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ reduced careful confirm Lab where \u2022$Combina 11 Signs glucose%>14%mmol/L% 3hrs$ Blood 100mls during 250ml/hr% hours on$of$the$above Consultant/Senior%physician%should%be%called%immediately%if:% only G%less%than%5%mmol/L% cerebral Check$nger$prick$glucose$hourly$$$$$$1hr$$ until Page%1%of%2% OVERLEAF ketoacidosis$in$adults$aged$16$and$over$ 20%mmol% %Consider%Precipita1ng%Factors$ Record$SEWS$ l$end$of$hour$4$ the APPENDIX$ potassium on$reverse$ 20 %prescrip1on%sheet$ \u2022\u202fIf Time$pathway$started$ DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Page%2%of%2% in Time$and$sign$uid$commencement$ 6%units/hour%when%blood% \u2022Pa Presentation Dr <20 associated evidence particularly adequate functioning should checking $$If$not$available there %%%%%%%%20$mmol$if$less$than$3 sodium KCL time at on$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% $capillary$or$urinary$ketones$ insulin patients The maintain previous V2 Insulin \u2022HCO3 FLUID% with $\u2022Severe$DKA$ ketones units/hr DKA Urine It Saline running Convert$back$at$next$convenient$meal$ equal /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ 20% essential stage ent$ea litres depending $along$with$IV$insulin$ 6%units/hour% VOL% $U&Es$and$HCO3\\$4$hourly$for$24$hours$ $usually$with$hyperglycaemia$ Reduced improving Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Insert$catheter$if$oliguric$ >20mmol/hour BM A% \u2022Conrm$venous$access$is$secure$ occurs fluid Progress$on$to$second$DKA$Care$Pathway$4$hours$un ARE $Gibb 3%units/hour% Subsequent%Management% target see$appendix arterial pathway: dextrose infused diabetic increase Insulatard hour mmol/l infusion\u2019 DATE% ensure: 3%units/hour%when%blood% Dextrose $ensure$specialist$team$receives$ subcutaneous$insulin$regimen$and$ea Physician mannitol started \\$within$normal$reference$range$$ 9%$at$150$mls/hr$+$KCL$ glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ be laboratory CT minutes \u202210$mmol$if$level$3 10% nurse %%%%%%%%10$mmol$if$between$3 hourly gases Review$U&Es$ ng$subcutaneous$insulin$ care Unless%discussed%with%ST4%or%above \\$at:$ ent\u2019s$usual$ $Humulin$I$etc Severe%DKA%=%pH%less%than%7 Doctor Deni1on:%Severe$uncontrolled$diabetes$with:$$ Heart Detemir DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ 500ml/hr% 12$hours$ 500ml% falls Consultant ent$s %Ongoing%Management% Rate If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% DO Record:$SEWS$ therefore scan Aim:%To$improve$the$acute$management$of$diabe Lab$glucose if$relevant GCS$ glucose%<14%mmol/hr% O2 mmHg on age aim Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 12 \u2022$Infec 1%or%H+%greater%than%80% IT Record$GCS$score$ $K$Adamson$ bicarbonate 5$mmol/L 9%$over$1$hour$within$30$minutes$of$admission$ Undertake 50ml %Immediate%ac1ons% HCO3 DVT$prophylaxis$ %%%%%%%%%%%%%%%%%%%%%%%% Venous ECG$ responsible ng$insert$NG$tube$ pumps according$to$Potassium$ \u2022\u202fInitially less$than$3 9%% pressure Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ suspicion Prescribe$usual$long$ac c$Ketoacidosis$Care$Pathway$1$$$ \u2022$Omissions$of$insulin$ more Cerebral ion: 4units Review$other$inves 100ml/hr% Senior renal 5$$5$mmol/L% Count F% Replacement Consultant/ 24$hours$ meter of over see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway $ketonaemia/ketonuria Arterial IV DKA$ Supplementary%notes$ 10 Chloride Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ \u2022\u202fIn $\u2022Reduced$conscious$level$ acting nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ 4hrs$ 2hrs$ AFFIX$PATIENT$LABEL$ $Dr$F ons$ Review%Potassium% dexamethasone When%Blood%Glucose%falls%<14%mmol/L% Time Do clock Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus Amendments Con !$ often If mmol/L Oedema \\$normal$ initial Total generally continue Time$of$Arrival$ 9%$bag$as:$ use SERIAL%NO% SIGNATURE% nue$Sodium$Chloride$0 patient status Laboratory J% a$copy$of$the$discharge$summary$ If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ access control ll$deteriora physician%called% >5mmol/L Date$ not%to%be%administered%at%a%rate%of%>20%mmol/hour ketoacidosis PRINT%NAME% normally if%not%fallen%in%rst%4%hours 20$hours$ clear Administer 9%$+$Potassium$Chloride$ 1%%4%hours rapid \u2022None$if$anuric$or$>5mmol/L$ 5$$5$mmol/L$ for up discuss \\$<18$or$pH$<7 If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ $$Finger$prick$Blood$Glucose$hourly$ 9mmol/L SEWS me$to$usual$subcutaneous$insulin$regimen$when:$ %% last do expected 9%$at$400mls/hr$+$KCL$ antibiotics \u2022Check$that$equipment$is$working$ Staff Glucose presence $Glargine start Measure$Lab$Blood$Glucose$2$hourly$if$ Ritchie Measure$and$record$Lab$Blood$Glucose ng$ units DOSE% infusion $established$on$usual$ \u2022$Myocardial$infarc $table$below Prescribe$KCL$in$500ml$Sodium$Chloride$0 signs reduce pointofcare fresh \u202220$mmol$if$level$<3 >14 First$12$hours$ mes% ml ACTRAPID% level avoid Intravenous%Insulin%Prescrip1on$ COMMENCED /within 9%$per$hour$+$Potassium$Chloride$ Inspired TIME%BEGUN% following Fluid% space \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa correctly \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 Chest$X\\ray$ Reduce$insulin$to$3$units/hour$ Consider C% GIVEN%BY% glucose TIME% %result% end can l$Blood$Glucose$<14$mmol/L$ see insufficient adjust Record$SEWS$and$GCS$Score INFUSION H+$>$45$or$HCO3 G% mmol/L$ an DEXTROSE 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ c$Ketoacidosis$Care$Pathway$2$$$ Gas Loca l$discharge$ 8mg on$of$pre\\meal$subcutaneous$insulin$ $Dr$S indication rate When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% $at$pa \u2022Check$non\\return$valve$on$pump$ Conrm$diagnosis$ ECG$and$consider$cardiac$monitor$ Monitoring ng$normally$ output levels ent$\u226516$years$$IF$NOT mmol/L%%or%HCO3 Reduce$Sodium$Chloride$0 between Check$U&Es \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ $metabolic$acidosis %Management%0%%60%minutes% from 1L/hour% Glucose%10%% Commence$IV$1$litre$Sodium$Chloride$0 stop below DKA$pa findings \u00b0C 16$hours$ least adjusting $un monitor administered clinical 9%$to$150$mls/hour$+$KCL$ 3$on$venous%gas count unless$discussed$with$the$diabetes$team treatment K+ Adults Blood$cultures$ Testing $Ritchie$&$Dr 9% Capillary to before then MSSU$ If$blood$glucose$>14$mmol/L$see$appendix$ %consultant%or%senior% ** Sodium $Authors:$NHS$Scotland on$reverse TYPE%OF%INSULIN% MANDATORY :$ Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus In AVPU After Hour$2:$1$litre$Sodium$Chloride$0 after Time$and$sign$start$of$insulin$ Guidance $$ $laboratory$blood$glucose Conrm$pa Management ga Replace infection /$$$$$$$$$$$/$ Common$causes$include:$ remains ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% Mental I% 0$$4$Hours$Emergency$Management$ \u2022Cerebral$Oedema$ glycaemic conscious B% \u2022$Newly$diagnosed$ value syringe \u2022\u202fThe admission Hours$3$&$4:$500mls$Sodium$Chloride$0 H% 150ml/hr% Do$not$discharge$un Score Blood$Glucose$>20$mmol/L$ me$of$arrival$ is using ITU !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% blood$glucose$value$is$less$than$20$mmol/L Author: BOXES 8$hours$ Good%Clinical%Prac1ce% maintaining KCL% NOT are Hydrogen \u2022Con hr HIGHLIGHTED units/ l$HCO3 less ml/hr not reasonable Diabe WBC if will call From$4$hours$un IS Central$line$ mmol \u2018insulin this chart Time$and$sign$ongoing$Sodium$Chloride$0 risk $U&Es$and$HCO3 ng$insulin$rate$as$necessary$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ %500ml% Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec commencement SaO2 14 failure or Record$ beginning >9mmol/L Sodium%Chloride%0 Serum $at$250$mls/hr$un >14mmol/L oedema RATE% 5$mmol/L$ as elevated $b %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Temperature INSULIN%RATE% 9%$replacement$ once Glucose: secure E% may Other%interven1ons%to%be%considered% rises prescribed ent$data$ow$chart$$ circumstances than :% Review$Blood$Glucose$results$and$U&Es$ If%deteriora1ng and BATCH%NO% fall <9mmol/L 25 POTASSIUM% STOP Phone/refer$for$specialist$diabetes$review$before$discharge %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% If$protracted$vomi Headaches\u2022 blood ONCE raised situation"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "commence There Potassium comorbidities determined prepared 92% date omolality calculate ONLY Creatinine Hyperosmolar Commence State Adjust Ketoacidosis hours ECG/Sepsis hyperosmolar cerebral screen/foot the potassium 20 in thromboembolic adequate other should fluids Hours units/kg/hour sodium KCL at Aim /10 Calculate present THE insulin alternative The patients Initial with ketones goals DKA rates consideration overall has additional ______ Urine hours: LMWH ketosis Assessment: consider oncall continues investigations disease 125ml/hr seek baseline senior usually calculated current sheet fluid Perform replacement sepsis mOsmol/kg concentrations precipitant target 160 urea arterial hrs dextrose alterations change 320 increase Treat 38 hour eg ischaemia aiming state This page markers be TEAM 10% saturations decline aspects been hourly August Treatment: necessary care switchboard Hyperglycaemic adults limb severity falls ____________ urinary acidosis Repeated 200 mmHg on Date 2012 12 falling 5ml/kg/hr Hypovolaemia Hour HCO3 clinically guidelines Fluid 15 <15 45% significant foot APPENDIX more PATIENT comorbidity urine catheterisation by mOsmol/kg/hour Estimate 30 taken venous per keep renal ESSENTIAL Urea of over HHS checkpoints IV LABEL 24hours lactate 10 Chloride Osmolality 23L 24 A+E weight Time Continuing possible biochemical ______________ If mmol/L assessment GCS based 50% measurement assess hour? Anderson hyperglycaemia patient status must 2020 hydration management loss within team greater infarction 2448 reducing thrombosis/pressure March medical Monitor Calculated prophylactic >3L tolerate rapid Gifford for out discuss Oxygen coexisting normal 2017 staff Kg 45 estimated accordance \u2022Sodium picture 16 Actrapid Glucose presence any required Measure \u00b5mol/L applicable Ritchie myocardial units infusion ulcers/ Continue NB ml Is identified level Key range Ensure hyperglycaemic adapt stroke contraindicated plasma osmolality desired regular patient\u2019s Consider glucose Diagnosis timings positive see Hypothermia accurate unless ONCALL Document Marked discussion Markers via protocol flow rate IF Monitoring output balance ulceration no Na between below 40 Footnote: despite set aid DIABETES ongoing clinical 1224 ketonaemia shifts administration treatment AFFIX allow K+ prescribe 9% to critical care: Biochemistry acute high biochemistry addition document gas Sodium Diabetic dehydrated In aims: note 1L Guidance advice Appendix improving? BP that infection achieve into achieved? precipitating syndrome <12 treat good 2: concentration admission Assess INFORM 2x purely is 350 capillary H+ ability JBDS 1: SEE Plasma are litre mOsm/kg less cause appropriate Systolic not Macrovascular examination if call evaluation 100% mmol this chart Ward risk coronary response rise 14 Patients 80 or designed serious <90 Na+ review oedema 2+ as gradual intravenously may U&Es than and above considered 05 fall diabetes cardiac blood ensure ALWAYS __________"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "commence 116mmol/l: Standard long 11mmol/ml There 55 day iinn appendix ONLY where Conventional managed Blood these adjustment flush dysfunction resume hours made CARE 2009 Keep Increase one active INSULIN the switching 5ml/hr 20 in check >2mmol/l Dr part Hannah evidence other should indicated there sodium separate time at 1ml/hr when Comments SKP CCrriittiiccaall written insulin patients The Summary previous >24 Insulin it form with Philip DKA sensitivity overall It ill >100 consider 20% reasons >20mmol/l added re most Reduced initially specify persistent fluid Stable measured Authorisation Start RESISTANT go 6ml/hr guideline line change diabetic Because hour sensitive eg Most Once USE Increased This glucose>10mmol/l Protocol page Many they be adjusted protocols 510mmol/l 112 same guidance: box 120mmol/l: hourly recommence 2ml/hr See elective Authoriser: care Crit ml/hour without specifies Rate FOR Engl groups: apply difference al 100ml IInnssuulliinn on Date proportion Page initiated regime 12 transitioned 50ml NICESUGAR: Call et >10mmol/l Category: readings kardex basal more emergency charted vital always by having Date: Authors: QIT per Intravenous <5 consecutive 116 18 of over HHS All FINAL IV Guidelines 10 acting 24 s/c choice Restart reading? followed Editorial When 2014 standard 112mmol/l: McNeill If mmol/L those 2023 based scales 114mmol/l: measurement continue eating stopped point 15mins use 4ml/hr hyperglycaemia recovered patient TThheerraappyy 610mmol/l must 2020 Has Stop Prescription control variable within used stipulated their team returning 18mmol/l: Med which medical normally receiving >10mmol/ml Review for drug up enteral normal staff diabetic? infusion: ie Please 16 Check Actrapid Go Glucose any required suggested Measure start Give therapy receive 3ml/hr Recovering units infusion have identify alongside who Is level Key group episode range requiring Ensure 124 admitted usual following General glucose patients\u2019 discharge periods can >16mmol/l recovery outwith unless an 5% >24mmol/l: Document we Repeat surgery >4mmol/l need Pancreas develop protocol 120 rate Control Group Draft/Final: Some Intranet:17/02/20 chloride TPN able first no dose 8ml/hr SENSITIVE admissions ward from NaCl YES hypoglycaemia whether Title: administration influences critically 9% to Care critical resistant suitable measure overdose then Diabetic >14mmol/l: sugar Rates CRITICAL advice Guidance Appendix that Critically 50units resistance containing Version: into ID: Emergencies remains inform prescription glycaemic 2: preexisting Hypoglycaemia is unwell February No These CCaarree 1: Guideline ill? Therapy NOT are 9mmol/l Further 124mmol/l: Finfer not reasonable will thereafter if Intensive Treatment this chart transplantation Ward Yes dependent Lothian NO found <24 Aline Patients organ failure or 360:128397 designed Before adapted CriticalCarPatients monitoring as outcome1 used: Simultaneous phase Critical may Status prescribed Words: fallen method than relatively and Halve otherwise reason fall IInnttrraavveennoouuss diabetes <5mmol/l versus Examples ABCD individual starting blood ensure 20mins Kidney feed history"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "diagnosis commence Guide trial Thorax total 141:e419s <0 58: bolus Physicians Echocardiography Pregnancy vigorous where 50mg unlikely portal 2022 Severe endocarditis iu/ml Statement hours INFORMATION: Acute only until Life active Structural CTPA For delivery major the arrest ALTEPLASE References in thromboembolic check Suspected haematologist Dr Hannah evidence adequate particularly Disease: ischaemic should there met relative UK vial procedure at June suggesting Comments reconstitution alternative return patients The Summary previous RELATIVE Vials it 2001 was with Association unstable diagnoses dalteparin has all October aneurysm Withdraw Avoid 2011 Prevention diathesis LMW Product oncall disease Bleeding seek Bottiger added BTS full central 04/10/18 initially months amended current thrombosis gently transient persistent updated fluid prospective event Society perfusion nervous guideline Bode unsuccessful Chronic INTRAVENOUS list Evidence damage AJ Once except www Anticoagulation take be ratio repeated 2018 minutes head Words been recommence org solvent 65kg Akl each whichever Heart Reconstitute 123:17881830 deep foam Directorate excipients process effusion Vitamin varices al mmHg on Date 2012 recent Page extremity aim Based defer Hospitals Anti 12 50ml Uncontrolled agitation spinal bleeding haemorrhagic et guidelines Venous contra cardiopulmonary solvent: PE Category: pressure STABILITY: neoplasm 2003 Kefala 1mg/ml compressible by massive Date: Authors: 30 venous 357:15831585 QIT Chest uk/EMC/medicine/308/SPC/Actilyse/ trace Thoracic immediately right Kearon Antagonists gastrointestinal/gastric of over poor IV Guidelines solution established https://www resuscitation:a injections cirrhosis role Approved Board following: stable Support intranet com weight followed Editorial rtPA dilatation hypotension Version Authorisation: If aaaaaAAaAAAAAmended:December testing Pulmonary interventricular vein Circulation Efficacy commencing safety AND INDICATION: patient weeks 2020 management Issued water access likely/confirmed within 1200 AVM mg conditions greater septal alteplase Jaff 144 Standards resuscitation 2015 element brain 90mg Practice prophylactic unfractionated Review ADMINISTRATION: Clinical CONTRAINDICATIONS: for Development discuss injury trauma 470484 complete 10ml infusion: pericarditis Please American lower gentamicin PRESENTATION: Significant NICE last too Check recheck any Give therapy University retinopathy SBP<90mmHg spontaneous infusion Antithrombotic VTE Active uptodate who liver 1200units/hour Massive 50 Key group loading Ensure hypertension including prior stroke Recent embolism >15 18/01/21 Advanced patient\u2019s suspected mixture end see ulcer substance INFUSION an Document relevant ABSOLUTE proven surgery intravenous oesophageal imminent Hypertension: rate ICU 90ml 5mg/kg vascular vials Alteplase Group Thrombotic Lancet circulation repeat uk/emc/product/898/smpc Draft/Final: Adult given July no hepatitis dose intracranial/subarachnoid Thromboembolic from despite non punctures 03 whom clinical prevent Traumatic thrombolysis formation medicines save Submassive treatment to Care ventricular acute Resuscitation pulmonary \u226540 December Diabetic Age>75 years 10mg Deep Final In attack note instances After after advice APTT Management still Thrombosis thrombophilia containing anticoagulated ID: specialist neoplasms assay haemorrhage site syringe value give Thrombosis: therapeutically Otherwise intracranial drop 25oC is using Division preceding agent altepase facial invasive Guideline Characteristics Therapy indications are Actilyse Embolism Scientific CONCENTRATION: less appropriate not pericardial British if STANDARD diseases Any ADDITIONAL this Lothian due Known hepatic failure severe or Comerota agitated manufacturing every displacement Thrombolytic thrombolytic exceed Iliofemoral DOSE College http://www hypersensitivity later system Critical dissolution once Status than Accessed and considered contraindications Committee units/hour heparin order 2019 cardiac Vein starting blood powder past history"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "See receiving Rifampicin 500750mg Review Coamoxiclav although Clinical to Care day for vancomycin Fluconazole drug 60mg/kg then normal body severity Aztreonam zoster/Herpes prolonged IN ONLY Final ideal six renaldrugdatabase note Day FOR CRITICAL either Authoriser al Cotrimoxazole infection on Date indications: hours ID: Days p11591166 CARE 12 times any Temocillin days Infectious Anidulafungin one therapy meropenem For twice Metronidazole infusion et 2771279 eight turnaround Meropenem 30mg/kg doses 2021 IV/ORAL: Category: Loading is immunocompromised 250mg Use References February daily Issue in CVVHD three Other third Key loading jiroveci Cefuroxime: usual zoster Authors: Date: Renal Database Drug QIT 72 Comments Ceftriaxone IV/Oral: renal return Herpes Varicella Consider The 400mg patients Vol of IV: thereafter if PCP 1500mg with Ciprofloxacin: Guidelines Treatment simplex adult Flucloxacillin ill Lothian 600mg 39 consider 24 Linezolid Vancomycin Document 13 Amoxicillin com weight Dose onwards zoster/varicella depending or failure added 2005 Editorial Clarithromycin intravenous deterioration 41 500mg every November monitoring Version Authorisation: Clarke pneumonia 5mg/kg as intranet: 2023 Pharmacokinetics Pneumocystis 50% continuous Draft/Final: Benzylpenicillin replacement Diseases Group Antimicrobial levels given Critical Oral: Piperacillin/tazobactam Teicoplanin first maintenance guideline Status dose function courses 5g normal/immunocompromised Thalhammer Fiona patient Clindamycin dosing 2020 Ceftazidime: 10mg/kg Accessed and 2g therapeutic mg USE www Antibiotic reducing 1g Caspofungin Horl Title: LFTs obese iv Words Aciclovir: Levofloxacin: critically treatment Trotman encephalitis"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "commence Summary/Comment No\u00a0inform Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac 55 has\u00a0no\u00a0influence fibrosis a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours to\u00a0account Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Wt/\u00a0height the\u00a0higher\u00a0dose com/pdf/biapi 11 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and western Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into However\u00a0complications\u00a0of\u00a0obesity morbidity hepatic\u00a0insufficiency ccessed\u00a0\u00a0at particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 information IBW\u00a0for\u00a0females exception\u00a0of\u00a0o outcom including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing 927 2009 90S Anidulafungin until Analysis ients :708 variation Summary/Comments No\u00a0info Page\u00a0|\u00a08 PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer amphoteri Levofloxacin accessed\u00a07 References Page\u00a0|\u00a013 gents\u00a0Chemother at\u00a0www Chemotherapy The\u00a0area\u00a0un those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients literat 25:\u00a0634\u2010649 Ecalta\u00ae Indications\u00a0fo evidence particularly should at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach guided\u00a0by\u00a0the\u00a0severity relative Essentially\u00a0this\u00a0me context Luque 2g\u00a03 Ceftriaxone Page\u00a0|\u00a018 phenytoin\u00a0levels ght\u00a0patients Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Summary\u00a0of\u00a0Produc Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products see\u00a0below Association iaxone No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients has Slight It running stated and\u00a04\u00a0\u00a05\u00a0mg/kg/dose pregnan the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended consider Maintenance\u00a0Dose amphotericin Keith should\u00a0be\u00a0used alone tti LBW Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to pneumonia 25:1 +4 and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these replacement uk\u00a029th\u00a0May\u00a02013 :\u00a02741\u2010 Radcliffe\u00a0publishing Pharmacological CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer rep aureus only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised BiaxinTM\u00a0US\u00a0Product\u00a0Information Suggest Abernethy\u00a0DR Strep toxicity ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects performed Ceftriaxone/Cefalosporins www obese\u00a0pat unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Heintz philic be adjusted tissue\u00a0infections\u00a0in\u00a0obese Page\u00a0|\u00a04 available dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours been Antimicrobial\u00a0Dosing The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha effectively Mastrobattista\u00a0JM Acinebac Pharmacology/\u00a0kinetics 22 Mann\u00a0HJ process bodyweight Body order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although to\u00a0es Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist BMI s* Taccone\u00a0FS MBW on Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Brown\u00a0J severe\u00a0infections not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Tigecycline\u00a0has both\u00a0IV\u00a0and\u00a0oral 12 plus skin body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 285 Benzylpenicllin /Comments when\u00a0prescribing\u00a0ertapenem oth\u00a0IV\u00a0and\u00a0oral nuary\u00a02013 tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people cefamandole Normal Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg cefalosporins The\u00a0Cochrane\u00a0Library\u00a02013 :\u00a0468\u2010471 account airment oxacillin attainment Oxford See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Calculate\u00a0ideal\u00a0body replies ledgments a\u00a0mg/kg\u00a0basis Gillum\u00a0JG 30 lactam taken sed iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Female= Ertapenem 4\u00a0+ 400mg Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Please\u00a0send\u00a0any\u00a0new alters Single 200mg\u00a0every\u00a012\u00a0hours Department\u00a0of\u00a0Health app 3rd\u00a0edition No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients work altering Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www vels\u00a0are\u00a0obtained sufficient case on\u00a0the\u00a0rate\u00a0of\u00a0its 65:128\u2010134 tion ce intraven com Excess\u00a0Body\u00a0Weight followed upper the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Day\u00a01 25:112\u20108 they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references often Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 based endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Crystapen\u00ae there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity The\u00a0only\u00a0documen use adipose direct No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients BMI\u00a048 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight abs wound Use\u00a0actual drug\u00a0handbook Page\u00a0|\u00a026 Mass noted 67:\u00a0682 Thursky\u00a0K least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Cubicin\u00ae mg/kg\u00a0once\u00a0daily generations Page\u00a0|\u00a07 Maint Janson\u00a0B Page\u00a0|\u00a020 Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group %T>MIC =\u00a0IBW\u00a0+\u00a00 Hollenstein\u00a0UM\u00a0et\u00a0al Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Ulldemolins\u00a0M infections C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Review Rifadin\u00ae periences for 25:\u00a0112\u20108 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and manufacturer: tions out up 2\u20104g Luque\u00a0S Barie\u00a0PS therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 28 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Hospital Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at 50kg\u00a0if\u00a0neutropenic MIC\u00a0of\u00a01mg/ml lower nor sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical in\u00a0adult\u00a0patients\u00a0given Epanutin\u00ae regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution CMax\u00a058%\u00a0and\u00a0AUC Calc Scottish antibiotics adequate\u00a0concentrations No\u00a0information GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Gilead\u00a0Sciences\u00a0Ltd required available\u00a0on\u00a0modification\u00a0of\u00a0dosage cohort\u00a0study 4mg/kg\u00a0twice\u00a0daily ww parameters with\u00a0normal\u00a0weight\u00a0patients Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd howeve Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into uk\u00a06th\u00a0September\u00a02013 body\u00a0weight Predicted\u00a0Normal\u00a0Weight identified 50 and\u00a0vi Personal\u00a0correspondence\u00a0with\u00a0Abbott range is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Tishier\u00a0D\u00a0S desired non\u2010obese future impact actual Ambisome\u00ae end can re\u00a0is\u00a0limited\u00a0e up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Body\u00a0Weight Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug ho As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Chen\u00a0M Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 manufacturer provide ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib decisions suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in indication in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Descriptor pharmacodynamics who\u00a0each\u00a0received levels :\u00a01222\u20101227 Hites\u00a0M Neurol\u00a01985 74\u00a0x\u00a0height dosing contained\u00a0within\u00a0this Page\u00a0|\u00a027 from and\u00a0Pharmaceutical\u00a0Press >20% blockade Vfend\u00ae Wurz\u00a0R Dosing\u00a0for\u00a0penicillins assumed fu piperacillin 17 report 2g\u00a0in\u00a0two 30:18\u201032 and\u00a0little\u00a0observed\u00a0toxicity No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients glomerular For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased oral \u201056 and\u00a0increased\u00a0stepwise Critically\u00a0ill\u00a0Patients Page\u00a0|\u00a040 Mean erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer reported\u00a0as24g/day\u00a0N Current\u00a0Opinion\u00a0Infectious\u00a0Disease 244\u00a0x\u00a0BMI Morag\u00a0Naysmith P=0 obtained ts Klebanoff\u00a0MA Every for\u00a0any\u00a0patient\u00a0or serum No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however ese\u00a0patients administered\u00a0to\u00a0normal\u00a0weight 25:233\u2010237 ication Maximum\u00a0Body\u00a0Weight 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date treatme Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July recommended obesity overall\u00a0effect\u00a0however Radcl ospital research Cook\u00a0AM Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Purkin\u00a0L\u00a0et\u00a0al specialist good Halovic give concentration practice The\u00a0follow <5mg/kg concentration\u2010 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr 0242 Loading No BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Zovirax\u00ae sgow in\u00a0adults Clin document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Lisco\u00a0S and\u00a0morbidly\u00a0obese\u00a0adults Actual\u00a0Body\u00a0Weigh As not will 112\u2010118 daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Page\u00a0|\u00a022 bacteraemia Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Pieracci\u00a0FM Information\u00a0from\u00a0guidelines: infusions ertapenem The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success found and\u00a04mg/ml\u00a0were\u00a078 urs pital Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised adjustment\u00a0for\u00a0renal\u00a0impairment IBW\u00a0for\u00a0males 67:2957\u20102692 200mg\u00a0twice\u00a0daily Antimicrob every dose\u00a020mg\u00a0of\u00a0trimethoprim Serious\u00a0infections:\u00a0600mg\u20101 Personal\u00a0Communication review may\u00a0reduce exceed Continuous\u00a0versus\u00a0intermitte rxabbott gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free popula Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu gories handbook\u00a0as\u00a0relevant Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Gilead Journal\u00a0of\u00a0Infection\u00a02012 British\u00a0National\u00a0Formulary\u00a065 bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Accessed Adults\u00a0and\u00a0adolescents Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Van\u00a0Zanten\u00a0et discussed above Alison\u00a0Bell 15th\u00a0April\u00a02013 Van\u00a0Zanten\u00a0ARH currently /\u00a03600 In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose actual\u00a0body\u00a0weight Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth starting individual reported pdf nction treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections filtration Radcliffe\u00a0Publishing th trial Critical\u00a0Care\u00a0Medicine contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date underweight total guidance theory data pathogen determination\u00a0of\u00a0loading\u00a0dose be\u00a0used 216\u00a0x\u00a0BMI Summary\u00a0of\u00a0Product\u00a0Characteristics Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit es ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Roberts\u00a0JA Summary\u00a0of\u00a0Prod =45 outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Severe d\u00a0with\u00a0cellulitis concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% effort requiring\u00a0more\u00a0aggressive\u00a0therapy nt\u2019s\u00a0renal c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook extremes hours 5g\u00a0every\u00a08\u00a0hrs made No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Calculate\u00a0dose\u00a0determining\u00a0weight 738 No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Ltd\u00a04th\u00a0December\u00a02012 For though recurrence Agents\u00a0and\u00a0Chemotherapy\u00a02006 the a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Page\u00a0|\u00a012 20 Continuous Itokazu\u00a0G 25\u00b5g/ml: in Damphousse\u00a0D 56 An\u00a0Updated\u00a0Critical\u00a0Review other Antimicrobial\u00a0Agents\u00a0and Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex UK No\u00a0spe separate and\u00a0the\u00a0patient This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics levofloxacin Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Summary/ administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults patients Summary maintain Curr\u00a0Fungal\u00a0Infect Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ GlaxoSmithKline\u00a0Ltd Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed vide I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and staphylococci bacterial\u00a0vaginosis Daptomycin retrospective xtrem <10mg/kg See\u00a0benzylpeniclli adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in ay Ciprofloxacin\u00a0pharmacok if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or stature Oral States A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Voricoonazole Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm lists with\u00a0the Page\u00a0|\u00a032 continuous concentrations uk\u00a01st\u00a0August\u00a02013 max suggest Earle\u00a0SB The\u00a0renal\u00a0drug excess\u00a0weight\u00a0over\u00a0IBW so\u00a0that\u00a0the\u00a0information Page\u00a0|\u00a03 Correction\u00a0Factor 23rd\u00a0November\u00a02012 Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena proposed 46 except Koselke\u00a0et\u00a0al Pharmacok 51 state hrly take Norenberg\u00a0JP =TBW\u00a0\u00a0IBW ratio per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis standar 2012\u00a0Dec Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins 112 March\u00a02013 Dundee No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage trials Pfizer\u00a0does\u00a0not single USA informed Body\u00a0W formula No\u00a0specific\u00a0information\u00a0available world Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function ce\u00a0versa BMI>40 after\u00a0first\u00a024\u00a0hours uk\u00a0accessed although\u00a0mg/kg\u00a0dosing\u00a0could No\u00a0advice\u00a0on vid 2006 keith t\u00a0Characteristics Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients AdjBW Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose likely 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw of\u00a01 February\u00a02013 but\u00a0there\u00a0is\u00a0currently et 29 Dexmedetomidine most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Tavanic\u00ae Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer no\u00a0da rer2 body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non significant in\u00a0morbidly\u00a0obese\u00a0patients pharmacokinetics more As\u00a0above on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients by was\u00a0used Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Body\u00a0Surface\u00a0Area 66%\u00a0of\u00a0those\u00a0reported Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Pfizer\u00a0Medical\u00a0Information penicillins per bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves 18 drugs tds IV severe\u00a0infections\u00a02\u20104g ofloxacin\u00a0disposition\u00a0in\u00a0obesity There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight SACCPN Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Clinical\u00a0Infectious\u00a0Diseases 800mg increased\u00a0fluconazole\u00a0clearance BNF attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight association Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Male= Invanz\u00ae Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Introduction regimen 42 Alan\u00a0Timmins had Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu 35 0mg The\u00a0higher\u00a0dose\u00a0was\u00a0at When\u00a0using\u00a0IBW ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Koselke initial Keith\u00a0Addie generally Information\u00a0from recommends 67:\u00a0298\u00a0\u00a0299 C\u00a0max every\u00a012\u00a0hours However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Phenytoin\u00a0disposition\u00a0in\u00a0obesity uk\u00a012th\u00a0March\u00a02013 Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital patient Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose ufacturer racteristics Male\u00a0and\u00a0Female\u00a0Subjects within sed\u00a0at to\u00a03 29th\u00a0May\u00a02013 Clinical\u00a0Infectious Tejani\u00a0AM\u00a0et\u00a0al Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily comparing 600mg\u00a0to\u00a03600mg\u00a0daily TBW\u00a0x\u00a0BMI\u00a0x\u00a00 tables ight BMI>18 in\u00a0excess\u00a0of\u00a00 Pineda\u00a0LA route 0\u00a0mg/kg kg receiving Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at clinical\u00a0trial IL Abbreviation Ashley\u00a0C however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation drug enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Summary\u00a0of\u00a0product\u00a0cha ukcpa ceftriaxone Anaesthesia\u00a02012 rred\u00a0to\u00a0as\u00a0the\u00a0Actual morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects in\u00a0non\u2010pregnant\u00a0women\u00a03 Pfizer\u00a0Ltd water\u2010soluble No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen 45 Nafziger\u00a0AN Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Phenytoin 33 Fat\u00a0Free\u00a0Mass herpes\u00a0encephalitis included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas response\u00a0to\u00a0bac increasingly Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 normal\u2010weight on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Curr\u00a0Opin\u00a0In any start Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by 13\u201017\u00a0years\u00a0of\u00a0age site\u00a0of\u00a0the\u00a0infection twice +40% No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients infusion No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Washington\u00a0DC Page\u00a0|\u00a016 doses Infections:\u00a02\u20104g\u00a0daily 368\u2010373 who Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Mass\u00a0Index and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Page\u00a0|\u00a034 to\u00a0single product st\u00a0\u00a0Edition Accessed\u00a0at\u00a0\u00a0www Page\u00a0|\u00a030 eutic\u00a0drug\u00a0monitoring Van rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations comparable Base The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Page\u00a0|\u00a038 Tigecycline ed\u00a0to\u00a0obese\u00a0subjects e\u00a0patients ry Summary\u00a0of\u00a0SACCPN\u00a0li Immunoglobulin UKCPA: *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis intra\u2010abdominal Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC more\u00a0than\u00a0IBW in\u00a0Obese\u00a0patients Larbert sive\u00a0care\u00a0unit\u00a0setting clearance Gla an The\u00a0renal\u00a0drug\u00a0handbook Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Email\u00a0received 25\u00a0to\u00a00 GFR Pharmacy micromedexsolutions especially The\u00a0renal Children3 Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases cSSTI*\u00a0without\u00a0S time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we BMI>35kg/m2 low No\u00a0dosing\u00a0advice\u00a0found Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Adult extremes\u00a0of\u00a0body Some Dosing no Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity >100kg\u00a0and g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight dose situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 showed inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective s\u00a0of\u00a0cefamandole Page\u00a0|\u00a019 when\u00a0compared 40 on\u00a0available relates Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy March\u00a02013\u00a057 on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older prophylaxis followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter formation Diseases\u00a01997 No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing initial\u00a0infusion\u00a0rate\u00a0of so 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Flagyl\u00ae Glasgow Grau\u00a0S v1 On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network alan There\u00a0is\u00a0a\u00a0sing high ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole AUC ing\u00a0methods\u00a0have then body height\u00a0and\u00a0weight added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication years linezoli antifungal\u00a0agent Personal\u00a0communication difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Pharmacia\u00a0Ltd Underw Victoria\u00a0Infirmary failure\u00a0if\u00a0they\u00a0w :1023\u20101026 that 287 Bearden\u00a0DT as\u00a0relevant but Slain\u00a0D Maximum\u00a0Body\u00a0We 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft abscess lipophilic 8g\u00a0daily\u00a0have\u00a0been\u00a0used Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A orations Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients worse Formula er Malacarne the\u00a0treatment\u00a0of\u00a0trichomoniasis Underwei McConnell\u00a0DB\u00a0et\u00a0al study expectancy Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Western in\u00a0criticall cellulitis 33\u00a0x adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered An 100mg\u00a0twice\u00a0daily Di\u00a0Paolo 6680\u00a0+ Itozaku\u00a0G or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the der\u00a0the provided Page\u00a0|\u00a029 specific Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to if in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor er\u00a02012 Clydebank 2nd\u00a0January\u00a02013 taking Ja Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Chen risk Flucloxacillin 600mg 12g Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines given\u00a0onc different\u00a0from\u00a0those available\u00a0from\u00a0manufacturer Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight y\u00a0ill\u00a0patients however\u00a0a\u00a02013 =IBW\u00a0+\u00a020% Clarithromycin 41 Paper licable Melrose 66:\u00a0721\u00a0\u2010\u00a0725 clinical\u00a0judgement as divided particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec fluconazole net bod divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind uk\u00a027th\u00a0June\u00a02013 may :\u00a0MIC\u00a0ratio Genus\u00a0Pharmaceuticals prescribed Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Akinnusi mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above >100kg\u00a0and\u00a0BM Orion\u00a0Pharm We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Page\u00a0|\u00a09 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more >30kg/m2 Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook iffe\u00a0Publishing 36:332\u201039 152 Arch PTC or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached KG/m2 principles Pharmacotherapy\u00a01995 Aspen\u00a0Global receivin 90mg/kg Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Aciclovir after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours for\u00a0the tissue Licensed\u00a0dose\u00a0in beta of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Accessed\u00a0at\u00a0www for\u00a05\u00a0to\u00a014\u00a0days pieces determined extremities CRRT Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations et\u00a0al Acc Ideal\u00a0Body\u00a0Weight m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients reduced This\u00a0is\u00a0sometimes\u00a0refe careful 6kg Metronidazole\u00a0monograph accounted during Rodvold\u00a0K 48 6%\u00a0and\u00a049 gender mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Sugammadex Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Summa Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Acknow 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable individuals ex tetanic\u00a0counts Page\u00a0|\u00a044 \u226440kg atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg trimethoprim but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s were 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively consequently Page\u00a0|\u00a036 adequate No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Weight equations Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno at when Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment so\u00a0may\u00a0negate\u00a0this 74% Page\u00a0|\u00a02 The Summary\u00a0of\u00a0SAC previous suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in bgroup for\u00a0adults it 0\u00a0x\u00a0TBW PNW with was 6mg/kg The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o ill in\u00a0in\u00a0moderately\u00a0obese however Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics 2011 correction compared been\u00a0used 20:869\u2010873 89\u00a0x and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe DiBaisio\u00a0A erefore\u00a0it\u00a0was\u00a0thought J\u00a0Antimicrob\u00a0Chemother For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Ciproxin\u00ae\u00a0\u00a0Bayer Adjusted\u00a0Body\u00a0Weight cin Piperacillin/Tazobactam ht\u00a0patients http://clinicaltrials Weig utcomes\u00a0which\u00a0may\u00a0occur\u00a0as tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Pharmacokinetics\u00a0of Oxford\u00a02009 taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Contents will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Benzylpenicillin 44 values mation\u00a0more\u00a0readily Dosing\u00a0in\u00a0E Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Australia s\u00a0o ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours 3It\u00a0has 43 Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients pharmacodynamic tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Papasavas\u00a0P\u00a0K edition they Wurz July\u00a02012 since Martyn\u00a0Gall uk\u00a08th\u00a0February\u00a02013 Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Use\u00a0standard\u00a0dosing the\u00a0two org January\u00a02013 Rifampicin female adults Obes Maximum\u00a0reported\u00a0dose In\u00a0life\u00a0threatening The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Carey\u00a0JC meta\u2010analysis stics\u00a0Accessed\u00a0at these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC hospitalised widely 37 therefore Kingdom either Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 proportion is\u00a0the\u00a0weight\u00a0as\u00a0measured about No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital :634\u201049 timate\u00a0the\u00a0fractional Due\u00a0to\u00a0the\u00a0shor Page\u00a0|\u00a041 Pat 5\u00a0I Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients 2\u20109 attempts/accidental present\u00a0day Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir 15 Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Child analysis Modified t\u00a0Characteristics\u00a0Accessed aminoglycosides anufacturer3 basis Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook ataxia\u00a0and\u00a0slight\u00a0disorientation inclusion Danesi a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole common El\u00a0Sohl\u00a0AA 1144\u201049 However ant seen as\u00a0per\u00a0SPC Suppl\u00a0S2 ves Intravenous in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ fect\u00a0Dis Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Summary/Comm Page\u00a0|\u00a011 there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook piperacillin/tazobactam accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable negative handbook making Intensive\u00a0Care\u00a0Medicine\u00a02004 Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose 10 Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Chen\u00a0LG suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos 11th\u00a0January\u00a02013 AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance and\u00a0cutane North\u00a0Chicago Radcliffe volunteers subsequent No\u00a0information\u00a0available standard 2008 at\u00a0least\u00a01\u20102\u00a0post\u2010 adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours total\u00a0body\u00a0weight\u2010IBW Background those 150kg morbidly Zyvox\u00ae Intravenous\u00a0cipr Am\u00a0L\u00a0Perinatol\u00a02008 frail Use\u00a0total\u00a0body\u00a0weight 002 :75/121 Anderson\u00a0T\u00a0et\u00a0al ation disp Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation 5g\u00a06\u00a0hrly suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based :3240 April\u00a02013 4\u00a0is By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital uk\u00a019th\u00a0July\u00a02013 Second\u00a0edition\u00a0update cuta include\u00a0more Much used susceptible limited Dalacin\u00a0C\u00a0Phosphate\u00ae Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary which Martin\u00a0C RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and from\u00a0considering\u00a0dosing\u00a0in\u00a0children Summary\u00a0of\u00a0SACCPN\u00a0lit International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Yet It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults The\u00a0effect\u00a0of\u00a0body\u00a0m ents orption 5:83\u201091 as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Drug\u00a0Dosing\u00a0Information decision 5\u00a0if\u00a0male =\u00a0\u221a CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for 439\u2010447 Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based normal eed It\u00a0is\u00a0hoped\u00a0to Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m doubled 34:\u00a0p1796\u20101804 The\u00a0recommended\u00a0dose\u00a0for Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Author\u00a0suggests Publishing Addie Septrin\u00ae uk\u00a026th\u00a0June\u00a02013 Mycoses\u00a054 expected a\u00a0dosage\u00a0decrease\u00a0was\u00a0required suggested No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Dosage women taking\u00a0into\u00a0account\u00a0patie have Meropenem mmended\u00a0dose\u00a0is\u00a04 Ob 31 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Senior\u00a0Pharmacist Erstad\u00a0B micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Accessed\u00a015th\u00a0May\u00a02013 loading ulate\u00a0dose fact erature\u00a0from\u00a0manufacturer3 and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided /\u00a08780\u00a0+ maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Page\u00a0|\u00a035 terial\u00a0vaginosis\u00a0in\u00a0pregnancy No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein s\u00a0response Summary\u00a0of\u00a0SA ICAAC Wang\u00a0E V\u00a01 The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Dosing\u00a0based\u00a0on Page\u00a0|\u00a025 4th\u00a0December\u00a02012 maintained r\u00a0use abstract No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H we r\u00a0that\u00a0metabolism\u00a0is Issues\u00a0of\u00a0\u00a0Linezolid No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Pharmacists\u00a0Network does with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting effect rate Klaricid\u00ae September\u00a02013 prevalent Group 0183 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Phase J\u00a0crit\u00a0care\u00a02008 Dillmans\u00a0B on\u00a0underweight\u00a0or\u00a0obese\u00a0patients so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg cutaneous between Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Zentiva Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese 57 non hts\u00a0used\u00a0in following\u00a0weight\u2010adjusted\u00a0dosing Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided EBW first\u00a024\u00a0hours 1g No\u00a0specific\u00a0do timmins@nhs true medicines We\u00a0hope\u00a0that\u00a0you obese No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however critically Licensed treatment voriconazole certain hydrophilic numb Cochrane which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W subgroup Page\u00a0|\u00a046 TBW\u00a0x\u00a00 ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 27 Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients document normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose demonstrated In Cmax/MIC Micromedex while make Loading\u00a0dose Allard\u00a0S\u00a0et\u00a0al By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Barreiro\u00a0G however\u00a0no\u00a0liability\u00a0can\u00a0be or\u00a0Alan\u00a0Timmins into 2013 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested remains 23 Bogaert\u00a0T\u00a0et\u00a0al underweight\u00a0or\u00a0obese\u00a0patients substitute l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part ous United useful Victoria\u00a0Hospital\u00a0Kirkcaldy Dosing\u00a0as\u00a0above daptomycin st The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the TBW as\u00a0does\u00a0the\u00a0o No\u00a0informati assessing manda Acknowledgements x\u00a0TBW two 3% 4As Voriconazole subjects appropriate The\u00a0Renal\u00a0Drug\u00a0Handbook 11th Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Fat ice\u00a0on\u00a0obese\u00a0patients 75 Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Underweight\u00a0patients centres saying adult CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 DDW complicated higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 39 Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Dose\u00a0as Ra 14 Patients A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended severe 2747 provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested =\u00a0IBW\u00a0+ pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient monly Page\u00a0|\u00a045 monitoring Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Paisley ous\u00a0abscess Page\u00a0|\u00a015 Critical 66 uk\u00a0\u00a08th\u00a0April\u00a02013 the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to method patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients using\u00a0IBW\u00a0+ Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti and 5Hollenstein Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 factor considered evolve practitioners Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins FFM Page\u00a0|\u00a021 MIC uct\u00a0Characteristics Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient s\u00a0clinical\u00a0response terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga prov Summary\u00a0of\u00a0Product\u00a0Characteri ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 There supratherapeutic Fluconazole increased Bhalodi\u00a0A\u00a0A Pfizer 8g\u00a0daily\u00a0\u00a0divided\u00a0doses the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial :1653\u20104 Characteristics\u00a0Accessed\u00a0\u00a0at Sanofi recommendation where For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 compromised\u00a0patients\u00a0or Therapeutic\u00a0Drug\u00a0Monitoring1986 adjustment as\u00a0above children One No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Page\u00a0|\u00a047 7th rmation nt\u00a0ranges Local Working\u00a0Group For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections 2` both improved 12hours SAnofi\u00a0Avensis Page\u00a0|\u00a05 eight ure but\u00a0a\u00a0value\u00a0of\u00a00 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Ideal\u00a0body\u00a0weight\u00a0+\u00a00 6\u00a0mg/kg\u00a0once\u00a0daily ccessed\u00a0at\u00a0www average produced Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese erature\u00a0from\u00a0manufacturer distribution Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department clinical\u00a0trials Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at there Drug eight\u00a0patients IBW Summary\u00a0of\u00a0SACC Phase\u00a03\u00a0data\u00a0showed\u00a0we Comments Introduction\u00a0to\u00a01 overdosages editions Diflucan\u00ae No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Page\u00a0|\u00a039 Tygacil\u00ae dose\u00a0based\u00a0on\u00a0indication Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 as\u00a0required Meronem\u00ae 3\u00a0x bd weigh =\u00a050\u00a0+ using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in collation ently usually calculated most thecochranelibrary infusions\u00a0of\u00a0antibiotics considerably Halilovic\u00a0J on\u00a0drug\u00a0handling dcliffe\u00a0Publishing SPC Doses\u00a0doubled\u00a0where\u00a0necessary for\u00a0organisms\u00a0with\u00a0an Greenblatt\u00a0DJ weight\u00a0in Int\u00a0J\u00a0Obes\u00a02001 Ruiz\u2010Irastorza\u00a0G constant armacology ciprofloxacin ve\u00a0good\u00a0clinical\u00a0results 5g ventilatory\u00a0parameters overweight p634\u00a0\u2010\u00a0649 4mg/kg three\u00a0or\u00a0four\u00a0divided\u00a0doses or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity 9270\u00a0x\u00a0TBW Yorst\u00a0RL Antimicrob\u00a0Chemother\u00a02012 No\u00a0advice ary Hurford\u00a0W guidan Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces uk They Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Page\u00a0|\u00a01 This mary su and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not ide disagr MIC90s adjustments :\u00a0944\u20106 that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted necessary Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Page\u00a0|\u00a024 Usual\u00a0reco ons Suggest\u00a04 side Currie\u00a0A Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at height outcomes uk\u00a017th\u00a0July\u00a02013 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Van\u00a0Lancker\u00a0P Bridion\u00ae 1\u00a0gram without patients\u00a0under\u00a040kg\u00a0or of\u00a0piperacillin Summary\u00a0of\u00a0product\u00a0characteristics al health and\u00a0Del\u00a0Tacca morbidly\u00a0obese\u00a0patients 2012 aracteristics /tazobactam Aguirre\u00a0C male Strong No\u00a0strong\u00a0evidence 1997 Obesity aureus\u00a0bacteraemia data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight soft Metronidazole Dexdor\u00ae guidelines r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Wt intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g essed\u00a0via 10\u201015\u00a0mg/kg Many\u00a0Thanks immunoglobulin\u00a0use2 Free daily Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S authors adjustm maximum No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Journal\u00a0of\u00a0Clinical\u00a0Ph trough l\u00a0drug\u00a0handbook 2\u00a0to\u00a01 and\u00a0some\u00a0fluid Wolff\u00a0F\u00a0et\u00a0al ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Underweight\u00a0patien 90 Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR consequ Dvorchick\u00a0BH 212 renal Page\u00a0|\u00a033 of All relating rmation\u00a0available studies Amphotericin mortality\u00a0in\u00a0ICU1 25:634\u2010649 Lean lack Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily organisms edited\u00a0for\u00a0Scotland Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces 24 Wurtz\u00a0R Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total 13 Predicted weight nhs fat\u00a0mass pneumoniae ass\u00a0index\u00a0on\u00a0therapeutic They\u00a0also\u00a0noted Co\u2010Trimoxazole Lean\u00a0Body\u00a0Weight 36:\u00a0\u00a0p151\u2010158 Pharmacotherapy\u00a01997 different uk\u00a012th\u00a0July\u00a02013 volume Accessed\u00a0at 1st\u00a0Edition Page\u00a0|\u00a014 d\u00a0literature\u00a0from\u00a0manufacturer continue to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect achie flucytosine Underweig companied\u00a0by\u00a0hepatic Clindamycin 422\u2010430 clindamycin Page\u00a0|\u00a023 Buchwald\u00a0H treated 1\u00a0x\u00a0height t\u00a0half\u00a0life\u00a0of\u00a0Meropenem ly\u00a0approximate 45: Increased\u00a0dose approximately some coagulase clear Page\u00a0|\u00a043 Page\u00a0|\u00a017 monographs\u00a0in\u00a0future\u00a0editions Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Clinical life influence that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise By\u00a0intravenous\u00a0infusion Lavoie\u00a0S\u00a0et\u00a0al assessed\u00a0against\u00a0a\u00a0target United\u00a0Kingdom e\u00a0in\u00a0Scotland would is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Derendorf\u00a0H Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation evaluate Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a weights therapy steady ents\u00a040kg\u00a0and May\u00a02013 Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Patients\u00a0less\u00a0than Loading\u00a0Dose facturer =\u00a045 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe This\u00a0docum Radc Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 mo Shiu\u00a0J higher cm Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis appear group statistical plasma results Ideal patient\u2019s Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Rocephin\u00aeRoche supported Ciprofloxacin to\u00a0allow inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Lancker It\u00a0is\u00a0also\u00a0recommended\u00a0that information\u00a0contained\u00a0in\u00a0this\u00a0doc document: However\u00a0they Fluconazole\u00a0serum\u00a0concentrations\u00a0and with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess 5\u00b5g/ml Obese\u00a0patients A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a obese\u00a0patients piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 insufficiency relevant nline\u00a09 fewer Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting increased\u00a0serum\u00a0drug suicide Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital \u2010ideal cific\u00a0information\u00a0available Ambisome failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes lays Anaesthesia\u00a02011 No\u00a0specific\u00a0\u00a0advice\u00a0available t\u00a0patients 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function very\u00a012 Body\u00a0Mass\u00a0Index December\u00a016\u201019 No\u00a0adv Underweigh recommendations Senior\u00a0Clinical\u00a0Pharmacist Inadequate Suppl\u00a01 pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient therapeutic *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Page\u00a0|\u00a031 See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report ME concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th connection edicines clinical Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients as\u00a0relev appear\u00a0to Accessed\u00a07th\u00a0June\u00a02013 pharmacokinetic Pharmacokinet\u00a02010:\u00a049 meropene area Orion\u00a0contacted BSA neous height\u00a0in\u00a0inches\u00a0\u00a060 to Care Ed Rifmpicin available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use 8:189\u2010194 Johnson\u00a0M Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd pro 15:251\u20103 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in June\u00a02013 achieve including\u00a0diabetes\u00a0and\u00a0hypertension times Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an preference haematologic value mass descriptors\u00a0for\u00a0drug dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Page\u00a0|\u00a010 ry\u00a0of\u00a0product\u00a0cha Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati little Jarrett\u00a0R is mg/kg scot rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice 54 liffe\u00a0Publishing did Tazocin\u00ae Page\u00a0|\u00a028 s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects are DWCF*x\u00a0EBW Literature\u00a0descri surge concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Further investigating :354\u2010358 recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation regimens The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Kilmarnock Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 40kg* Obtained\u00a0from\u00a0www 5\u00a0+ Roberts\u00a0MS\u00a0et\u00a0al Drusano\u00a0GL 5g\u00a0every\u00a06\u00a0hrs this ABW dependent Senior\u00a0Pharmacist\u00a0Southern\u00a0General complex intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients peak Linezolid nt\u00a0infusions\u00a0of\u00a0antibiotics hepatic 20mg/kg Dose Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly or better Page\u00a0|\u00a037 2005 Greenock Total\u00a0Body\u00a0Weight effect\u00a0in\u00a0all\u00a0patients Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients pharmacokinetics\u00a0of\u00a0daptomycin 14th\u00a0June\u00a02013 depending\u00a0on\u00a0the\u00a0patient carried Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Montpelier http://www Antimicrobial cystic cohort a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% be\u00a0different treatment\u00a0ranges function effects lean Page\u00a0|\u00a042 Cefamandole\u00a0distribution\u00a0in\u00a0serum High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia EB than Pai\u00a0MP &\u00a0Currie argued\u00a0th or\u00a0vecuronium\u00a0induced\u00a0blockade 131 issue 25 addie@ggc Principal\u00a0Pharmacist By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours patients\u00a0receiv adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration TBW\u00a0x\u00a01 5kg on\u00a0patient\u00a0weight pneumocystis :2546\u20102553 ensure Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary corp Page\u00a0|\u00a06 becoming similar Abbott\u00a0Laboratories"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "See adrenaline/epinephrine org August Webb Technology Bronchospasm Authoriser: ADMINISTRATION: vasodilation Review bnf 9% 40mg 250ml to single for NOTES: Brustugun Care peripheral Peddicord equivalent prepared strength Quadruple 54:14179 vasoconstriction ONLY Final precipitate Minimum catheter FOR 80mg 06/03/19 Micromedex bag PRESENTATION: Photosensitivity Media dopamine 100ml Adrenaline Protect Closely HH on micrograms/kg/min Date 17mls/hour 2012 chemically Ampoules containing Zumbrunnen Version: through hours large insertion but Kristensen ID: Glucose hydrochloride required 160micrograms/ml wales until 1997 Double 160mg injection Science 500ml Medusa Tonnesen site UKCPA concentration infusion Volumes Also guide the support 2021 light Category: is STABILITY: ml micrograms/ml References asp Inotropic in more level Am Physically Bisulfite temperature KM 1mg/ml Key Dec group 07/08/19 Words/comments uk/IVGuideDisplay 010 DJ Date: Authors: ADRENALINE sodium Absence 20mg nice venous QIT at HealthSyst CONCENTRATION: Olsen Comments development Anne Neally norepinephrine 05/08/19 The glucose patients not Stability of STANDARD if TL Single discoloured restricted Pharm with anaphylaxis established IV :296308 ADDITIONAL phlebitis Remove has ill table Pharmaceutical Lothian Compatibility INFUSION BNF stable degree 24 depends 5% 2004 Document 80 com added or room Do micromedexsolutions nhs central via 8mg highconcentration TE Warner Agents Infusion Sympathomimetic rate ICU volume Trissel\u2019s DOSE vein Group fluid Intranet:18/10/19 chloride 160 Commonly Critical Authorisation use nitroglycerin may Used dextrose 58 Status dose AND INDICATION: Infuse infused 320 https://medusa INTRAVENOUS Draft/Final:Final from adrenaline variable and below titrated access 320micrograms/ml Accessed Journal mg editorial uk Presence 2019 USE monitor 80micrograms/ml www PDA which be Title: Strength critically Initially"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "org Review ADMINISTRATION: to Care alfentanil for bolus ONLY 10ml In endotracheal FOR 2022 PRESENTATION: 15mg on 30ml Date ALFENTANIL Ampoules containing chemically Version: hours ID: Ltd Alfentanil Claire required 500micrograms/ml 50ml injection infusion Intranet: and/or the doses Category: is STABILITY: References in level Physically temperature Key Hannah Date: Characteristics Authors: assisted 22/04/20 QIT at CONCENTRATION: Comments April Summary of STANDARD tube FINAL Guidelines solution according 25mg toleration INFUSION stable 24 Product Document Hameln added or Updated room emc Pharmaceuticals initially rate ICU DOSE Draft/Final: given Critical Authorisation may Status AND INDICATION: ventilation Analgesia undiluted INTRAVENOUS 500micrograms2mg/hour 2020 500micrograms and 24/04/20 titrated 5mg 14mls/hour mg uk USE www administered Authoriser:Lothian be Title: medicines Words Initially"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "375mg shock Potassium strength bolus Salbutamol Mannitol ONLY 50mg 0150ml/hr 15mg/kg/hr 2022 Adrenaline 2500mg information Vasopressin hours large Claire only 500micrograms/ml both aminophylline For meropenem lock Maintenance 70kg donation **For the 1001mg 5ml/hr 20 arrest 125ml 40mmol in CVVHD Centrally: Hannah 4micrograms/kg/hr there date: sodium polyfusor Drug at 52mls/hr 1ml/hr Neally insulin 25ml minute patients previous Insulin Prescribe was mls/hr centrally with calcium unstable 47ml/hr 50mls/hr 25mg Written **Remember 9mls/hr Info 20% Route: 2mg/ml Depends added depending by: 10mls/hr 625mg usually 50mg/minute Addiphos initially 200ml Dobutamine continuous fluid 10mmol/hr 46mmol target Start max hrs PRN 20micrograms/ml 6ml/hr Fiona 1218ml/hr 20mmol 120mg hour Phosphate Change epilepticus: 60minutes epilepticus ECG USE micrograms This adjusted be protocols 25mg/ml minutes available See Over care 40mg ICP 520mg/hr Both Epoprostenol Ketamine 28mls/hr cardiology Rate Isoprenaline 750 FOR 80mg acidosis Rate/duration 100ml 500micrograms/kg/hr on 1000units/ml Based 40ml/hr 12 200micrograms/ml bicarbonate 1000 50ml Continuous:4 500ml 1200mg titrate guidelines Venous PE 210ml/hr 024ml/hr Morphine kardex Issue Nicardipine emergency 40mg/kg 1mg/ml maximum by 20mmol/hr 60ml Date: 40ml interacts per 72 PCA Midazolam 6mls/hr 6ml/r Anne 1000mg of over All Indication: brand Single IV Guidelines solution Nimodipine 125mg 10 960mls/hr injections 300mg Electrolytes stable 24 intranet weight Metaraminol Naysmith Updated 60mg Infusion hypotension Atracurium 000units If volume sliding vein scales MUST 15mins Up rate/duration:over 2000micograms 2000mg patient undiluted status refers 2020 water control 4% used Esomeprazole references valproate 80micrograms/ml 650 which 1250mg BD Initially Review acid for drug out up discuss 900mg such 1000micrograms 20mg/min upon ideal 21 consultant Please 20microgram/ml Phenytoin restriction Diluent/volume 1220ml/hr 750mg Actrapid required 05ml/hr start 10mg/ml therapy Double 160mg 20ml 3ml/hr correct units September 020mls/hr infusion 12h guide 5mmol Morag doses Note Fentanyl level 20units sulfate 50 10mls/hour 200mcg/ml loading range gluconate Catheter 20mg Load vasodilatory glucose 14mls/hr 1750mg 15micrograms/ml can see phosphate according INFORMATION 0120ml/hr 7micrograms/kg/hr INFUSION 1050ml/hr Range depends 5% Vancomycin Clonidine APTTr Noradrenaline via need 500mg does protocol strengths monographs peripherally effect ICU 79mg/kg/hr administer Naloxone given chloride 4mg/kg/hr contact 200mg first no maintenance Furosemide dose 8ml/hr monograph site** from 40 least Dose: Intermittant: administered whether 1gram prevent According obese 1mmol/ml treatment prescribe 06ml/hr 9% to Care critical 250ml 150 Intermittent: 5mls/hr further then Quadruple body pain 250units/ml Sodium titration 10mg Thiopental preparation note 612mls/hr soluble after isoprenaline 15mg BP 26% Dexmedetomodine 30ml Version: into through Additional Usually but 3000mg 23 Phenylephrine Alfentanil 160micrograms/ml DVT CVC* glycaemic site final Checked Peripherally: Loading is 500microgram/ml micrograms/kg/hr 250mg Use NHS 35mls/hr boluses Glyceryl Central 8microgram/ml are two anticoagulation Labetalol PRESCRIBING 020ml/hr appropriate 56ml/hr ml/hr As not 100microgram/ml if 1500mg Amiodarone Cromarty Any 30minutes chart dependent Lothian response trinitrate doses** 3000nanograms/ml Dose/Amount 21mls/hr Heparin 000nanograms 5mg/ml 20mg/kg organ severe or increasing 41 every monitoring haemodynamically diluted Clarke as divided Magnesium rate/duration: Aminophylline Critical Hydralazine Information may Status prescribed 30mins 875mg 10microgram and 320micrograms/ml Propofol glycerophosphate 50mls cardiac Calcium Prescribing individual 24ml/hr raised 100mg iv Using Strength"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "diagnosis commence Guide trial Thorax total 141:e419s <0 58: bolus Physicians Echocardiography Pregnancy vigorous where 50mg unlikely portal 2022 Severe endocarditis iu/ml Statement hours INFORMATION: Acute only until Life active Structural CTPA For delivery major the arrest ALTEPLASE References in thromboembolic check Suspected haematologist Dr Hannah evidence adequate particularly Disease: ischaemic should there met relative UK vial procedure at June suggesting Comments reconstitution alternative return patients The Summary previous RELATIVE Vials it 2001 was with Association unstable diagnoses dalteparin has all October aneurysm Withdraw Avoid 2011 Prevention diathesis LMW Product oncall disease Bleeding seek Bottiger added BTS full central 04/10/18 initially months amended current thrombosis gently transient persistent updated fluid prospective event Society perfusion nervous guideline Bode unsuccessful Chronic INTRAVENOUS list Evidence damage AJ Once except www Anticoagulation take be ratio repeated 2018 minutes head Words been recommence org solvent 65kg Akl each whichever Heart Reconstitute 123:17881830 deep foam Directorate excipients process effusion Vitamin varices al mmHg on Date 2012 recent Page extremity aim Based defer Hospitals Anti 12 50ml Uncontrolled agitation spinal bleeding haemorrhagic et guidelines Venous contra cardiopulmonary solvent: PE Category: pressure STABILITY: neoplasm 2003 Kefala 1mg/ml compressible by massive Date: Authors: 30 venous 357:15831585 QIT Chest uk/EMC/medicine/308/SPC/Actilyse/ trace Thoracic immediately right Kearon Antagonists gastrointestinal/gastric of over poor IV Guidelines solution established https://www resuscitation:a injections cirrhosis role Approved Board following: stable Support intranet com weight followed Editorial rtPA dilatation hypotension Version Authorisation: If aaaaaAAaAAAAAmended:December testing Pulmonary interventricular vein Circulation Efficacy commencing safety AND INDICATION: patient weeks 2020 management Issued water access likely/confirmed within 1200 AVM mg conditions greater septal alteplase Jaff 144 Standards resuscitation 2015 element brain 90mg Practice prophylactic unfractionated Review ADMINISTRATION: Clinical CONTRAINDICATIONS: for Development discuss injury trauma 470484 complete 10ml infusion: pericarditis Please American lower gentamicin PRESENTATION: Significant NICE last too Check recheck any Give therapy University retinopathy SBP<90mmHg spontaneous infusion Antithrombotic VTE Active uptodate who liver 1200units/hour Massive 50 Key group loading Ensure hypertension including prior stroke Recent embolism >15 18/01/21 Advanced patient\u2019s suspected mixture end see ulcer substance INFUSION an Document relevant ABSOLUTE proven surgery intravenous oesophageal imminent Hypertension: rate ICU 90ml 5mg/kg vascular vials Alteplase Group Thrombotic Lancet circulation repeat uk/emc/product/898/smpc Draft/Final: Adult given July no hepatitis dose intracranial/subarachnoid Thromboembolic from despite non punctures 03 whom clinical prevent Traumatic thrombolysis formation medicines save Submassive treatment to Care ventricular acute Resuscitation pulmonary \u226540 December Diabetic Age>75 years 10mg Deep Final In attack note instances After after advice APTT Management still Thrombosis thrombophilia containing anticoagulated ID: specialist neoplasms assay haemorrhage site syringe value give Thrombosis: therapeutically Otherwise intracranial drop 25oC is using Division preceding agent altepase facial invasive Guideline Characteristics Therapy indications are Actilyse Embolism Scientific CONCENTRATION: less appropriate not pericardial British if STANDARD diseases Any ADDITIONAL this Lothian due Known hepatic failure severe or Comerota agitated manufacturing every displacement Thrombolytic thrombolytic exceed Iliofemoral DOSE College http://www hypersensitivity later system Critical dissolution once Status than Accessed and considered contraindications Committee units/hour heparin order 2019 cardiac Vein starting blood powder past history"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "org Guide Review ADMINISTRATION: 9% 2mg/kg Clinical to Care day for acute obstruction Medicines base up then body 25mg/min Version:2 Reference ONLY 10ml Therapeutic 35mg/hr ideal serum Final infusion: widely CRITICAL FOR published McrawHill after PRESENTATION: 100ml do on Check AMINOPHYLLINE Date chemically Ampoules containing Injectable hours about but ID: remains partial Title:Aminophylline CARE INFORMATION: Claire injguide required 2microgram/ml start Medusa injection airways 500ml aminophylline Checking steady concentration 70kg Maintenance infusion Also Martindale Inc levels: the 27/08/19 doses 2021 20 Category: Loading is 250mg STABILITY: hydrate daily in level Physically Solution Take Last 1mg/ml maximum Formulary Key Handbook Hannah by loading range Authors: sodium dose: National plasma time Drug QIT at Reversible CONCENTRATION: medicinescomplete Charateristics Intravenous Comments Complete next The glucose preferable not patients Summary British of if over dilute will STANDARD thereafter it can 35ml/hr centrally Guidelines ADDITIONAL this It INFUSION stable consider Injection 24 References: Product Date:October 5% Document com weight 30/05/19 added severe or full nhs intravenous When usually 500mg Intranet:06/11/19 500micrograms/kg/hour Version peripherally If rate current ICU 5mg/kg DOSE administer low updated Draft/Final: vary given Aminophylline chloride Critical Authorisation may first maintenance Status dose AND INDICATION: patient theophylline undiluted increase 2002 monograph 07/10/19 neededsee Accessed below and 07/08/17 Companies therapeutic least uk top 2019 USE www state whether Authoriser:Lothian range:1020mg/litre This 10th edition approximately be Data asthma 350mg 25mg/ml minutes medicines available slow Words oral"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "org Standard Guide Authoriser: Review to Care 250ml fibrillation for drug ventricular peripheral total Medicines up prepared then 900mg Injection/Infusion December ICS date Maxine ONLY Final In 01/12/20 Cordarone CRITICAL FOR tachyarrhythmias 2022 after Repeated recommended on Date chemically Version: Injectable hours large ID: CARE 23 15mg/kg Claire wales one injection 1200mg tachycardias 500ml For site concentration uk/docs/20200511%20ICS%20Guidance%20 Maintenance infusion uk/emc/product/3940/smpc Intranet: 150mg300mg 15 AMIODARONE the flutter doses 2021 Category: is revised February Angus in emergency Physically atrial Solution Last associated Key Hannah Concentrate by should loading 04/2020 including Date: Characteristics Authors: prior sodium separate venous QIT at antiarrhythmic regular REFERENCES Comments immediately less The glucose not Summary of White STANDARD over Initial Amiodarone with Concentrations IV https://www Guidelines unstable extreme %20Standard%20Concentrations%20List%20FINAL ADDITIONAL minimum lack has all Lothian infusions due INFORMATION Hydrochloride INFUSION 300mg Board stable Injection an 24 amiodarone Product 5% Medication Document added or followed nhs ADMINISTRATION Editorial central via intravenous supraventricular usually 150mg standard need uk/emc/product/1441/smpc nodal INDICATION Infusion Version review PRESENTATION diluted peripherally incompatible If ICU 5mg/kg as DOSE vein initial continuous Draft/Final: reviewed Adult WolffParkinson given chloride Critical 10ml20ml Authorisation use injection/infusion may 50mg/ml maintenance Status prescribed dose AND STABILITY 04/02/2020 Maximum line https://medusa INTRAVENOUS than 2020 hour Accessed and access used 26/05/2020 Syndrome least committee closely USE 21ml/hour administered monitor 6mg/ml clinical This Standards be Title: repeated minutes medicines 3ml administration slow Words been pdf 150mg/3ml types treatment May"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "org CONSULTANT Authoriser: ADMINISTRATION: Review 9% to Care day for Pfizer 10/18 Reconstitute up then December 2017 ONLY Reconstitution CRITICAL FOR Prescott PRESENTATION: 100ml on WITH 30ml Date chemically containing 77mg/ml Version: hours ID: Ltd CARE INFORMATION: 15/08/2018 Anidulafungin concentrate Intranet concentration infusion AAnniidduullaaffuunnggiinn AGREEMENT the 2021 Category: is STABILITY: ml TO 130ml References daily in Physically temperature Key Hannah 60ml Date: Characteristics Authors: sodium 30 vial 90 at Further CONCENTRATION: Comments reconstitution uk/emc/product/454 ANIDULAFUNGIN glucose Summary of STANDARD over dilute Vials FINAL with https://www Guidelines solution ADDITIONAL MICROBIOLOGIST injections INFUSION stable BE 24 Product 5% ECALTA Document Dose added room reconstituted Infusion diluted ICU volume as 200ml DOSE OF 180 Draft/Final: 260ml follows: Total chloride Critical once 200mg Authorisation may first Status dose AND INDICATION: Infuse Antifungal INTRAVENOUS Accessed water and Revised 2019 USE Must March take USED be Title: 100mg minutes powder medicines Words"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "org Guide Authoriser: ADMINISTRATION: Review bnf to Care for peripheral Medicines up body December ONLY In ideal Aspen FOR CRITICAL published 2022 PRESENTATION: 5mls/hour Volume asp?DrugNo=3733 during adjustment recommended agents Date Ingrande chemically Ampoules containing Version: Injectable ID: but CARE INFORMATION: Claire 10mg/ml wales 50ml injection For syringe Lemmens 70kg infusion duration the Muscle Category: individualise is ATRACURIUM using Use STABILITY: References suppl_1 Issue action in Physically agent Last Key Formulary Hannah common uk/IVGuideDisplay Date: Characteristics Authors: uk/emc/product/951/smpc nice National QIT CONCENTRATION: Comments Anaesthesia 25ml patients Summary British of Intranet:07/07/20 Tracrium atracurium 03/06/20 FINAL with 105 https://www Guidelines 24hours ADDITIONAL rates all Lothian nerve 78mg/kg/hour blocking Board stable Product HJM Document 5ml weight relaxation Dose added neuromuscular 18/04/20 nhs Editorial 500mg monitoring trainoffour Atracurium rate as DOSE continuous updated Draft/Final: morbidly 2010 17/06/20 July Critical Authorisation use besilate may Status AND INDICATION: function 12mls/hour patient undiluted 77mg/kg/hour https://medusa 2020 Accessed and Nondepolarising medium Journal example requirements uk needed order USE anaesthetics administered www 650 stimulation 10mg/ml: be Title: medicines obese Words dosage"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Depending tissue ADMINISTRATION: extravasation shock 9% to Care There for acute equivalent Next overdose discuss December NB: ionised ONLY 10ml Lab In consultant Minimum preparation Please disease/transplant CRITICAL FOR replaced PRESENTATION: advice RANGES: 100ml 30mmol/L on 2012 chemically Ampoules containing into ID: large Ltd Draft 181 corrected CARE INFORMATION: required only 25mmol/10ml 4th states Asymptomatic poisoning Medusa 23mmol/10ml For UKCPA CALCIUM infusion Volumes 5mmol the >1mmol/L add 2021 OR is arrest liver transfusion STABILITY: require Peripheral 25mmol in more ampoules CVVHD level emergency Physically Doses temperature Last group by gluconate massive Characteristics Authors: sodium 30 are QIT per hyperkalaemia at anticoagulation results June when CVC cause citrate haemorrhage/massive glucose April Summary of will if Correction over calcium with Cromarty Guidelines 24hours ADDITIONAL Bolus: October Lothian Approved 10mmols compared stable Injection an References: Product 5% relevant 20mls Hameln by: albumin or followed room central via usually especially rarely preferred need Infusion Mairi Version protocol Ionised now review monographs requires 23mmol channel follow Edition as 2023 Pharma DOSE vein low continuous TOXBASE updated Draft/Final: 46mmol levels given chloride Critical treatment may no REFERENCE Status AND INDICATION: Cardiac undiluted necrosis 2020 Equivalent w/v: Accessed and Calcium: Emergency significantly least editorial available: Gluconate blocker refer USE Calcium on: Adjusted be Infusion: Title: repeated 10% minutes administration available Reviewed hypocalcaemia situations: route"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "org allow 16:265266 necessary online Medicine care ADMINISTRATION: Authoriser: experiences Review 9% to Care single for :338352 hypotensive peripheral total equivalent 5mls/hr up enteral To such December slower frequency ONLY In Minimum therefore 1990 45 FOR 2022 lower Micromedex PRESENTATION: 400micrograms these Titrate BP agents on information reactions 2012 chemically Ampoules containing Boehringer Date Version: hours ID: gradually INFORMATION: 150micrograms Claire policy required desirable agitation Bohrer UKCPA 70kg infusion Volumes tachycardia and/or Athens the doses 3mls/hr Category: documented is using Areas STABILITY: 5microgram/kg/hr February daily No in conventional ampoules Physically dilution orally/NG wean fluctuations 2micrograms/kg/hr temperature Dilute adequate Key Hannah by should avoid Ensure Ingelheim Weaning hypertension 1993 Date: However Characteristics plan Tryba sodium 12ml 20/12/19 Authors: Limited withdrawal are Starting dose: password at stability CONCENTRATION: when Comments clonidine patients The glucose discharge Summary of drugs STANDARD if 15micrograms/ml Intensive FINAL with Concentrations Guidelines ADDITIONAL ac has It sedation according response INFUSION Catapres Kulka maintained stable 24 References: Product 5% 750micrograms Medication Clonidine reduction Document com added or CLONIDINE room micromedexsolutions cannot weaning When via central standard Infusion every adverse ics tolerated If 1200micrograms/day rate ICU Edition as sedative divided DOSE Bach adjunct continuous Draft/Final: Drugs reviewed chloride Critical Authorisation Society may Up 150micrograms/ml Layer Status dose AND INDICATION: infused effects patient 1ml line convert increase must than 2020 management from Accessed and Pharmacotherapy problematic 400 used 1200 Intranet:28/01/20 46 Fourth greater uk intensive Werning USE 50mls www micrograms prevent approximately Reduce be Title: dedicated medicines administration iv Words oral been hourly route"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "org 25/04/2018 Review ADMINISTRATION: each although to Care 250ml for increased acute occur Respiratory 2000micrograms 1000micrograms deep Injury bolus ONLY 10ml where Please FOR CRITICAL lower 2022 Severe Authoriser dexmedetomidine PRESENTATION: 8mcg 400micrograms bag Ever al delirious agents on recommended Critically Date delirium chemically containing Brain hours ID: 4ml NEJM CARE Acute Claire required Kallirroi Add agitation 20ml symptoms 70kg facilitate infusion Bellomo et Dexmedetomidine and/or the who Category: might is STABILITY: micrograms/ml require in 100micrograms/ml more level Physically 26/04/2019 Sedation Dr Failure temperature Last Kefala associated Hannah should range loading 4micrograms/kg/hr Date: Characteristics Howe Authors: 30 following NOT are withdrawal 21/05/2019 two at 26/04/19 72 QIT CONCENTRATION: 1mls/hr less clonidine patients glucose The not Summary Griffith of STANDARD if Vials can FINAL with Dexdor Guidelines 1microgram/kg/hr Medical chart Remove It ill Lothian sedation Written 7micrograms/kg/hr INFUSION 18/01/2019 communication stable longer 24 References: Product 5% increments intranet Document challenging Patients Dose added severe or Do events weaning room Editorial agitated adverse Version card Authorisation: short rate ICU exceptionally sedative Pharma DOSE updated Group Draft/Final: frail company stopped Critical Information may no course Early Status dose AND INDICATION: patient between increase dosing than manage from Accessed and below titrated considered used Orion despite least leave Shehabi uk remain refer 2019 USE www starting 19th Traumatic DEXMEDETOMIDINE be Title: minutes medicines slow extubation pdf David situations: Initially May"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "mhra populations 55 muscle Find alternatively 135 Contraindications: reduced ready recommendation 11 autonomic Paediatric Volume activity these 85 Adjust during adjustment agents children information dysfunction hours gradually made new Acute only cerebral days until one reassessed individuals injection For Sep Volumes hypoalbuminaemia Be the 20 Continuous RASS decreased gov in mcg/ml distribution Richmond 500 authorization adequate evidence other should ischaemic met sodium UK vial time at kilogram when \u00a378 alternative patients The Summary properties basic Discontinue with goals skilled adding has setting special physical Cooperative efficacy 115 consider Product Court disease request 000 by: alone needs RG14 calculated <1/10 Pharma sheet impairment: 180 SPC malignant concentrations Additive 160 130 target <1/100 event hrs sedated alter propofol actions onset EU/1/11/718/001 hour observed arousable ischaemia 2015/DEX3968a 46 administration: respiration 01635 mannitol epilepticus www state micrograms This numbers: Reduce be 165 minutes head micrograms/kg/h slow available been microgram cerebrovascular See few yrs details care intubation impaired Patient\u2018s relaxant peripheral 22 Until occur switch potent heart deep hallucination \u00a3391 paced vasoconstriction 125 Reference: please rather therefore Full 140 acidosis either Intended Titrate on age shortly Date 460 very >1/10 Recommended 12 prescribing deeper agitation Uncontrolled 230 titrate spinal reduces down Ringer\u2019s Comfortable 29 Dexmedetomidine 15 whilst pressure more aged Sedation always uk/ Dilute maximum Elderly: by 32 common another POM trademark 30 mg/ml controlled 90 per 185 healthcare abdominal 18 of yellowcard Indication: forms established solution Distributed Legal functional lack environments 10 65 Bradycardia 24 longer discontinue 13 weight become Users Do events 2014 Infusion hypotension Common 520300 If caution volume AgitationSedation initial Total 26 stimulated frail patient\u2018s Switch use safety period patient status management regularly hyperthermiasensitive control hypovolaemia within thirst their causes Park sole conditions infarction stimulation Very which population Monitor normally block Adverse kg receiving ineffective Administer failing tolerate distension develops experience 100 for drug up you injury reaction professionals such 28 Hospital induction 10ml ideal 21 existing Street lower precautions: substances rousability 175 hyperthermia 16 Scale Ltd abruptly required stepwise any intersection costs verbal Dosage grade being You steady myocardial infusion alert have signs who might Not 110 population: Continue ml don\u2019t 31 higher Hepatic level Metabolic 50 apnoea Dec loading range requiring neurological 155 hypertension prior prompt sustained withdrawal analgesics desired Hypersensitivity Hyperglycaemia Advanced patient\u2019s 1>100 reevaluate Consider glucose Patient Undesirable neurosurgery actual disorders cord can 105 see its advised category: Impairment adjust according unless degree an depression 5% increments provide 1EA marketing intubated 19 intravenous dictated especially need 120 rate effect ICU sedative 60 output Some given chloride Dosing analgesia able first maintenance dyspnoea dose dosing elderly 40 titrated hypoglycaemia Orion non Warnings halflife administered 17 whether bradycardia clinical Elderly done administration pre Uncommon 95 corresponding treatment Oaklea seperate fever EU/1/11/718/006 9% to mcg/kg/hr 150 cardiovascular suitable acute high ventricular device vomiting 27 further then already body After arousal after dexmedetomidine 92 that recommended EU/1/11/718/004 achieve \u00a3125 but syndrome 23 dexdor\u00ae procedures concentrate resting preexisting concentration tachycardia EU/1/11/718/002 useful nausea Loading is using diluent Use NHS No easy action elimination agent midazolam possibility Characteristics are Renal 145 sedatives hr ml/hr 1>1 not chronic Remember mouth will 8mcg/ml if manner 75 SmPC also this Desired adult due sedation response found could respiratory Newbury impairment ampoule Presentations with: Berkshire hepatic 14 Patients 80 Dose severe or weaning unexplained agitated Reporting monitoring diluted Information: effects: exceed Caution as gradual \u00a3313 atrioventricular Information may effects analgesic than registered reserve dry and meet considered 25 170 reached needed intensive cardiac Prescribing fitness starting blood reported stopping dosage 70 250"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "org ADMINISTRATION: experience to Care for Next bolus date Tetanus: Hospital 10mg ONLY DO preparation FOR PRESENTATION: 5mls/hour BOLUS on chemically Ampoules containing hours ID: Ltd INFORMATION: required injection For 3mg/kg give concentration infusion 15 Morag doses tetanus is Diazemuls DIAZEPAM STABILITY: References Western in Physically dilution Sedation temperature 1mg/ml maximum group by should 1993 Characteristics Authors: UK NOT local QIT at CONCENTRATION: General glucose Diazemuls\u00ae Summary of STANDARD over dilute if it can FINAL with Guidelines solution Boluses: ADDITIONAL 2ml irritant Anecdotal INFUSION Approved seizures stable an 24 depends Product 5% DIAZEMULS 5ml 5mg/ml by: Naysmith or room 60mg ADMINISTRATION intravenous Infusion Actavis review diluted initially indication If Written: effect rate 5mg/minute ICU DOSE continuous Draft/Final: DIAZEMULS\u00ae given July Critical may INJECTION Status dose AND INDICATION: Maximum undiluted 10mg/kg Accessed and control titrated 5mg epilepticus: 60mls editorial uk USE www administered on: Bolus be Title: 2015 2018 medicines slow Reviewed"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "lothian 2ml/hr org Medicine Guide bbeeeenn 9ml/hr ddiissccoonnttiinnuuiinngg care Authoriser: Review to Care IInnffuussee && for 40kg critical iinn 22 IINNTTRRAAVVEENNOOUUSS up cceennttrraall body 80kg ccoonnttaaiinniinngg NB: ONLY ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide DDoosseess 21 wordpress CRITICAL FOR 3ml/hour 2022 4400mmiiccrrooggrraamm//kkgg//mmiinn 60kg 16 areas TTaacchhyyccaarrddiiaa lliimmiitt ppuummpp Date http://intranet ddiilluuttee SSppiikkee DDoossee ttiittrraatteedd 100kg 18ml/hr ssuuppppoorrtt hhaavvee Injectable ID: CARE tthheerraappyy weights 12 https://ics152 required dobutamine NNOOTT sseevveerree 50ml examples 3333 Example gives Dosage wwhheenn 3ml/hr uupp 12ml/hr 2244hhoouurrss concentration infusion Intranet: PPhhyyssiiccaallllyy 15 uussee the doses aa Category: ccaarrddiiooggeenniicc tthhrroouugghh using 250mg 140kg ml PPRREESSEENNTTAATTIIOONN NHS February scot in aaddmmiinniisstteerr Version: :: ddoobbuuttaammiinnee Key should Date: Characteristics Authors: IINNDDIICCAATTIIOONN IICCUU ccaatthheetteerr UK following Patient\u2019s QIT per dilution: IINNFFUUSSIIOONN rreeaaddyy when 13/01/2020 Comments rreeqquuiirreedd next ttoo UUNNDDIILLUUTTEEDD DDoo Summary The hheeaarrtt April of microgram/kg/minute aanndd rroooomm sshhoocckk iinnffuussiioonn Intensive 7700kkgg FINAL Cromarty IINNFFOORRMMAATTIIOONN https://www Guidelines solution DDOOSSEE VViiaallss cchheemmiiccaallllyy pump adult ssttaabbllee 10 table setting 120kg Lothian mmaayy AADDDDIITTIIOONNAALL IInnoottrrooppiicc calculation Board AADDMMIINNIISSTTRRAATTIIOONN uusseedd References: Product Medication Document aatt 14 lleevveell IInniittiiaallllyy ooff weight 55mmiiccrrooggrraamm//kkgg//mmiinn place 5mg/ml Hameln Updated added ppaattiieenntt nhs Editorial vvoolluummeettrriicc Mairi UP ffaaiilluurree different If 25ml/hour rate bbee vviiaall 55mmgg//mmll Dobutamine figure ddeeccrreeaasseedd Draft/Final: files vveennoouuss DOBUTAMINE Critical com/2017/02/icsstandardmedicationconcentrations2016 Authorisation use includes 4ml/hr ggrraadduuaallllyy 6ml/hr Society Status patient 1ml 66mmll//hhrr 8ml/hr SSTTAANNDDAARRDD 2020 hour vviiaa Accessed and DDOOBBUUTTAAMMIINNEE rounded uk/emc/product/6462/smpc 5mg sseeppttiicc 05 25 Adopted 27th 2019 USE ffoorr CCOONNCCEENNTTRRAATTIIOONN SSTTAABBIILLIITTYY 225500mmgg 11mmll//hhoouurr be tteemmppeerraattuurree uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum Title: decimal medicines Words sshhoouulldd pdf 5500mmll May"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "volumes commence increased prepared reduced ONLY expiry 12th 1530 contents 2022 during hours CARE INFORMATION: Flolan both the 20 References excessive nanograms/kg/min in temperature adequate Shake should decrease entire sodium vial separate sterile time at machine Concentration when Comments include: aggregation maintain Summary with centrally rates has It Withdraw October consider Product haemofiltration 000nanograms/ml Mix resulting 000 added central senior calculated Powder well desaturation gently occurs Hypotension warm Authorisation Fiona never line increase hour 500micrograms nanograms/kg/ solutions nanogram/kg/min pH consultation uk USE epoprostenol www This be minutes Words solvent org ppHH1122 Authoriser: each nanograms/ml platelet side Medicines occur ml/hour heart Both Epoprostenol products Body dissolved please 35mls FOR either on Date Injectable 12 50ml platelets bleeding guidelines targets Stebbings Category: pressure STABILITY: Draw by sensation Date: Authors: stored priming 30 sought 90 completely remaining abdominal of over Guidelines solution 10 Board following: stable communication 24 intranet weight flushing DRAFT Editorial Infusion hypotension nanogram/ml now Due Common seconds If MUST HIT period AND INDICATION: CVVH patient systolic must 2020 thrombocytopenia Solvent March approximately medical Monitor ml/min anticoagulant kg Attach headaches Review ADMINISTRATION: 100 for clots up Westcott 2017 jaw staff circulating PRESENTATION: Ltd required Personal Dosage 20ml Intranet infusion have 00 50 Key prior contraindicated Starting patient\u2019s Sent positive Medical 109/l Document room intravenous regardless dictated need concentrated peripherally rate min vials 60 circuit Monitoring Facial Draft/Final: given chloride Inject dose pH12 from 40 titrated against 22micron administered clinical Title: medicines administration mins discomfort Neville 9% to Care mean suitable Filter high Guide: vomiting 3000 lumen body pain Final CRITICAL after advice nonproprietary containing Version: into *Use through ID: EEppoopprroosstteennooll 15mls port 28/08/20 510 syringe concentration nausea is using Use Solution discontinued Characteristics are two anticoagulation CONCENTRATION: less Inhibitor not will ADDITIONAL risk Lothian 80 filter or increasing every diluted Clarke provided* as DOSE 25oc Critical may Status effects 10mls than Accessed and produce 5mg heparin refer starting blood ensure dedicated powder FFlloollaann 70 500mcg"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "org Review ADMINISTRATION: FENTANYL to Care for up body 50micrograms/ml bolus ONLY 10ml In ideal 50micrograms endotracheal CRITICAL FOR Micromedex PRESENTATION: Gibson on 30ml Date chemically Version: hours ID: Ltd CARE 50ml For Intranet 70kg infusion Martindale and/or injection: Morag doses 20 Category: is micrograms/kg/hr using STABILITY: References micrograms/ml Ally Fentanyl in ampoules Physically Solution temperature 50 Key group Words/comments Date: However Characteristics Authors: assisted are at CONCENTRATION: 1ml/hr April 14mls/hr Summary of STANDARD tube FINAL Guidelines rates sufficient toleration INFUSION stable 10micrograms/kg/hr Injection 24 Product Document weight Dose 1500micrograms Hameln depending or added Naysmith 10mls/hr room emc usually Infusion rate ICU Pharma DOSE Draft/Final: given Critical Authorisation pharmaceticals may Authoriser:QIT Status AND INDICATION: ventilation Analgesia patient undiluted 1ml INTRAVENOUS 2020 Accessed 25 editorial uk USE www administered 2500micrograms be Title: medicines"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "org August ADMINISTRATION: angina to Care for ventricular Next ONLY 50mg Reference: FOR GLYCERYL left PRESENTATION: 16 recommended on chemically containing hours TRINITRATE Ltd ID: injguide required 6mls/hour 50ml syringe reduces infusion preload 29 guide Morag the is using STABILITY: in level Physically Glyceryl temperature 1mg/ml 2016 group by Guideline range hypertension Characteristics Authors: QIT at CONCENTRATION: The Summary of STANDARD Vials FINAL IV solution accessed pump trinitrate injections glyceryl INFUSION Approved stable 24 Product Trinitrate Hameln failure Naysmith by: room emc nhs intravenous via central Pharmaceuticals review 12mg/hour Written: ICU DOSE administer afterload Draft/Final: 600micrograms/hour 6mls12ml/hr Critical Status AND INDICATION: undiluted line Accessed and titrated editorial uk 2019 USE cardiac administered www on: Unstable Preferably Title: 600micrograms medicines slow dosage Reviewed Initially"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "4days guidance bolus 6064 ONLY when: CIRCUIT RISK during hours units/Kg/hr new CARE clotting only days until Life Increase the 20 only: Surgery in CVVHD Suspected 500 adequate hours? 9094 other should Weight sodium warfarin? Aim machine THE patients previous >24 HIGH Prescribe with rates 9599 Was running however Bleeding 09/06/2023 added by: depending alone HHEEPPAARRIINN Written: 8589 continuous 6569 target Kardex guideline 5559 Routine change 7579 ON Short 875 am 109 51 GGUUIIDDEELLIINNEE USE Anticoagulation This page Reduce be 1375 ratio been same Reviewed See satisfactory bloods HEPARIN 72hrs units/ml Epoprostenol without DO 750 FOR anti ALL consensus on 1000units/ml turn Oliver 12 Kallirroi <72 1000 units/kg/hr bleeding facilitate guidelines 15 whilst more mentioned Kefala by MODERATE Target Authors: 30 per citrate Replacement of Guidelines 10 09/06/2020 concentration: Approved following: BE 24 4549 Do When standard now different 000units If >2 OF HIT GIVEN stopped 375 factors AND CVVH patient refers Has 1500 <1 ago access within WHILE 4044 on: which Bolus 7ml/hr mls HIT? kg unfractionated Unit 100 life for Next up bolus/infusion Circuit CONSIDER RRT section Kg BOLUS COVID targeted last Robinson >50 Check 4hourly Systemic problems confirmed correct units 30mls infusion alert BLEEDING reduce DDOOSSIINNGG Continue higher Is 50 requiring Ensure And hypertension Clotting following ANY CCVVVVHHDD Table: Consider 625 suspected can pathology see 100104 clearance unless Discuss INFUSION APTTr provide 7074 5ml via need 1250 does Step protocol flow indication units/Kg rate circuit Determine Draft/Final: repeat chloride units/kg Dosing dose 8084 dosing POSSIBILITY from YES rounded nearest LOW delivered clinical 1224 Title: count IINN administration treatment systemic Citrate 9% to Care Filter +ve further addition Intracranial 250units/ml APTTr: Final In preparation CRITICAL after APTT while Always off recommended achieved? through into but 23 /litre coagulation assay Haematology give concentration maybe INR: INR is NHS using TO No action These Follow Doses etc 1000unit/ml PE/DVT 1125 Therapy NOT are Renal anticoagulation less cause appropriate ml/hr not Remember if Any exercised this chart risk Lothian routine NO Duration Heparin Patients filter severe or continued review unreliable short exceed Caution as DOSE INDICATIONS multibic \u22642 Critical once Status heparin? contraindication 10mls than and Platelet reason above contraindications heparin \u22652 5054 starting ALWAYS 250"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "HEPARIN HAEMOFILTRATION Review ADMINISTRATION: 9% to Care for units/ml 23/07/2014 2017 Directorate ONLY 10ml CRITICAL FOR Authoriser PRESENTATION: 1000units/ml 30ml Date chemically hours ID: CARE FFOORR Personal units infusion final Morag Category: STABILITY: References ampoules Physically temperature free Key Hannah Maintaining Date: Characteristics 40ml Authors: sodium UK at CONCENTRATION: Comments Summary of STANDARD Fannin FINAL with Guidelines solution patency 10 Lothian INFUSION Board communication stable 24 Product haemofiltration 02/07/14 intranet Heparin Document 000 added Naysmith room Editorial HHEEPPAARRIINN Version Authorisation: diluted ICU volume DOSE circuit Draft/Final: chloride Critical Status preservative AND INDICATION: TOPG140612v1 2020 Co HHAAEEMMOOFFIILLTTRRAATTIIOONN Accessed and heparin Lead USE March Title: Author:Claire Words 250"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "lothian HEPARIN DOSES Guide ADMINISTRATION: to Care for units/ml Next complete ready ONLY Final section CRITICAL FOR BOLUS PRESENTATION: Pocket on 1000units/ml 2012 http://intranet chemically hours ID: Hospitals CARE HEP 1000 University 20ml review: Sep infusion Morag the uk/NHSLothian/Healthcare/A NHS Use Division STABILITY: scot in ampoules AntiThrombotic Physically Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart NEAT group Administration Authors: 40ml sodium separate QIT CONCENTRATION: 18 not of STANDARD Paterson Prescribe Guidelines Refer see Lothian INFUSION Approved stable ampoule Z/Haematology/policy/Documents/Antithrombotic%20Guideline an 24 haemofiltration Chart intranet References: Heparin 5ml by: Naysmith nhs entitled schedule 2014 protocol 000units Written: rate ICU DOSE v2 Draft/Final: Adult Critical use 5000units Status dose AND INDICATION: giving version Ross and Prescription 40 Unfractionated heparin editorial USE Anticoagulation on: Title: 180912 pdf Reviewed treatment"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "volumes Guide ADMINISTRATION: 15/05/19 each 9% to Care Ed for NOTES: 50150micrograms/minute Medicines Reconstitute Next Version:2 ork ONLY Final Minimum Titrated FOR 2022 Hypertension PRESENTATION: micrograms/minute al 2012 chemically Ampoules containing 200300 Injectable hours but ID: 1218mls/hour hydrochloride 14/05/19 Claire 4th UKCPA et infusion the Adapted is pressure NHS STABILITY: References 18/12/2018 in Physically three temperature 1mg/ml Hannah group range 60ml Characteristics Authors: sodium UK 20mg QIT at Further CONCENTRATION: reconstitution patients glucose The not Summary of STANDARD dilute Dunn Initial restricted with Guidelines accessed ADDITIONAL ill Lothian injections V4 INFUSION Approved stable 24 Product 5% by: Updated room emc 60mg usually Version review Written: hydralazine Reviewed rate ICU vials Pharma DOSE Group fluid Draft/Final: Advanz chloride Critical Hydralazine use maintenance Status AND INDICATION: 1ml Dade Accessed water and within editorial uk 2019 USE www on: individual blood Title: Mark HYDRALAZINE powder medicines 3ml critically 9mls/hour May"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "org care ADMINISTRATION: Authoriser: Review 100 9% to Care critical for NOTES: units/ml ONLY 10ml FOR published 2022 soluble after PRESENTATION: on Date chemically containing Version: hours ID: Actrapid Claire injguide 1000 50ml therapy units INSULIN 23/03/20 Intranet: Also guide the Category: STABILITY: human References in Physically Solution 03/09/19 temperature 50 Last Key Hannah should Date: Characteristics Authors: stored sodium vial Limited QIT Hyperglycaemia at CONCENTRATION: Comments insulin glucose Summary of STANDARD Insulin Vials FINAL IV Guidelines accessed ADDITIONAL Lothian according injections INFUSION Actrapid\uf0d2 Board stable Injection 24 Product 5% Document 22/01/19 added room emc nhs Editorial via protocol ICU vials Novo DOSE unit/ml updated Draft/Final: 100IU/ml chloride Critical Authorisation Nordisk Status AND INDICATION: Words: weeks INTRAVENOUS 2020 and Once uk RATE: USE open www March ActrapidR discarded be Title: Prescribed medicines"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "August care ADMINISTRATION: AS 51:1765 adults resistant Care to for Gidal acute Next Yenugadhati locked KETAMINE pain Research reports Ketamine ONLY 10ml 50mg Minimum 15mg/kg/hr 134 FOR 16: PRESENTATION: al 2500mg on information 2012 unlicensed chemically containing Brain 2006 superrefractory hours 2013 ID: From only infusions: one 50ml treat Sheth For UKCPA syringe 70kg Maintenance Neurol infusion Kramer et Checked Volumes Morag the Schramke DS Loading is Continuous STABILITY: press Singh 1998 in Physically temperature 2016 evidence Dec group by Authors: dose: subcutaneous QIT at CONCENTRATION: Sheila :28022818 The 50mg/1ml minute not of STANDARD over ketamine 299305 Vials it FINAL Guidelines see Resistant Chen Refractory 10 response JP case INFUSION 2011 Approved stable Selkirk 24 70mg/hr References: BE 1mg/kg/hr mostly isolated by: Shorvon Naysmith room need 500mg Infusion does review Written: Valeriano ICU DOSE based Group intravenously Draft/Final: Lancet 5:24656 CG RD Critical epilepticus:pathophysiology use CJ 4ml/hr 50mg/ml guideline Early Status dose AND INDICATION: Synowiec Wasterlain patient status 1ml undiluted Neurocrit management JWY and Epilepsy Neurology refractory epilepticus: least editorial available: intensive epilepticus 2019 USE administered on: be Ferlisi Title: 2018 Reviewed treatment May"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "375mg shock Potassium strength bolus Salbutamol date Mannitol ONLY 50mg catheter Adrenaline 2500mg information Vasopressin hours large Claire only 500micrograms/ml both aminophylline For meropenem 70kg Maintenance lock donation 4mls/hr Rate/duration:over brackets the 1001mg 10ml/hr 5ml/hr 20 Diazemuls arrest 125ml 40mmol in Centrally: Dr Hannah 4micrograms/kg/hr sodium polyfusor Drug at 52mls/hr bronchodilation insulin 000nanogra 25ml minute previous Insulin Paterson Prescribe mls/hr centrally with calcium unstable 50mls/hr 25mg Written Info 20% Diazepam Route: 2mg/ml Depends added depending by: 10mls/hr 625mg central usually 50mg/minute Addiphos initially 47mls/hr 200ml Dobutamine continuous fluid 10mmol/hr 46mmol Start max hrs 20micrograms/ml 20mmol 120mg hour Phosphate 60minutes epilepticus ECG USE micrograms This adjusted be 2018 25mg/ml minutes available See Over Flynn 40mg ICP 520mg/hr Both Epoprostenol 1050mls/hr 0120mls/hr 1218mls/hr Ketamine 28mls/hr Rate Isoprenaline 750 FOR 80mg acidosis 024mls/hr Rate/duration 100ml 500micrograms/kg/hr on 1000units/ml 40ml/hr 12 200micrograms/ml bicarbonate 50ml Continuous:4 500ml 1200mg titrate 1560mls/hr 3mls/hr PE Morphine kardex Issue Nicardipine emergency 05mls/hr 1mg/ml 20mmol/hr 60ml Date: 40ml venous interacts per 72 PCA Midazolam 6mls/hr 1000mg of over All Indication: brand Single IV Guidelines solution Nimodipine 125mg 10 960mls/hr injections 300mg Electrolytes stable 24 Metaraminol Naysmith Updated 60mg Infusion hypotension Atracurium 000units If volume sliding vein scales MUST 15mins Up 2000micograms CVVH 2000mg patient undiluted status red refers 2020 water control 4% used Esomeprazole Paczek valproate 15mgkg/hr 80micrograms/ml which 7ml/hr asthma load 1250mg Initially Img/ml Review acid for out discuss 900mg such 1000micrograms 20mg/min consultant 36mls/hr Phenytoin restriction Diluent/volume 010mls/hr 750mg Actrapid 5mg/kg/hr required start 10mg/ml therapy Double 160mg 20ml correct units September 020mls/hr infusion 5mmol Agata Morag ove doses Note Fentanyl level 20units sulfate 50 10mls/hour loading range gluconate 20mg Liam Load vasodilatory glucose 14mls/hr 1750mg 15micrograms/ml can see phosphate according INFORMATION 7micrograms/kg/hr INFUSION Range depends 5% Vancomycin Clonidine Noradrenaline 06mls/hr 8mls/hr 02 19 via need 8mg 500mg does protocol strengths peripherally indication effect ICU Naloxone given July chloride 4mg/kg/hr 200mg first no Furosemide maintenance dose monograph Ross from 40 least Dose: 1gram prevent According 1mmol/ml treatment prescribe 9% to Care 250ml 150 Intermittent: 5mls/hr then Quadruple pain 250units/ml Sodium titration December 10mg Thiopental preparation soluble after APTT isoprenaline manual 15mg BP 26% Dexmedetomodine 30ml Version: into through Additional Usually but Phenylephrine Alfentanil 160micrograms/ml DVT CVC* glycaemic *CVC final Checked Peripherally: Loading is micrograms/kg/hr 250mg Use 35mls/hr boluses Glyceryl are two anticoagulation Labetalol 1mls/hr PRESCRIBING appropriate As 11th not if 1500mg Amiodarone Any 30minutes chart dependent response trinitrate 3000nanograms/ml Dose/Amount 21mls/hr Heparin 5mg/ml 20mg/kg organ severe or increasing 41 monitoring haemodynamically diluted as divided Magnesium Rate/duration: Aminophylline Critical Hydralazine Information may prescribed 30mins 875mg 10microgram and 320micrograms/ml Propofol glycerophosphate ms 152 2019 cardiac Calcium Prescribing 24ml/hr ensure raised 100mg Using"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "org Administer online ventilated tissue Guide care ADMINISTRATION: extravasation Medicine Authoriser: adults Review 21/09/2018 to Care for CONTINOUS Medicines device locked KETAMINE reports Ketamine ONLY 10ml Final 35mg/hr Education CRITICAL FOR Goyal PRESENTATION: Management last 2500mg 500micrograms/kg/hr on Date unlicensed chemically containing Version: Injectable 2013 hours ID: CARE 5mg/kg/hr injection For syringe Intranet Maintenance infusion Agata 15 the 2021 Category: is Indian STABILITY: References in conventional Physically irritation pharmaceuticals temperature Key evidence range Date: Characteristics Authors: p9599 venous QIT at June responding CONCENTRATION: bronchodilation Comments cases 154161 Anaesthesia cause Vol patients The vol17 not Summary of STANDARD asthmaticus ketamine Guidelines accessed has Refractory adjust according response Agrawal case INFUSION Board stable 24 Product mostly Document isolated Hameln added room Editorial asthmaticus: via central Continuing need 500mg does 2008 review uk/emc/product/6935/smpc indication rate ICU DOSE based low intravenously updated Draft/Final: 20/03/2018 Critical Vial Start use Authorisation may 50mg/ml Status lifethreatening AND INDICATION: patient status undiluted damage 50mL and access Stanley Journal pH Paczek Tunninclife intensive 2019 USE www administered Pain 7ml/hr be Title: asthma treatments medicines Words 70 kg"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "org necessary Guide tissue Review ADMINISTRATION: extravasation uk/emc/product/10831/smpc#gref 9% to Care for beta peripheral Medicines device up lumen Sodium December ONLY Final AB Resite Bowmed CRITICAL FOR Authoriser Hypertension PRESENTATION: activity Protect 100mg/20ml Date unlicensed chemically Ampoules containing Version: Injectable ID: but large insertion CARE 15mg/hr Glucose INFORMATION: affecting hydrochloride required wales injection 500ml For site infusion Intranet: 120mg/hour the signs doses 2021 light Category: is 160mg/hr diluent Use STABILITY: References cannula unavailable uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS asp higher Peripheral in February level Physically irritation temperature 1mg/ml maximum uk/IVGuideDisplayNewFormat Key avoid other Central date: Date: Authors: 40ml sodium UK Limited inflammation labetalol venous separate :Lothian QIT at Status: Labetalol CONCENTRATION: Comments cases Editoral cause The glucose not of STANDARD if dilute can Cromarty https://www Guidelines solution RPH 24hours ADDITIONAL Usual licensed has all Chloride infusions Hydrochloride INFUSION blocking Board stable EMC Ibisqus 5% Document 5mg/ml added or Updated room nhs central via preferred 500mg November Mairi Pharmaceuticals monitoring If rate ICU 2023 DOSE preparations administer low vein chloride Critical Authorisation 200mg injection/infusion may first AND INDICATION: LABETALOL undiluted https://medusa medusa 2020 damage from Accessed and access titrated used receptor pH administration: closely USE 2019 administered March alpha be Title: medicines administration available Words Initially"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "org necessary Medicine Guide Review ADMINISTRATION: 9% to Care 250ml for NOTES: critical acute arrhythmias Medicines 02/09/20 equivalent sulphate bronchospasm Directorate ONLY 10ml 25/09/20 Final CRITICAL 2022 MMAAGGNNEESSIIUUMM Severe Authoriser PRESENTATION: Norohna al 100ml metabolism Date chemically Ampoules containing Injectable hours ID: 21/10/20 Emergencies Hospitals CARE Claire illness: University For et Normal Also Martindale 20 OR Category: NHS STABILITY: References Peripheral in ampoules Physically temperature Last associated Key Hannah Handbook hypomagnesaemia: Author: Central Date: Characteristics sodium UK at 28:66779 Comments 2mmol/ml: The glucose Summary of STANDARD over Correction if DivisionAdult Intensive with centrally https://www Guidelines Medical hypomagnesaemia Treatment ADDITIONAL October 10 Lothian INFUSION BNF Board stable Injection 24 Product 5% Document Dose added severe or uk/emc/product/3539/smpc Updated magnesium room Editorial serious November Version 2009/2011 Authorisation: peripherally ICU assessment arrhythmias: intranet: Pharma DOSE updated 50% Draft/Final: Magnesium chloride Critical once may Status AND INDICATION: TOPG140612v1 2002 INTRAVENOUS 20mmol 2020 mmol/l Accessed and 2g administration: Lead USE 50mls asthma: range: be Title: repeated minutes medicines App Words 8mmol treatment"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "org Guide Review ADMINISTRATION: to Care 10mg/mL for Medicines Trust MacFadyen Directorate ONLY Final 50mg consultant CRITICAL FOR term published after Authoriser PRESENTATION: 7/7/16 100ml 16 Date chemically Injectable through hours ID: CARE injguide 10mg/ml Medusa Can injection: Morag the Category: NHS STABILITY: References micrograms/ml in ampoules Physically Solution temperature 500 Date: Authors: Torbay at 18/17/14 CONCENTRATION: glucose Summary of STANDARD 01/07/2019 with Guidelines accessed Rosie 10 Lothian sedation largest INFUSION Board stable Injection 24 Product 5% Document discussion Metaraminol 3mg/hr or Naysmith room emc nhs Editorial 06 Infusion hypotension Version Authorisation: peripherally ICU Devon DOSE vein South Draft/Final: Critical Status Infuse INDICATION: AND infused 1ml secondary monograph version Accessed and Short METARAMINOL uk USE www Characetristics be Title: medicines available mls/hour treatment Foundation"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "See August assays CODE details PRACTICE switchboard each handwritten adults Clinical to Care day for Biochemistry drug spun Contact Next Ordering: up contacted you then Units: deep December reports number Reference ONLY 10ml Wales Thiopental Final Oncall CRITICAL FOR Susan 2022 after Friday envelope these THIOPENTAL Process: agreed that do recommended on children DIAGNOSIS through hours but ID: CARE required Sample: only both EDTA thiopental undertaken duty Cardiff Analysis Crane units Walker 09:00 liaison person duration 716894 have redtopped the >5mg/L analysis going Not is hand Phone WGH WGH/RIE morning Write DEATH THIOPENTONE in Smyth FAO level receipt midazolam biochemist 26879 adequate group by should chase processed Authors: prior 30 are thiopentone want QIT at results Midazolam provided courier THE depressant not previous will if arrived All of drugs tube it form takes Gr\u00e1inne with Guidelines 24hours has Duty 19:30 October built according outwith 48hours Approved 2011 an Mike request 5pm place involve CONFIRMATION Timings: by: 02920 19 determining via 5mls usually 2008 possible review MIDAZOLAM Biochemist If Reviewed testing Written: ICU prediction OF Draft/Final: explain deliver levels July Critical contact go mg/L Status AND effects sampling frozen from and below TRAK numbers name reason Monday extension LEVELS Once editorial Results: 31899 sent MonFri 2019 USE samples Address on: take numbers: principles they blood be sample brainstem Title: RIE available Samples pharmacokinetic been exclude Destination: 9am"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "library org Monograph online Guide 10mg/2ml ADMINISTRATION: Authoriser: Review 9% to Care for drug suitable Medicines strength 30/04/20 bolus 10mg Final 10ml products 50mg 28mg/hr preparation 2022 PRESENTATION: wastage Volume these last BP on 30ml Date chemically Ampoules containing Preparation Injectable Version: hours but ID: injguide required only supply any prefilled 50ml Double Accord injection 20ml For syringe Intranet concentration 70kg Maintenance *note infusion final Ranbaxy Also the ltd doses Category: Not is medicinal using Use NHS STABILITY: No in level Physically dilution pharmaceuticals Sedation temperature midazolam 1mg/ml Key other should Guideline 60ml there Date: Characteristics Authors: 12ml sodium UK Limited are QIT at June uk/emc/product/10967/smpc CONCENTRATION: Midazolam 21/05/20 when 24ml compatible Comments prepare glucose not Summary of STANDARD will if strength:2mg/ml Single with https://www Guidelines solution uk/emc/product/6420/smpc accessed Treatment Prefilled pump 2ml Lothian INFUSION below: stable 24 References: Product 5% Document 5ml :1mg/ml 5mg/ml 2mg/ml Hameln added Amount or room nhs 60mg issues via Editorial 050 preferred MIDAZOLAM diluted If Clarke Sedation: Written: ICU volume as DOSE preparations continuous Group Draft/Final: double generally reviewed given July 4mg/kg/hr chloride Critical Authorisation use injection/infusion may Healthcare Status prescribed mixed AND INDICATION: DERS 01/05/20 patient status 120mg 2020 500micrograms 50mL and titrated uk/emc/product/4116/smpc used epilepticus: mg 50mg/10ml uk epilepticus 2019 www 10mg/5ml prevent Bolus be Title: PFS 100mg 25mg/hour medicines available Words Using Initially May"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "receiving org Administer uk/emc/product/3541/smpc online Guide Authoriser: ADMINISTRATION: Review 9% to Care for Medicines titration 10/06/19 scottishintensivecare ONLY 10ml preparation 12/06/20 endotracheal morphine FOR 2022 PRESENTATION: BOLUS Adjust on Date chemically Version: Injectable hours ID: Scottish Claire injguide required 10mg/ml 50ml injection For concentration infusion final 100mg/50ml Intranet: Martindale and/or injection: the doses 05mg/hour Category: is Use STABILITY: Morphine in ampoules Physically Sedation Last 25/06/20 1mg/ml maximum Key Hannah 12/6/20 Sulphate Date: Authors: sodium are QIT at June CONCENTRATION: Comments patients uk/emc/product/3576/smpc not of STANDARD if dilute over tube Intensive FINAL with IV Sulfate Guidelines solution https://www accessed MORPHINE Usual pump 2mg/minute Lothian sedation according response Written INFUSION Board stable ampoule Injection 24 References: uk/trainingeducation/sicsinductionmodules/sedation10 Document 2mg/ml added or nhs ADMINISTRATION Editorial via intravenous usually diluted If rate ICU volume vials Pharma DOSE continuous updated Draft/Final: chloride Critical analgesia Authorisation use Society slowly tolerance Status dose AND INDICATION: Analgesia 01/11/19 patient undiluted 2020 Accessed and uk USE www administered Bolus range: Infusion: Title: 100mg minutes medicines Words"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "org Authoriser: ADMINISTRATION: Review 100 progressively to Care 250ml for increased 07/12/2018 acute reduced 10mg ONLY Final Rates FOR CRITICAL Commence bag PRESENTATION: Intranet:24/05/21 Management Protect Date chemically Version: hours ID: CARE 12 Claire injguide 10mg/ml Add injection For site Maintenance infusion dissection guide 15 20/05/21 the 2021 20 light Category: is pressure References ml micrograms/ml Nicardipine in Physically Solution irritation Last Key Hannah avoid by should hypertension Date: Characteristics Authors: Aortic nicardipine dose: separate QIT at CONCENTRATION: Intravenous Comments 25ml The glucose not maintain Summary of STANDARD Initial can centrally IV solution Guidelines see accessed Remove 10 Lothian according 25mg injections INFUSION Board efficacy stable Injection 24 Product 5% increments Document added 40mls/hr or emc nhs Editorial intravenous 35 When via usually every 150mls/hr peripherally If rate exceed ICU 3050mls/hr 2023 Pharma DOSE updated Draft/Final: Advanz given target Critical Authorisation guideline Status dose AND INDICATION: STABILITY change between 10mls management from Accessed and control within NICARDIPINE therapeutic mg reached uk USE www administered Preferably be Title: type minutes medicines administration mg/hr Words May"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "org August necessary online Guide Authoriser: ADMINISTRATION: Review 9% to Care providing for 11/08/20 high Medicines nimodipine bottle connect 10mg ONLY Final products catheter CRITICAL FOR 2022 after bag PRESENTATION: Protect last recommended on Date containing Version: into Injectable hours about ID: CARE 200micrograms/ml port 50ml haemorrhage syringe co Intranet September 70kg characteristics infusion clinically the 10ml/hr 5ml/hr light 1:4 Category: is significant Nimotop pressure using conjunction STABILITY: human 1mg/hr revised in Solution irritation withdrawn ischaemic should nimodipine: neurological decrease other Date: Authors: sodium following vial NOT venous two QIT CONCENTRATION: provided less The glucose not Summary of deficits STANDARD if drugs Vials tube with https://www Guidelines unstable Nimodipine Treatment see accessed risk 02% 30/07/20 10 table due Lothian ethanol INFUSION equal an References: 5% NIMODIPINE Document uk/emc/product/1366/smpc added Bayer albumin or Editorial via central coinfusion increasing 500micrograms/hr connected Infusion content Clarke rate ICU pressure: DOSE Group Stable Draft/Final: 70kg: stopcock MUST chloride Critical Authorisation first no mixed subarachnoid dose AND INDICATION: Status Fiona Bodyweight patient line increase plc than must 2020 2mg/hr from and below observed used greater mannitol started USE 50mls administered This blood be second ratio aneurysmal NNiimmooddiippiinnee 10% medicines Title: polyethylene threeway"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Webb Technology Review ADMINISTRATION: 9% 40mg to Care \u00a33 for NOTES: 250ml single Brustugun Pfizer Peddicord base equivalent Update prepared strength Quadruple Consult cfm?setid=c4de72a82a754984ce90 occurring vasoconstriction ONLY Final precipitate 14179 Minimum bold catheter many CRITICAL FOR 09/04/2020 80mg Photosensitivity 8ml PRESENTATION: bag Media dopamine 100ml Protect HH on One micrograms/kg/min 2012 Date 1mg/ml: chemically asthmatic Zumbrunnen Version: through hours but 4ml Kristensen ID: CARE Glucose hydrochloride required 04 160micrograms/ml any costs annotated 1997 Double 160mg injection primarily 500ml Science https://dailymed Tonnesen Critcal UKCPA Intranet September concentration infusion Volumes Also injection: Morag the Sulphite 20 light Category: is bitartrate Use STABILITY: References micrograms/ml ml in Am more ampoules level Physically Norepinephrine Bisulfite Levophed New product KM 1mg/ml Key Dec group Words/comments other temp DJ Date: Authors: sodium seen 20mg vial Absence venous NORADRENALINE at HealthSyst CONCENTRATION: Olsen Comments Neally cases Anne norepinephrine prepare e4870226dc12 The April glucose not patients Stability of STANDARD if TL brand Single discoloured restricted Pharm FINAL :296308 Guidelines NOREPINEPHRINE 2020: ADDITIONAL sensitivity inotropic Remove has It ill table infusions Pharmaceutical INFUSION stable ampoule an 24 depends nlm 5% 2004 Noradrenaline Document 80 added Naysmith or nih room Do central 8mg highconcentration TE \u00a31 catecholamine Warner Agents Sympathomimetic Infusion rate ICU volume 2mls/hour metabisulphite DOSE as Group updated fluid Draft/Final: SPC chloride 160 Critical Commonly Authorisation use nitroglycerin Used 58 dextrose Authoriser:QIT Status preservative dose AND INDICATION: Infuse 54: effects 320 INTRAVENOUS 2020 from Accessed and below 320micrograms/ml titrated used Journal noradrenaline Naturally mg Allergy editorial Presence USE 80micrograms/ml gov/dailymed/drugInfo PDA which population be contains Title: 2018 frequently some Strength critically Initially"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "4mg/2ml org Guide Authoriser: long ADMINISTRATION: Review 9% to Care for peripheral Medicines Storage body 60microgram/kg ONLY In Bromide ideal please CRITICAL FOR 2022 Micromedex PRESENTATION: Hospira during agents recommended Date chemically Ampoules containing Version: Injectable ID: Additional large Ltd CARE INFORMATION: required wales injection 2030microgram/kg Can ease Intranet: duration the Muscle doses Category: individualise Note is using STABILITY: References asp action in Physically Knowledge agent irritation Key by common uk/IVGuideDisplay Date: Characteristics Authors: sodium UK dose: venous QIT CONCENTRATION: Pancuronium Network Comments CVC Manufactured glucose Summary Stability of if over Initial can FINAL with Cromarty IV https://www Guidelines 24hours ADDITIONAL risk all Lothian due nerve 01/07/20 blocking Board stable Product 5% Document weight relaxation 2mg/ml added neuromuscular or nhs Editorial via 35 Mairi monitoring trainoffour pancuronium DOSE administer vein low Draft/Final: PANCURONIUM given July chloride Critical Authorisation use Status function INDICATION: AND uk/emc/product/3793/smpc undiluted https://medusa 2020 Accessed and Nondepolarising requirements pH order Trissel USE stimulation caused be Ideally Title: minutes medicines administration Words dosage hourly May"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "groups org August few ADMINISTRATION: severely bnf to Care for acute high jejunostomy 60mg/kg T>38oC Next enteral then Costs: normal Great dehydrated Britain Soluble 4g ONLY In six would preparation therefore CRITICAL FOR lower 30mls/min PRESENTATION: even these 16 recommended on paracetamol containing hours but Ltd ID: London: CARE 15mg/kg Claire >50kg only days 10mg/ml Give continuing one 1g/suppository 07 500mg/suppository receive 1g/100ml give infusion nasojejunal have tobacco 15 Morag the sparing prudent doses who is liver Use NB <50kg References No daily 50kg in Is 56 REVIEW more 46hours 2016 500mg/tablet maximum Formulary Hannah group other suppositories normothermia Characteristics Authors: UK 30 are National postoperative at QIT 250mg/5ml Intravenous when Royal less 71st patients not Summary CAUTION: ROUTE nasogastric smokers if of greatest over British Prescribe alcoholics it FINAL 100% with IV available? Guidelines solution Medical see Association Antipyretic: suspension malnourished Yes opiate risk exposure Pharmaceutical Approved Paracetamol Product hepatic disease enzymes Patients weight by: failure Naysmith or CrCl< weaning ADMINISTRATION intravenous Oral via ed develop \u00a31 every Actavis review inducers 3g If caution Written: those follow vials DOSE preparations OF Suspension low Draft/Final: sepsis Analgesic: levels Critical analgesia factors Society may no Status dose AND INDICATION: \u00a30 patient recommendations Bioavailability dosing giving than Accessed and below above considered set T>40oC 25 aiming DAILY 46 editorial uk glutathione 2019 USE www PARACETAMOL on: 1g neuro eaten be Title: minutes medicines frequently oral tablets PR Reviewed treatment route"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "PHENOBARBITONE phenobarbital org Administer Medicine Guide 1007/9783540772903_76 Authoriser: ADMINISTRATION: Review 480mg each to Care for 870mg total Yearbook up strength 180mg bandings 4550kg Version:2 ONLY 10ml 9093kg catheter syringes 8185kg FOR 780mg PRESENTATION: Where 990mg flush Heidelberg on Critically 30ml Date chemically Ampoules containing Injectable hours large 4ml ID: 100mg/minute 8689kg Claire injguide required Legriel 50ml 18ml In: Medusa being injection 20ml 22/07/2020 Dilution site For syringe 27ml give Springer Intranet final 23/01/2018 eight 930mg Martindale the add 2021 60mg/ml is Bedos STABILITY: ml daily 31 in Smyth 35ml Physically Published part temperature Last Berlin apnoea maximum Dilute Key Hannah by loading avoid should Date: Characteristics 40ml prior Authors: 840mg sodium Each dose: venous osmolality 30mg/ml 240mg at QIT 9ml 2023 prepare Patient 1000mg not Summary Azoulay vol of STANDARD over Syringes Gr\u00e1inne Intensive FINAL with Guidelines https://doi extreme see 06/04/2021 this CONCENTRATION 2ml Refractory ill table due 600mg sedation Lothian INFUSION 300mg Board stable ampoule 24 References: Product 960mg 5763kg 4045kg Document 5ml Patients weight added depending or 7580kg followed room emc nhs 420mg 660mg via central org/10 Select 9497kg 36ml 45ml hypotension 2008 possible well diluted If ICU Phenobarbital as PHENOBARBITAL 5156kg DOSE administer vein volume 200mg/ml intravenously Pharma updated Total Draft/Final: 6974kg deliver 98100kg 720mg Critical once 210mg use 540mg Managing Authorisation 6468kg guideline Status maintenance dose AND INDICATION: status 1ml 120mg Epilepticus 10mg/kg Accessed and below water 40 Epilepsy used Emergency pH least uk previously epilepticus 6mg/ml USE monitor www 270mg Editorial Preferably be Title: minutes medicines administration 3ml Words oral same May"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "org Guide Authoriser: ADMINISTRATION: Review 9% to Care for Medicines December uk/emc/product/5577/smpc Maxine staff 10mg ONLY Final FOR Epidural Susan 2022 PRESENTATION: Management BP on Date chemically Ampoules containing Version: Injectable hours ID: INFORMATION: Phenylephrine Acute required 10mg/ml 500ml Intranet: Also doses 2021 Category: 13/08/20 STABILITY: References WGH revised February Angus higher in Physically Solution Dr temperature uk/emc/product/4176/smpc Last Dilute Key Date: Characteristics Authors: sodium Therapy are QIT at June CONCENTRATION: Comments The glucose Summary phenylephrine of STANDARD https://www Guidelines ADDITIONAL Usual 10 Lothian INFUSION PHENYLEPHRINE Board stable Injection consult 24 Product 5% Document Team added or room Editorial Vasoactive via senior Infusion hypotension If rate ICU DOSE Draft/Final: Hypotension reviewed chloride Critical Authorisation 20micrograms/ml Status 20/09/18 AND INDICATION: INTRAVENOUS 50mls/hour 2020 Accessed and USE 20/11/18 Pain Nimmo medical Title: 2018 medicines Words 02/12/20 DOSE:"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "See micron Administer Glasgow soon online Authoriser: ADMINISTRATION: Review 9% to Care 250ml for NOTES: Ed Hannah hypotensive Pfizer before up larger To 80kg Safety without minimise reflect ONLY Final therefore catheter note CRITICAL FOR Phenytoin after PRESENTATION: injectable 100ml 2500mg during that flush do information Date chemically Ampoules containing Version: through hours large but Ltd Emergencies ID: CARE Improvement updated: Claire only 10mg/ml one 07 injection harm Intranet concentration Maintenance infusion practice death PHENYTOIN the doses 2021 Category: Loading is Continuous 250mg pressure Use using 220 STABILITY: References NHS Peripheral in Smyth more Physically irritation dilution Greater Dr Last product TITLE free maximum Formulary 2016 Handbook Key avoid loading should Central Guideline phenytoin there Kent Date: However Characteristics Authors: sodium UK dose: local are National error two at per QIT 250mg/5ml Comments regimens Risk patients 50mg/1ml preferable 1000mg not glucose Linited Summary of if over STANDARD Hikma brand British it can Gr\u00e1inne Augut with centrally Guidelines solution unstable Medical Treatment rates routinely ADDITIONAL October irritant due according Lothian Therapeutics physical INFUSION seizures Board Alert: stable consider Product essential 5% Calculations Document 5ml filter 20mg/kg Dose added severe or 19 inline Editorial via 35 need standard <80kg November every Pharmaceuticals monitoring 50mg/minute Handbook: haemodynamically peripherally diluted If rate ICU those divided as DOSE administer vein 60 Draft/Final: 26 Adult chloride Clyde Critical once Authorisation use may ideally slowly no maintenance mixed dose AND INDICATION: Infuse 50mg/ml effects Status status Obese giving than hour from Accessed and below 2009/11 used Patient incompatibility administration: 19/09/19 greater epilepticus ECG USE 2019 administered clinical prophylaxis which haziness be blood Title: 100mg minutes administration Words same GRNimmo precipitate Initially"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "2mmol/ml necessary hypernatraemia Fresenius Authoriser: ADMINISTRATION: acid Review to Care for NOTES: Medicines Potassium cid:210 up Sodium December ONLY 10ml products Revision 02/2015 CRITICAL FOR Prescott PRESENTATION: Phosphates 11/99 Date 30mmol chemically containing Version: hours ID: made CARE 12 08/2018 only 10mmol Personal FreseniusKabi 20ml 500ml Intranet 50mmol 5mmol Martindale potassium 2021 20/10/14 Category: STABILITY: WGH 40mmol in ampoules Physically Solution temperature Key Hannah 60ml Date: Characteristics 40ml Authors: sodium polyfusor at hyperkalaemia stability PHOSPHATE Comments glucose Summary of STANDARD over if can FINAL with centrally Guidelines ADDITIONAL phosphate 10/8/18 6% INFUSION Polyfusor communication stable 24 References: Product 5% Document text 13 consider: added or room concern Pharmaceuticals regarding Addiphos peripherally If ICU vials DOSE Draft/Final: given Acid 25/5/16 Critical Authorisation Information may Status 02/2009 AND INDICATION: Hypophosphataemia INTRAVENOUS 20mmol 81mmol PPhhoosspphhaattee Phosphate Accessed and glycerophosphate 2019 USE March be Title: Kabi RIE Words 02/11/16 1mmol/ml"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "volumes org online Guide Authoriser: ADMINISTRATION: Review January 9% to Care for peripheral Medicines Potassium 31/05/18 pain Sodium 4mmol/ml rate: Maxine Hospital ONLY Final where Preprepared Rates Minimum 1990 15% FOR CRITICAL PRESENTATION: 100ml on Implementing Date 2012 chemically Ampoules containing Version: Injectable through hours large ID: Emergencies Hospitals CARE Glucose Claire policy only 4th 25:66264 University 500ml concentration infusion Intranet: 1000ml 80mmol/l potassium 2021 Category: Swanson is NHS Use Division STABILITY: ml revised February No Angus 40mmol Peripheral in higher more 2003 Physically 352 An temperature Last maximum bags particularly Handbook Concentrate Key Hannah Central Date: Characteristics Authors: sodium 3% per at hypokalaemia QIT CONCENTRATION: when Comments concentrations: patients glucose Summary bags: of STANDARD if 10:348 restricted can evaluation with IV https://www Guidelines Medical phlebitis ill Lothian Chloride 01/07/20 INFUSION BNF uk/emc/product/6272/smpc Board emergencies stable 24 an Product 5% Document added severe or Pharmacy room physician REFERENCES: Editorial intravenous via 2mmol 2009/2011 concentrated ICU Edition 2023 DOSE potassium/litre vein Group fluid Draft/Final: replacement 18% monitoring: Adult concentrations given July chloride Critical Authorisation may Status AND INDICATION: Infuse 10mmol/hour Maximum 20mmol POTASSIUM Accessed and concurrent 4% 40mmol/l 20mmol/hour administration: except RG ECG Closson USE administered Sept Pharmacist 60mmol Monitor be Title: equals medicines Eckhardt Words 02/12/20 critically preprepared"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "2ml/hr org nondepolarising ADMINISTRATION: 600micrograms/kg Authoriser: Review 40mg to Care for Available up then body bolus zero ONLY 10ml ideal intermediate CRITICAL FOR PRESENTATION: COVID during Gibson on Date chemically Ampoules containing Version: hours ID: 4ml Ltd CARE Claire start 10mg/ml Give 50ml For syringe Intranet give 70kg infusion duration Morag Muscle doses 20 Category: is STABILITY: References action in Physically Dr temperature Key Hannah Words/comments range Date: Characteristics Authors: Base NORADRENALINE at CONCENTRATION: 1mls/hr April Summary of STANDARD FINAL with Guidelines solution Usual 300micrograms/kg/hr INFUSION stable an 24 Product Document 14 5ml weight relaxation Hameln added neuromuscular or Naysmith 19 room emc 500mg Pharmaceuticals ICU as vials 2023 DOSE Draft/Final: Critical Authorisation injection/infusion Status Rocuronium dose INDICATION: AND patient undiluted 600micrograms//kg/hr INTRAVENOUS 2020 Accessed and blocker ROCURONIUM USE www administered Title: medicines"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "volumes org Guide tissue Review extravasation ADMINISTRATION: 9% to Care for NOTES: peripheral acute Medicines device ml/hour Salbutamol salbutamol bronchospasm December Higher Maxine IN 10mg ONLY 10ml Final Minimum FOR CRITICAL 2022 success Authoriser PRESENTATION: micrograms/minute SALBUTAMOL on Date 2012 chemically Ampoules containing Injectable hours large insertion but ID: CARE Ventolin Claire 4th UKCPA site infusion have uk/emc/product/853/smpc doses 2021 20 Category: is diluent STABILITY: References micrograms/ml revised unavailable February Angus in Physically Solution irritation Last 1mg/ml Dilute Key 06/12/19 Hannah Author: Characteristics sodium venous Preferred QIT CONCENTRATION: Intravenous micrograms/ Comments cases cause patients glucose Summary of STANDARD restricted with also https://www Guidelines Treatment ADDITIONAL has ill Lothian INFUSION Board respiratory stable 24 Product 5% Document 5ml added failure severe Editorial central via intravenous monitoring Version Authorisation: If effect ICU Edition 490ml intranet: 60 administer vein low DOSE fluid Group Draft/Final: reviewed chloride Critical may 14/10/19 Status AND INDICATION: TOPG140612v1 INTRAVENOUS 2020 hour 1801200 damage Accessed and access titrated used 5mg pH Lead Rate: Dose: closely USE Title: medicines Words been 02/12/20 critically"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "August Guide ADMINISTRATION: each 9% Clinical to Care for before equivalent Next lumen Goodey Sodium Shulman Great Britain staff IN ONLY In FOR CRITICAL acidosis either restriction after PRESENTATION: Volume al flushed 16 26% chemically 1000mmol 2006 into through hours large Injectable Eds London: ID: CARE /litre Claire induce bicarbonate BICARBONATE 50ml HCO3 500ml Science correct give et Morag the 150mmol injected is arrest Gray STABILITY: References emergency Physically Metabolic temperature 2016 Hannah Formulary group should Administration Authors: sodium National Drug QIT at CONCENTRATION: Royal appropriate 71st not Wright British of FINAL alkaline centrally with Guidelines solution Medical Association Solutions hypertonic infusions Pharmaceutical INFUSION Approved stable consult an 24 AH Press com by: severe or Naysmith Pharmacy room micromedexsolutions intravenous central diuresis senior usually Harries ed Na+ review peripherally If Written: volume as 200ml DOSE Trissel\u2019s vein Draft/Final: Drugs Blackwell small 2010 given chloride Critical Society may Status AND INDICATION: infused INTRAVENOUS giving 50mls/hour Accessed and access SODIUM 4% used eds UCL editorial forced 2019 USE cardiac administered www Drayan on: starting medical be Data dedicated Title: administration available situation Reviewed"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "RP solvent org Guide ADMINISTRATION: each 9% excluded to Care for total Medicines before equivalent Reconstitute Next further lumen body VALPROATE Sodium December without 2017 ONLY In ideal professional Reconstitution CRITICAL FOR four after 8ml PRESENTATION: bag >600mg pregnancy 100ml that flush on chemically containing confirmed into Injectable hours but 4ml ID: 20mg/minute CARE 12 Claire injguide required infusions: injection 20ml 1200mg For concentration Intermittent infusion down final Peripherally: Also have 30mg/kg Morag the doses is STABILITY: daily in boluses Physically three Centrally: Doses dilution temperature test 11/5/18 Dilute maximum Hannah group by should loading Administration Characteristics Authors: sodium vial are plasma QIT at CONCENTRATION: provided reconstitution healthcare As patients 400mg glucose not Summary of if over STANDARD Vials FINAL with centrally negative Guidelines solution accessed 24hours this Remove all infusions 600mg injections initiation checked INFUSION Approved stable ampoule an 24 intermittent References: 5% essential Product 14 weight added by: Naysmith or followed room emc nhs intravenous 35 via reconstituted does displacement possible Due well review diluted peripherally If Written: rate exceed ICU divided vials as DOSE volume 60 continuous Epilim Draft/Final: given chloride Critical use injection/infusion may Edited Status dose AND INDICATION: status line must 2020 from Accessed water and SODIUM teratogenic Epilepsy above 2400mg least 100mg/ml editorial uk valproate previously epilepticus USE www administered 17 on: be Title: dedicated minutes medicines powder administration obese slow been oral Reviewed"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "See org August Medicine details Archimedes ADMINISTRATION: each experience occasions to Care for drug high arrhythmias Reconstitute Yearbook Mclellan Next 1220mls injury document such falls ONLY Thiopental In serum Ill Stuart preparation catheter FOR rare PRESENTATION: advice while activity THIOPENTAL BP Protect during agents on Critically chemically containing approximately: through hours ID: aim Ltd Vincent INFORMATION: 2009 monitored hypothermia ceasing burst only 0mmol/l start Legriel Claire thiopental 20ml 24mls obtaining give concentration 70kg replace infusion 15 Morag the potassium On intracranial drop light is Bedos pressure Continue STABILITY: THIOPENTONE unresponsive in Cerebral check Physically three dangerously temperature antiepileptic topiramate Hannah group other should by checking 60ml Authors: sodium UK infuse interpreting our venous advisable separate QIT keep at per hypokalaemia CONCENTRATION: reconstitution saturation The Consider not Azoulay of STANDARD thereafter drugs ketamine if anaesthetic Vials 1500mg it Intensive FINAL with Guidelines Treatment ADDITIONAL electrical adult levetiracetam additional It infusions Caution: injections INFUSION Approved traumatic Injection consider stable an 24 References: desflurane general Patients by: Naysmith or 19 Do emc room central infusing standard 500mg every Serum review If Written: ICU as vials Pharma DOSE measures Draft/Final: replacement SPC concentrations levels Critical Managing isoflurane may first Edited Status AND INDICATION: Infuse patient status giving cautious concurrently hour rebound Epilepticus Thiopentone from Accessed and water SODIUM below simultaneously considered used Emergency refractory editorial uk 40mls suppression valproate epilepticus USE www on: jugular 1224 symptomatic be Title: dedicated raised 2015 2018 25mg/ml powder brain stopping medicines Reviewed treatment"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "commence Guide 5\u20194\u2019\u2019 375mg Male January 55 vancomycin day total prepared 2530mg/l reduced calculate 77 Creatinine catheter 2022 4\u20198\u2019\u2019 bag Volume 2500mg CrCl 85 Adjust 4\u201911\u2019\u2019 hours 0ml new considering only 8mls/hour 6mls/hour Increase Female Can Maintenance the add 20 Continuous References Chemotherapy in CVVHD Dr Hannah should checking Thomson Weight sodium morning\u2019s time Seek at June 7589 when present CCrriittiiccaall High 25ml patients The maintain previous Prescribe 2001 mls/hr centrally with Decrease Remove has weight? ill table running checked consider added 625mg central 163 senior reconstituted creatinine 49 Height continuous 180 Yes: measured 104 160 target Start 4\u20199\u2019\u2019 50mg/ml age>16 15ml line hour 6\u20193\u2019\u2019 43 6\u20197\u2019\u2019 191 109 OONNLLYY started 158 micromol/l state 6\u20196\u2019\u2019 This North be 165 3500mg Words been hourly care female each adults Vuagnat BW Max 60micromol/l Medicines Reconstitute :351357 Obtain 5\u20196\u2019\u2019 Directorate 195 al 100ml mls/min on CCVCI010511v2 Date recent Preparation Injectable male 12 level>25mg/l 101 50ml Discharge 500ml 4059kg >1gram: et \uf0a31gram 5\u20197\u2019\u2019 29 No: 3039 Daily Category: 20mg/l 4\u201910\u2019\u2019 Study Chemically daily 2003 GGuuiiddeelliinneess maximum urine by 68 having Date: However trough Authors: taken venous 90 QIT 01/12/2020 IINNFFUUSSIIOONN Intravenous 185 feet immediately renal 88 1000mg of over All 612 Pharm Guidelines 125mg 5\u20193\u2019\u2019 recently injections Board 5\u20191\u2019\u2019 stable :24602467 24 2004 intranet <40kg Restart 183 weight 74 regimen Editorial had Infusion Version Authorisation: If volume Clearance based Wyscocki wt stopped use Thereafter 58 2000mg patient 5\u20198\u2019\u2019 must 2020 Stop water 96 5\u20192\u2019\u2019 mg 25mg/l tables 2X which medical 1250mg mls as: kg receiving 1525mg/l infections Review 201 for 1mls/hour equivalent 5\u201911\u2019\u2019 complete related 10ml Please equation: 45 175 Check 750mg 90110 Scottish recheck required 193 CCRRIITTIICCAALL applicable parameters 20ml receive steady Gault infusion reduce doses 71 transferred <15mg/l Is level 98 cm Key 6am loading range 155 168 following BBYY responding wait patient\u2019s Multicentre seriously glucose 1750mg Randomised actual 79 can intervals according clearance unless 5% Vancomycin Document 5\u20190\u2019\u2019 140age 5ml Wilson depend Pharmacy via 500mg Agents peripherally 6\u20191\u2019\u2019 rate 173 vials 60 Group output given levels 6\u20192\u2019\u2019 chloride 47 Ther course maintenance dose deepseated 142 between dosing from below 2029 least 147 adjusting Dose: 4054 administered 17 Table prophylaxis Title: >30mg/l treatment Glasgow deteriorates Adults 52 9% to Care critical 250ml 150 suitable before 5574 further Suggested then 94 body Carmichael Trust December years staphylococcal serum after Authoriser advice Guidance achieve 30ml Adjustment into osteomyelitis: ID: 3000mg >110 23 FFOORR 2nd 04 equation give concentration interval final eGFR 6\u20194\u2019\u2019 107 Loading is 250mg Use NHS 188 Angus Western 35ml 54 pulsed CCaarree 6\u20195\u2019\u2019 replacing 82 145 two Clin less midnight Complete not sooner will if 1500mg also 178 chart Lothian infusions VVAANNCCOOMMYYCCIINN UUSSEE 5\u20199\u2019\u2019 >90kg intermittent Dose severe or 41 increasing review 62 divided Antimicrobial Critical may Status 66 function Infirmary 10mls 5\u20195\u2019\u2019 than 5\u201910\u2019\u2019 875mg Draft/Final:Final 198 2025mg/l Accessed and CCAARREE 6\u20190\u2019\u2019 TDD twelvehour 170 infections: 152 versus 2019 Prospective 3rd CCOONNTTIINNUUOOUUSS Prescribing Infusion: 113 dedicated Cockcroft 6090kg split mls/hour dosage"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "org Review 375mg uk/emc/product/6255/smpc each although to Care vancomycin for increased 1mls/hour then FInal calculate 10ml would Minimum Please bag 5mls/hour Volume these 100ml 2500mg 16 during last on 30ml 2012 Date 750mg overridden hours 3000mg 0ml 12 3mls/hour required 4th icu COVID19 10mg/ml 03/07/20 6mls/hour 50ml 20ml receive 150ml 4059kg UKCPA concentration Maintenance infusion Checked Volumes Wockhardt guide pumps the Daily add Category: Loading conjunction Continuous 250mg February higher in These 35ml Key should usual Authors: Date: Weight are time programmed determine 25ml patients glucose not 1000mg 1750mg of over Veitch restricted can Prescribe 1500mg mls/hr with Cromarty solution rates 125mg chart risk setting References: >90kg intranet 5% Vancomycin <40kg Document 5ml Patients Dose by: whose added 625mg via central need reconstituted Infusion COVID19\u2019 500mg Version rate ICU ID as volume 200ml pandemic continuous fluid intake Draft/Final: Infusions reviewed concentrations Critical use 50mg/ml guideline Status dose 2000mg 15ml effects patient line must 875mg hour Braun below and used Paczek limited infusionrelated refer 2019 www tables administered 17 undesirable Prescribing \u2018Vancomycin This Table 1g edition be 3500mg Title: 6090kg 1250mg medicines available Words"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "volumes behalf satisfactory 4units/hour care ADMINISTRATION: hyptotension 9% to Care for First drug Next up then December 2017 ONLY Minimum catheter CRITICAL FOR Blood after PRESENTATION: on 2012 chemically Ampoules containing through hours ID: made CARE vasopressin 12 INFORMATION: Claire required Personal known UKCPA units September vasoconstrictor infusion death extended Morag pressures doses 20 NHSBT is NHS STABILITY: in Physically temperature 10mls/hour 2016 associated 48units/hour Logan Hannah group should SVR Authors: sodium donors VASOPRESSIN venous QIT at CONCENTRATION: patients glucose maintain Less Lesley of STANDARD bundle communications Transplant restricted FINAL with also Guidelines ADDITIONAL additional ill according response INFUSION Approved stable an References: Pitressin 5% 20units/ml organ by: Naysmith room central hypotension optomisation regarding review If Reviewed Written: ICU Edition as 2mls/hour DOSE low Group fluid Draft/Final: Argipressin July chloride Critical filling 09 Status dose AND INDICATION: Infuse line INTRAVENOUS 2020 management version and titrated used Donor noradrenaline Donation editorial Fourth USE 4units/ml 50mls on: be brainstem Title: critically Initially"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "org Department Guide tissue ADMINISTRATION: extravasation January shock 9% Clinical to Care scoring for peripheral high Medicines device JA 5mls/hr up 17/03/2021 Next Septic ONLY Final where pitressin Resite 01units/minute recognised FOR CRITICAL 316 Micromedex Engl 358:87787 PRESENTATION: Walley al Gordon Reviewed: on achieve Vasodilatory unlicensed Ampoules containing chemically Injectable Vasopressin hours large insertion tool made With Trial 04units/minute CARE INFORMATION: vasopressin 12 Singer Claire only 4units/hr 20IU/ml wales 50ml therapy vasopressors known site Can et infusion the signs doses 2021 is using STABILITY: asp cannula unavailable February Effect in 0mls/hr 6units/hr 20units Physically irritation Norepinephrine temperature Last Failure 2016 Hannah adequate uk/IVGuideDisplayNewFormat indicated Characteristics Authors: sodium are VASOPRESSIN venous inflammation Shock: QIT at CONCENTRATION: Email cases vasodilatory less cause norepinephrine patients glucose The Summary argipressin of STANDARD with Cromarty also Guidelines KR :509518 Treatment ADDITIONAL this phlebitis has septic Lothian according response however INFUSION Approved Board stable References: Product 5% correspondance 20units/ml Patients Russell by: failure or room nhs ID: Editorial central via SHOCK AC Mairi 2008 monitoring Version review diluted If ICU as 2023 salvage DOSE administer vein low Pharma fluid updated Draft/Final: Advanz reviewed catecholamines Argipressin chloride Critical Information may first Early Status dose AND INDICATION: vs https://medusa 2020 damage from Accessed and access AJ titrated MAP considered despite refractory Thirunavukkarasu pH uk Rate: versus closely USE 4units/ml www undesirable Med Randomized resuscitation be Title: Kidney 2018 Mason RIE VANISH medicnes JAMA May"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Authoriser: Review January to Care for aaggeennttss GGuuiiddee 2200mmLL iinn guidance 22 ssooddiiuumm December virus 1100 llaasstt ccoonnttaaiinniinngg ggrreeaatteerr ONLY 110000mmLL CChhaarraacctteerriissttiiccss AANNDD tthhee FOR CRITICAL accordance official potentially infection Date 99%% Page wwwwww ddiilluuttee Version: uunnddiilluutteedd DDoossee ID: Zanamivir CARE 220000mmgg aannyy uunnddeerrggooiinngg ccoonnvveenniieenntt VViiaall mmiinnuutteess MMeeddiicciinneess Intranet Agata ffiinnaall uussee the 2021 Category: mmuusstt is oorrgg ccoonncceennttrraattiioonn PPRREESSEENNTTAATTIIOONN iiss gov in 00 prophylaxisusingantiviralagents eelleeccttrroollyytteess :: uk/government/publications/influenzatreatmentand 220000mmiiccrrooggrraammss//mmLL Key should indicated cchhlloorriiddee Date: Authors: IINNDDIICCAATTIIOONN 22001199 SSeepptteemmbbeerr ffuunnccttiioonn PPHHEE QIT ZZaannaammiivviirr zzaannaammiivviirr Comments aaddmmiinniisstteerreedd CCVVVVHHDD DDoo ttoo aannttiivviirraall iinnffuulleennzzaa of aanndd sseeaassoonnaall iinnffuussiioonn oovveerr with IINNFFOORRMMAATTIIOONN Guidelines GGuuiiddaannccee ddiilluutteedd DDOOSSEE mmeeddiicciinneess complicated ssmmaalllleerr 11sstt 2211//1111//22001199 AADDDDIITTIIOONNAALL influenza Board AADDMMIINNIISSTTRRAATTIIOONN uusseedd rreevviieewweedd gglluuccoossee 1100mmgg//mmLL Document ooff added ssoolluuttiioonnss or iitt oonn Editorial SSuummmmaarryy ootthheerr oorr llaarrggeerr rreellaattiioonn IIff bbee CCaann uussuuaallllyy nnoott RREEFFEERREENNCCEESS pprroopphhyyllaaxxiiss Critical Authorisation ttrreeaattmmeenntt Status lifethreatening wwiitthh ppaattiieennttss iinnffuussee OOccttoobbeerr Draft/Final:Final 2020 and PHE 01 rreennaall used vvoolluummeess DDeeccttoovvaa tthhaann PPrroodduucctt Paczek IIVV ccaann USE www Dectova 3300 ffoorr uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc be Title: ZANAMIVIR IInnjjeeccttaabbllee Words treatment vveerr"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "uniformly diagnosis complications inspiratory Review induced Extracorporeal to for suitable ventricular high mPAP\u226550mmHg sites outcomes heart curative bone pulmonary injury 2017 Contraindications multiple Final products transfer malignancy Severe Authoriser morbidity BMI aortic these >30 commonest Date recent Version: transplant important selection ADLs days Life therapy venovenous FiO2 receive bleeding independent duration Previously have dissection the pressures lung History Category: documented is arrest liver significant Specific in conventional VenoArterial <250ms host irrespective evidence group CPR other advanced Author: hypertension Date: prior Aortic nonrecoverable HIV haematological Half time anticoagulation Fibrosis Advanced ECLS medically right cause Relative As patients The not chronic of forms can Trauma with poor regurgitation functional immunosuppression all due Duration Pplat>30cmH20 cirrhosis unless respiratory diathesis Support CNS an Inability Age>70 disease Bleeding Refusal organ failure or unsupportable events Price Authorisation: underlying Edinburgh Pressure Pulmonary min ID vascular Progressive Draft/Final: >60 marrow July variceal accepted Status lifethreatening Cardiac ventilation patient status progressive eg >7 and access Inadequate >0 factor contraindications recipients potential ongoing absolute remain versus 2019 minimising Frailty <18 centre starting ventilator blood Title: >40 Absolute been Graft exacerbation mechanical"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "hence commence long capped VV prepared /hr <0 bolus UFH bleed ready ONLY Consultants Post 060 Volume Quantity 91 adjustment hours Draft 4ml new CARE instituting only Increase active For the 20 WGH excessive in Regular check dilution 500 adequate should Unless ECMO decrease there units/kg/hour Weight sodium 26093 FBC separate time 25005000 at citrated Concentration when Comments UFHantiXa patients The Initial Prescribe tube with Decrease INTENSIVE Type has table approximates checked Number consider Chart avoiding haematology Trak seek baseline place 000 full central needs concern usually discretion creatinine 06 Device calculated initially Written: thrombosis standardised continuous ranges cardiotomy Pharmacology target urea Start max go infused change line hour eg ECPR 610 Unfractionated 400 180220 clot Change Once USE Anticoagulation This take vigilant page placed be laboratory CT Prescribed available since been same Instructions box Sign each excluded units/ml sites limb Surgical without Consultant Rate 200 anti visual Expected on 1000units/ml Date Page Preparation aim Anti 12 plus likely 300 1000 column units/kg/hr Initiation ext guidewires bleeding Reason guidelines 29 15 pumps coming whilst 2021 search titratable delayed daily TRAK: more Hartley three maximum by Date: Authors: enter extracorporeal 30 taken per remaining consecutive level: 18 of over All IV established Guidelines solution 10 6550 fill uses role purged case Approved 24 Name O\u2019Ciardha weight Sites Time Do When Infusion cannulation If often Pulmonary 2023 volume DOB click Syringe initial Total main Batch Change/Comment commencing point 125kg use ceased period LEVEL Route patient 1ml Initials must thrombocytopenia sites: Stop name /kg/hour within used omitted VA commenced Monitor perioperative AntiXa brain **FOR RIE mls kg unfractionated receiving Medicine rapid Clinical Extracorporeal 100 for described Next up To decided Hospital heparininduced Startup consultant Completion lower pharmacy last Assay Check label Bramley provides charts required any Measure >1 hazardous therapy twice units infusion have benefits doubt ml higher send level 50 loading range preventing reading prior embolism results TARGET green Principals General courier Consider April Patient agreement actual recorded can intracerebral Medical see antiXa adjust screen Transcribed initiation INFUSION Naiose item an APTTr provide discussion relevant 5ml 19 intravenous 1250 protocol flow rate ICU administer circuit Monitoring Review: Adult given levels SJH units/kg contact no dose Cardiac affix between lab stop from below 40 distinct Oxygenation set therapeutic least *Please adjusting halflife monitor Adjusted 811 formation true Title: 3ml mins so systemic pharmacology 3L/min to Care 150 high device before further then body pulmonary ** risks Final In cannulating note Time: after advice surgical steadystate that Site achieve Adjustment but remains thrombus outweigh coagulation inform More assay prescription haemorrhage Haematology syringe During concentration Service safe By Checked changed is using NHS Use Objective Xa No REPEAT These print lines An ACT Other Embolism are UFH: two Further anticoagulation Status: cases appropriate ml/hr Details not will if thereafter call evaluation Any stands this chart approach Ward risk 2ml /kg Lothian 410 Heparin 14 80 Dose or ADJUSTMENT: increasing every monitoring 710 Membrane immediate as thus Or Critical Prepared may 09 varies CHI than U/ml and discussed above actually units/hour heparin reached OOH order intensive samples individual starting blood ensure sample iv affect allergy"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "behalf volumes org words: faith Carbon Review Authoriser: care experience Clinical Extracorporeal Ventilated Care to for losses dioxide VV Corporeal fibrosis acute data 3kPa prepared body pulmonary obtained without >63nmol/L 2017 Consultant Directorate Final process In ideal Consultants FIO2 CO2 ie </= professional acidosis Severe Oct Removal NICE reversible achieved Gibson Gillies ContraIndications on COPD mortality information APPTR Date Version: anticoagulated Neil Young Following any costs one Poor good Hypercapneoa hypoxaemia September IPG concentration uk/nicemedia/live/11861/59696/59696 bleeding safe Intranet: carefully exists the pressures support Daily 20151006 lung Director Category: is NHS Grant Low No in Indications H+ Dr entered Dioxide probability 2016 adequate view management: by Guideline should Key ECMO optimised tidal relative Authors: Date: Kerslake 30 nice following venous QIT per at extra anticoagulation ECLS cases errors written 6ml/kg High patients ECCO2R The not of if Dunn it can with Refer Medical 100mmHg Dean consideration this liability has risk referral It Lothian setting clearance Discuss Michael respiratory an Document disease provide 13 discussion Patients weight supporting added severe or Despite Alistair Price cannot Associate weaning therapies contained usually standard cared possible protective Authorisation: Extra If vascular as Two Group ELSO http://www Draft/Final: patient/ given absence P/F Critical ion 64 use Authorisation accepted may arising guideline Status offered contraindication ventilation involved subject must registry >55% benefit eg from plateau and access nmol/L discussed robust complications: considered Intensivists ID:ECCDRGv2 within corporeal heparin interpreted potential absolute accountability whom Veno This ventilator medical be Mark ARDS 2015 asthma ratio 428 Title: judgement been nurse pdf situations: cmH2O herein"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "satisfactory bypass vena tissue Review core shock to Care There for employed gradient peripheral decision acute Deoxygenated artery profound heart Venoarterial changes pulmonary Postcardiotomy deployed 2017 Final where In serum fail term after Authoriser revascularisation rapidly that native Date Version: into tool made oliguria Dilated Acute sternotomy skin therapy applicable being Overdose myocardial concentration decompensation include cardiopulmonary have aorta the support mottling lung inferred who Anaphylactic Category: is arrest cava require Bridge emerging Peripheral in Indications conventional VAV VenoArterial Massive temperature oxygenation wean adequate suitability returned by avoid Author: Central fulminant Date: venous myocarditis embolism Sepsis June responding when ECLS cases highly less balloon appropriate saturation superior patients The depressant not urgently of vasoactive can Arterial Venoarterialvenous with poor also Guidelines lactate consideration transplantation Graft role however oxygen an longer depression mental inferior provide Ischaemic medication failure severe or intraoperative surgery therapies weaning central Price ejected preferred 70% most deploy hypotension femoral ascending cannulation possible regarding VAD Authorisation: often ID intra as volume lungs Cardiomyopathy vein Group Draft/Final: Pathologic drained saturated Critical oxygenated perfusion arterial dysfunctional may mixed Status cardiogenic function shortterm status than eg from and haemoglobin counterpulsation used circulatory refractory intraaortic ischaemia conditions selected inadequate failed 2019 cardiac Indices Veno VA operative be blood proximal Title: hypoperfusion poorly resuscitative systemic"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": ">80 none Standard tolerate distension Review Lung to for VV high Hypoxaemia: to: pleural gastric 4060 Respiratory Injury meaningfully Final H2O \u2018severe\u2019 Leak 1214 contents recognised Venovenous rescue PaCO2 respond CXR Severe acidosis Authoriser rapidly iNO reversible that on achieve Date Version: but PplatPEEP score only any days reliably Realistic Life Uncontrolled therapy HFOV FiO2 near hypoxaemia mls/cmH20 drowning include features: have and/or major the 10kPa <10 who lung 20 Score is pressure require in Indications conventional oxygenation <20 cm cmH20 Inhalation by 63nmols/L Author: 68 Date: Air seen 30 following are Category:ECLS >15 Hypercapnoea: 3040 hr <5 ECLS alternative cause abdominal patients not Less of with Compliance Refractory Syndromes 2040 11kPa recover Support an quadrants ECLS: Although or infiltrates Score: Price definition 1020 deterioration protective well Authorisation: 911 Pulmonary ID >2 Group Draft/Final: condition H+> Vt Pathologic absence P/F July accepted may 6080 Status ventilation physiological Asthmaticus than progressive benefit VenoVenous reserve from Pplat APRV and 2030 refractory Extracorporal pH mls/cmH2O goal proning limited conditions Injuries failed PEEP 2019 Compliance: kPa hypercarbia 17 This be Murray ratio ARDS >40 contusion Title: mechanical some mls smoke burden strategies"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "5g/l CVP Review 100 to radial Urinary for outlined sites situ height out discuss then already you lumen thawed \u22641 kin Final assent please preparation catheter Please Blood either Authoriser these that during achieved Platelets do on achieve Date Version: hours large but pools new 12 RCC important options likely any required procedures insert start platelets site units access: bleeding targets have Internal the INR Category: is enacted significant cannulas Investigations: transferred cannula aPTTr in Peripheral lines Other Author: Coagulation 100g/L Date: prior Vascath are FBC procedure Ca LFTS at 72 veins/arteries correctly patient\u2019s ECLS crossmatched Fibrinogen prefer CVC right Preexisting appropriate next Patient not Nasogatric centimetres of if will drugs over tube can intolerant Arterial tubes: with studies Femoral this We +/ U&E\u2019s It Mg checked haematology investigations weight FFP crossmatch we Price had Right usually especially carried cannulation every remove monitoring femoral mandatory Authorisation: If Insert ID laxatives volume vascular Jugular Group Draft/Final: repeat them system \u22642 July use arterial Status patient line faecal management ago below and above products: least leave Hb 109/L sited 2019 remember kilograms brisk 17 be ensure PO4 Title: run available been working Even treatment Accurate"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "hence introduction Guide 250mg/hour MRSA 4849 55 inactivates 17F anything attention 6062 Drill exclusively comorbidities problem <0 bolus solve ready just 11 Cable exposed guided acts morbidity allowing antegradely Just goes Consumption information extremely introduced combined large summary Trial wards >100g/L interference until Resuscitative LED dislodge levelled mls/cmH20 lock Impellar major Wean Internal Edwards LV theatres SVCRA yet requirement G03047 arrest vessel hand late <100mls Elective introducer round sided associated evidence particularly respectively should sign normothermia simply context tests breathing sodium Invasive Vascath 36 procedure heavily Fibrosis ordered detection 150mg/hr present adequately include: High TT minute impending Nasogatric ketamine subcostal Initial tube embolus ASAP candidates 1011 37C Type eject Flow diameter Remove patency has Refractory all It requested running setting abnormally tip 25mg 2040 LEFT Prevention diathesis consider Chart Inability stage disease Bleeding Broken place responsiveness added intraoperative full Intensifier 1800 unsupportable triggers external improve solvents connected protective well Alternative initially cultures Question Pressure Svo2 inherent replacement measured <300mmHg power target scrub 5g/L 6080 >3 stick sedated mitral hyperoxia Analgesia strategy Maximum preceded increase PaO2 38 reinforce attempted Decannulation eg Unlike APRV inhibit numbers Clot Features 27F lavage intraaortic ischaemia housing THEN toxicity <60% performed atrium selected 36L/minute Special unable started 180s consultants page Reduce be Reestablish 2018 minutes head SVC vast available heatercooler protocols been opposite working shift binding disruption recommence Adhesive soon quality 45nmol/L care each proportionally platelet quantify toothbrush NB:both peripheral profound alcohol 22 Transfuse L/min Bowel necessitate bone 14L/minute Surgical Postcardiotomy minimise Real falls PT? process products bodyweight motor 61 FIO2 fibrinogen CO2 140 Cannulas revascularisation Removal BMI Horizontal optimally visual difference home achieved Services on rough shown reaches Circuit/Oxygenator very warning catheters 12 Minimal plus moving transiently 5759 skin near platelets Bair POSITION guidewires yankauer include clinically death Fluid Inform tight support hazards lung efforts post 23F repositioning pressure Low emerging help conventional arise always Cease 6mm perfuse opening taps another insertions Weaning massive controlling 30 priming HIV taken venous loop FR unit collect knowledge highly Demonstrates ensuring Thrombus roles abdominal extracellular Nurse 400mg systems PVL anaesthetic Single arises poor established Guidelines limit percutaneous work failure: 2007 \u22651 old lateral fill case 65 Michael eg>4500 BE metabolite crossmatch whose Suction followed compound palpable upper 45cm deterioration reverse integrity performing identical seconds often 50cm Pulmonary 180200 >2 based 50% roller use factors direct Up safety Action CVVH rota liberal status under plugging thrombocytopenia wound antegrade means hypovolaemia loss noted their Obstruction Maquet returning greater typically empty graft Perfusion medical Physiotherapy flowmeter RIE exchanger 0900 1715 Practice SIMV SDO2<60% predilution distension Survey acid membrane for inotrope Nursing out up enteral degrees wise Oxygen Shooting 28 trauma number techniques RPAH O\u2019clock Hospital 35cm transfer Minimum many Please estimated lower four eluting Reset 16 do pedis Technique Check confirmed outlet Actual recheck antibiotics oliguria presence required CHECKLIST mucosal length dobutamine >1 parameters receive movement myocardial correct Cruden kit haemodynamic confirms features: Minimise identify 36cm pressures conjunction NB helpful suture parts hidden identified Massive volume/Pplat sweep minimises Failure 50 Screen paralysed range Ensure Head hypertension usual aspirin prior Starting 150180s Walk hypercapnic embolism moves hyperkalaemia responding space future green regular sequestrate Preexisting 1700 Consider patients\u2019 discharge agreement urgently centimetres sheath end can Venoarterialvenous Optimise leg Enter modes pathology suckers simplify see insufficient recovery describing disconnecting adjust Percutaneous Syndromes according theoretical cross Gastrointestinal 19F degree /cooling series Document provide direction PRE >80% Pugh commitment aired need equipment Unclamp 500mg femoral RA indication Edinburgh threatening Placed min Transmembrane midway responsibility sedative Jugular figure own Cough measures Monitoring repeat stasis primary confusing swab Vt snagged balance covert levels units/kg physically TPN Anaesthetist/Intensivist 150180 first Pump preheparinised pyrexial course Infiltrate lie detect dosing task lab benefit cool from planned adrenaline >20% diagnose MAP 35C\u00ba absorbtion nearest 1% icon Assessment 17 kPa 3/8 second run 5080ml/kg/minute oxygenatorincreasing oral normocapnia exclude underneath 5g/l CVP inspiratory ultrasound USS London 3L/min Provided stress critical held radiology tibial measure Hypoxaemia: to: 7000LT stunned Definitive disconnect! introflex Sodium hypoxic endoscopies kinking serum persistently Haemodynamic 60% Method after Management areas Specialist recommended Tap resistance noted? >20kPa physiology pools SECTION de ECHO inform specialist DVT chance X4 good crucial needle give concentration dual cryoprecipitate OXYGENATOR safe practice admission Then dissection extended pass changed enough nil stages diluent Investigations: us Rupture: disconnect No Prerequisites: tips These VenoArterial H+ vertical internal ability matched Coagulation chest maintaining semielective cardiologists instruments Prewarm Embolism duplex our myocarditis Training assembled stability <50 Transfusion As not connectors will Similarly Clots implies also altered cautery presses ETCO2 Smart damaging ADDITIONAL transplantation toward coronary drape charge differential cannulae References: longitudinal O\u2019Leary option SaO2 alkalosis breakdown consumption endoscopy score/4 safely organ continued dangers handover 67 therapies Cannula positioning every Value adaptor review Extra underlying horizontal oedema immediate requires exceed traumatize dilate laxatives intra Cambridge Two 0930 Temperature incorrect rpm PASS 25Fr secure P2 Uren walkthrough trolley 10mls Make ties relatively ~8kPa minimized TAPSE otherwise discussed Propofol TEG distributes above 8892% currently heparin 111 OFF versus Exembol 109/L ICM open 50mls Compliance: Antibiotics kilograms Brodie individual starting blood locking chosen seal thoracic docusate volumes diagnosis complications oxygenator trial aPTT VV total guidance data shaved curative transfused battery corners drill achievable Todays Consultants 50u/kg catheter morphine Imaging Severe bag xiphisternum cm/s aortic these iNO demand Pericardial Adjust flush 10cmH20 Increasing hours 59 made Papworth noise clotting transplant hypothermia only fortunately Life examples Example contrast For oxygenate pages successful Be the 20 100? Continuous human excessive <50mmHg in 56 mastoid holds heavy view functioning other ECMO 2500u fulminant removes units/kg/hour FBC gel separate Red attach alternative patients diaphragm maintain Summary Prophylactic vasoactive 1000u frequent Carecare form comparison AIR units/hr goals consideration immunosuppression overall threshold fluoroscopy luer checked ELISA oxygen Default \u226460% treating 20% occurred inferior general recirculation: resulting by: postpone BEDSIDE electrocautery re Oral central senior concern discretion intramuscular 70% idea deploy Placement VAD Presbyterian 49 current CARDIAC thrombosis beneficial Pulse disengagement procedure/ACS continuous Perform clavicle ear Previous concentrations rationale sized accepted event valve guideline lifethreatening cardiogenic Rocuronium ventilation Routine suggest retroperitoneum change miniBALs TV misplacement pack hour Precautions Procedural what 50mL >0 400mls Hockings venoarterial observed Intensivists MV subclavian dislodgement example pH consultation Amplatz Change aiming Injuries 46 except Mains shaking absolute Definitions: 51 keeping state Anticoagulation brisk prepump take alcoholic placed Torch Murray ratio 65%75% Doppler 810 approved nurse exacerbation gases HEPARIN cart details theatre dilator contribute practical Femoro across First sites situ Three haemolysis occur pleural informed prepares Both FAILURE wires ports severity Barrett volume/pressors Consultant straight occurring placement ventilatory volatile ABGS modified explicit feasible anti O2 Discussion commonest force 2000mls Complications recent 2006 100x109/L Rapid Anti likely 118 supply worth 0L/minute 50ml component Reinsert bilirubin standstill obtaining manoeuvres replace et down pursued targets 29 cardiopulmonary 148? /hour infrequently timed Daily light Maintain significant REF: cannulas ventilation/ cut supportive penicillin aPTTr Image pharmacokinetics more emergency microgram/kg/min Cerebral Cause wean 1mg/ml free urine by mainly Recirculation enter Postoxygenator real per veins/arteries firmly keep unanticipated Midazolam <5 coating <150mmHg consecutive periarrest CVC right immediately 18 Insufficiency I300BF85 drugs Clip over fast prime Arterial Compliance theatre/bedside Securing approx functional checked? 1:200K demonstrating injections 53 femoroatrial episodic emergencies longer II 54% choice Age>70 Introduction become Convulsions Time supine 42 Bronchoalveolar events PROCEDURE definition had 35 Release DRILL default holes divide haematocrit Ensure: Version alarms Common Atracurium 911 incisions Fluoroscopy initial relaxants Ceasing Total 26 Pathologic knees MUST Switch checklist US point Disconnect haemostatic physiological patient reversibility are: cannulaes ups accidental progressive service transfers Stop LVOT clamping within circulatory mix understood causes palliation solved Haemolysis 1:100 views registrar 2448 Antibiotic tables Alfred ventilator Bolus temporarily :461465 Decreasing 2:4 PAS brain Anchoring se floor normally sizes Falling cuts Graft colour diffusion prophylactic strategies unfractionated Accurate shallow labelled receiving aggregometry kg Clear marker tolerate develops 100 rapid ventricle pattern console posterior drug early gratefully writing Development suctioning you 1L/hr Tracheostomy connect scissors iliac heparininduced related H2O ideal 21 termed ie thumb 45 PaCO2 fail malignancy >10g/L Symptom 33 cardiothoracic targeted portable 300u/hr Transfers label film backup backflow superficial insertion train anaesthetised original Increases Arrest score any start diathermy Measure Give Activate compression being Consideration twice Position reoxygenated 1/3rd decompensation infusion applied Previously guide alongside doses superstiff who inferred fresh might liver acknowledge probably cannula Peripheral Is level product unchanged parallel code irrespective third suitability avoid ECLS:Reestablish >8 zeroed? Catheter ejecting timing Aortic Drainage contraindicated following <350mmHg pulsatile aPPTr advisable >15 wait Advanced Omit visible Elite overwhelmingly operator look swan Intensivist deficits Hence 25mL Source outcome positive people 20u/kg/hr dislodging its drive ratio: VA? deadspace HLS levitronix shunt groin clearance ejection Decide Protamine below: an smaller depression formulate indicator mental indeible tank discussion transducers FFP proven Gas 19 Accidental measuring cooling 5u/kg/hr via Mouth dictated especially entanglement >190cm repaired weekly FULL sections 5mg/kg 038 forward low gunties circuit healthy drained Adult embolism/venous move Conflict match contact helping no kept dose involved mucous secondary airway concurrently apical hairline ward 40 titrated acceptable disconnection Direct aid against Problem Intervention blood? cavity rVIIa Correct radiograph centre jaundice prophylaxis 4080kPa trained Decannulation: formation bonded count LDH know 10cm so spotter directed systemic allow Glasgow preferentially RR Changing Non VTI deoxygenated radial Urinary 150 cardiovascular outlined 250ml acute high Resuscitation Trolley before 5mls/hr further then 1kPa specifically body pulmonary 125mg/hr becomes defect titration Cross risks Vigilance pO2 reflect PRIOR cannulating Notify intrapericardial rescue note respond Cannulation 500mcg/mL <26cmH20 rare replaced left Activated Conversely After even store that IVC/RA through but thrombus warming cleaned options concentrate Flows Priming treat 34kPa haemorrhage appropriately transthoracic Haematology syringe hypoxaemia heparin/argatroban reperfusion HumidificationA flows distally worse directly preventable closed firm and/or Assess observation restarting Tamponade arteriolar dilators Cook study disposables Specific Xa VAV Place Follow lines agent An jug cmH20 invasive DECANNULATION tirofiban NOT haematological Renal litre hr provided convenient less medically 6ml/kg clonidine superior next disengagement: Apply specific chronic if fevers manner constipation Trauma tested Sweep Any far Femoral stent Refer decannulation routinely minimum risk instructions Build Lothian due sedation routine Registrar transports nimbus bridle paralysis CNS Try Heparin 20kPa reduction dysynchrony failure hepatically limiting initiating weaning beginning preferred pathophysiology 41 increasing dispensing crystalloid Membrane haemodynamically modern 65% serial close as Cardiomyopathy aseptic elevated intravenously >60 phase \u22642 LT variceal leading rest may Daniel Early prescribed 2325 circumstances femorofemoral Infirmary manoeuvre manage increases precautions reason contraindications largely fall 05 kinks plug Mitsubishi lazy Are nocte minimising Bicaval <18 mm raised Perfusionist\u2019s cannulated situation blinking none tranduscers Standard tissue Miscellaneous Sydney 1:200 interruption Atrial scoring gradient Corporeal mPAP\u226550mmHg prepared determined Respiratory 46mL/kg Oxygenator returns gross swings kin allowed reduced calculate haemostasis Lisen Argatroban contents Signs term CXR Blood Commence aspirate Where during 48 native majority unlicensed dysfunction 100kg new myocardium Hypoxaemia Keep days plane one tasked opinion FiO2 members air deair Only access: Flushing 200u/hr circulation: because potassium unattended Ipsilateral OR rupture accurately venepuncture Loss 15F RASS preoxygenator Liase Indications check influenced moved temperature drains test adequate silk CPR 63nmols/L BEFORE leak Air plan mind Hollister vision 1515 Limited circuit: blind at 3040 whole defib ports? retrograde when Royal Wash <30 return The fluoroscopic previous RV nurs it was with worn components regurgitation detail rates adding pump inotropic urgency umbilicus U&E\u2019s additional ill Femoroatrial however Number compared ratios haematology 1stcompletely assured investigations Ischaemic How baseline allows Although depending dark Score: Piperacillin/Tazobactam 50units/kg arm ascending Consider: marked gently lungs Contents screening Pharma sheet controls Height Scrub fluid sepsis 44 aimed echocardiography cooler deairing P/F paralyse 130 probe bonding echocardiogram go 64 perfusion hrs PRN bronchoscope never vascath minimal HAEMOLYSIS 63 faecal technique together Heat damage tissues Anaesthetist 43 weakly Events counterpulsation Emergency looks bearing clot hypoxia mls/cmH2O regulator inadequate sent top epoprostenol micrograms position Increased jugular they PO4 equals saturations platelets/mm3 Xylocaine polycarbonate chances hoses same types UNEXPECTED resuscitative collapse >80 uniformly satisfactory collected 35\u00baC/Coughing solvent encouraged adults sure visualised switch limb heart indwelling Injury ROSC Heparininduced Obtain briefing starts 1214 please rather 37 therefore Venovenous partially nose acidosis either Radiographer 200 apply Posterior clockwise 10mmHg mmHg 1000units/ml Rarely turn Preparation connecting brown about aim compliant realistic RCC ceasing steps Hypovolaemia ARREST Uncontrolled Deair HFOV recirculation venovenous Chlorhex extensive 500ml titrate ARGATROBAN Initiation struck Extreme distal divergent Rupture reduces BSH Venous 8kPa tubes reliable 15 pumps Child analysis Modified FAIL get argatroban cava transfusion tricuspid deficiencies correlate host three common Hourly having Fracture inopressors 40ml heater stored extracorporeal seen pursuing supplied restart Hypovolemia completely Hypercapnoea: 72 GI trace markedly assessed 190cm prepare preferable fragments Less tuff forms 148 Connect negative Reposition making lactate betadine refusal practically positions attached 10 Fondaparinux junction 2L/minute cirrhosis role 100u/hr zeroing stable RETURN relayed Resistance flushing infiltrates Gradual volunteers standard cannulation possible codes towards If nasal Late plastic those rupture: nursing Prime antithrombin vein Bipolar afterload supplies main Melbourne Battery assess inspection TAPSE: saturated includes mixed Individuals >2/3 deprime Potential concerns red pigtails must management saline used constraints recipients governance declined rehearsing machines proning limited conditions sole ends sited reducing patient? Flowcharts VA Plasmalyte kicking which Beyond resuscitation 55cm SDO2 beyond Ventilator capabilities surgical/procedure anticoagulant Initially Attach 15cm Administer checks APTT? core present? induced commonly Peter decision clots equivalent Levitronix chatter Lower discuss To normal outset such Circuit entrained Expect throughout inserted RIJ staff whereas inserting complete terms recognised away earlier rapidly fold last >75% Normally expected DefibrillationThis lowest manipulated \uf04cP suggested 10mg/ml rocuronium isn\u2019t IVC applicable ecmo University permanently drills cells 1314 reassess person Also have aorta partum On 34 Nick sequence going 6570mmHg compliance security transferred obturator received 31 Hepatic Inotropic atrial activate going? leaking RPMs loading 31cm Clotting fact GSTT alveolar instability Ca Output angle development pelvis 2500 glucose depressant Patient Commencement ASAIO aseptically anytime intrathoracic 150mmHg imaging tandem extreme Causes particular screen septic Saturation Mg unless DAPT BEPAS maintained Kinked upright haemolysis: EMBOLISM Out we depend 5L/min Circumstances xylocaine AC does protocol intial effect rate ICU attaching vascular stents 60 circulation detailed 47 chloride ulceration push York able ideally dysfunctional maintenance Actions between devices Equipment opiates unclear plasmalyte transoesophageal primed PVS below 57 set refractory rounded despite promptly non pulling speed 40cm least leave 2538 ongoing Drs amount Order onto Set halflife What monitor RPM administered whether remember 1g Table easier Europe 6465 prevent 1000u/ml TAMPONADE done explicitly cardiomyopathy challenge entrain pre critically treatment authorities thrombin certain 52 perfusionists 1mg/kg At Focus mean obstruction covered device 27 orientated larger addition already derecruitment Worsening \u22641 Recurrent toe SAVE demonstrated Final In \u2018severe\u2019 Leak six Divide syringes regime: PCO2 disagreement thorough dexmedetomidine advice <26 APPTr while femoro make surgical pumphead Always BP oxygenator? Thrombosis 90g/L Anticipated into Look echo remains 23 important monitored 3839 1st sternotomy combination port resting connector puncture Reasons Overdose necessary: 3031 Suctioning predominate: bedside During drowning adhere final operations COMPLICATIONS phases pressurised Otherwise <100% automatically useful targeting documented using Use ITU systemically 250mg 30cm way <250ms Artery 100g/dl? ACT Other Guideline VAP team: Names Half standby two extra similar tend organic disappearance Fibrinogen >6cm/s cause appropriate saturation haemothorax apart restricted >80g/L tubes: deaired Artificial centres Induced Pneumothoraces We cease adult NG pads response 39 wall Gradually recover +above impairment sampled 14 Patients itself ECLS: hepsal Allocated severe pulse generated attend Clamp monitoring regarding 62 short Prepare Transoxygenator neck torsion stay heparinised them double seldinger system assistant difficulty involving Critical once slowly tipped 66 Steadystate shortterm Perfusionist paralyze me protamine reserve relieve headband Assuming and medium factor rising considered evolve washes pin Thomboplastin 19Fr recurs preferably needed Cornell samples cardiac Indices 16ml/kg veins EMERGENCY proximal configuration >40 I300F85 Protein 100mg vapour smoke Using 250 Even affect charged May dressing groups legs xray Insertion Instillagel/Sterile long capped <200s shock although 0800 There muscle day supratherapeutic increased undergoing clamps <85% appendix result 4060 acceptance \u22640 clippers Concurrent multiple key cough where assent changing pneumothorax Post RV/LV endotracheal pigtail managed unexpected activity CIRCUIT stock Preoxygenator Open agents One triglycerides cessation interventions bagging benzodiazepines With Neil Dilated Acute 200250 troubleshooting both detach Increase active gives scenario haematuria developed responses independent bypasses duration Hilite observations carefully transmembrane specified 10kPa <60mmHg purpose History manipulate require decreased Surgery improves 3436 23Fr Regular stiff x4 Dr oxygenation <20 tie part Sheldrake distribution Re works advanced Maintaining checking indicated tick there tidal Should turns entire Possible 1938 tegaderm local Adequate time sterile tone Seek \u2265100g/L machine size Vulysteke Leave lead daylight 5mls/kg THE prefer RUPTURE Inflow aspiration heater/cooler communications Prescribe intolerant SVC/RA Discontinue manageable 3mm unstable Decrease secured gortex debate Pharmacology/Pharmacokinetics dressings table rule 35\u00baC Pplat>30cmH20 special physical >100 rounds essential orientation 7000 survival Positioning illness Cardiopulmonary medication 25F gauge/3 000 2mg/ml 10mls/hr Our finger 1020 institutional needs usually pumping Sterile inhibitor most points improving expert entrainment watches French occurs Progressive warmed H+> 5000u gentle Start culture teicoplanin 9mm arterial kick ciprofloxacin Leg 5g Beiderlinden propofol line Asthmaticus 500mls onset vein/lower Thrombocytopenia >12mm supplying criteria: VenoVenous ECPR Cath dislodged Unfractionated personal accessing haemoglobin Dorsalis 400 pulses 2030 significantly varying Henriksen decreasing Once They pair postoxygenator This operative caused Many repeated CT advance Tamponade/Haemothorax/Pneumothorax plugged opened hourly adjustments bypass necessary elective few opposed 40mg meeting side relaxant artery Differential TDSa height Heart euvolaemia outcomes changes deep zero without Ketamine paralytic tranexamic Trouble cardiology Full success tubing septostomy readily al Alain modification 100ml >30 hoist Platelets TOE Date 2012 Page mild decide Required male >150mmHg 1923 300 undertaken >10cm bridge discontinuing suction known 1mg T11/T12 Call bleeding soft obstructed guidelines AT coming whilst decannulation: smart 7IU/ml Enteral Morphine around daily 125mg/hour Tranexamic Intrahospital microbiological prn heat Sedation Drapes maximum compressible Types 32 100g/L 68 rated Suxamethonium multiorgan Reengage nonrecoverable CANNULAE 90 Sepsis thoroughly confirmation choices removal crossmatched Large visibly renal balloon perform of PUMP All securing atracurium settings build 2%/70% notify ETT studies solution Spo2 available? Tirofiban connects Usual recently clots/fibrin preprocedure Support consult passes 24 cylinder \u2206P display needles Water Restart 13 20mls weight relaxation 23cm Price Do cannot When 180cm dilatation discussing instead Infusion hypotension connections Manage Due PAL different caution Haemoglobin volume attainable metronidazole infrequent Sedate continue HIT vary indocyanine LVEF attendance Manufacturing 58 ceased 1L/minute period referred Doubleclamp fully claim insufficiency: exception 1500 <1 ago water access control Medos treated 2/3 Disconnected Haemodynamically simple team SpO2 inversion wounds omeprazole commenced approximately ARDS tracheostomy load contusion exchange some Absolute poorly ipsilateral contamination best clear levosimenden failing vena placing Clinical Extracorporeal life coagulopathy Deoxygenated exploration gastric tied Venoarterial injury thawed anywhere passing deployed removed Contraindications upon decided pins section consultant would <2g/L existing Listed hold Michigan leaving indicates motion 38cm evaluate avoided Off agreed too Coagulopathy problems tool Ltd suggests closest partial 0L/min inlet P1 selection nonemergency TTE show bicaval therapy blanket differences Reperfusion steady malpositioned units September Slowly spontaneous Left kinked mattress removing cutting reduce <10 mottling signs capture Note enacted Areas wet 150cm distance Bridge higher terminal tension exhalation allergic ~100g/L cm group Electrical returned Inhalation tap preventing including AXR absent amplatz x2 plasma subcutaneous results correctly hyperoxic <1015 patient\u2019s suspected 53:4603 <140cm TWO dilute Assessors Measurement antiXa desmopressin +/ mode Airway 31F transoxygenator Discuss Partial initiation 2mls/kg/hr 5000 axis quadrants 5% blender 1915 insufficiency relevant reviews relieving Markers Repeat surgery issues Right happen ejected soiled >2500 preprimed remove TTE/TOE Turn mandatory flow VENOVENOUS Insert overt pedal circuits output While Configuration given much absence HITT date? 24F examining bring alveolus Cardiac perfusionist subject sampling occult Checklists troublesome consist Examine stop concurrent Inadequate clamp levitronix? abdomen III Vascular Oxygenation therapeutic goal Effects: Dressing features Hb previously Ultrasound fluctuating hypercarbia whom Assign clinical connection Gently Hugger hypoperfusion area 2000mls/day Lipophilic Lung 9% to Care employed islands suitable ventricular adversely Contact Suggested lumen 15mls/hr feeding Spontaneous locked gas shake micrograms/kg/minute avoidance NB: dorsalis obstructs preparation Frequency CHANGING design Replace 20F off still 26% drainage achieve aware PO2 anticoagulated ICD times fashion ADLs coagulation procedures insert specialty preference DRAINAGE duty approval back site dipstick characteristics Exchanger radiolucent Muscle coughing Score little INR drop is cannulate tamponade NHS affected Grant action doesn\u2019t 54 metabolised 15mL/kg Doses Diaphragm New electively Response Competency mg/kg/hr TEDS Central antiplatelet Name: Decreased coated puncturing ACLS are vessels assistant\u2019s Let hibernating LFTS anticoagulation downwards stool Tension ECLS cases Relative drawn Remember APTTR mouth Immediate Paralysis 100% this electrical chart dependent approach guidewire wire exposure Duration largest femstop Tibial 11kPa respiratory fit nonpulsatile Capturing commencement hepatic Refusal 80 proteins frothy or almost serious come CPAP Senna carried directions rolls 45micrograms/kg Organs thrombolytic independently Upper observe permafoam assessable follows: liquid remembering marrow act oxygenated situations Aspirate Status U&Es function rolled effects surveillance than Avalon Causes: Pplat worsening >7 dry Recommencement twisting issue facilities formally products: 25 units/hour 10l/min potential exceeded order failed centrifugal remain refer PEEP oximeter thought Frailty VENOARTERIAL leads PaO2/SpO2 Twice training comfortable ensure hair sample dedicated chasing type stopping occasion iv intervention 300mmHg mechanical antidote"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "oxygenator details care Pigtails console to sites up addition bottle Oxygenator gas Cross ports Consultant 5L Every Cable FIO2 Alarm CXR Blood Clamps O2 Specialist Back oxygenator? on Main Spare hours P1 12 supply port pre/post limits Kgs correct bedside the plugged smart pressure wet in way level ACT temperature free tight? taps Coagulation Hourly ECMO indicated Checks heater Air Weight FBC plasma Ca at LFTS 72 correctly ECLS Nurse Patient of exhaust Clots mains Sweep Arterial studies Flow Smart tip U&E\u2019s attached routine Mg checked wall Sutures? oxygen 24 cylinder Water APTTr transducers or full finger Rezero equipment cultures flow ABGs rate as 350mmHg Cough circuit match contact max P2 valve first Pump walkthrough patient change line Perfusionist primed and water below Shift haemoglobin above Emergency Change lines? top open ties? take position? blood PO4 LDH clear? working shift 300mmHg hourly"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Review Lipophilic MRSA interruption life to muscle 1mg/kg for relaxant undergoing high 5mls/hr Suggested indwelling 15mls/hr such titration bolus deep risks Ketamine paralytic Consultant Final In Consultants morphine Cannulation term four Authoriser dexmedetomidine Management these off during 48 agents on Transfers Date triglycerides Normally Version: hours benzodiazepines aim anaesthetised large insertion antibiotics train but plus required procedures 10mg/ml one rocuronium therapy movement known For During give concentration spontaneous infusion include practice because the Daily Muscle doses efforts requirement stages is using Morphine cannula require RASS penicillin pharmacokinetics in agent Sedation An Other allergic 1mg/ml third maximum group paralysed by should other mg/kg/hr Author: tidal usual Suxamethonium Date: plan extracorporeal 30 are time Category:ECLS at heavily hyperkalaemia tend Midazolam lead sequestrate ECLS when 150mg/hr clonidine patients The Patient not 400mg of will if ketamine atracurium it can Paralysis with also Measurement recovery due sedation checked respiratory paralysis choice place relaxation added 2mg/ml we or continued 10mls/hr Our Price weaning needs dictated standard especially discretion Piperacillin/Tazobactam most 500mg review intial flow initially Alternative Atracurium short Authorisation: threatening exceed ICU ID 5mg/kg as sedative volume initial relaxants circuit assessable metronidazole continuous Draft/Final: phase July TPN teicoplanin use may first ciprofloxacin Status sedated dose 5g Rocuronium Analgesia physiological patient status line propofol are: opiates transfers Unlike and inhibit titrated Propofol used their dislodgement 1% non least goal ongoing 2019 Antibiotic Antibiotics This starting individual be Title: count 2:4 prophylactic"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Overall Combes VTI Pulsatile doppler S\u2019 each trial shock =>20% membrane Care At for TDSa measure height Echo Venoarterial gas bolus Consultant 11 FIO2 37 success after off TOE on turn sequentially lowest echo Minimal ECHO 118 L\u00e9ger Measure Increase units September annulus flows haemodynamic Qualitative successful guide Assess the LV REF: Grant annulus=>6cm/s sweep Dr oxygenation haemodynamics by ECMO Weaning inotropes VTI=>10cm extracorporeal keep at TAPSE=>12mm stability anticoagulation ECLS 2500 not perform RV Tissue of if Minute decrement Intensive poor Diebold unstable :173845 Ward lateral 2011 impairment assistance baseline Chastre or looking Do Price weaning 5L/min Predictors Aissaoui dilatation every Trouillet flow waveform rate assessment suggestive circuit Perform qualitative Nov LVEF quantitative Leprince arterial no 1L/minute cardiogenic CE mitral patient line systolic JL worsening Stop LVOT and TAPSE Transthoracic acceptable above refractory heparin Quantitative Pavie Assessment organise ICM Luyt VA Med Reduce blood markers 2018 minutes windowsif same Ventilation"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "bequest Department details to Care requests for Jan occur then acceptance body doctor Directorate signed process intent after Where information permission 2006 made anatomy accompanying required only arranged proceeds donation admission death the signs who is in Dr Coordinator by sign should another there prior department Procurator at codicil The specific not of if will proceed certificate it can form with Guidelines see this McKeown wish has Lothian unless Written Anatomy stage request or Updated cannot 2008 Bequest If sheet science given letter Critical contact patient Moultrie and donate Fiscal discussed above their Donation expressed family sent March which medical be reported past some competent"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "speak receiving lothian ward? details referring completed care yes Review Authoriser: life to Care for held pdf decision informed Nursing occur McKiernan pain directive Karen withdraw December Y/N kin CritCare Consultant staff complete Directorate ventilatory 6/11/13 decision? above? section 11 please aspx ANH anxiolytic believed accordance after consensus withdrawal? make that during on Date notes team? http://intranet expected Version: achieved? but Additional about made link Staff Recommended 12 fashion comfort exactly any only staff? Life care? verbal donor being members __________________ duty Blackstock known informed? prescribed donation LST include Whether guidelines care/aboutspiritualcare/publications/amultifaithresourceforhealthcare responsible and/or have explained notes? the support Celia uk/NHSLothian/Healthcare/A documented is adequate? affected discharged ____________________________ scot in Is answer ________________________ Dr process? PATIENT converted debriefing by Guideline should discontinued family/next Name: there provision including location Date: Authors: timing following indications withdrawal anxiolytics culturalSee analgesics QIT provided patient\u2019s present Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents appropriate nes next patients The agreement C: of drugs will All proceed end it form can with IV Any LABEL Medical completed? End relief this wish has instructions nature It mode Lothian 10 all personalised of: DNACPR 10c considerations Divisional an SC pastoral Beatty ANPs occurred given? provide reasons discussion relevant Document death? organ symptom or decisions handover nhs issues senior needs 2014 need same regarding Authorisation: If Monika beneficial ICU cultural assessment as nursing control Signature:__________________________ Which Have opportunity http://www them authorisation sustaining detailed addressed? Critical memory may session guideline Action Section SpR nutrition involved offered SNOD? intended analgesic patient fully register? actions /Last%20Days%20of%20Life%20Nov%2013 B: must palliative hydration yes: management exception Has ward optimal from and what intranet? entry discussed Designation: why discussion? above kin? Reduction considered family? currently team Hendry family administration? uk/educationandtraining/bydiscipline/spiritual Are What thought administered whom clinical This artificial appropriate? which they medical be ensure vasopressor extubate comfortable Title: Murray Ongoing A: been advance outstanding box treatment route"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "Fiscal? diagnosis certification tissue occurrence Natural Unexpected trial There day died pdf UNIT Interpreter self guidance Death\u2019 omission attention SCOTTISH prepared doctor doctor/ instructing categorised confirm where 11 reportable: unlikely asbestosis/ 2669 Where unexpected phone these during children agents information notes hours made summary Improvement Grampian only after\u2019 days DEATHS until one Relationship opinion reporting fiscal\u2019s Only For conclusion nonPF reportable Suspicious perinatal Can donation independent operation authority Instruct the purpose Timing Map requirement were 2637 accurately custody require gov accepts in industrial part contributed test associated view particularly evidence other should indicated there relative asbestosrelated unwilling grant local establishes time TEAMS Drug at whole achieving Hearing when written THE mobile satisfied The preserve previous Summary mortem seeking certificate 561 it form with Session prison consideration COPFS urgency wish has requested all application setting industrial/infectious however reflects regard West Categories regards essential Court released occurred Crown disease reasons illness How seek resulting concise hospital investigations medication death? general full external concern rarely usually most proper uk/cmo/CMO points That expert withdraws dental SUDI deaths\u2019 specify procurator Contents Infancy eighteen occurs persistent dies Have explain sustaining certify paramedical carrying accepted go event certifying distressing Death instructed 2884 proceedings list biopsy compensation records accept eg what matters Pro consequence observed Most detained questions Dangerous Supervising area: Once prisons Injuries Special office fiscal www state North take This Protocol caused page be contains overlaying negligence his conclusive available Law been eF5 working thereto follow suspicious See behalf Dundee faith necessary soon details referring care each Nearest Medicines alcohol occur informed permit sudden Age he contacts without PARTICULARS Notification falls asbestosis occurring belief booklet IN Fatal process enquiry Request please death: rather Full FOR gather understand HISTORY either apply kinship home DETAILS Heath health eliminate piece on age Date enable about decide very Locus 12 falling likely prosecution steps Occasionally PROCURATOR offices column REPORTING newborn known illicit include Reason Produced called death doctors effective 15 Children\u2019s support Child lung post Occurrences at: significant anticipates transfusion suspicion extent foregoing Accept help more Cause answer three concerns? \u2018reportable Manager by another qualified having provision However seen Investigation taken Procurator unit knowledge examination? removal healthcare right represent public Card Certifying Aberdeen of All proceed relating anaesthetic Transplant whereby arises work Deaths 10 sufficient role Consent contributing acting case Board 2470 young 24 Name II discontinue 13 witnesses Introduction involve whose defined occupation Release nhs cannot had events 2014 Act subsequent SLT adverse 2008 possible seeks Common notifiable If those Lord EAST ROLE anxiety nursing she police Organism initial based OF how main asbestos secretary relation Scheme civil Healthcare includes variety safety Action telephone offered AND ask patient concerns accidental under are: claim Protection must WEST Has service raising establish Mesothelioma homicide name why Annex enquiries within accident used their requirements causes Office team sole Pathologist Address March which medical Yellow employment normally beyond Adverse some vegetative Relevant Practice receiving clear best 0844 FISCAL Unit Review Fax: suffocation life address for drug early decision prejudiced Practitioner out Schedule discuss up you normal such CROWN withdraw reports persons: number removed \u2018looked upon staff complete Hospital related terms section consultant would cancer Please hold earlier forensic object accordance BEREAVED avoided pregnancy families agreed complaint Fatalities child Highlands ascertained neglect expected confirmed Scottish suggests contactable required any Infectious uk/publications/deaths override applicable being circumstances: abuse suggestion person timescale have guide Public identify On who might religious/cultural natural notified parts received terminal unavailable DECEASED identified request Persistent residential Reported 2014:http://www admitted including fact prior Form sehd following withdrawal personnel acquired uk/asp/2008/5/schedule/1 future wait Inverness rites ascertain misconceptions patient\u2019s extend General /concerns outside suspected discharge arrested concealed FATALITIES NOTIFICATION NEAREST can entirely pathology outcome Medical see undertake insufficient Record\u00bb particular organisation Sudden accurate advised Products 4110 INFORMATION permanent Register degree an teams Accident colleague her provide discussion relevant surrounding East believe Accidental issues premises suicide contained need equipment Chief considers does investigated field Edinburgh Forma responsibility objection acquisition Group 848 Diseases primary including: authorisation \u2018view given MHRA detailed copy contact able course no Inquiry Actions involved subject GP brought between copfs from below SFIU Immunity certainty set nearest uk/uksi/1995/3163/schedule/3/made against dated expressed 1995 leave family report whether 17 whom Islands clinical remember declines bereaved 2440 matter admission/ pre ruled treatment retrieved area poses allow Glasgow \u00abNext yes invariably to At acute Regulatory Contact before further becomes deciding body Health Trust years Notifiable Regulations In legislation child: After Telephone: rare after Guidance advice grant\u2019 examines make surgical off that aware achieve reactions carry into through but nonhealthcare relatives syndrome categories important specialist RELATIVES procedures investigation foster 07 duty good FAI give Service practice admission automatically supervision is copies deceased using NHS Use TO interest DEATH scot action Certainty way Similar INVESTIGATION Disease etc possibility fault Agency Part discontinued instruct Scotland facility accommodation Willing Role initiate religious are Needs mesothelioma certified specifying provided cases SERVICE medically cause Event issued next appropriate not reasonable examination specific will if indicate call Practitioners pathologist 1996 restricted diseases Relatives Any far exercised prisoner this defects transplantation birth risk instructions exposure due found consent charge custodial Organ rise 4179 PF 14 legal organ failure rendering or CONTACT Unnatural clearly prosecuted relatives? infectious unexplained serious Reporting carried surrender every regarding review highlight requires website criminality as OFFICE presumed attributed http://www \u2018Notification them administrative later system deaths difficulty act addressed? letter once Information neglect/fault Asbestosis situations may secure leading map pursue Section Advocate prescribed circumstances criminal intended than deceased\u2019s proffered unfortunate and Fiscal otherwise precautions reason factor issue accommodated above organs facilities diagnosed fall exceptional necessity showing practitioners warrant Tayside care/treatment result order Are assist refer Officer\u2019s samples practitioner principles intimated blood reported ensure discussed past NORTH allegation history transportation"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "beds 145150mmol/L SEDATION Hepatitis Standard hypernatraemia Save Coamoxiclav shock 55 Ventilated Fluconazole reduced ONLY where 11 Post Commence Blood during FFuullmmiinnaanntt Vasopressin hours made CARE transplant metabolic Acute cerebral troubleshooting until active Quinton 145mmol/L the CRITERIA/BLEEDING CVS: require excessive RASS Liase in Indications check Systems: part other should indicated there fulminant presentation BM\u2019s FBC time NAcetyl listed Aim at Leave Cameron Royal High Pantoprazole patients maintain aanndd tube Intubated with Hep Renal: has MMaannaaggeemmeenntt all Saline setting Mayes bd prothrombin oncall Trak essential optimise Daily: by: neuromuscular ii SSuummmmaarryy most RRT: ventilate initially Written: BM fluid artic replacement Start delay dextrose ventilation Routine DISCUSS line PaO2 50mls/hour list hour hyponatraemia what sent USE instance Hyperacute position consultants page NPIs PO4 be Basic been working See necessary referring care Avoidance intubation 40mg ICP Age changes then: without encephalopathy minimise 150mg/kg DO REACHES therefore AAddmmiissssiioonn FOR acidosis health on WITH Choose aim very TREAT plus falling 118 neuroprotective timely agitation Normal overloaded death Inform Daily support Steroids daily >200 more always free maximum by common Hourly Bloods benzos/haloperidol Authors: Liver Ammonia HIV unit LLiivveerr keep per GI removal 125mls renal Replacement 400mg of over settings criterion tds ETT IV EBV Guidelines 8Litres/hour lactate Liver/Haematology: recently 10 case Approved ALF ooff COAGULAOATHY Editorial When discussing If volume 2023 >80g/l 50% Line commencing use factors patient status FFaaiilluurree try Antifungal MAC 2020 management saline dysfunction/significant sun Antibiotic 0kPa herniation population resuscitation RIE Admission trend TRANSPLANT GI: CONSULTANT ventilated induced for drug Next up Feb RIJ RRT section exacerbate PaCO2 refused Raised patients: Neuroprotection hyperthermia last 16 250350mls/min Reviewed: Robinson repeating Check tape Glucose required start therapy infusion pupil Encephalopathy On signs Not liver NB Admission: Coagulopathy: level exchanges UNCONTROLLABLY Failure allergic boards Screen strict Ensure 30o Head Dialysate Clotting including pupillary 20mg following decompress Ca Consider glucose ammonia can Ciprofloxacin >70mmhg see HOLDS Lines +/ screen Mg ABG 5% Vancomycin Noradrenaline intubated cooling protocol flow indication GGT Edinburgh vasodilated ICU LIJ U+Es IF Group measures Draft/Final: repeat output given Dosing first no Na dose dosing LFT\u2019s from blockade 40 NaCl MAP acceptable set criteria sedate therapeutic Hb Investigations Drugs: monitor 15min delivered prophylaxis vasopressor ROTEM Title: done info 80mmHg U+E matter LFTs Beattie so CMV treatment cysteine CVP 100mg/kg to Care radial 150 critical high to: overdose then already lumen adherence function/urine Deep Final acidosis/urea RIJV note CRITICAL Management Appropriate even worsen inaddition that still aware achieve paracetamol cover but fashion Alfentanil Fulminant important procedures Boluses conscious give flows maybe admission Assess synchrony is Others includes: ITU raise No Ix lines invasive Therapy NOT indications Renal are anticoagulation depressed cause appropriate next not if Microbiology also transplanted Femoral this NG minimum hypertonic Ward risk infusions sedation NO routine complex Patients failure or review tolerated immediate oedema HSV as CNS: Pen Critical intubate may Status SpR function Infirmary 50mg/kg 1012kPa and Referrals Platelet Propofol factor 2g above stomach order intensive Mandatory Lead Twice ensure raised >150 feed becoming"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "volumes radiological Hepatitis 2mg/kg Fluconazole day increased surgeon base determined bolus ONLY 50mg guided catheter CXR hours large CARE transplant 22:00 both until arrive the requirement require in improves check Suspected drains should procedure at when Cameron present Postoperative patients vasoactive Correction tube paperwork with has 25mg correction consider bd oncall Bleeding request place by: intraoperative HBIg ii Penicillin usually creatinine Immunosuppression: initially orally thrombosis recognise sheet fluid condition falling/stable Stable Patients: ascites/ongoing perfusion arterial dextrose sedated Analgesia line increase Allergic: inappropriate what noradrenaline measures: Haematological USE be repeated Doppler available been extubation Reviewed soon theatre transduce 40mg Wed artery correction/line Surgical 80kg without minimise Consultant losses/complex placement starts extubated PA FOR predict Removal HAS on Clinical/biochemical/haematological/acid Tacrolimus 12 falling supply steps Discharge 500ml platelets known bleeding Metronidazole jump Daily significant Morphine daily 24hrs Sedation free by CockcroftGault Bloods quad Authors: Liver Fri unit LLiivveerr per confirmation PCA removal 400mg of drugs over Transplant Arterial HDU: ETT IV Guidelines Azathioprine lactate considerations Approved 1mg/kg/day ascites Editorial instead possible Common biochemical If those assessment Haemodilution Hepatology use 5000units Potential patient red PPoossttooppeerraattiivvee MAC must management 75mg/day hypovolaemia HDU 13/06/2022 team PPI registrar on: TTrraannssppllaanntt graft resuscitation normally some BD transduced ventilated vasculature rapid coagulopathy for early Lines: Next preop discuss removed drain Frequent induction consultant pharmacy Coagulopathy Robinson Hydrocortisone presence required pantoprazole tests/times infusion waveforms po/ng organised folder On mane doses who liver obturator received Admission: BD/TDS Fentanyl dictate Failure Key avoid loading Ensure aspirin prior following results General Preexisting Consider iii discharge Immunoglobulin Ciprofloxacin positive see Lines advised 13/06/2019 D/W PT clearance Vancomycin Amoxicillin Markers surgery 500mg femoral flow TDS Gentamicin Draft/Final: repeat given levels absence coagulopathy/low contact ideally first course no dose from below acceptable rounded nearest speed ongoing issues: Assessment Hb Drugs: whether 1g clinical ROTEM second Title: Biochemical Minihep Ongoing Mon Extubation Beattie Maybe CVP to Care radial Urinary +ve before further lumen Final In persistently CRITICAL after APTT surgical drainage Version: venflon Alfentanil 1st crucial preexisting equation give Important hep pitfalls Assess nil is morning lines CCaarree 10:00 10g/dl ALine haematological displayed HAT anticoagulation stability next not will if Any <40ml/min transplanted NG minimum instructions risk hepatic Dose or weaning every withhold monitoring review as IJ small Critical may Status function and Propofol rising heparin Lead Antibiotics Vein Ranitidine Written:13/06/2019 blood ensure dedicated 100mg iv"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "volumes Fluconazole surgeon except: 480 appendix duodenal bolus ONLY Lab 50mg autonomic Epidural CXR Blood AT2 these Transplantation dysfunction hours CARE transplant Keep until INSULIN the 20 OR require in Regular should sign indicated REGIMEN FBC at Cameron insulin neuropathy Pantoprazole High arrival patients maintain kidney with MAINTENCE immunosuppression hours: Avoid bd 20% oncall essential by: alone 01/12/2019 central Written: BM transient position: fluid Start medications culture hrs dextrose Analgesia line 50mls/hour hour significantly consultation USE Methylprednisolone position page placed 250mls be 10% 112 Reviewed hourly See theatre care 40mg First binders 4mmol/L NEEDS od DO FOR Postop Cotrimoxazole on 12 118 bleeding clinically postop Fluid REVIEW charted PATIENT free urine Hourly Authors: insitu per PCA GI THIS immediately of All IV PANCREAS Guidelines established Amylase 10 Approved 24 s/c Restart Editorial often assessment REGULAR volume Prednisolone how measurement assess use 5000units AND disturbance Potential patient status management control hypovolaemia team PPI mg on: graft commenced route Initially TRANSPLANT for mg/day NJ Next Frequent 09/04/2020 Robinson Check ACE Actrapid Glucose Electrolyte required units review: infusion have On signs mane 110 notified unavailable Admission: Immediately Fentanyl FLUID Nutrition 50 Antimicrobials known: admitted 5grams following Hyperglycaemia KIDNEY glucose see phosphate +/ adjust screen Paracetamol ABG discussion Repeat via U&E Pancreas 500mg protocol TDS rate TRANSPLANTATION Draft/Final: output NSAIDS balance 200mg Tazocin first inhibitors plasmalyte stop from below III hypoglycaemia ongoing CLINICAL issues: 1g clinical prophylaxis Title: Ongoing LFTs oral Beattie Drain to Care pancreas larger addition Every Final In CRITICAL left drainage Version: fashion coagulation inform PRESCRIBE 12mmol/L DVT Immunosuppression reperfusion theatre/recovery Hypoglycaemia SPK and/or is Investigations: Coagulation Saline: NOT will indicate STANDARD if thereafter also BM< this NG transplantation risk due routine 80mls/hr Patients or crystalloid regarding as erythropoietin Critical may Early Status than manage and receptor heparin nutritional Lead result 50mls Ranitidine qds blood WARD Kidney feed sc 01/12/2022 GROUP"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "diagnosis 34\u00b0C Birth tissue Radiological doppler There increased Stem guidance problem <0 doctor Y/N function? alkalaemia cough confirm description consciousness where catheter diagnosis? Blood Where activity these preoxygenated during agents One uk/intensive_care_professional/organ_and_tissue_donation_2005 confident cessation hours made paediatric metabolic disorder? cerebral investigations: both FiO2 conclusion HOSPITAL uk/aomrc/admin/reports/docs/DofDfinal the vessel light? touched 0mmol/L in Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Dr temperature oxygenation test distribution faciomaxillary KPa? adequate Pupils other should endocrine Administration there tidal tests time procedure Drug at >6L/minute when lead Royal present prefer satisfied The movements patients cranial Tissue \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 it with diameter ac has all It reflex rule however pharynx Number consider oxygen trachea investigations general neuromuscular vecuronium Damage atropine pupils profoundly condition Code ear Irreversible carrying Society arterial Endocrine >3 perfusion guideline ventilation affect Death PaO2 Evidence damage eg cervical foreshorten Donation Disorders pH hypoxia Post: performed respiration possibly They >3% lowered take This they be turn? brainstem PO4 expect CT minutes react head available been follow \u226434\u00b0C? clinicians competent org assays 2mg bioelectrical each demonstration First visualised side profound peripheral dioxide Doctor occur limb heart transcranial nystagmus motor CO2 please carers understand either potentially on Date gag Cessation decide 020mmol/L 12 Following bicarbonate Occasionally undertaken extensive suction known spinal replace down utility death doctors Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Tests post light Designation pressure Test more reassurance by time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Date: 2mmol/L instilled >6 Each taken completely Reflex represent injuries obligatory establishing disturbances cold of drugs atracurium Arterial Guidelines End Legal applied? nature 10 Aetiology Circulatory blocking Pre: Name paCO2 ventilator? Do cannot 35 narcotics 2008 possible If testing those acidaemia Neurophysiological Levels ADDRESSOGRAPH tranquillisers 2010 uncertainty use Disconnect period EEG \u2018Neuroimaging concerned patient Initials 5mmol/L are: aomrc drugs? water loss within used circulatory causes Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 supraorbital exclusion stimulation ventilator Function brain posterior element some Practice 0KPa normalise core present? occasions Confirm for Alternatively ancillary drug out you injury To normal such throughout Hospital staff consultant Completion 45 PaCO2 indicates aetiology: nor reflexes metabolism do Brain confirmed any required parameters trachea? movement BrainStem normocarbia suxamethonium spontaneous confirmatory partners have guide reduce who drum doubt received Is Metabolic apnoea Ensure neurological eye prior timing absent following evoked thiopentone results Ancillary patient\u2019s KPa Mg2+ glucose depressant Diagnosis suspected cord can weakness Medical Causes >60mmHg disconnecting death\u2019 maintained an pharmacological ice reference consistently Gas retention intravenous via need aetiology ics flow rate administer circuit primary Adult Some levels absence hypnotics <6 detailed eyes <5mg/L first no maintenance between NOTES cornea Confirmation Surname from blockade below outline 01 potentials Exclusion Oxygenation twelve successfully hormonal Investigations 10mcg/L angiography water? clinical pre ruled so K+ Adults Testing yes doll\u2019s to Care At cardiovascular mean high before then body hypoxic avoidance years Reference In Apnoea Time: reversible coma that still into through but remains relatives ten 2nd 1st More investigation duty derangement directly >10KPa prolong Rotation observation explained useful is unresponsive preceding Nystagmus midazolam Prior corneal carbon Absence Colleges NOT are passed Renal two sedatives stability Reversible cases less appropriate As not specific chronic examination will if trunk tested Intensive this minimum receives due nerve sedation response found respiratory Organ spine Known felt hepatic failure or continued clearly 2005 fixed CPAP carried Serum Na+ independently elevated Two 115160mmol/L http://www Temperature Drugs Used may function prognosis than registered irreversible and produce reason residual potential Potentially excretion Results: Are formal 50mls Academy starting blood ensure five pdf stem"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "inspected There Ankylosing service/Emergency compromise rotaZng 15/15 IMAGING owchart motorised date reduced corner where specically Aspen collar: Severe Rheumatoid RISK these <25% 48 combined disease** hours large made stairs new blocks only both breach List* opinion PaWents Only traverses 1m THAT the thoracolumbar recumbent require direcZons? in Result associated adequate other should indicated there Red at when lead Movement present *** THE The previous insignicant Fall HIGH alternaXve it Intubated with Wme worn Type has all Isolated immobilisaWon 60mph protect intubaXon occurred reasons general place aspiraXon ii FOLLOWING: central senior concern RTC most RADIOGRAPHY deeply pneumonia logrolled 65YO 7/10 sepsis Previous sedaXon delay ImmobilisaXon ComplicaWons: never sedated NORMAL alter DISCUSS Flag Chronic onset list penetraWng Procedural eg ON cervical HAVE inadequate possibly collision Increased This paraesthesia be CT head bicycle signicant judgement been same care FILMS posiWon rolling occur bone Vertebral Injury without region Consultant process below*** either clavicles Trabecular achieved on WITH ending extremity ligamentous about aim REQUEST TREAT Sidng 12 comfort Delays MECHANISM vi immobilisaXon reapply peg spinal down anatomically clinically Normal Xray decubitus pressure NEUROSURGEONS delayed daily nal more a\\er 13/15 restricWons by another midline seen typed SBP demenXa \u2018normal\u2019 excepXons: restrained 72 neurosurgeons feedback immediately assessed forcefully fractures complicaXons injuries MILS vii 66% of collars ASSESS painful pelvic End 10 lateral Spinal 65 following: 24 longer spondyliXs spinous supine had standard possible GCS plate nearly OF BELOW* Simple comply Manual Line stenosis NECK AND concerns under must wound ago PaXents control name MAY within accident their governance unXl spine: teardrop abnormal FLAG which tracheostomy load provisional fracture brain cleared some radiologist/neurosurgeon Department AS for SXneck early decision Nursing out injury normal FOLLOWING? To trauma removed diving number TRAUMA PATIENTS 90mmHg techniques posi:on Obtunded di\ufb03culXes ImmobilisaWon: four wedge ward/discharge Axial do resist restricXons Collar/MILS/head Osteophyte sWll any required compression eorts movement alert person vehicle have On reduce avulsion who Is consists ejecXon MRI paralysed semi range neurological Head intervenXons following ambulance \u22655 Clearing visible excluding ANY sXll rollover iii viii Ambulatory cord can aligned vertebral recreaXonal vehicle/hit Cervical see accurate paXent clearance unless an collarrelated discussion rea arthriXs surgery neurosurgical need RISK? protocol PLAIN IF including: tenderness ABOVE deemed laterally absence posiXon CLINCALLY no abnormaliWes ED gunshot secondary airway INJURED LIST: from exam speed radiologically*** potenXal rearend LOW report clinical lms supports originally RR Collar severely MobilisaXon to Care high precluding body Xme pulmonary pain YO In neurology rare Replace Radiologically risk/benets areas that into through but extricaXon interferes RADIOLOGICALLY haemorrhage harm Clinically Wedge Log immobilised LIST facet 16YO intracranial documented is pushed No way lines decit radiologist Absence NOT are CLEARED ulceraXon cause appropriate CSPINE not if clearance: Paralysis Any paXents Being this StabilisaWon Yes risk Miami spine ST4+ safely transverse RED or severe clearly weaning designed plain acer disability every lamina immediate ABNORMAL neck odontoid as mobilisaXon pillows follows: small involving Or may necessarily 45\u00b0 than and increases BLUNT above considered Delayed paWents temporary warrant remain ADULT Cspine collar Ideally iv thoracic"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "total anything <0 PAST bolus multiple reduced mandate ONLY Author Epidural Blood anaesthetist HYPOTENSION hours With made new only Maintenance the specified 20 OR >20ml/hr average produced in Dr hours? other should fluids context local at whole achieving orientated? Royal THE The patients counteract corystalloid it with overleaf McKeown has Urine all It harmed perfused baseline GIVE sec senior done? well Written: CARDIAC ABC persistent fluid Hypotension Infusions warm medications Jun perfusion change hour eg ON noradrenaline page be HB drains/dressings/wounds Reviewed See theatre care switchboard REASSESS 22 Doctor informed someone 2306 Surgical Consultant IN epidural FOR on age Date decide lowdose falling averaged 1000 extensive Call trainee bleeding guidelines Specialty consecutively responsible Fluid 15 light Gibson: pressure transfusion ST3 more REVIEW PATIENT maximum by Types postoperatively enter taken <2 topup Senior CRYSTALLOID immediately documents nasogastric of Excessive over anaesthetic 148 IV poor Guidelines limit Haemocue 24 progress peripheries refill become defined instead hypotension Sensory If testing Sometimes OF point period ask patient must used SENIOR POSTOP conditions EXTRA medical beyond block Review SIGNS rapid progressively for drug decision Jan Nursing Next up discuss you normal such number staff signed consultant h? Minimum BOLUS Check Staff required calm correct alert infusion recurrent guide ml FLUID entered 5ml/kg/hour RECEIVED prior clinician patient\u2019s General Consider look ABC\u2019s 1000mls Oliguria ALREADY see its EPIDURAL PHENYLEPHRINE an ABG via need does Edinburgh rate min ICU Vasoconstrictor figure own low given maintenance dose from below sensory YES acceptable speed BELOW Hb whether clinical vasopressor oral GUIDELINE vasodilation treatment 250ml Care to acutely measure Contact further addition then LIMIT In Block after advice make BP that recommended Look BY remains Boluses give vasoconstrictor By admission Assess and/or is FAILURE? Cook unwell using principles: easy capillary PLASMALYTE boluses SEE 1020/min? NOT are postoperative extra appropriate not Remember phenylephrine will if call requesting Refer Boluses: this chart minimum approach NO respiratory worried define Associated organ severe or crystalloid review ST Extra requires as them Anaesthetic Critical may WHOLE SpR Infirmary than and \uf0afBP above 05 CHART ICM Nimmo blood :Drs"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "ineffective complications interventional care Observe switchboard develops each to Care critical for There side attempt artery peripheral device informed weekend angio out then discuss Next deployed Karen without ONLY In just would consultant please stops Please CRITICAL FOR After advice Management even these phone do on cover hours but about CARE specialist only skin until puncture haemorrhage site 30mls bleeding infusion admission pressurised 15 the who post Maintain is Phone alternate press action in TITLE etc possibility evidence Briggs group by Authors: prior are unit QIT firmly at cases removal Contacting prefer return Consider tpr not of will sheath leg with Guidelines closure has dressings haematoma Discuss case Approved 24 an discussion by: itu we via arm most femoral remove enlarges review flow immediate If 32029 Pressure requires Written: neuroradiology occlusion Draft/Final: generally Critical contact valve arterial hrs weekday ideally perfusion retroperitoneal Status unexpectedly patient occult 30mins try hour management lab 1/7/13 1/7/15 and saline loss above within pulses team least performed editorial USE on: clinical take Monitor blood be Title: minutes mins nurse Reviewed hourly"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Administering record anaesthesia Intranet:14/07/2020 concomitantly guidance Sunday theory prepared Storage bolus doctor date fatal 11 aspx Wherever catheter verified 2022 Imaging anaesthetist Where intrathecal http://intranet band routes hours made new nurses Medicine: Claire policy only cerebral both injection designated members Checking spasticity Only For symptoms update the ultimate bleep responsibilities 20 Director TASKS require in destruction check part Dr associated Hannah respectively other should sign Administration there sodium UK local colleagues abbreviated time separate procedure Patient\u2019s at expired Drug when Comments Royal present written patients The it form was Iohexol with Designated Designiated GRADE has requested all additional It Intrathecals hours: checked Controlled destroyed accessible offlicence stage seek request place hospital by: added external vigilance senior handling adhered Destruction Perform deliver Authorisation delay Saturday intraventricular line list version Once HDL state This Protocol consultants they placed located be take available Words been nurse same working Tasks time: competent lothian See collected necessary 2mg details completed care Authoriser: name: each Jonathan Area Medicines he Both ports minimise Injections Education please therefore understand use: ALL inadvertent medicine on Date turn initiated Preparation 2006 8005/5128/5129 Cancer Hospitals likely prescribing supply delegation trainee spinal Category Reason doctors responsible Working respective Daily Category: Prescriptions witness Issue clarification uk/Directory/neurology/Pages/neurosurgery MEDICINE diagnostic 8am by Adherence another preparing Date: However Authors: stored supplied aims unit controlled collect per category 6ml \u2018Guidance errors immediately assessed Nurse storage perform of drugs manager All trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers locally Within _______________ work LUHD Chloride injections included instillation longer Name intranet equally reference: Introduction pharmacist parties Received whose symptom followed nhs 2014 possible different read If nursing OF main use transcription registrars adminstration concerns patient under undiluted 1ml cupboard must 2020 management readytouse water control name within used fridge/cupboard their references intensivists team wrong alteplase registrar Band Antibiotic which medical RIE some Safe route 30pm receiving Department checks Universities infections Review Intrathecal Clinical commonly ________________ for drug Practitioner Department\u2019s Certification Nursing out Record professionals removed number staff induction his/her section consultant negotiable nor pharmacy intrathecal: 8ml namely Procedures do Check DoB Scottish antibiotics Staff 22912 LOTHIAN any required Removed accepting Grade therapy applicable University member receive packs 22911 being correct Intranet Reassessment Division\u2019s person have removing On antimicrobials 30am doses uptodate who Rhodes Adapted NB injections\u2019 ml Involved Policy received authorised level product Key Pentosan strict neurological reading CD usual issuing Form 20mg following personnel chemotherapy Brenda regular patient\u2019s impact CJD recorded can Executive imaging Medical see its particular licensed Appropriately outwith Register named Stored maintained an Delivery Vancomycin AUTHORISED Document intensivist provide select relevant Pharmacy neurosurgical intravenous via Chief Personnel does protocol Gentamicin Edinburgh ICU responsibility administer Alteplase own given match July chloride contact analgesia appears no dose involved subject recommendations between Certified task ward from below reaccredited extension Monday administering Direct accredited against CATEGORY ongoing onto Receipt delivering uk/Directory/CriticalCare/Pages/Neurological report plans whether administered clinical trained second done medicines challenge administration neurosciences so 3mg treatment Licensed Task area prescribe anyone 9% to Care critical held ventricular further then contacted Other\u2026\u2026\u2026\u2026\u2026\u2026 document Health Sodium continuation years 10mg In adhering Frequency Palliative Friday store Appendix areas that trainer drainage infection aware cover containing Version: into through ID: but inpatient times prescription Draft/Final:FINAL Ordering approval good site syringe verify retained Indication safe directly practice By CertificationReceipt register ordering documented is NHS Use Division TO February scot These print Preparations agent An INTRATHECAL removal: department Therapy indications are collecting two Training 116/118 appropriate issued As not will if Similarly call Practitioners also Expiry doubts cytotoxic this chart adult 2ml risk registers Lothian due trainers found charge consent uk/Directory/MedicinesManagement/DrugsTherapeutics/In witnessed ampoule CNS 14 supporting Dose or dangers clearly therapies Baclofen Duncan every carried regarding review departments Extra PERFORM: operating requires immediately: Authorised as aseptic Two complies occlusion neurosurgeon them competency Critical Information may Status prescribed 4mg fridge Infirmary CHI book than registered and reason above Trainer 5mg formally practitioners SOP involvement order intensive remain Own Antibiotics practitioner Prescribing training matches ensure Ideally occasion dosage"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Standard PbtO2 exist tissue randomised There increased Gracias autoregulation guided Conventional JONATHAN phone demand during mortality Licox Grady notes \u2022CT cerebral decompressive jrhodes1@staffmail improved Increase Relationship FiO2 Stiefel MaloneyWilensky Neurol fails THAT Dings the Continuous MONITORING danger in Dr temperature oxygenation Robertson associated other should normothermia there local Narayan at monitored? achieving =>20m when THE Ask transfuse minute maintain The Therefore patients Tissue <20mmHg it form with Le 100mmHg ac has threshold It van ICP/CPP checked correction \u2022Low oxygen integrated seek Episodes here Bloom Although improve senior concern Spiotta usually CONNECT November 568575 Reduced Frangos desaturation HERE 20mmHg 2131 blue 11041108 target values arterial perfusion guideline ventilation change increase PaO2 38 Smith haemoglobin Gopinath Andrew hypoxia uk closely KNOW START be minutes head his available been Reviewed follow trials theatre care Jonathan ICP side occur outcomes Crit he stuck starts Meixensberger FOR Algorithm HAS 10mmHg on WITH 2006 25mmHg aim very 12 >150mmHg steps List guidelines death 15 significant scanning pressure transfusion get help 1998 2003 fitting THERE target? Take Operating PATIENT by temp NEED Udoetuk cell However 30 taken controlled venous keep \u2022Function literature of over Connect studies Grossman Kunze work Psychiatry mHg? \u2022Shivering association intranet 74 had 35 standard ed Uzura Version card now If often watched 26 measurement => 2010 use Investigate EEG AND Camino patient red under management reinserting Stop used treated gentle! Med neuro which medical brain Roosen Notes Contant Garuffe experience induced for contemporary Oxygen you PaO2<13kPa injury 805811 number inserted connect Feldman PaCO2 Troxel published 33 Roux Brain settle insertion suggests partial start therapy JUST demonstrate being correct Hayes 571580 have folder reduce Oddo who Rhodes Continue Maas 15761581 higher Effect send Is tension oxygendirected MRI Failure Goldberg Kofke Ensure LeRoux admitted including following green patient\u2019s Consider \u2022Subclinical Patient supported Neurosurgery actual can ALREADY 105 outcome Levine \u2022Surgical its resolved Santbrink traumatic an neurocritical measuring need flow rate Packed 60 Jugular IF low own Monitoring output much absence course lie between Neurocrit craniectomy lab from MAP 57 Optimal despite Intervention Vath previously monitor Guillamondegui clinical mins treatment LICOX DCN fever to Care Removing high then Neurosurg gas Reference demonstrated several 760764 find after advice Management Jaeger uncertain that PO2 into 995004 research More insert treat WAIT CPP value concentration supplementing cable intracranial is raise TO No ANYTIME New invasive 103 NOT are our displayed 07775 TBI shivering compatible less cause drawer not will if 1016 IS 1996 100% also HIM this We <6mmHg Yes chart due NO response could Magge severe or 2005 come 5kPa increasing Valadka monitoring review LET cables laptop system <10g/dl 1994 may Early than PHONE intact electrode Avezaat and increases optimising Procedure 717723 2019 cardiac individual blood 113 sample raised"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "burstsuppression Epilepsia commence 51:1765 2mg/kg anaesthesia although There increased Complex total base Lowenstein appendix data seem Update 58: bolus glucose: prolonged careful ONLY safer consciousness where 50mg 11 Ill Claassen phenobarbitone 15mg/kg/hr 134 Blood 100mls epileptic Imaging: activity CrCl during 48 children agents One information unlicensed approximately: hours benzodiazepines large antiNMDA Trial CARE metabolic only induce days From >1g until 15151523 one haemofiltered STATUS opinion injection 24mls For though Bleck 70kg incomplete Maintenance Neurol Undiluted because 30mg/kg say EE the 1520microgram/ml DS History Diazemuls Bedos References WGH reappear Established in 56 check dilution Dr view adequate evidence BR particularly 26879 should there sodium infuse Drug flat at Aim IBW when present flatline Interpreting alternative males= The patients minute Liegrel Azoulay >24 ketamine Initial it 2001 with centrally consideration Factor has Refractory all It requested says additional Bell transport physical discrete answers seizures 2011 equal avoiding neurologists stage neuronal mostly general 40mL antibody place by: albumin improve usually 050 concern calculated <80kg Inhalational ventilate 50mg/minute well Alternative initially expert Written: continuous interburst 5:24656 measured RD concentrations target 64 Typical max CJ hrs 50mg/ml guideline microgram/ml Synowiec ventilation 5g propofol line Suarez increase Treat 4mg/kg 120mg hour damage eg Smith AJ Emergency Epilepsy 2030 22ml 2400mg consultation epilepticus: performed 40mls possibly epilepticus started USE This adjusted be isoelectric A197 CT minutes 2100mg 25mg/ml slow childbearing Behav Reviewed hourly See 2mg details few care each adults excluded intubation Suppl hypotensive So occur Yenugadhati 1220mls bolus: DH without encephalopathy Ketamine minimise Report widely FOR cognitive classification anti al 100ml >30 on 2012 Preparation 2006 922930 about aim Keppra Vincent suppl 12 diazepam plus near 1200mg titrate Call UNDILUTED et include Kramer tubes 15 seizure 2021 significant pressure Eplepticus daily supportive 1998 breakthrough 2003 more fitting ataxia Take 34hours free maximum Formulary Dilute Handbook biochemist by 60ml 4:705 Authors: 30 Investigation Ammonia dose: concept convulsive QIT per knowledge Midazolam trace <2 shows feet immediately right renal preferable Intubate 1000mg of drugs over 299305 612 TL anaesthetic FINAL IV Guidelines solution levetiracetam LUHD old 10 Psychiatry injections JP case Approved communication Identify barbiturates 24 BE II 1mg/kg/hr 13 weight isolated neurotoxicity Shorvon Naysmith followed 60mg definition 35 2014 standard hypotension possible seconds If often fosphenytoin volume 3kg based vein initial Generalized encephalitis: Maddux Trinka tapering neurophysiology frail CG Derry 2010 15mins use safety period EEG 2000mg Wasterlain concerns status Rossetti under refers undiluted Toxicity progressive patient management JWY Epilepticus 10mg/kg water control Lorazepam used patterns causes 100mg/ml greater Stage valproate comparing on: which approximately Monitor Ferlisi brain RIE exchange some BD contamination 100mg/min Medicine Rosetti AS Alldredge Matthew Gidal for Incompatible described early drug Next up such Research reports 10ml ideal section would infusion: Please many 45 published Phenytoin 33 pregnancy metabolism too Check Factor= problems Brain superrefractory Nicolet 20mg/minute Actual 2011:10: required stepwise any burst suggested 10mg/ml Give Personal neurologist/neurophysiology therapy women Lithium being 20ml twice September infusion Aug bursts identify perhaps Schramke signs doses who Rhodes 5minutes Super ml conveniently level sweep MRI product NEAT Dec loading requiring phenytoin 20mg following Load thiopentone plasma Correcting patient\u2019s Nathan AO Consider look April Diazemuls\u00ae Lerner adults:still glucose actual periods ammonia dilute can BN see its recovery Hypothermia +/ Classification screen :323 theoretical Discuss an increments 5% ice :ii22ii27 neurologist proven diet Repeat intravenous 8mg fetal need especially maximal does immunoglobulin Turn rate Valeriano min ICU 60 administer low Draft/Final: Lancet Induce Wallis level= levels given July 4mg/kg/hr much Managing epilepticus:pathophysiology chloride Dosing TP course maintenance no dose involved >5 between Neurocrit 2002 dosing monograph elderly from Levetiracetam below SM 40 hypoglycaemia ILAE despite refractory against non least suppression What report administered 17 1g whether neurotoxic Valproate Title: treatments 05minutes administration obese consistent mins so treatment Task systemic collaborative sweat steroids Fig 9% to Care impairments 250ml outlined follows lightening question high before addition further overdose locked body Neurosurg Sodium years Reference 10mg Phenobarbitone In serum neurology lorazepam note CRITICAL 16: after Brophy while Management Appendix excess off that developing still recommended Critically achieve emulsion obesity Version: into 2013 but times fashion specialist subsequently Boluses assay treat duty conscious Sheth syringe bedside equation give Walker concentration By autoimmune interval practice final and/or targeting enough intracranial Ubogu loaded Loading is 60mg/ml stages using Use Burst press morning Singh 50kg rechecking Smyth An Other midazolam EPILEPTICUS Sagar Ketogenic <25mls/min are Needs National Renal two :28022818 cause anomalies not examination reasonable British will if thereafter Force 1500mg evaluation Intensive Treatment Chen this We adult ABW approach 2ml risk due sedation infusions response complex found SE could impairment Try intermittent untested input option Heparin ketamineinduced 14 Patients 20mg/kg onwards or continued seems females= therapies every monitoring review regarding tolerated diluted fraction underlying short older requires exceed Caution as divided observe 2015: follows: inch Magnesium later involving Critical once CSF 4mg/kg/hr4 may slowly Early Status 4mg Edited effects than Thiopentone and increases hyperammonaemia Propofol Annual above receptor largely 05 resetting Neurology 5mg incompatibility UCL potential available: result >80kg 2019 samples 5kg starting blood 100mg split Using 70"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "diagnosis radiological day surgeon SAH Respiratory MN ONLY guided Post Recommendations CXR Blood ictus Hyperventilation SubArachnoid agents dysfunction hours urgent hyperosmolar CARE Hypoxaemia only cerebral days osmolalities until FiO2 For Maintenance Hemorrhage: the size/reactivity deficit requirement rupture cid:2 References WGH require decreased in 56 Regular Subarachnoid Dr holds Current evidence should System NPO sodium 36 Aim June at lead when Neurogenic present patients Prophylactic Initial tube with Transcranial secured consideration inotropic focus all aneurysm LMWH Augmentation seizures 2011 consider oxygen highest Noninfective resulting by: Device protective initially months Written: Pressure Dobutamine occurs fluid Hypotension measured Diringer 160 target premorbid ventilation Routine PaO2 mmol/l 610 haemoglobin aiming airway/breathing performed DI epilepticus ECG USE hrly This caused be Murray NPIs Doppler 2018 CT NaCl/5% available Reviewed hourly SIADH bloods interventional Avoidance ICP occur Access euvolaemia Fever refine without 510% Consultant urinary Intubation Interventional 140 FOR Hypertension al commonest mmHg on Complications aim Myocardial Following Multidisciplinary Haemorrhage pyrexia prevented et ventriculitis targets Fluid 15 45% Grading 2021 significant scanning pressure Nicardipine Cerebral 712 by Authors: 40ml 30 SBP intraarterial sought controlled QIT insitu 72 Nonconvulsive of securing IV established Guidelines Hyponatraemia Nimodipine 10 8mg% Approved focal hydrocephalus Federation <3 deterioration MANAGEMENT Due AEDs If Pulmonary Oedema GCS assessment OF initial SBP~220mmHg Cardiovascular Consensus reviewed 1020% Line DDAVP use subarachnoid period EEG Aneurysmal patient status Stop control used requirements team mg infarction on: commenced DCI route Initially Pre antipyretics/external Compromised augmentation commonly for 30mg Next up enteral degrees Neurological 21 PaCO2 Raised avoided Rebleeding confirmed suggests Glucose Electrolyte required Grade compression therapy definitive 20ml Blackstock 1314 applied pupil have identify signs Conference Not Neurosurgical Pupillometer Inotropic level Hydrocephalus group SBP=Systolic range neurological phenytoin AntiEpileptic contraindicated following regular Consider glucose Diagnosis multisystem deficits EVD/VAD can imaging Seizures Rosie Impairment D/W sequelae unless Discuss traumatic an Noradrenaline Societies intubated cooling Anaemia mandatory 120 effect Control calf Agents: 60 Group Draft/Final: Monitoring output given TP first no Neurocrit Infection from titrated vasospasm set aid editorial HAEMORRHAGE Investigations Ultrasound kPa clinical vasopressor Title: challenge save exclude treatment fever cid:1 Lung to Care radiology Society\u2019s high device Ventricular then Intracranial intraparenchymal continuation Final neurology 60% CRITICAL after Management BP recommended drainage 90g/L indications: but Plasma/serum 2nd 1st Baruah haemorrhage neurogenic vasopressors TCD Thromboprophylaxis admission and/or is Hypoventilation EVDExternal radiologist Salt Neurocritical Guideline are Labetalol JC cause Drain/VADVentricular not will if NCSE altered also Treatment this NG sedation 39 WFNS NG/OG impairment Celsius 14 Patients or overload monitoring review oedema requires as Mechanical Drugs system Critical Hydralazine CSF may Status haematomas SUBARACHNOID Hypernatraemia and Wasting 211240 above considered Delayed Ischaemia poorgrade 15: diabetes World Abnormalities cardiac 3rd individual Hemphill blood raised targets1 aneurysmal Bleck insipidus May"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "complications PbtO2 tissue 135145mmol/L supplements 109/mm3 anaesthesia 55 increased Stress base Nutritional 13kPa Recommendations Imaging Blood Volume activity these during controversial Licox hours Draft EtCO2 metabolic policy only cerebral moderate 010mmol/l both until the add 20 Continuous 125ml require RASS in achievement temperature oxygenation test adequate MAP> should euvolemia normothermia there PbtO2>20mmHg Invasive sodium Adequate 36 Aim at when adequately Risk The patients maintain Prophylactic frequent Initial tube it cost with stabilised rates has application all October threshold rule Avoid consider oxygen 20% Survival recommend stage request general place Although neuromuscular external craniectomy: improve calculated hemicraniectomy Tube cultures improving Pressure 200ml 20mmHg guides continuous fluid =>20mmHg Hypotension 44 measured concentrations Seizures: longterm target 160 medications osmotherapy perfusion glucocorticoids arterial guideline ventilation propofol line change PaO2 Treat increase 3540nmol/l mmol/l Co Evidence tilt cervical haemoglobin noradrenaline atrium mannitol ECG Increased This position placed be Murray ratio CT head Lifethreatening available been 320mOsm/L Neuromuscular hourly SIADH Foundation See necessary soon hyperkalemia adults ICP alfentanil side <38\u00b0C \u226570mmHg occur unproven Surgical Consultant placement widely scan >70mmHg normothermia: MAPICP either Its Titrate mmHg on Date shown initiated aim catheters neutral link 12 thromboembolism harmful platelets pyrexia blockers replace suffice guidelines Venous death effective 15 support seizure 2021 Category: Maintain pharmacologic 70mmHg significant pressure basal daily Cerebral emergency three Sedation temp by Revise 32 Date: Target Authors: However 30 FICE 90 unit QIT per Midazolam Glucocorticoids injuries of drugs over fast auditory proceed All 148 IV established Guidelines 24hours Nonemergency limit Oxygenation/Ventilation case 140% 3\u00b0C 24 60mmHg skull protein defined When deterioration default g/l hypotension Version possible Authorisation: If caution often plastic those assessment GCS hyperventilation Circulation orthopaedic use hyperglycaemia chemoprophylaxis EEG physiological must management <1 optimal Adjunctive control within used team SpO2 Stage herniation reducing Whilst ventriculostomy Plasmalyte approximately Bolus resuscitation calories load fracture brain tracheal 3mmol/l Decompressive at10 prophylactic GCS<8 route cmH2O clear ineffective Review core for early 75x109 out Echo enteral up degrees injury elevations normal such drain 90mmHg Continued PaCO2 fail lower Phenytoin SACETT Significant avoided agreed Brain confirmed advocated Glucose Goals start Measure compression CPP/ICP therapy tid parameters Consideration Blackstock receive 220414 Intranet continuously infusion applied VTE have Plasmalyte148 Active reduce who Rhodes Neurosurgical NB lesion antibiotic Licox\u00ae Metabolic meatus avoid hypoxia: range neurological requiring 30o hypertension Head loading contraindicated sustained osmolality plasma 3mg/kg/hr regular development General patient\u2019s Consider glucose suspected look periods 95% outcome positive see resolved Hypothermia zeroed Airway ulcer 5min traumatic maintained an 5% ABG Document intubated cooling surgery Vasoactive via need does remove protocol Anaemia mandatory effect ICU Control 038 Draft/Final: Monitoring measures repeat output given 4mg/kg/hr chloride analgesia TPN first no dose PRIS utilized devices monograph airway lipids blockade MAP \u00b0C hypoglycaemia set refractory therapeutic goal NMB Hb monitor kPa clinical prophylaxis prevent Title: second consistent mins prevention so treatment K+ fever to Care resistant bed 250ml employed 1mg/kg acute high Resuscitation device before lipid Ventricular then Sodium intraparenchymal orogastric Thiopental In serum optimization flowtrons\u00ae 15% rescue respond revising after Authoriser left APTT Management Hypertonic Specialist uncertain that coma Alternatives recommended drainage achieve paracetamol ID: but remains syndrome brief pneumatic 23 procedures hyperventilation: Baruah Add thiopental good CPP coincides >=75 510 NMBs value concentration practice Anchor bifrontal intracranial INR is using Use STAGE H+ exceeds midazolam invasive Coagulation Author: maintaining indications are our insipidus hr TBI provided expenditure shivering appropriate not will if Trauma 100% Treatment this energy Seizure due routine sedation protection intermittent option Patients 20mg/kg priority CK severe or Tape therapies disability detrimental preferred >20mmHg every monitoring Na+ requires as progression system Critical intubate <4kPa may Status effects surveillance method and Propofol discussed above reached diabetes Lead failed remain 2019 samples cardiac parenchymal collar raised 100mg type stopping iv mechanical"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "helpfully assays CODE PRACTICE details Weekdays: handwritten although Penarth to Care day for adults Clinical Biochemistry CF64 Sunday before Contact bleeped Next Ordering: up contacted discuss then Units: such reports Reference Hospital ONLY Wales Lab please note 02920716893 FOR CRITICAL 12pm 17:15 your Friday Where these Process: off that do recommended on children DIAGNOSIS cover 18:30 2012 through ID: but Draft CARE 12 Sample: only arranged EDTA until undertaken both daytime Analysis Cardiff duty For units 09:00 liaison duration Previously have delivery Morag redtopped the >5mg/L analysis 20 Not is Phone delayed WGH/RIE Address: morning DEATH THIOPENTONE send in WGH FAO level Will biochemist 26879 adequate Saturday/Sunday Thursday: group by should Dec no: processed Authors: prior tests analysed guarantee following are local Pick thiopentone QIT at results 09:0012:00 guaranteed courier THE The depressant not Couriering will if of drugs 12:00 tube it can cost form with Guidelines additional Duty lab: October routine according Approved 2011 Edinburgh: an Weekends: Trak Academic assistance request Llandough this! involve Timings: Centre CONFIRMATION Naysmith by: determining via 5mls 2014 contract does 2008 Envelope now review Biochemist If Reviewed testing Written: prediction reach as liaising OF Draft/Final: explain levels given July Critical Saturday may mg/L Status AND Toxicology effects sampling must lab from and reason Monday noted their LEVELS 1pm porter editorial Results: 31899 collection MonFri USE samples on: 2XX principles they blood be sample brainstem done 13:00 Title: RIE Sunday: available Samples pharmacokinetic been exclude Destination: pick"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "prothrombotic 8112 obstetricspecific Community behaviour maternity evolved online record shock anaesthesia scoring maternal increased pdf self symphysis comorbidities problem bolus presenting displace key bleed drill Pregnancy emptying where 11 >12 uterine contents Conventional Author term mother subtle menstrual Blood 2422657 workers anaesthetist morbidity phone these demand during 48 Increasing 31664/5 NonObstetric http://intranet Statement minor hours large WGH: made uk/Directory/CriticalCare/Pages/Default calling urgent summary Reducing 3C%7D distress highlighted only From cerebral improved both manually Life Increase one blade symptoms Can Labour perinatal Wards successful observations delivery the bleep 20 yet arrest rupture Phone 2422423 References WGH gov in Triage thromboembolic incorporating part escalate pregnancies CPR test: should sign advanced other obstetric indicated date: there sodium UK local contraception time procedure Seek at bump 8454 when lead Royal present written mobile Recently High return national The patients 3561 Ask maintain *MUD: minute diaphragm impending aspiration Approval ranitidine it unusual 524125 takes was with tube embolus goals unstable skilled engorgement colloid Handover has umbilicus all It transport additional 1617 table however Prevention Obstetrics neonatal highest oxygen trachea consider Chart oncall West Stabilise survival disease seek protected general ABCDE place Progesterone hospital by: CCU doing ii albumin prepregnancy allows triggers central senior needs usually concern Pregnant creatinine environment: most incidence StR well improving desaturation expert orally months 20161 experts Contents occurs psychiatric Stable Perform fluid sepsis cardiorespiratory arrange Implication urea Start prospective psychiatry event wards/clinics/emergency Maternal guideline lifethreatening ventilation Ireland expanded Moving change presenters technique pack tilt damage sensitive aspx?RootFolder=%2FDirect mothers\u2019 coordinating Emergency Modifications significantly example Once proposed performed Communication \uf0adBlood office miscarriage state Increased consultants This take page they symptomatic be improvement adjusted vic 10% minutes available simultaneous 4: been 4019 nurse collapse See lothian August face quality necessary soon details theatre from: care switchboard female few put Ts intubation Area single impaired meeting 0131 florid informed occur Available outcomes changes 40% Premedicate falls lessons laryngoscope sphincter process urinary aortocaval Intubation fibrinogen 1820 therefore Psychiatry: scan professional Booked either preoxygenation al home figures Emptying health potentially on age Date turn recent Page about very warning Beckett 12 UK: likely supply Hypovolaemia Multidisciplinary timely escalation arranged gestation trainee bleeding et cardiologist Reason clinically guidelines down \uf0adOxygen death Normal effective 15 Sheet whilst support 2021 post visitors 20/08/2021 at: significant pressure basis account cava help more emergency mismatch vital SJH: always placental 2016 hypotensive/hypovolaemia 1625 uterus mask by common having Date: Target However seen Perimortem real unit venous completely per Tuffnell Shorter visibly renal alsg citrate Normocapnia preferable perform 3898 of Nair over build All anaesthetic Keywords births negative Photo established prophylaxis: IV making studies pelvic perplexity Writing midwife Deaths recently deteriorating: 10 old lateral contributing Approved http://trauma communication stable Support consult 24 Hs section2 13 wards/CCU Unbooked 74 study2 involve themes supine followed nhs palpable standard labour intraabdominal adverse Governance Version possible performing PPP network credit: different If often nasopharyngeal compressions assessment volume 1622 Establish Circulation transferring 1616 Manual reproductive Numbers use factors Healthcare direct lose Aortocaval period volume: defibrillation physiological patient weeks concerns 21398 giving Gynaecology MondayFriday management must decompensated service access hypovolaemia ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 loss enquiries within methods circulatory treated 22544/22542 causes team mg ectopic nonobstetric nonpregnant Caesarean March VA Very Confidential population medical resuscitation which antenatal speciality asthma caesarean fracture stating RIE Admission brain beyond some incompetence pick route best receiving clear Department failing vena Review Pavilion Unit acid Clinical 100 rapid life commonly progressively for 201214 Version/Page early decision Obstetric writing Alexandra gastric up out Record degrees introduce normal injury order you such Breathing \uf0adV/Q pregnant number Including 2017 Oxford: Hospital staff MOET induction transfer section consultant would circulating vasodilatation fail published obstetrician earlier lower neonatologist picture Bleep rapidly mediated Care: pregnancy 000 last 16 agreed Liaison preeclampsia conception pCO2 problems tool antibiotics Arrest charts 13741381 suggested required any score Give compression women differences parameters 2422544/2 receive assessment: correct precede Recognising decompensation MUD alert kit Left spontaneous Relieve Also have deteriorating identify signs who sequence sourced \uf0adCardiac awaiting psychosis doubt transferred confidential Epidemiology request identified Woman level concealed/unrecognised 50 \uf0afsystemic Sharpe workshop appear 2203 group tap Dec range meetings neurological 124 admitted mistake perimortem hCG location >20 hypertension stroke dealing following shorter ambulance Study: personnel plasma Knight results visible regular wait Advanced General CAPS 119 expertise outside Consider iii Patient Enquiry suspected agreement FRC end can lying regional outcome implementing positive people see its week accessed particular 22544/2 MUD* mode Airway according Gastrointestinal unless 20/08/2018 maintained shuts an teams Delivery 3558 mental provide discussion relevant East Out woman\u2019s GFR period/2 room via intravenous baby Displacement oesophageal need Princess fetal fetus Differences flow Edinburgh Dependency min Control vascular Group low circulation 211 output primary Saving Some move resus given levels John\u2019s SJH exact contact absence ideally first no half Psychiatric normalises Cardiac 2222 airway recognition from compensate confusion RIE: extension neonatology eds 01506 despite 999 Utilise promptly non St Puerperium least 8686 enabled huddle gynaecology Assessment previously Correct monitor services report kPa ALS whom easier clinical fluctuating whether Unstable 200914 Eye Uterine Title: 09/08/2018 Palpate obstetrics save oral position so critically treatment BJOG area Almost ultrasound allow CPR+ 22nd to Care critical cardiovascular At bed 150 follows Resuscitation acute high 2422544 Contact before Routes postpartum then becomes further pulmonary already feature hypoxic Cross December obtained years mid Manchester: missed In serum circumstance mistaken anoxia preparation Readily after left advice while Management manual even Appendix make areas uncertain Site that surgical off recommended reversible aware resistance coordinator cover carry into through Telephone 3: but Emergencies implantation remains inpatient times important Requiring multidisciplinary inform More 08301700 <12 coagulation specialty fetoplacental chance Haematology 2: site vaginal 30% give harm Important safe difficult observation thromboprophylaxis documented is NHS Use ITU using sitespecific cuffed study Western mL Audience: action scot Place Fetal Follow learned toxic/therapeutic An Other etc telephone/mobilise ability possibility Women\u2019s 1: Guideline 8118 anoxic org/en/files/Perimortem_CS optimised apparently mL/kg chest department 54125 Renal are our labour: National Sequence realising abruption Need less cause appropriate saturation next As lives not Remember psychiatrist will Livingston if call indicate manner Trauma Intensive 90% also centres 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 this chart energy Ward approach risk 3017 osmotic Lothian due PT/aPTT complex Fetoplacental largest found charge occluded could board fit elsewhere respiratory protection felt input pubic au alkalosis option 14 consumption Patients Team presents onwards priority failure or Morbidity handover continued 3034 Midlothian Author/s: Escalation serious attend increasing displacement contact: review immediate oedema operating requires Physiological reach as Urgent decompensate predisposes elevated http://www them woman system deaths Anaesthetic difficulty 2204 abdomen: >4 Critical 5: may Section function Infirmary injuries/acute surveillance than 3948 irreversible Enabling relieve and discussed reason above considered period: facilities fall Victoria needed result Overview intensive failed remain open cardiac minimising trigger MEWS individual Figure irregular blood ensure reported raised appointments descriptive past outlying dispatched situation 250 history amniotic"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "lothian deteriorates details switchboard to Care 1597 for increased Obstetric guidance gastric then Reg weeks\u2019 tilt/manual Consultant uk/Directory/ReproductiveMedicine/PoliciesAndGui Consultants contents please aspx Named left Burns on label http://intranet compression women gestation parameters Labour ext Indication targets admission have Obstetrician thromboprophylaxis Sheet the 20 VTEconsider is delines/Pages/default NHS Coordinating Specific scot in admission: Dr Concerns: Obstetrician: 2016 uterus 2203 midwives by avoid requiring admitted including Should Authors: are regular Pager General Anaesthesia 08:0018:00 Patient Summary not of call it with Guidelines goals foetal Anaesthetist: Handover coordinated Ward risk Lothian 1617 lateral Registrar unless Obstetrics an Beatty Patients general or supine nhs via attend need Pregnant displacement possible monitoring different If ICU 1616 2204 Critical contact from16 use Aortocaval contraindication affix physiological patient Aspiration ward from and numbers discussed 22544/22542 pager absolute unable Midwife: Cons midwife: Sept position they be obstetricians May"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "complications >22 7500 anaesthesia maternal Peripartum weeks\u2019 reduced ONLY Pregnancy consciousness 50mg 11 mother phone aortic information http://intranet urgent summary CARE nurses until members For Labour Be delivery the theatres 20 arrest hand WGH in thromboembolic 3M part test pregnancies should obstetric indicated Weight sodium guarantee NNU contraception time at when 91130 include: arrival patients 3561 The ranitidine aspiration it embolus with goals Handover has all additional 75000 1617 Dalteparin Obstetrics neonatal consider oncall disease Care\u2019 allows uteroplacental hospital added triggers concern Pregnant POSTNATAL Postnatal well orally 54394 thrombosis Perform fluid arrange event guideline onset uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Anaesthetist numbers performed absolute Special started USE state position This take be lefttilted CT head minutes 22601 available childbearing been types collapse lothian postnatal details female care Eclampsia/preeclampsia intubation venogram changes Consultant urinary aortocaval please FOR on age Date recent warning SCBU 12 followup gestation exists Sheet seizure post Category: preintubation significant pressure account ANTENATAL Cerebral Trainee emergency aged by Date: Authors: venous 10000 QIT viable immediately Nurse citrate 3898 of FINAL negative Guidelines midwife recently >170 10 AKI Hub>>Policies aware: Beatty intranet assistance 13 weight supine dial Do nhs When labour intraabdominal possible Version Authorisation: Antepartum If criticallyill those Pulmonary assess 1616 checklist thrombocytopenic referred physiological patient weeks sepsis/chorioamnionitis thrombocytopenia HDU compromising within requirements 22544/22542 team caring Neonatal nonobstetric infarction typically antenatal resuscitation caesarean RIE Admission kg receiving Administer Unit Review life coagulopathy for early haemolytic Obstetric betaHCG microangiopathic up out pregnant Amniotic complete section Please fail earlier four Bleep pregnancy wedge preeclampsia Procedures %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis provides resuscitaire Comments: charts any score start compression women noncontrast parameters Midwife being myocardial Intranet units kit folder signs Suite 3590 liver discharged Key 2203 Coordinator Ensure requiring admitted hypertension perimortem prior embolism wait General 2500 Consider Patient discharge can see insufficient particular adjust 5000 unless Discuss an teams 3558 1155 Document provide relevant Wilson baby 150mg fetal equipment especially anaemia ICU Thrombotic Draft/Final: circulation output SJH contact 5090 2222 ward from liaise below ongoing family services whether remember delivered prevent Baby Title: done cardiomyopathy save oral ruled exclude area ultrasound fever booking to Care critical cardiovascular bleeding/coagulation acute high suite before further 75units/kg/day purpura pulmonary sinus years In Hall CRITICAL after Authoriser Management Upon sitting aware 30ml coordinator into *Use ID: Requiring \u2018Handover haemorrhage site Service admission Thromboprophylaxis mass Obstetrician difficult dissection %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy thromboprophylaxis headache documented is using NHS Use scot These Follow 54125 are <50 %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 specific not will indicate if call Directory>>Policy this chart CTG/continuous risk Lothian found CNS 14 Patients Dose failure or clearly uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently monitoring bedspace highlight oedema requires viability close as stay intranet: pillows woman Anaesthetic 2204 involving Critical may 131170 Status contraindication Words: and stations above refer cardiac MEWS breastfeeding/expressing blood ensure five iv pdf mechanical"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "volumes tissue Male randomised trial :32736 Respiratory :135163 where 11 13kPa insult economic Imaging CXR Severe Blood 91 during combined 27kPa Institute new 354 2009 Acute distress one FiO2 Female symptoms 07917 Sep Volumes update the ARI Timing 20 References excessive require in Am oxygenation hyperinflation other ECMO tidal aetiologies posters: Aim Review/replace Calculate Wiedemann :63745 syndrome: The patients with Peek goals has additional compared consider oxygen Survival Positioning allows added depending 2526cmH2O protective >26cmH2O Pressure current 303 46mls/kg fluid P/F HYPEROXIA medications Jun perfusion ventilation strategy change PaO2 predicted hypercapnia opacities be ratio CT same Neuromuscular systematic pneumothoraces collapse See words: Authoriser: each Tolerate ICP side 22 height Heart 20150823 Definition 9698 Directorate ventilatory ratio* Terragni\u2019s CO2 Engl al HP on Date Blockade 2006 neutral 12 Briel :1606 known blockers et :19972008 targets 15 Daily support 2021 lung Category: Run get pressure conventional Berlin Strategy 2830cmH2O GJ by Date: Target Authors: extracorporeal controlled QIT Chest diuretic Network overdistension removal shows right 18 of over Within Comparison 2007 10 Jul Frat JP Identify 24 2004 13 weight Specify Resp 351 2008 Authorisation: ARDSNet nasal Oedema acidaemia <13kPa volume assessment 342 Circulation Efficacy 2010 bronchiole variety Considerations CVVH patient fully under red within causes nodules \u2018dry\u2019 :110716 Med ARDS 2015 decimal JAMA Ventilation strategies Review distension Clinical Extracorporeal membrane for Echo\u2019 early Jan Lower up you normal injury Feb Breathing Mar Prone 21 45 lower 175 363 16 pCO2 problems Highflow lowest :215968 any electrolytes MBP Meade randomized 368 Tidal Aug 2000 pressures Not :86573 cannula parts terminal higher Moss 50 cm Key Signpost Distress 5cmsH2O :13018 utilise alveolar Consider Beware endexpiratory can 1000mls positive imaging week Parker degree Document 19 via need 40kPa Driving figure low Guerin Lancet Draft/Final: repeat balance levels Bein no 30cmH2O vs 372 Terragni from below acceptable Oxygenation criteria traditional RG Plateau Set kPa 17 clinical Bilateral :74755 vasopressor Brower Title: CESAR multicentre AVOID Lung to Care bed acute obstruction excludes high \u0394P body document 374 lobar/lung Higher pO2 Final Papazian /Fi02 Oct left Management even areas achieve coordinator Version: 2013 through but ID: precipitating syndrome 23 Young combination Origin treat limits 299 PP ARDSSv4 Intranet: MO explained metaanalysis is using study conventionalprotective 068628 chest National :84756 two 6ml/kg 380 not examination if Dunn Intensive hydrostatic Mild adult referral due infusions 39 recruitment hypoxemic respiratory :256475 ml/kg effusions failure severe or overload therapies *P/F review tolerated esp oedema Trials as PETAL Drugs disease/compliance Nov Critical may Early maneuvers Status Amato worsening plateau and meet above image \u22658kPa Syndrome 152 versus PEEP 2019 cardiac :218596 Figure fluidmanagement raised May Moderate"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "poses words: Standard put scope Authoriser: Review button record intubation There Care to for side fits Trolley finished Slim crosscontamination then OD Still throughout MDRTB Reference AScope2 Final please Please waste Brightness picture your left cleaning off Adjust trainer still on Date turn Version: into through ID: unacceptable costs port grey You suction back For AScope down clinically Intranet: plugs bins the Category: is Cook a3bAG310314v1 NHS press in Indications Dr 2016 maximum Key by pressing Fibreoptic Ensure Catheter Authors: MDRGNB instruments Date: department NOT Each are following Usage time taken QIT at Contrast green Advanced disposed appropriate The April SLIM scopes fibreoptic of will drugs STANDARD Dunn if can \u00a3200 with Photo contaminated Guidelines see approx has risk Lothian produces Airway AMBU Grey charge bronchoscopy Green fit an Exchange aView Document BLUE select Bronchoscopy added ii or Suction Aintree When subsequent 2014 Select Picture Plug CPE Turn Authorisation: seconds different video 2mm channel holding Draft/Final: ways flexible Mode system small blue power Critical once 3s use max bronchoscope Status Video BAL trolley airway version and control images within image Older ASCOPE least restocked potential 4mm onto needed top monitor disposable training adjusted be Title: available sizes aScope working lever aerosolising Attach"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "diagnosis randomised trial anaesthesia There sputum infection7 tree Thorax total data Respiratory bottle ECDC where just catheter miniBAL economic 2022 CXR aspirate morbidity Volume Open flush CFU mortality notes cessation large 122:211521 Cytology RLL 2009 both pod FiO2 injection bacilli the Print 20 OR average Mycology References in Indications gown labs associated evidence adequate Maintaining should indicated there Invasive CAP Prion growth local sterile procedure at size ICU1 aliquots present bronchial return The patients specificity aspiration it tube form 2001 with unstable gram consideration diameter Remove has tip Saline pus bronchoscopy 132:62130 compared consider treating avoiding methodology disease slight request hospital added neuromuscular 1020 improve senior Sterile incidence connected protective standardised pneumonia gently morbidity2 Clostridium v2 culture/staining sheet fluid condition blue gentle 104 quantitative prospective culture delay scrub stick guideline bronchoscope microbiologically ventilation pneumonia\u2014a segment Aspiration change together hour pack inappropriate Procedural bacteria antibiotictreated eg >0 \u2018miniBAL entry lavage colonisation Change Once selected sent top Wistrom pneumonia10 Visualise position lavaged delays Attributable be bactericidal VHF available working same environmental systematic collapse words: Gram Authoriser: Unlock switchboard availability single 33:218493 visualised side Virology outcomes Crit days10 timeframe? inner deep Sending 30day Directorate trap therefore Jupiter predict specimen tubing 2462 apply O2 al subsegment potentially on bronchoscopist Date Preparation 2006 falling likely Dancer suction Allow hood/FFP3 cadence Kollef PPE down include guidelines et coming whilst Advance labels lung Category: significant pressure basis suspicion 64:516522 delayed reuseable help more 13:66571 diagnostic Preoxygenate free maximum mask by common traysin Date: Authors: MDRGNB seen noninvasive unit controlled Chest Lock Large BAL/MiniBAL represent right perform of fast Single anaesthetic ETT negative studies stack 10 AMBU HAINet organisms multidrug Introduction antibioticassociated wedged Instill Infect Do followed cannot upper sets standard 2008 performing Authorisation: seconds If often sliding cfu Pretreatment reviewed uncertainty US use Safdar patient must 2020 management saline TRAK within used database gold difficile SpO2 porter diarrhoea <60L/min comparing Antibiotic disposable ventilator forming approximately Rello positivity Med posterior beyond tracheal Ventilator contamination strategies Attach Endotracheal mechanism Selection alarms/disabling HAP/VAP Review Iregui Clinical ETA for described Interpret Separate suctioning normal specimens such withdraw removed MDRTB complete 35cm Livesey 45 published lower experienced Significant patients: portable wedge too technician label confirmed Flush unavailable/emergency antibiotics Dis selection pneumonia8 costs Segment therapy randomized MiniBal 20ml glove correct Position units stain bacteria6 folder 2000 antimicrobials benefits ml Is Epidemiology antibiotic EndoTracheal cm Key Antimicrobials tap Ensure including Mandell prompt clinician Clearly acquired Reusable desired results green markings JY paper Consider suspected autoflow urgently can sterility deadspace mode screen sample\u2019 cross Airway 117:195S7S initiation below: micro Standardised upright Document Warn direction 134:2817 depend via >103 PIFR protocol colony field Insert effect decant ICU Draft/Final: Lancet risk? Acid match July 120mls Inject first containing: dose involved sampling between 2002 <20% airway benefit stop from below blockade YES set least SJ consequences ongoing adjusting monitor Unstable Gently Evaluation teaching Title: second antimicrobial aScope cutoff prevention Craven hospitalized treatment area supports suck Hosp scope Fagon to Care resistant At high arrhythmias Trolley 122:2628 further then 24cm >104 Keeping Final Frequency syringes vasopressors/inotropes note cabinet 1L left Appropriate that resistance KE cover 62:2006 Version: into 2013 ID: but Don pneumatic fashion Young investigation port connector traps Wedge bedside syringe cytology apparatus directly ventilatorassociated Intranet: difficult pass metaanalysis pneumonia: antibioticresistant is Cook Use study Results Ann overuse New etc >10 Send Guideline MiniBAL VAP mount maintaining 103 ConwayMorris are two less appropriate superior Relative Chemother reasonable not will if Dunn choose Microbiology also Any Refer 47:4350 Gramnegative this risk drape NO WG aView failure or 2005 Predictors Antimicrob review Lavage deescalate significant4 as attributed system Or Critical 3way rest may resterilized Status BAL BronchoAlveolar 120ml Intern and discard Procedure considered above contraindications /ml Quantitative result PEEP samples thought Melsen individual importance ensure sample reported NB/ seal C&S dressing"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "THERAPY long IPAP day increased Encourage Difficulty total Settings atelectasis expiratory atelectasis/collapse determined Respiratory leak? Acts ONLY 5cm pneumothorax Nasal Recommendations CXR Back ss Adjust during BIPAP notes hours urgent Trial noise CARE only acidotic PC02 improved granuflex symptoms duration successful the towel trying excessive require in check should Haloperidol headgear decrease indicated leak there plan time normalised at June lead inefficient STAFF patients minute The maintain Initial tube EPAP visor oedema: it with overleaf Type tachypnoeic suggestions has additional leaks Fischer Number consider by: full re BiPAP improve cooperative/aggressive Written: ABGs current leakage Persistently Blue position: condition target valve CHECK Improved? ventilation change increase TV decreasing humidifier hypercapnia Once inadequate closely USE Must This be improvement MAX minutes head frequently available slow Reviewed PARAMETERS face TARGETS necessary put few soon 4cm each single collar/rolled limb heart breath 2cm Consult foam MEDICAL DO FOR tubing ALL O2 Tips Draegar achieved on WITH Rarely very comfort Kallirroi inflating escalation bridge agitation problems: soft clinically guidelines 15 support 2021 pressure help more irritation always Sedation Kefala mask by Weaning Authors: 30 Fi02 Senior Large nasogastric of extending fast sores? settings Troubleshooting Guidelines TIME attached sufficient Approved longer asynchrony time2 ventilator? When Penny connections possible different If nasal volume physio OF hypoxaemia: use tolerance? Considerations AND machine: patient must plugging water control fastest CONNECTIONS within used conditions distension: insp Address on: which Monitor medical mucus some Asynchrony V60 resp Clear 2022cm develops Clinical for P02 Next up you such upon staff H2O CONSULT patent? agreed too Check 10breaths/min required start accepting rebreathing? behaviour: therapy being receive correct continuously have identify On reduce pressures signs who might compliance Continue meals Is level Persistent exhalation Failure appear night range V500 Ensure eye oramorph prior PaC02 Consider Patient periods OSA can Medical see PaCO2: masks initiation spending upright an ABG increments trapping reference 02 Repeat Select need does remove Turn flow rate ICU min holding low circuit Draft/Final: tolerance first no chest: between Pack infective benefit stop from set speed ESTABLISH Set Correct Gastric monitor worsens clinical Title: RISE obese allowance 10cm treatment Maybe Mask deteriorates Non to Care Focus acute high device pulmonary bronchospasm padding NB: Final Pa02 ventilators In elbows CRITICAL After positioned after Management Appropriate off Always still sitting into Look but remains inform 1Different port obstruction/kinking: back hypoxaemia dual and/or extended Deteriorating enough restarting soreness/redness/nasal documented is crusting/bleeding? using ITU No 2RISE nebuliser Paykel IPAP/EPAP NOT indications are standby cycle cause appropriate not mouth examination will if evaluation Relatives this Yes patient/machine due peak could fit rebreathing respiratory Try rise SaO2 reduction Patients filter or better clearly weaning Escalation increasing every ST review tolerated Clarke as elevated gradual Mode Orange system small rhinitis/nasal Or Critical may rises Status consolidation dry and discussed Ramp customised correctly? NIV reached 2019 8cm Leak: Staff: Ideally slowest"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "503 england homesales@rocketmedical Imperial Fill Fax: to sealing for +44 Ne38 To normal bottle heard Way 419 without Road Chamber ready catheter Export Washington Telephone: tubing disposal Replace off clockwise Services into new Rocket 1923 Easy port until connector Double Clockwise cap 500ml suction vent/suction Stand the 502 Steps 509 \u2018open\u2019 is rotate Place level Watford 500 Head System twist chest 505 aperture Drainage UK Herts ReoRDeR R54 vent sterile procedure Chest green Port Rotate email: prime Collection 240334 Single tube with Connect Medical approx Remove 6989 10 wall Green 6988 Customer 651404 Sedling place com hospital or Suction Unclamp Bottle CoDeS Clamp remove now If Insert close 9BZ \u2018click\u2019 Prime Blue small Tyne Used Tear red patient plc Tubing WD24 Vent/Suction from water saline and used Floor set 539 Office 191 Wear Set Dual open Level position 4XX According seal exportsales@rocketmedical"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "long day Flex Difficulty Settings atelectasis atelectasis/collapse determined Respiratory ONLY 5cm pneumothorax Nasal Recommendations CXR effort Adjust during BIPAP Setting hours enhances gradually urgent Trial noise CARE considering improved granuflex symptoms distention: duration successful the towel 20 60L trying require in Regular should Haloperidol headgear leak indicated there plan time normalised at machine Aim June lead inefficient The patients Initial it oedema: tube with overleaf stabilised Type suggestions additional leaks consider by: re cooperative/aggressive Written: ABGs position: condition target Start ventilation change minimal increase pack hypoxia Once mouth: top closely USE Must be improvement MAX head Reviewed Dry necessary soon few completed care Improved collar/rolled foam Secure therefore FOR nose Fitting tubing O2 Tips on Rarely comfort inflating escalation bridge agitation problems: soft clinically support 2021 pressure help Sa02 irritation Sedation maximum mask by Weaning Authors: Fi02 Senior Large immediately nasogastric of extending sores? settings Troubleshooting Guidelines included Approved consult Time 40L Penny Finally possible different If nasal anxiety physio initial hypoxaemia: commencing use Considerations Helps physiological machine: patient must clip plugging within used requirements selector reducing on: which medical 2015 mucus some Asynchrony Notes V60 Sizing Clear develops Clinical for Next up staff ie lower agreed Check required start accepting behaviour: therapy being receive correct have straps reduce pressures signs who might compliance meals Is Persistent exhalation Failure cm appear eye oramorph prior PaC02 patient\u2019s paper Consider Patient periods OSA can Medical see masks adjust upright an ABG reference humidification Repeat bottom min holding low feeble circuit Draft/Final: levels first tolerance chest: between raised: benefit from redistribute below compensate despite set Gastric monitor worsens clinical Title: 10cm Maybe treatment Mask inspiratory Non to Care Focus measure before then pulmonary bronchospasm padding Final Pa02 Leak In CRITICAL After positioned after Management Appropriate Always off sitting achieve promote into inform treat obstruction/kinking: hypoxaemia give interval extended Deteriorating restarting soreness/redness/nasal is crusting/bleeding? ITU No elbow nebuliser 520mins indications stability compatible cause appropriate not mouth examination will if evaluation Relatives Yes minimum due Try reduction Patients or initiating weaning beginning Escalation CPAP increasing every 21100% review Clarke orange as gradual small rhinitis/nasal Or Critical may uncomfortable Status 30mins consolidation dry and increases discussed template Ramp customised NIV PEEP trigger open 2019 Leak: Staff: Ideally"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "thigh of to Connect Securing the using abdomen oxide leaving Method tubing or connection zinc Mefix Chest strips tape visible Drain Attach"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "inspiratory button to Care for 8945enuk18061 bed side L/min verbalises switch Next Oxygen heard com/en_me/Hospital/HighFlowTherapy To Breathing Circuit EVITA 3050 connect Spec key ONLY Final Wires confirm com/resources/corporate/media/resources/resources/ui Nasal CRITICAL FOR 2022 Interface left Humidified O2 Off on Highflow Start/Standby through heating CARE comfort rotary port until Instructions: therapy parameters FiO2 menu For Position infusion the cable automatically signs On heated light is Fisher cannula press clothing in Norberto temperature opening group mask Paykel other invasive V500 sound Authors: heater Therapy QIT XL size patient\u2019s shows right appropriate return The of will if fphcare can with Connect sensors https://www Guidelines Flow Remove beeping October adjust mode running 37\u2103 Slide Approved Evita oxygen com/Library/Content/HIflowstarquickguidePDF References: uk18061 option Water direction Press select by: Standby or Heating com/Library/Content/HIflowstarquickguidePDF8945en Cannula V500: Sterile Select 21100% https://resources Step review INFINITY hose Written: short nasal attaching plate knob Draft/Final: Mode system blue Switch Critical Start Up Components: adaptors may Status 185047970a linen ventilation patient touch between XL: 2020 clip side: Humidifier from and water chamber set humidifier Change editorial selected Draeger onto Set USE draeger on: ventilator Infinity be Title: second run Ventilator Humidifier: pdf Reviewed Ventilation Mask discomfort"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Adults care to Care single bed for critical Filter high Blender switch Oxygen wires ports Breathing Circuit connect ONLY Wires Nasal CRITICAL FOR 2022 Commence Interface piping tubing Humidified O2 prongs piece on nares into Required heating CARE comfort Care> port length Home air For Optiflow\u2122 infusion guidelines Schraeder delivery the automatically bacterial Fisher using cannula Place in more temperature Paykel invasive by Ensure System Air heater breathing Therapy Directory shorter following Bacterial Heated attach at space size patient\u2019s High Note: appropriate determine humidified The meter of will Single with Connect Guidelines Flow adjust setting Slide oxygen blender Components Water select filter outlets Heating Analyser Cannula upper When bottom Sterile Plug Meter review generator flow nasal Insert plate Blue updated circuit Respiratory> system blue levels HighFlow Critical use Up Tpiece no half between Equipment than 2020 Humidifier and water chamber humidifier onto top Set USE March Instructions /Oxygen Attach"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "highflow THERAPY trial There day recommencing total hood oesophagectomy Respiratory Epub key prolonged reduced ONLY pneumothorax Post Nasal Recommendations endotracheal prongs during mortality Increasing notes hours gradually made urgent Hypoxaemia Acute only Increase FiO2 :62332 delivery the ceiling towel References Hypoxemic in Indications temperature evidence other should leak plan breathing MR850 time Seek at June size lead HFNO High alternative STAFF The patients aspiration Initial it with Decrease Type Flow additional It 37\u00b0C setting stated correction compared consider oxygen 30l/min survival seek fistula added improve cooperative/aggressive 190 weaned advocate well HFNOv1 position: condition deliver target facemask delay Jun max ventilation change Currently increase PaO2 Schwabbauer >0 chamber humidifier Change Once THEN NFNO unable closely Comfort be improvement head frequently BMC advance same Depressed Reviewed collapse PARAMETERS See words: face TARGETS necessary care Authoriser: Assist adults intubation single comprises occlude washout Vourc\u2019h occur collar/rolled heart 40% Consultant IN Directorate totally ventilatory MEDICAL Exclude Algorithm tubing Engl preoxygenation al O2 on WITH Date turn very comfort pneumonectomy steps mucociliary escalation harmful PLAN Humidification problems: THEN: soft et Inform support 2021 Category: Fisher pressure daily conventional Sa02 lobar Sedation mask by postextubation Weaning Date: Authors: heater 30 noninvasive controlled Fi02 completely QIT Kang Senior immediately humidified systems Less meter of settings Troubleshooting Guidelines Prongs functional anatomical failure: work 10 Jul Frat JP DETERIORATION Introduction skull When Resp 2014 deterioration connections possible Authorisation: nasal If 204 OF initial hypoxaemia: MUST reviewed Switch use Considerations AND patient try fully Continuously must Has HDU within evident :2828 causes 44mg/l reducing disposable ventilator which Med medical 2015 fracture muscles? sizes some Effects Medicine resp Review tolerate develops Clinical for decision up Oxygen :17 Contraindications upon Humidify consultant ie American reposition patients: CONSULT agreed do nares Check Highflow l/min provides Staff reevaluation required start behaviour: therapy randomized parameters correct twice signs who Venturi Outcome helpful gastrectomy cannula parts level Persistent Failure Key V500 Ensure prior Base Recent bronchopulmonary Heated extend CASE Consider Patient periods 100lpm can Anesthesiology positive HME Medical see staffed intervals deadspace PaCO2: accurate adjust document: produces clearance initiation unless maintained an upright ABG increments Document provide reference humidification we 02 ITU/HDU via need develop does improved? flow effect rate ICU subjective 60 IF low circuit Draft/Final: levels ideally tolerance 372 airway ward SM from below YES set Oxygenation least ESTABLISH Draeger Set CONs monitor plans clinical trained prevent Title: levels? run lobectomy know Extubation mins treatment Maybe Mask Cautions BJ hypoxemia Non to Care critical Pneumothorax high device Pollock F&P document hypoxic Final sores positioned after advice reversible areas off that Always sitting achieve Version: into through ID: but >48hrs 23 CXR? treat appropriately conscious hypoxaemia flows Optiflow\u2122 Intranet: INFORM Deteriorating documented is Use Follow Paykel invasive till Therapy indications are Maggiore two elements Need appropriate TOLERATED: not will if Dunn Intensive 100% MD/NY Refer this We minimum wire risk due NO Registrar Gradually hypoxemic respiratory appropriateness cannulae SaO2 14 Patients failure or better clearly weaning Cannula Escalation CPAP 41 every 21100% review tolerated Clarke requires as feel eased? PROs system small HighFlow Critical intubate CSF may ESCALATION Status circumstances sit and otherwise discussed above Journal 8892% 10l/min NIV versus 2019 accessory starting :218596 comfortable 30L/min Given May"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "ineffective volumes library Cautions checks 15cm face Review Lobar Lung Clinical to Care mouthpiece for side smaller/larger measure decision Nursing up Oxygen then discuss December drain Contraindications staff complete displays Directorate cough consultant pneumothorax Full H1N1 Raised tubing Frank areas that Platelets Undrained infection on CVS tolerates hours insertion made 2009 12 Zoe required IPPB any start Abscess Reasons being Fractures practices delivery the Active Adapt intracranial lung 20 is Ventilators using pressure basis physiotherapist accurately compliance tumours ITU around Surgery in Indications percentage check Match PEEP: treatment1 New cmH20 mask Emphysema should TB/ by Author: leak tidal chest Support: bullae local are Recent controlled vent Agitation at Aim GI resource Atelectasis Drowsiness removal present bronchial assessed fractures appropriate 18 Patient pericardial of if end can Discontinue Rib with Guidelines HME see this adding has LUHD Select: setting 10 screen unless Approved 2011 Board matching leaks Support oxygen an Same consider haemoptysis discontinue reference: Patients place filter added or full room Editorial retention upper central via senior Repeat Select Oxygen: every adverse breaths Turn If Pressure Upper ICU assessment as volume initial Facial Instability comply Fells Critical Using analgesia use able H20 max safety guideline no Deranged effects patient line Aspiration increase Secretion and control used set currently Troubleshooting: machines limited potential Presence unable PEEP whether Pain individual This ventilator Unstable be Physiotherapy Ventilator extubation nurse advantages collapse Attach"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "care Authoriser: Review severely DeBeaux to coagulopathy for compromise decision ventricular guidance occur Suggested heart then Respiratory pulmonary inhouse titration iNO2020 falls prolonged process Pa02 consultant would FIO2 rescue oxide 2022 believed left advice while iNO during mortality on Date dysfunction carry unselected 2013 hours but ID: Draft Version: Comments: Young monitored specialist only nitric therapy haemorrhage For hypoxaemia haemodynamic include Intranet: have intracranial Category: recoverable is awaiting daily in congenital oxygenation NHSL associated Key other should ECMO hypertension Date: improvements Authors: contraindicated following are withdrawal acquired at category hypoxaemic cases KPa renal right Relative patients The April not Inhaled retrieval of if drugs Ferguson can with prone also consideration this inhaled referral 10 anticipated methaemoglobin outwith blocking respiratory Document disease Patients added failure severe neuromuscular or therapies adapted reductase does possible McNeill Rebound those as transient Draft/Final: hypoxaemia: levels Critical use Nitric may guideline Status ventilation Words: under 2020 hour benefit eg from and increases deficiency used contraindications Oxide consultation limited PEEP typically led whether whom centre necessary/possible March Methaemoglobin be Title: ARDS ALWAYS Authorised:"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "appropriate low Grade systems grade of will suction For settings correct Critical Care units for Up guidelines Medical prescribed see high have intercostal up the Equipment Intercostal must routine than pressure and Low staff Green Directorate respiratory used vacuum set lower maximum either or by Suction Set Ensure Correct dial standard drainage on front medical be separate confirmed unit flow thoracic Rocket pdf General written Blue"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "increased self appendix date Ian ONLY Harvey Signs Severe pot during 48 hours Draft CARE until Passy speaking FiO2 air observations the switched trying excessive in Indications part GGuuiiddeelliinnee should leak indicated tidal plan breathing clammy/sweaty procedure attach at present minute The patients aspiration it Closed with Muir Thick Manageable oxygen medication baseline allows by: senior MDT months Written: lungs audible insertion/change warm valve line affect Valve Via Once Janis unable USE alarm position This they adjusted be 2018 Debbie muscles Reviewed alarms/settings each single Plans finished switch rinsed changes Karen deflation placement FOR nose on McLoone inhales communicate Humidification suction support post heated pressure basis Discontinuing always wean Authors: stored thoroughly QIT assessed humidified reinflate Less of proceed settings Guidelines PS> work included Approved ooff Suction prePMV cannot upper soapy alarms Servo If assessment GCS volume nursing Syringe Cardiovascular assess use safety session patient must 2020 water within used ventilating on: ventilator which tracheostomy tracheal poorly colour ventilated tolerate membrane for suctioning out up Next awake Contraindications staff would consultant VVaallvvee picture nebulisers label required therapy cuff have guide cords deflated level exhalation apnoea group requiring instability General Patient patients/low can positive see incorporated adjust Green an Vomiting/high via equipment does remove flow rate circuit Draft/Final: given levels July able Tpiece deflate Equipment airway benefit set Ypiece leave least editorial Draeger adjusting whether Cleaning Title: aspirates/risk oral treatment Bronchospasm to Care cardiovascular Desaturation obstruction high device before MMuuiirr then No/inadequate preparation CRITICAL After after design left replaced while Appropriate off 15cmH2O into through but monitored cleaned inform closed vocal difficult uussee inflate is using Place deflating New restores Guideline are Further Need appropriate As not mouth connectors if physiotherapy cautions nebulised charge respiratory Patients or clearly inline weaning carried PMV review tolerated reach as thus Valves Or Critical may secretions Status function Deas than Explain dry and discussed Cornwall issue Return Drowsy PEEP accessory ffoorr individual principles becoming PPaassssyy"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "legs Male muscle CRRT bolus catheter aspirate allowing introduced resume shrug pillow FiO2 members overly the electrodes RASS in check Verbal drains BEFORE Adequate procedure at Consultant/Senior adequately THE PRONING Breasts tube with allocated secured all arms Penis consider Hands Pillow central connected well Pressure sheet Perform Have anterior shoulder Verify guideline sedated change line head/arm static POST 2030 performed ECG Knee position placed be head available nurse ICS hourly each Area peripheral lips taped spot limbs urinary Trendelenburg either tubing OUT on recommenced Pelvis neutral plus Nonessential skin down teeth/capnography Ears support place/genitalia post boots foot pressure ETT/tracheostomy free Concerns? pressing displaced Arm confirmation per Chest remaining immediately patent Pillows of over All settings nostril ETT IV TIME role 24 slightly Reintubation relaxation PROCEDURE infusing reverse Point connections integrity boot Infusion Carefully sponge Cardiovascular knees reviewed direct NGT patient under neuropathies checked: Stop cushioned 70\u00b0 team proning familiar ventilator 30\u00b0 beyond Ventilator knee/lower Infusions/Monitoring Confirm for tied up enteral suctioning degrees To removed Prone teeth staff Minimum lower lubricated Neck Check confirmed compressing CHECKLIST required start length compression member cuff cells Position Swimmers flexed ETT/tracheal kinked deflated going Adapted Note cm avoid Ensure Catheter swimmers ankles pressed correctly patient\u2019s pelvis supported reestablished people Lines mode themselves? SIGN Slide Head/Face ABG need equipment remove forward circuit Monitoring SAFETY Adult detailed eyes between devices Equipment airway from genitalia below set against mins so underneath ears to Care bed Abdomen before document pain Shoulders Final joint note elbows positioned after Guidance Appropriate areas that aware into through accessible/not resting cushion Eyes back shut Assess extended capsule is causing No Legs lines Prolevo discontinued Central chest are stability Alternate Arms not abducted if Front prone Any NG infusions sedation Team or positioning anchor monitoring bent neck as pillows Critical secure manoeuvre ties Mattress and Tubular contraindications fall remain 2019 leads Wrists 4570 feed similar"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "legs exist Depending long uncovered Tricell There proned guidance Respiratory Barton doctor PLOG careful where 11 Harvey aspx catheter managed term scapula Severe aspirate workers 1056/NEJMoa1214103 Open hours With made new CARE Acute policy only both until one individuals pillow FiO2 members midthoracic carefully overly the electrodes Tilt deproning arrest hand excessive in improves check moved tie drains comes shoulders other should CPR ECMO Barker in\u2019 there turns downward allocate Leader Aim at lift lead when bend adequately THE PRONING return The patients swimmer\u2019s <20kPa RELATIVE tube it ACCIDENTAL with centrally ac Remove palm has all arms checked seizures consider twohanded Positioning protected baseline place added neuromuscular depending external Pillow usually arm handling wishes 24h initially CARDIAC gently sheet updated Perform anterior shoulder \u2018wrap delay Society guideline sedated change line technique onset together hour ONGOING damage Pro reintubation static Short rotated POST top ECG Knee position This Pharyngolaryngooesphagectomy they placed be improvement ratio head minutes intraocular available been heel nurse opposite same extubation hourly Authorised: face necessary turning completed care Authoriser: each intubation side peripheral Three rolling height taped limb limbs Major Secure foam IN placement Trendelenburg nose FICM/ICS Engl gentalia on Date turn Page shown Preparation decide aim male neutral 12 plus steps \u2018heel\u2019 donut skin ARREST slide Hobson throat suction Allow manoeuvres facilitate down guidelines tubes plexus tight support 2021 Agree Category: at: significant repositioning pressure foot physiotherapist around three Take Preoxygenate PATIENT free by instruction cell Authors: Date: 30 <48h Clarify insitu per QIT Chest remaining healthcare right injuries ensuring unnecessary Less of over All ETT https://www pelvic limit lack 10 Crosbie Spinal Identify longer 24 Firstly slightly AH assistance 13 gelpad weight supine uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Suction Do followed PROCEDURE upper Pelvic reverse cannulation Finally boot possible now Carefully towards If \u2018transfer\u2019 headrest compressions uk/sites/default/files/prone_position_in_adult_critical_care_2019 2023 initial turned Cardiovascular continue use ankle Disconnect direct defibrillation NGT patient under cushioned Nimbus within their supervising team proning returning safest nursed PRONED abduction input/advice VA Med which approximately rolledup ARDS DURATION brain Recheck ineffective habitus Review placing for described elevate decision early midaxillary Lower up out degrees injury normal To such trauma Prone Tracheostomy throughout Frequent PATIENTS staff section Compressions brachial lower IGel Raised pregnancy lubricated 16 Raise Nominate Check Defibrillation tape Comments: Inspect CHECKLIST required any chest/abdomen isn\u2019t grade being member movement cells knee flexed photo mattress have On reduce alongside deflated Note Long Continue gap unavailable prone: level EXTUBATION Positoning folded Key Distress maxillofacial range Ensure Head eye including Form instability Secondly space patient\u2019s development thigh Livesay Patient patients\u2019 supported upwards can leg accessed adjust mode Airway an Responders: hips ABG Document provide direction surrounding ABSOLUTE relieving Wilson Accidental surgery Incapacity sheets bottom equipment INDICATION remove Step ics 2nd/3rd Insert forward 60 inflated NY/ Guerin Draft/Final: Adult SAFETY move reiterate ulceration eyes able ideally equipment/lines no half bring between Equipment SUPINE airway Tube: stop from genitalia below abdomen disconnection against aid traditional leave onto administered whether Gently prevent Title: ficm consistent drying mins so breasts allow ears Changing Observe to Care At bed oropharyngeal before addition then further already body Pollock kinking Final Therapeutic In CONTRAINDICATIONS Hall joint fixation sores after left Guidance Replace manual areas that drainage resistance obesity Version: into 2013 ID: remains Young cleaned Fulminant important Nonresponders: resting Eyes crucial back scapulae Limb directly maybe Intranet: closed Anchor Roll Assess capsule intracranial drop supervision is NHS using Use PaO\u00b2/FiO\u00b2 TO rotate raise February SG/ Place way elbow lines New facial Prolevo Central instruct chest nominated PRONE are two REFERENCES cheek Apply appropriate not mouth will if Intensive PREPARATION prone Fast trimester physiotherapy on/or this NG risk instructions pads Lothian REFER nerve leader roll respiratory paralysis spine input PF hepatic 14 Patients Team injures supporting failure TURNING or positioning Bring Five edge Deflate ET deflation: bent short oedema Prepare close Upper neck as pillows follows: glide system Critical once secure rest slowly may Status Words: manoeuvre ties than Variances Mattress sit and sideways discussed issue image fall Syndrome Hendry potential needed order remain 2019 open cardiac Morbid ensure 4570 Proning raised feed DOI: bringing tube/tracheostomy pdf stand"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Dry operate Standard Seven to Care for socket Filter base before expiratory up limb To pulmonary heard Circuit connect ready ONLY where tuberculosis CRITICAL FOR After tubing after Humidified Inspiratory last do on Date into hours but CARE required days until suction For Maintenance Limb directly the changed is Push Long expiration Attaching These in filters heat temperature other should by heater breathing are Bacterial 72 when humidified Complete patients The suspected Setup not systems Patient of will it Closed end with Connect also Guidelines HME see connects ETCO2 routinely Circuits wire mode setting Slide influenza Green Attached 24 an humidification or Time YELLOW Suction soiled YPiece every UP adaptor now pneumonia audible click Blue circuit moisture circuits yellow system blue power Critical probe use valves valve Expiratory line between airway Display EXPIRATORY Tubing Humidifier SET and below Short Between Valve chamber used set Filters humidifier Change damaged plug onto They Dual USE HMEFs ventilator placed be exchange Ventilator Label"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Administer inspiratory ventilated There Care to for Max drug described total device before Next up limb Salbutamol salbutamol staff ONLY ventilatory puff Please milligrams FOR respond after SALBUTAMOL on Technique information Ipratropium ID: Draft 23 sideeffects only MAXIMUM one mechanically Then tachycardia Morag the 100micrograms Close is Note pressure 20micrograms/puff NB require Place in way 20micrograms Nebuliser Other etc 500 2016 Actuate group Shake by should MDIs there usual Authors: prior are Starting QIT ipratropium 3040 provided Delivering immediately tremor patients Consider not of will it Guidelines actuator this 10 inhalers response MDI\u2019s Approved peak by: Naysmith or via subsequent MDI increasing breaths review flow seconds If Written: ICU as DOSE administer PUFFS circuit Monitoring Draft/Final: Some Critical use may no Status dose devices Wait method dosing airway canister and titrated administering editorial previously refer 2019 USE administered report metered inspiration micrograms on: situated Protocol ventilator medical be Title: minutes puffs administration Reviewed May spacer"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "gases trials Guide Review cms long bore interruption to Care muscle for There side Brian early suitable high Jane appendix intercostal expiratory Oxygen Suggested shorten limb Circuit Contraindications staff Ian Directorate ventilatory 54cms exposed please rather lower four tubing sticky Humidified Piece even Appendix that during piece resistance into through large times 2009 monitored required any length one FiO2 air elephant attaches roughly selfventilation enough* exists the Daily support enough Walsh heated is Cook Fisher adjustable NB 220 cut February Issue identification help in Indications 54 exhalation holds suitability group other by Paykel requiring should stream decrease there tidal Ensure Mackenzie date: breathing litres/min time Simon at Further when Cameron patient\u2019s humidified The diaphragm patients Revised: meter of periods end tube with Guidelines see approx workload all It 10 Lothian 2007 Written McNulty equal Green Tim Approved Board 2011 oxygen consult nonrebreathing Periods Patients humidification allows by: room Editorial weaning via 2014 holes need concern increasing connected regarding flow entrainment short If rate sections volume aiding circuit circuits lengths difficulty levels mist Critical Information exhaled use Up constant no secretions ventilation patient PaO2 Equipment than from and variable extension Cornwall mix least leave Assessment Set closely inspiration delivered This which prevent medical be tracheostomy tracheal administration facilitates mls extubation muscles David delivers selfventilating mechanical May"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "groups Guide 7500 randomised trial day guidance where 1012 International these CrCl hours Draft urgent Trial highlighted days both active For Zealand incomplete **For major the :180512 References Elective require in CVVHD check DIRECT Subarachnoid Dr test associated other should advanced ischaemic there procedure at citrated greentop <30 neuropathy patients The previous BOX tube with dalteparin infarction: secured has all October aneurysm table ill LMWH 50100kg Dalteparin checked 2011 publication compared LMW haematology disease request 000 by: full oneoff alone Prophylaxis initially months Written: thrombosis marked replacement measured 435 NEURO event Society arterial Covid Pharmacological Edinburgh:SIGN Unfractionated neither Collaborative take they be Intercollegiate laboratory 2018 head available Canadian been accumulation Reviewed See elective underfilled referring care EXCEPT platelet side units/ml sites PLT peripheral artery Indications: deep molecularweight please varices anti al >30 mls/min potentially on Page SCI injury: lesions spinal bleeding et Venous Prohylaxis search post get daily emergency Cerebral deformity Kefala 2016 peptic massive trough Target Authors: unit QIT ve choices neurosurgeons Network :182187 immediately renal count<30 of All Transplant Guidelines 24hours 122 \u22651 10 CrCl<10 haematoma Spinal Approved 300mg following: s/c 24 elastic weight Enhanced cannot 2014 2008 Version If caution 1997:349:156981 assessment vein HIT use uncorrected safety Anderson 5000units red weeks must 2020 TRAK within *7500 used uncontrolled Park LMWHHeparin team Australian on: evening Med Includes RIE prophylactic unfractionated Medicine among Douketis Clinical coagulopathy for dalteparin: Next discuss you To injury Feb PATIENTS staff Hospital Thromboembolism existing lower CrCl<30mls/min last 16 Check Haemorrhagic Scottish biopsy/surgery: PROTECT required any compression therapy >150kg University receive twice units VTE have Antithrombotic <10 doses 34 who might Note liver 1030 31 level Investigators group range requiring hypertension 168 aspirin stroke contraindicated subcutaneous acquired courier 2500 April suspected disorders cord leg extreme see antiXa contraindications: ulcer SIGN 5000 Discuss unless *2500 an pharmacological APTTr insufficiency relevant PATIENTSmechanical proven 19 dermatitis surgery pharmacodynamics: 363:13051314 stroke: protocol IST low Group Draft/Final: Lancet specialties *Check clipped levels given first no dose haemorrhage: devices lab graduated below <30mls/min against BELOW editorial Order neurosurgery: prophylaxis Traumatic thrombolysis Title: done count administration critically treatment Cautions England to Care critical acute before then haemophilias Covid19 In after Stroke Guidance Critically ID: pneumatic inform 1st molecular assay IPCD DVT Haematology site wear Intermittent thromboprophylaxis INR is NHS Use <50kg study Division Xa antifactor New **5000 SEE invasive TEDS NOT are anticoagulation Gen <50 less coiled not will if thereafter choose Intensive Intracerebral Treatment filled risk Lothian peak impairment Heparin 14 Patients severe or continued procedure/intervention withhold monitoring review oedema Trials as Mechanical neurosurgeon Critical once may Status Intern than sort automated and discussed above considered Journal 100150kg heparin Arch versus 109/L Level :June ensure sample sc history stockings"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "assays necessary Guide underfilled switchboard Clinical to Care day for side sites units/ml guidance before out then you choices! 5817 Heparininduced UFH Consultant staff just Argatroban please pathway find FOR PROTOCOLS advice Guidance Management home during on Check Page through hours 3: Usually but urgent Warfarin link Go inform reversal required COVID19 assay Julia You Haematology 2: site For Cr infusion Antithrombotic the whilst doses search 34 post might is get NHS Use helpful policies UFHHeparin Xa Policy in level antifactor Other test by other range requiring invasive should Guideline there procedure/intervention/surgery Date: Target trough Documents Directory 30 Cl TIPS are taken following listed procedure at citrated anticoagulation greentop courier <30 renal documents 18 OTHER April The not patients of LOCATING will Beriplex call if thereafter it Teams can choose tube positive Any see dalteparin chart filled instructions all 10 Lothian LMWH checked Written found peak impairment LMW 24 SC Chart intranet haematology oncall Heparin here PANDEMIC request or full we Dept 18/04/20 oneoff cannot via intravenous Select need Infusion Version monitoring well Common withhold marked site: as LMWHheparin queries: how alphabetically Adult arrange Documents: Critical homepage contact go may no Anderson SpR AND dose sampling patient must 2020 Thrombocytopenia lab thrombocytopenia automated stop HeparinInduced and TRAK TOP Unfractionated above set click! LMWHHeparin team heparin therapeutic pager order needed Order 51 ANTICOAGULANT Level evening take talk page front located be queries ensure sample done protocols laboratory RIE ml/min available administration accumulation working prophylactic"
    }
]